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Abstract 
Development of Genetically Targeted Voltage Sensitive Dyes 
 
 
By 
 
Pei Liu 
 
Doctor of Philosophy in Chemistry 
University of California, Berkeley 
Professor Evan W. Miller, Chair 
 
Comprehensively mapping and recording the electrical inputs and outputs of 
multiple neurons simultaneously with cellular spatial resolution and millisecond time 
resolution remains an outstanding challenge in the field of neurobiology. Development of 
fluorescence indicators for direct visualization of membrane potential changes offers a 
powerful method for probing voltage dynamics in neurons with unprecedented spatial 
and temporal resolution. Despite the promise of voltage imaging, key challenges of 
speed, sensitivity, brightness, and localization remain. The Miller lab has developed a 
new class of small molecules dyes, VoltageFluors (VF), that rely on photoinduced 
electron transfer (PeT) and display voltage-sensitive fluorescence due to modulation of 
the rate of PeT within the VF scaffold by the transmembrane electric field. This approach 
allows for fast, sensitive and non-invasive recording of neuronal activity in cultured 
mammalian neurons and in ex vivo tissue slices in single trials. One major limitation of 
small-molecule dye imaging is the inability to target the dye to specific cells of interest, 
which significantly erodes signal to noise and cellular resolution. To solve this problem, 
we have worked to combine VF dyes with a genetically encoded component to enable 
high-contrast imaging in defined neurons. We first attempted a fluorogenic approach, in 
which the parent VF dye is chemically modified to be minimally fluorescent and non-
voltage-sensitive and must be enzymatically activated prior to imaging. We designed a 
couple of dyes which can only be activated by a cell-surface pig liver esterase (PLE) and 
observed enhanced contrast in both HEK cells and cultured neurons with good 
sensitivity. We have also shown that our genetically targeted voltage dyes outperform 
purely genetically encoded voltage indicators. In addition, we are exploring other 
enzyme/substrate pair for fluorogenic activation purpose. The second approach is 
covalent labeling of voltage sensitive dye to cells of interest using a cell-surface HaloTag 
enzyme. We have successfully demonstrated selective membrane staining in mouse brain 
slices and live animal using this strategy. Current efforts focus on applying this method 
for targeted voltage imaging in live animals to probe specific neuroscience questions.  
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Membrane potential (Vm) arises from an unequal distribution of multiple ions 
across the lipid bilayer. Movement of these ions, depending on ion species and types of 
channels or transporters, establishes changes in the electrochemical gradient that play a 
critical role in multitude of biological pathways and physiological processes. In non-
excitable cells, changes in membrane potential have been noted to impact cell division, 
proliferation and migration and are especially implicated in cancer cell biology.1-3 
Meanwhile, excitable cells such as neurons employ rapid changes in Vm or depolarization 
and hyperpolarization to transmit signals, creating intriguing communication networks in 
complex biological settings. Relentless efforts have been dedicated to understand the 
voltage dynamics in neuronal activity and connectivity to elucidate how the brain 
functions, a longstanding challenge in the field of neurobiology.  
The traditional method or gold standard to quantify Vm is patch-clamp 
electrophysiology in which a glass electrode makes contact with a chosen cell for direct 
measurement. Despite the high temporal resolution, this technique is destructive and 
suffers from low throughput and poor spatial resolution. Fluorescence-based optical 
sensors have emerged as attractive tools to visualize voltage changes in a non-invasive 
and high throughput manner.4-6 Advances in microscopy permit tracking fluorescence 
fluctuations in hundreds of cells simultaneously with desirable temporal and spatial 
resolution, which is particularly meaningful to dissect convoluted neural signaling 
pathways.  
Genetically encoded voltage indicators (GEVIs) are purely protein-based sensors 
that can be divided into three classes (Figure 1-1). The first and earliest class of GEVIs 
relies on coupling a fluorescent protein with the voltage sensitive domains from ion 
channels or voltage-sensitive phosphatases (VSP) (Figure 1-1a). Representative tools that 
have been shown to work in vivo include ArcLight which combines a single FP with 
voltage-sensitive domain from Ciona intestinalis VSP (CiVSD)7-8 as well as ASAP that 
uses CiVSD and circularly permutated GFP9-11. The second class involves the 
engineering of microbial rhodopsins to exhibit fluorescence fluctuations upon membrane 
potential changes (Figure 1-1b). One of the first designed sensors in this class is Arch12-14 
and shortly after, QuasAr (Quality superior to Arch)15-16 were developed with enhanced 
properties. To overcome the low brightness of opsin-based sensors, a third class of 
GEVIs combing opsin with a bright fluorescent protein becomes prominent (Figure 1-1c). 
The FRET efficiency between the opsin and FP depends on the electric field change 
across the membrane. Examples in this class include a mNeon-based reporter Ace2N-
mNeon17 and a mRuby3-based reporter VARNAM18, which both report neuronal activity 
with much improved signal. In the past decades, researchers have endeavored to improve 
the brightness, sensitivity, kinetics and membrane trafficking of GEVIs, but none is 
perfect or convenient enough for widespread in vivo applications in neuroscience.  
Organic molecules have long been synthesized for fluorescence detection of 
bioactive analytes and the synthesis of small molecule voltage sensitive dyes (VSD) 
precedes the development of GEVIs.4-5 Traditional VSDs fall into two categories: fast, 
electrochromic dyes to report neuronal action potentials but with low sensitivity19-20, and 
slow dyes such as oxonols21-22 and merocyanine 54023-24 that shows large fractional 
change but perturbs membrane capacitance and do not suffice to measure fast spiking 
events (Figure 1-2). The Miller lab has designed a novel small molecule scaffold for 
monitoring voltage changes with high speed, sensitivity and brightness. This new class of 
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sensors, VoltageFluors or VF dyes, consist of a fluorescence dye fused with a lipophilic 
and electron-rich molecular wire that allows VF dyes to localize to plasma membrane for 
voltage sensing (Figure 1-3a).25-26 Modulated by the transmembrane electric field, the 
rate of photo-induced electron transfer (PeT) from the electron-rich donor moiety affects 
the extent of fluorescence quenching on the dye head (Figure 1-3b). Depolarization slows 
down the PeT process and attenuates the quenching effect, thus fluorescence increase is 
expected. The mechanism of VF dyes to detect voltage changes relies on movement of 
electrons occurring on a nanosecond scale, which is fast enough to record millisecond-
scale action potentials. In addition to the superior speed, the chemical structures can be 
readily modified to achieve variations in the color, sensitivity, photo-stability and other 
photo-physical properties to create a wide range of sensors for different applications.27-31  
The first generation dye VF2.1.Cl is built upon a dichlorofluorescein sensor with 
a 27% ΔF/F per 100 mV change and its voltage sensing ability is demonstrated in 
cultured neurons and in ex vivo leech preparations.25 We have later synthesized a far-red, 
silicon-rhodamine based sensor BeRST 128 and a tetramethyalrhodamine-based sensor 
RhoVR 127, which both record spontaneous spiking events in cultured hippocampal 
neurons with favorable sensitivity and signal-to-noise ratio. Furthermore, due to the 
spectral separation, both can be used simultaneously with GFP-based tools such as 
GCaMP6 to assess calcium and voltage fluctuations at the same time. Besides expanding 
the palette, we have also modified the position27,32 or composition29 of the molecular wire 
that significantly enhances sensitivity or reduces photo-toxicity of VF dyes to investigate 
various biological questions. 
As chemically synthesized sensors lack the specificity provided by GEVIs, 
increasing attention has been attracted to combine synthetic sensors with a genetic 
component, a hybrid approach marrying the speed, brightness and sensitivity of VSDs 
with genetic targeting. The Fromherz lab describes the design and synthesis of an 
electrochromic VSD with long alkyl chains containing terminal phosphate groups.33-35 
The hydrophilic precursor dye requires a cell-surface alkaline phosphatase to remove the 
anionic groups before localizing to the lipid bilayer of plasma membrane. Selective 
staining is demonstrated in HEK cells without any functional data. Hybrid voltage sensor 
(hVOS) indicators designed by the Bezanilla lab and others is a FRET pair consisting of a 
membrane-anchored GFP and voltage-sensitive dipicrylamine (DPA).36-38 Movement of 
DPA in the membrane ensuing Vm changes affects the FRET efficiency between DPA 
and GFP. While action potential can be recorded in cultured neurons and tissue slices, 
one major concern is the increased membrane capacitance due to DPA addition. A similar 
strategy, FlareFRET, that utilizes FRET between a rhodopsin domain Ace2N and 
fluorophore is developed by the Zou lab, in which a lipoic acid ligase fused to Ace2N 
labels a cell-impermeant fluorophore via copper-catalyzed click reaction.39 While great 
membrane-bound fluorescence and voltage sensitivity were seen in HEK cells, toxicity in 
cultured neurons due to copper addition inhibits application in monitoring action 
potentials and neuronal activity. Another chemigenetic approach, Voltron, proposed by 
the Schreiter lab, is composed of Ace2N and a self-labeling enzyme HaloTag.40 
Membrane potential-dependent FRET occurs between Ace2N and a Janelia Fluor (JF) 
dye bound to HaloTag, providing a turn-off probe of 23% ΔF/F per 100 mV. The 
advantageous brightness and photo-stability of the JF dye allow for high-resolution 
voltage imaging in live animals. The Sames lab recently assembled a complex containing 
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VSD, dextran and a ligand targeting dopamine transporter (hDAT), a system named as 
VoLDeMo or Voltage Sensor-Ligand-Dextran Targeted to Monoaminergic Neurons 
(ChemRxiv preprint). Dextran improves the solubility of lipophilic VSDs while the 
ligand enables binding to endogenous receptors for staining a specific class of neurons 
and can be modulated. Selective staining and voltage sensitivity have been shown in 
hDAT-HEK cells but staining targeting endogenous receptors in tissue slice was 
inconclusive and not supported with functional characterization. Furthermore, the 
potential effect of binding native receptors on cellular physiology is not discussed.  
In more recent years, efforts in the Miller lab have also been invested to 
incorporate the targeting feature to VF dyes so that they can be effectively employed in 
more complex tissues. When applied to a biological sample, VF dyes indiscriminately 
label all the membranes, which not only lacks cellular and subcellular resolution but also 
raises background signal that compromises sensitivity in imaging. Two approaches have 
been designed and tested, including fluorogenic activation and covalent labeling, to 
accomplish genetic targeting of VF dyes to selected cells (Figure 1-4). The central idea of 
fluorogenic activation is the use of a protecting group to quench the fluorescence of the 
parent dye until light- or enzyme-mediate removal to restore fluorescence and voltage 
sensitivity. Ideally, the protecting group cannot be too big or hydrophobic; otherwise, the 
caged dye might cross the plasma membrane, thus reducing the membrane-associated 
signal while raising the background cytosolic noise. On the other hand, in the covalent 
labeling scheme, a small ligand is synthetically fused to the dye of interest. A self-
labeling enzyme expressed on the cell surface can react with the ligand such that the VF 
dye can more efficiently localize to the plasma membrane due to proximity. This process 
directly competes with the spontaneous insertion of the bright VF dye into the membrane; 
thus, enzymes with fast and selective reaction kinetics are needed. Also, a low 
concentration of dye is usually required to minimize background signal.  
For fluorogenic activation, our lab first attempted light-controlled uncaging of a 
dim and inactivated dye.  Using the first generation dye VF2.1.Cl as a proof of principle, 
we first chose dimethoxy-o-nitrobenzyle (DMNB) as a photo-labile protecting group, to 
yield SPOT or small-molecule photoactivatable optical sensors of transmembrane 
potential.41 Immediate fluorescence turn-on was observed with 390 nm illumination in 
selected cells while other untargeted cells remained minimally fluorescent. When 
uncaged at neuronal processes distant from the soma, the dye successfully diffused back 
to cell body, allowing for connectivity tracing in a complex neuronal network. The need 
of UV light precludes SPOT’s application in deeper tissue due to problems with 
scattering and penetration. Other photo-cages responsive to longer wavelengths are 
available and can be adapted to VF dyes for in vivo imaging.  
Instead of light, enzyme-mediated unmasking is favored since many fluorogenic 
probes that can be activated by enzymes ranging from hydrolases, transferases to 
oxidoreductases have been designed and applied in biological imaging. 42-44 Enzyme 
expression is easily manipulated by protein engineering to enable specificity in cell-types 
or subcellular localization, thus controlling fluorescence turn-on in targeted areas of 
interest. The Lavis group has previously reported a selective esterase-ester pair for 
targeted small molecule delivery in cultured cells and tissue preparations.45 Inspired by 
the remarkable selectivity and rapid reaction kinetics in their system, we appended a 
cyclopropylmethyl acetoxymethyl ester to reduce the fluorescence of VF2.1.Cl and 
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engineered a pig liver esterase (PLE) for cell-surface expression that specifically cleaves 
off the ester to reveal the parent dye.46 The VF-EX dyes (VoltageFluors targeted by 
esterase expression) exhibit staining of appreciable contrast in both HEK cells and 
cultured neurons while maintaining good sensitivity. In particular, VF-EX2 outperforms 
GEVIs including ASAP1 and Ace2N-mNeon by displaying greatly enhanced signal to 
noise. More importantly, this strategy can be extended to other VF dyes. A red-shifted 
and more sensitive dye, carboVF, is similarly alkylated at the phenolic oxygen to 
diminish fluorescence, followed by PLE-directed turn-on in targeted cells.47  
One caveat of this PLE/ester method is the bulky and hydrophobic cyclopropyl 
ester, which inevitably decreases water solubility of the decorated dye and limits its 
effective concentration and thus fluorescence signal on cells. We noticed this problem 
while working with the doubly protected carboVF, which showed no detectable cellular 
staining despite the usage of solubilizing detergent. To circumvent the issue, we have 
initiated projects to examine other enzyme/substrate pairs; one of which is to use 
galactosidase to unmask galactose as a quenching group while the hydrophilic hydroxyl 
groups increase solubility in aqueous buffer. Another limitation of fluorogenic activation 
is the background fluorescence in non-expressing cells, which primarily comes from the 
incomplete quenching of parent dye. Thus, the low contrast between transfected and non-
transfected cells in this strategy did not generate fruitful results in preliminary 
experiments with tissue slices.  
In the covalent tethering approach, our lab has utilized several self-labeling 
enzymes including SpyCatcher, SNAP-tag and HaloTag, all of which can successfully 
label VF dyes to specific cells of interest. Specifically, the small bacterial enzyme 
SpyCatcher is expressed on cell surface to capture the SpyTag ligand attached to 
VF2.1.Cl. At a low nanomolar concentration, more than 30 fold contrast ratio was 
observed in cells expressing SpyCatcher compared to non-expressing cells.32 Another 
exciting feature of SpyCatcher-mediated labeling strategy is that subcellular structures 
can be clearly distinguished from the surrounding, an accomplishment not achieved by 
VF-EX dyes due to low contrast. Evoked action potentials were detected in single trials 
in dendritic spines, highlighting the potential to analyze electrical signals in very defined 
positions. Projects focused on SNAP-tag and HaloTag are undergoing in the lab, which 
have demonstrated promising high-contrast staining in vivo, a further breakthrough of 
genetic targeting of VF dyes.  
 This thesis mainly describes work on PLE-mediated fluorogenic activation using 
VF2.1.Cl and carboVF as well as attempts and progress on covalent labeling using the 
HaloTag system. In Chapter 2, the design, synthesis and application of VF-EX is 
described. In Chapter 3, efforts on generalizing the PLE/ester activation strategy to 
carboVF and isoVF2.2.Cl(OMe) are discussed. In addition, targeting PLE to other neuron 
types or subcellular locations is reviewed. In chapter 4, the development of HaloTag 
enzyme for covalent tethering and the translation of this selective staining to ex vivo 
slices and in vivo animal are described. In chapter 5, the success of adapting BeRST 1 
and VF2.1.Cl for HaloTag labeling as well as the design of a soma-targeted HaloTag to 
confine dye staining to cell body for enhanced contrast in tissue slice is demonstrated. 
Fluorogenic activation using other enzyme/substrate pair is presented in Appendix 1 and 
2. Appendix 3 focuses on initial efforts to design and use HaloTag virus to increase 
enzyme expression and dye labeling.  
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Figures & Schemes 
 
Figure 1-1. Schemes of genetically encoded voltage indicators (GEVIs). 
 
 
 
Figure 1-1. Scheme of protein-based voltage sensors. (a) Fusion protein of voltage 
sensitive domain to a fluorescent protein. (b) Microbial rhodopsin-based sensor. (c) 
Fusion protein of opsin to a fluorescent protein.  
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Figure 1-2. Structures of representative small molecule voltage sensitive dyes.  
 
 
 
Figure 1-2. Traditional VSDs to track voltage changes include slow but sensitive dyes 
such as (a) merocyanine 540 and (b) oxonol VI or fast, electrochromic dyes such as  (c) 
Di-8-ANEPPS.  
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Figure 1-3. VoltageFluors represent a new class of voltage sensitive dyes for monitoring 
membrane potential changes.  
 
 
 
Figure 1-3. VoltageFluors dyes function through a photo-induced electron transfer 
mechanism. (a) Structure of the first-generation VF dye VF2.1.Cl. (b) PeT-based 
mechanism of voltage sensing in VF dyes.  
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Figure 1-4. Scheme of genetic targeting of VoltageFluor dyes. 
 
 
Figure 1-4. Strategies of genetic targeting of VF dyes to cell of interest. (a) Fluorogenic 
activation by a cell-surface enzyme to remove the masking group and release the active 
VF dye. (b) Covalent attachment of VF dyes by a self-labeling enzyme that reacts with a 
ligand synthetically linked to the dye.  
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Abstract 
We present a method to target voltage-sensitive fluorescent dyes to specified cells 
using an enzyme-catalyzed fluorogenic reaction on cell surfaces. The dye/enzyme 
hybrids are composed of a photoinduced electron transfer (PeT)-based fluorescent 
voltage indicator and complementary enzyme expressed on the cell surface. Action of the 
exogenous enzyme on the dye results in fluorogenic activation of the dye, enabling fast 
voltage imaging in defined neurons, with sensitivity surpassing purely genetically-
encoded approaches. We employ a bulky cyclopropylmethyl acetoxymethyl ester to 
diminish the fluorescence of a PeT-based voltage-sensitive dye, or VoltageFluor. The 
hydrolytically stable ester can be removed by the action of porcine liver esterase (PLE) to 
reveal the bright, unmodified VoltageFluor. We established that the chemically modified 
VoltageFluor is a substrate for PLE in vitro and in live cells. When PLE is targeted to the 
external face of cell membranes, it controls the apparent staining of cells. Use of neuron-
specific promoters can direct staining to mammalian neurons to provide clear detection of 
neuronal action potentials in single trials. All of the new VoltageFluors targeted by 
esterase expression report single spikes in cultured mammalian neurons. The best, VF-
EX2, does so with a signal-to-noise ratio (SNR) nearly double that of comparable 
genetically-encoded voltage reporters. By targeting PLE to neurons, VF-EX2 can 
interrogate the neuromodulatory effects of serotonin in cultured hippocampal neurons. 
Together, we show that a combination of synthetic chemistry and biochemistry enables 
bright and fast voltage imaging from genetically-defined neurons in culture. 
 
Introduction 
 Direct visualization of changes in membrane potential using fluorescent indicators 
offers a powerful method for probing voltage dynamics in neurons with unprecedented 
spatial and temporal resolution.1 Despite the promise of voltage imaging, key challenges 
of speed, sensitivity, brightness and localization remain. Purely genetically-encoded 
approaches based on fluorescent proteins or opsins afford the opportunity to target 
neuronal cell types of interest in complex brain contexts, providing exquisite fluorescence 
contrast between the cell of interest and its surroundings.2-6 However, brightness, speed, 
or sensitivity often limit the wide-spread application of these powerful new genetically-
encoded methods. To address these limitations, we have been developing fluorescent 
voltage indicators that rely on photoinduced electron transfer (PeT) as a membrane 
potential dependent trigger to control the emission of a fluorescent dye.7 PeT-based dyes, 
or VoltageFluors (VF dyes), display voltage sensitive fluorescence, owing to modulation 
of the rate of PeT within the VF scaffold by the transmembrane electric field.8 VF dyes 
therefore possess the requisite speed and sensitivity to report on action potentials in 
neurons in single trials. Although VF dyes localize to the outer leaflet of cell membranes 
to sense voltage,9-10 one current limitation of chemically-synthesized dyes is their 
inability to discriminate between membranes of different cells. This precludes cell-
specific targeting, which significantly erodes signal to noise and cellular resolution 
compared to genetically encoded approaches.9-10 To marry the speed, sensitivity, and 
brightness of synthetic VF dyes with the cell-type specificity enabled by genetically 
encoded approaches, we combine VF dyes with a genetically encoded component to 
enable high-contrast imaging in defined neurons. We achieve this with a fluorogenic 
approach, in which the parent VF dye is chemically modified to be minimally fluorescent 
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and must be enzymatically activated prior to imaging. The dim VF dye localizes to all 
cellular membranes where it remains weakly fluorescent until enzymatic cleavage of the 
chemical modification by an exogenously expressed enzyme (Scheme 2-1). This results 
in bright, localized fluorescence only in the cells which express the cognate enzyme. 
Based on our previous photoactivation studies,11 we hypothesized that a hydrolytically 
stable, bulky acetoxymethyl ester12 appended to the phenolic oxygen of 
VoltageFluor2.1.Cl (VF2.1.Cl)10 would diminish VF fluorescence. Previous studies 
showed that intracellular porcine liver esterase (PLE) is capable of unmasking bulky 
acetoxymethyl esters inside living cells.12 
 
Results 
VF-EX1 and VF-EX2 (Scheme 2-2) are synthesized in a single step from 
VF2.1.Cl. Addition of iodo-1-methylcyclopropanecarboxylate to VF2.1.Cl in N,N-
dimethylformamide (DMF) in the presence of N,N-diisopropylethylamine (DIPEA) gave 
VF-EX1 (stoichiometric iodoalkane) or VF-EX2 (excess iodoalkane) (Scheme 2-2). The 
two different products were characterized by NMR, HPLC, and mass spectrometry. Both 
VF-EX1 and VF-EX2 display optical properties consistent with O-alkylated 
fluoresceins13 – a weak absorbance at λ = 500 nm (Figure 2-1a/d, see Figure 2-2 for 
excitation spectra). VF-EX1 and VF-EX2 are minimally fluorescent, with quantum yields 
of 0.004 and 0.013, respectively (HBSS, pH 7.4). Compared to VF2.1.Cl, which has a 
quantum yield of 0.08 under identical conditions, this represents a 19- and 6.7- fold 
decrease in fluorescence intensity (Figure 2-1b/e). VF-EX0, in which only the sulfonic 
acid is esterified (Scheme 2-3), has a quantum yield of 0.24, consistent with a 3-fold 
increase in quantum efficiency for sulfonate esters (VF-EX0, VF-EX2) compared to their 
cognate acids (VF2.1.Cl, VF-EX1, Table 2). 
We confirmed that purified porcine liver esterase (PLE, Sigma, E2884) 
hydrolyzes VF-EX1 and VF-EX2 in vitro. The action of PLE on VF-EX1 or VF-EX2 
results in a 53- and 11-fold increase in fluorescence after 3 hr. The fluorescence increase 
is accompanied by a restoration of a fluorescein-like absorption and emission profile 
(Figure 2-1a,b and d,e). HPLC analysis revealed VF2.1.Cl as the product of PLE-
mediated hydrolysis reactions (Figure 2-3). Both substrates show saturation-type 
enzymatic kinetics with PLE. The Michaelis constant, KM, for VF-EX1 is 1.2 ± 0.5 µM 
and for VF-EX2 is 0.12 ± 0.03 µM, (Figure 2-1c,f and Table 2) comparable to the 
reported values of 0.5 µM for biscyclopropylacetoxymethylfluorescein.12 VF-EX2 is a 
better substrate than VF-EX1, as evidenced by the larger kcat/KM for VF-EX2 (1.3×106 
M-1s-1) vs. VF-EX1 (2.1×105 M-1s-1) (Table 2). We hypothesize that masking of the 
anionic sulfonate charge in the case of VF-EX2 makes it a better substrate for PLE. 
Having confirmed VF-EX1 and VF-EX2 as substrates for PLE, we next set out to 
target and express PLE to the surface of eukaryotic cells. Although trafficking to the 
endoplasmic reticulum (ER) is required for proper cellular PLE activity,12 we found that 
removal of the PLE-associated ER retention signal, addition of a transmembrane domain 
(platelet-derived growth factor receptor, PDGFR, from pDisplay)14 or glycophosphatidyl 
inositol anchor signal (GPI, from decay accelerating factor, DAF),15 and inclusion of a 
secretion signal derived from immunoglobulin K (IgK) results in clear membrane 
localization on HEK cells as determined by immunostaining fixed cells (Figure 2-4 and 
2-5). Bath application of VF-EX1 or VF-EX2 (500 nM, 30 minutes) to HEK cells 
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transiently transfected with PLE-DAF or PLE-pDisplay results in clear membrane-
associated fluorescence in transfected cells (indicated by nuclear-localized mCherry, 
Figure 2-6a-d, g-j).  
Cells in the same culture that do not express mCherry (and therefore do not 
express PLE) show negligible levels of membrane-associated fluorescence (Figure 2-6a,c 
and g,i, Scheme 2-1). Membrane targeting of VF-EX dyes with DAF gave the brightest 
cells and the largest contrast between PLE-expressing and PLE(-) cells (Figure 2-7, see 
Figure 2-8 for quantification). DAF-mediated targeting was therefore used for subsequent 
studies. We examined a number of flexible linker lengths (GGGGS repeats) between PLE 
and the DAF sequence and found no correlation between linker length and contrast 
between transfected and control HEK cells treated with VF-EX2 (Figure 2-9). We 
therefore used the smallest linker length for future studies. Quantification of the 
difference in fluorescence intensity for PLE-expressing cells vs. controls indicates a 
contrast of 7-fold between PLE-expressing cells and control cells for VF-EX1 and 17 for 
VF-EX2, which we attribute to the higher kcat/KM value for VF-EX2 (Figure 2-1f, Table 
2). Longer incubation times with VF-EX2 at 500 nM (up to 2 hours) increased overall 
fluorescence, but lowered contrast between transfected and untrasfected cells on account 
of increasing fluorescence in untransfected cells (Figure 2-10a,b). This increase in 
fluorescence in untransfected cells is due to accumulation of weakly fluorescent VF-EX2 
in membranes and not to uncatalyzed hydrolysis, since cells that had been loaded with 
VF-EX2 for 30 minutes (500 nM), washed, and then monitored over time showed no 
increase in fluorescence from untransfected cells (Figure 2-10c,d). 
The fluorescence associated with PLE-expressing HEK cells was voltage-
sensitive; VF-EX1 and VF-EX2 displayed high, linear voltage sensitivities of 19 ± 0.3 
and 21 ± 0.3% ΔF/F per 100 mV, comparable to 27% measured for VF2.1.Cl (Figure 2-
6e,f and k,l). We additionally confirmed that cell-surface PLE uncages VF-EX2 only 
within the cell membrane of the cell which expresses PLE (in cis) and not on neighboring 
cells (in trans). HEK cells expressing PLE on the cell surface and mCherry in the nucleus 
were plated on top of a monolayer of HEK cells that did not express PLE and had 
previously been loaded with VF-EX2. If PLE acted in trans, we predicted that addition of 
PLE-expressing HEK cells to the non-expressing, dye-loaded cells would result in an 
increase in fluorescence, similar to what we observe when we add purified PLE to HEK 
cells loaded with VF-EX2 (Figure 2-11a-d). However, if PLE only acts in cis, then 
addition of PLE-expressing HEK cells will not result in an increase in fluorescence. We 
observe no increase in fluorescence upon addition of PLE expressing HEK cells to cells 
loaded with VF-EX (Figure 2-11e-j), confirming both that cell-surface localized PLE 
cannot act in trans, and that VF-EX2 does not diffuse out of membranes to cells 
expressing PLE. Importantly, a positive control experiment demonstrates that the 
harvested PLE-expressing HEK cells can turn-over VF-EX1 if the VF-EX1 is added 
directly to these PLE-expressing cells (Figure 2-11k). Previous studies establish that the 
product of VF-EX2 uncaging, VF2.1.Cl, diffuses primarily within membranes and not 
across membranes.11 We also established that VF-EX2 does not cross plasma 
membranes, as HEK cell expressing ER-targeted PLE do not accumulate internal 
fluorescence (Figure 2-12). 
VoltageFluor-EX dyes provide enhanced contrast in neurons. Fixed-cell 
immunofluorescence established efficient cell-surface targeting of PLE in rat 
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hippocampal neurons transfected with PLE-DAF under the neuron-specific synapsin 
promoter (Syn, Figure 2-13, Figure 2-4) or calmodulin kinase II promoter (CaMKII, 
Figure 2-14, Figure 2-4). Use of a strong, non-specific promoter construct from pCAGS, 
results in primarily neuronal expression with some glial expression, as assayed by co-
localization with glial fibrillary acid protein, GFAP (Figure 2-15). Live cell staining with 
VF-EX1 and VF-EX2 (1 µM, 1 hour) results in clear enhancement of membrane-
associated fluorescence in transfected neurons, with a 4.1- and 4.8-fold increase in 
fluorescence for Syn-PLE expressing neurons stained with VF-EX1 and VF-EX2 (Figure 
2-16a-d, Figure 2-17a-d) and a 3.0- and 3.7- fold increase in fluorescence for CaMKII-
PLE expressing neurons with VF-EX1 and VF-EX2 (Figure 2-16e-h, Figure 2-17e-h), 
respectively (Table 2, Figure 2-18a). The cell-type specific membrane associated 
fluorescence with VF-EX1 and VF-EX2 is voltage sensitive. Like the parent VF 
dyes,8,10,16 VF-EX1 and 2 give clear responses to field-stimulation electrode-evoked 
action potentials (Figure 2-19a) and the ability to record spontaneous spiking in 
hippocampal cultures (Figure 2-16i, Figure 2-17i). We selected VF-EX2 for future use in 
neurons because of its greater brightness in neurons (Figure 2-18b,c). Longer incubation 
times with VF-EX2 (1 µM, up to 120 minutes), increased the relative fluorescence 
intensity of PLE-expressing cells (Figure 2-18d). The overall contrast between PLE and 
wild-type neurons decreased slightly as a result of increased accumulation of VF-EX2 in 
cell membranes (Figure 2-18d,e). As with HEK cells (Figure 2-10), this is due to 
nonspecific accumulation of VF-EX2 and not hydrolysis, as neurons loaded for 30 
minutes (1 µM VF-EX2) followed by a wash show negligible increases in fluorescence 
from non-transfected neurons (Figure 2-18f). 
We compared the performance of VF-EX2/Syn-PLE to genetically-encoded 
fluorescent voltage indicators: ASAP1,2 based on circularly permuted green fluorescent 
protein (cpGFP), or Ace2N-mNeon (here abbreviated Ace2N),4 which uses mNeon.17 VF-
EX2/PLE compared favorably to both ASAP1 and Ace2N, displaying improved 
membrane associated fluorescence relative to ASAP1 and Ace2N (Figure 2-19a-c, Figure 
2-21), turn-on responses to spontaneous action potentials (both ASAP1 and Ace2N show 
turn-off responses to action potentials, Figure 2-19e,f), and an average 7.3 ± 0.8% ΔF/F 
per spike (20 ± 2.7 SNR) for evoked action potentials compared to -6.5 ± 0.3% for 
ASAP1 (4.9 ± 0.6 SNR) and -2.9 ± 0.1% for Ace2N (11 ± 0.7 SNR) (132, 62, and 106 
action potentials from 16, 7, and 13 separate neurons, respectively (Figure 2-19g,h, 
Figure 2-20). Under the identical illumination conditions, VF-EX2 has photo-stability 
comparable to that of ASAP1 and Ace2N (Figure 2-20 and 2-21). The improved 
fluorescence staining on the cell membrane results from the use of the hybrid chemical-
genetic approach. Although genetically-encoded fluorescent proteins traffic to the cell 
surface, a significant portion of the fluorescent protein-based indicator remains in the 
cellular export pathways and contributes to unresponsive background fluorescence. In 
contrast, while membrane-targeted PLE is also making its way through the cellular export 
pathways, it is non-fluorescent. 
The ability of the VF-EX2/PLE system to label specific, genetically-defined cells, 
coupled with its high voltage sensitivity, make it a promising candidate for interrogating 
membrane potential dynamics in complex neuronal systems. For example, the 
neuromodulator serotonin (5-hydroxytryptamine, or 5-HT) exerts diverse effects within 
the brain and body, depending upon cell type, 5-HT receptor (5-HTR) subtype, and pre- 
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or post-synaptic localization of the receptor. Numerous serotonergic neurons project onto 
the hippocampus in the rat brain, delivering 5-HT to modulate neuronal activity. The 
complex expression pattern of the 14 distinct 5-HTR subtypes18 in the hippocampus 
complicates the dissection of molecular pathways involved in mediating the effects of 5-
HT. Treatment of hippocampal cultures stained with VF-EX2/PLE exclusively in neurons 
(CaMKII promoter) with 5-HT (10 µM) shows decreased spiking rates, from 2.5 ± 0.7 Hz 
to 1.5 ± 0.5 Hz in 5-HT (Figure 2-22 and Figure 2-23).19 Washout of 5-HT results in a 
recovery of neuronal spiking to 2.4 ± 0.4 Hz (Figure 2-22a). The decrease in firing rate 
could be mediated through a number of different pathways: the action of 5-HT1 receptors 
coupling to inward rectifying potassium channels (Kir channels) via G-protein coupled 
receptors (GPCRs), resulting in a direct hyperpolarization; the activation of 5-HT2 
receptors coupling to release of Ca2+ stores via phospholipase C (PLC) and activating 
inhibitory neurons to decrease overall firing; or through the opening of ion channel-type 
5-HT3 receptors causing a depolarization of inhibitory cells. To resolve some of these 
ambiguities, we again assessed the neuromodulatory effect of 5-HT on the activity of 
hippocampal neurons using VF-EX2/PLE. Pre-treatment with the 5-HT1A-selective 
antagonist, WAY 100635 (10 nM; 1.4 nM IC50),20 prior to 5-HT addition causes a 
complete loss of the serotonin-mediated decrease in activity in neurons (Figure 2-22b and 
Figure 2-23). These results suggest the decrease in firing in hippocampal neurons 
accompanied by serotonin treatment is mediated primarily through 5-HT1A receptors. In 
support of this model, pre-treatment with ketanserin (100 nM; 2 nM Ki),21 an antagonist 
with specificity for 5-HT2 receptors, has no effect on the serotonin-mediated decrease in 
firing (Figure 2-22c and Figure 2-23). Importantly, firing rates for all neurons were 
uniform prior to and after washout of 5-HT (p > 0.1, across all pair-wise comparisons, 
Figure 2-23). The use of cell type-specific expression of VoltageFluor-EX system enables 
a rapid method for dissection of complex neurobiological signaling pathways. 
 
Discussion 
In summary, we present the design, synthesis, evaluation, and application of the 
VoltageFluor-EX hybrid system for fluorogenic targeting of PeT-based fluorescent 
voltage indicators to specific cells. Fluorogenic targeting using a hybrid small 
molecule/enzymatic activation approach combines the speed and sensitivity of PeT-based 
voltage indicators with the cellular specificity of genetic encoding. We show that two 
VoltageFluor derivatives, VF-EX1 and VF-EX2, with methylcyclopropylacetoxymethyl 
ester modifications, provide an efficient means of generating high contrast fluorescence 
in individual neurons. While enzymatic targeting has been employed previously to 
improve membrane localization of electrochromic dyes,22-24 these strategies have never 
been deployed in neurons for functional imaging. Alternative hybrid approaches rely on 
lipophilic fluorescence quenchers25 that introduce prohibitive capacitance to the neurons 
under observation.26 Here we demonstrate that the VoltageFluor-EX system enables the 
use of fast, sensitive, non-disruptive VoltageFluor2.1.Cl8 in specified cells to report on 
neuronal action potentials with large, linear turn-on responses surpassing the signal-to-
noise and sensitivity achieved with fluorescent protein and FRET-opsin voltage 
indicators under identical conditions. We show that targeting VF-EX2 to neurons enables 
the dissection of the neuromodulatory effects of serotonin in hippocampal neurons. 
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When compared to their genetically encoded counterparts, VF-EX dyes lag 
behind in terms of contrast between transfected and untransfected neurons. Low contrast 
for VF-EX/PLE in neurons relative to HEK cells may be due, in part, to the lower 
expression levels of PLE achieved under specific, but weaker promoters like synapsin 
and CaMKIIα. This may be partially addressed by coupling strong promoters (i.e. CMV) 
to genetic methods for obtaining cell-type specificity. Improvements can also be made on 
the chemical side. The dynamic range between caged and uncaged fluorophore can be 
tuned by altering the amount of PeT between the fluorophore and pendant aryl ring.27 
Larger spectral separation between the excitation maxima of the caged and free dye 
would also improve contrast. Further improvement in cellular contrast is likely needed 
for routine usage in vivo. Taken together, this methodology sets the stage for employing 
fast, sensitive, fluorogenic PeT-based voltage indicators in intact brain tissues, and efforts 
are underway in our lab to apply this method both to new targeting modalities using 
complementary substrate/enzyme pairs, expand the palette of fluorogenic voltage 
indicators, and deploy these probes to intact brains in vivo. 
 
 
Experimental section 
 
General Synthetic and Analytical Methods 
Anhydrous sodium iodide and diisopropylethylamine were purchased from 
Sigma-Aldrich. Anhydrous solvents (acetonitrile, dichloromethane and N,N-
dimethylformamide) were purchased from Acros Organics. VF2.1.Cl and chloromethyl 
1-methylcyclopropanecarboxylate were synthesized according to literature 
procedures.11,12 
1H and 13C NMR spectra were collected in (CD3)2SO (anhydrous, Alfa Aesar, 
Ward Hill, MA or Cambridge Isotope Laboratories, Cambridge, MA) or CDCl3 
(Cambridge Isotope Laboratories, Cambridge, MA) at 25 °C on a Bruker AV-600 
spectrometer at the College of Chemistry NMR Facility at the University of California, 
Berkeley, or at the QB3 Central California 900 MHz NMR Facility. All chemical shifts 
are reported in the standard δ notation of parts per million using the peak of residual 
proton signals of (CD3)2SO or CDCl3 as an internal reference. Low resolution LC/ESI-
MS was performed on an Advion Expression LC-MS coupled to an Agilent Infinity 1220 
HPLC, with a Phenomenex Luna 5 µm C18(2) 75 x 4.6 mm column. Semi-preparative 
HPLC was performed on a Perkin Elmer Series 200 HPLC, with a Phenomonex Luna 5 
µm C18(2) 150 x 10 mm column. In both cases water (eluent A) and acetonitrile (eluent 
B) were employed as the mobile phase, with 0.05% trifluoroacetic acid present as an 
additive. For analytical HPLC the mobile phase was ramped from 10 to 100% eluent B 
over eight minutes, then held at 100% B for two minutes at a flow rate of 1.0 mL/minute. 
For semi-preparative HPLC the mobile phase was ramped from 10 to 100% eluent B over 
twenty minutes at 5.0 mL/minute. High resolution mass spectra (HR-ESI-MS) were 
acquired at the QB3/Chemistry Mass Spectrometry Facility at the University of 
California, Berkeley. 
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Synthetic Procedures 
 
Example preparation of iodomethyl 1-methylcyclopropanecarboxylate 
In a 4 mL dram vial chloromethyl 1-methylcyclopropanecarboxylate (205 mg, 
1.38 mmol) and sodium iodide (221 mg, 1.47 mmol) were dissolved in 1 mL of 
anhydrous acetonitrile. The reaction was stirred under N2 for 23 hours, at which time a 
small aliquot was drawn and the reaction was found to have reached completion by 1H 
NMR. The reaction was diluted with 2 mL of anhydrous dichloromethane and filtered 
through a cotton plug. Solvents were removed under reduced pressure at 25 °C to yield a 
golden liquid over residual salts. The supernatant was carefully pipetted into a tared vial 
to obtain 228 mg (0.706 mmol) of pure iodommethyl 1-methylcyclopropanecarboxylate. 
The reagent was then employed neat, or as a 1.00 M solution in anhydrous N,N-
dimethylformamide for use in subsequent reactions.   
 
1H NMR (600 MHz, CDCl3) δ 5.90 (s, 2H), 1.29 (s, 3H), 1.27 (dd, J = 7.5, 3.9 Hz, 2H), 
0.73 (dd, J = 7.6, 4.0 Hz, 2H). 
 
13C NMR (151 MHz, CDCl3) δ 173.86, 31.36, 31.34, 18.98, 17.00. 
 
Synthesis of  
((2,7-dichloro-9-(4-((E)-4-((E)-4-(dimethylamino)styryl)styryl)phenyl)-3-oxo-3H-
xanthen-6-yl)oxy)methyl-1-methylcyclopropane-1-carboxylate (VF-EX1) 
In a 4 mL dram vial VF2.1.Cl (25.1 mg, 36.7 µmol, 1 equivalent) was dissolved 
in 175 µL of anhydrous N,N-dimethylformamide and 25.6 µL of diisopropylethylamine 
(147 µmol, 4 equivalents), followed by addition of 36.6 uL of a 1.00 M solution of 
iodomethyl 1-methylcyclopropanecarboxylate in anhydrous N,N-dimethylformamide 
(36.6 µmol, 1 equivalent). The reaction was stirred under N2 at room temperature and 
monitored by LC-MS. After one hour approximately 50% of the starting material had 
been consumed. An additional 0.75 equivalents of iodomethyl 1-
methylcyclopropanecarboxylate were added. One hour later approximately 15% 
VF2.1.Cl remained and the reaction was neutralized with 50 µL acetic and diluted with 2 
mL of dimethylsulfoxide. The diluted reaction was purified by semi-preparative HPLC 
without further workup to obtain 4.77 mg of product (5.99 µmol) following evaporation 
of the mobile phase at a bath temperature of 60 °C and drying under high vacuum. 
 
1H NMR (900 MHz, (CD3)2SO) δ 8.17 (s, 1H), 7.80 (d, J = 7.8 Hz, 1H), 7.67 (d, J = 7.8 
Hz, 2H), 7.59 (s, 1H), 7.57 (d, J = 7.9 Hz, 2H), 7.48 (d, J = 8.0 Hz, 2H), 7.44 (s, 1H), 
7.40 (d, J = 16.6 Hz, 1H), 7.28 (d, J = 7.7 Hz, 1H), 7.21 (d, J = 16.3 Hz, 1H), 7.07 (s, 
1H), 7.03 (d, J = 16.3 Hz, 1H), 6.98 (s, 1H), 6.80 (s, 2H), 6.47 (s, 1H), 6.00 (s, 2H), 2.96 
(s, 6H), 1.25 (s, 3H), 1.18 – 1.14 (m, 2H), 0.84 – 0.82 (m, 2H). 
13C NMR (226 MHz, (CD3)2SO) δ 176.25, 173.74, 158.18, 158.02, 157.86, 157.75, 
155.20, 151.41, 151.07, 147.36, 138.54, 137.63, 135.19, 132.45, 130.08, 130.06, 129.75, 
129.74, 128.82, 128.81, 127.65, 127.62, 127.27, 127.19, 126.63, 126.52, 126.25, 125.31, 
118.41, 118.22, 117.07, 104.15, 102.84, 84.99, 54.90, 18.65, 18.29, 16.79, 16.76. 
Analytical HPLC retention time: 6.36 minutes.  
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HR-ESI-MS [M-H]- calculated 794.1388, found 794.1381 
 
Synthesis of 
 ((9-(4-((E)-4-((E)-4-(dimethylamino)styryl)styryl)-2-((((1-methylcyclopropane-1-
carbonyl)oxy)methoxy)sulfonyl)phenyl)-3-oxo-3H-xanthen-6-yl)oxy)methyl 1-
methylcyclopropane-1-carboxylate (VF-EX2) 
In a 4 mL vial VF2.1.Cl (23.2 mg, 33.89 µmol, 1 equivalent) was dissolved in 203 
µL of a 1.00 M solution of iodomethyl 1-methylcyclopropanecarboxylate in anhydrous 
N,N-dimethylformamide (203 µmol, 6 equivalents) and 35.4 µL of 
diisopropylethylamine (203 µmol, 6 equivalents). The reaction was stirred under N2 at 
room temperature and monitored by LC-MS. After two and a half hours VF-EX2 and 
VF-EX1 were present in an approximately 1:1 ratio. An additional 4 equivalents of 
iodomethyl 1-methylcyclopropanecarboxylate were added. Two hours later the reaction 
was found to have reached completion. The reaction was neutralized with 50 µL of acetic 
acid and diluted with 2 mL of dimethylsulfoxide. The diluted reaction was purified by 
semi-preparative HPLC without further workup to obtain 9.83 mg of product (10.8 µmol) 
following evaporation of the mobile phase at a bath temperature of 60 °C and drying 
under high vacuum.  
 
1H NMR (900 MHz, (CD3)2SO) δ 8.20 (s, 1H), 7.93 (d, J = 8.4 Hz, 2H), 7.86 (d, J = 8.3 
Hz, 2H), 7.81 (d, J = 7.7 Hz, 1H), 7.75 (d, J = 7.8 Hz, 2H), 7.68 (d, J = 7.8 Hz, 2H), 7.59 
(s, 1H), 7.51 (d, J = 16.5 Hz, 1H), 7.49 (d, J = 16.4 Hz, 1H), 7.44 (d, J = 16.4 Hz, 1H), 
7.40 (d, J = 16.4 Hz, 1H), 7.29 (d, J = 7.6 Hz, 1H), 7.07 (s, 1H), 6.98 (s, 1H), 6.46 (s, 
1H), 6.00 (s, 2H), 5.72 (s, 2H), 3.64 (s, 6H), 1.24 (s, 3H), 1.18 – 1.14 (m, 2H), 1.11 (s, 
3H), 0.95 (m, 2H), 0.83 (m, 2H), 0.78 – 0.75 (m, 2H). 
 
13C NMR (226 MHz, (CD3)2SO) δ 176.23, 173.73, 172.35, 158.15, 157.98, 157.73, 
155.20, 151.41, 150.97, 147.38, 141.41, 139.18, 138.35, 136.79, 136.16, 132.45, 130.98, 
130.09, 129.80, 129.71, 127.63, 127.51, 127.46, 127.27, 127.23, 126.64, 126.20, 125.45, 
122.02, 118.41, 118.20, 117.03, 104.16, 102.83, 84.98, 84.01, 51.01, 18.64, 18.28, 18.24, 
17.97, 17.01, 16.78, 16.75. 
 
Analytical HPLC retention time: 6.29 minutes. A minor peak (5.5% peak area by 
integration at 254 nm) with retention time 6.67 minutes can be observed eluting after the 
main product peak. This minor peak also has the correct product mass. It has been our 
experience that installing bulky esters at the 3 position of xanthene-based VoltageFuors 
leads to the formation of conformational isomers, and we believe that this is the case 
here.28  
 
HR-ESI-MS [M+H]+ calculated 908.2057, found 908.2079 
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Spectrum 1-1. 1H NMR of iodomethyl 1-methylcyclopropanecarboxylate. 
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Spectrum 1-2. 13C NMR of iodomethyl 1-methylcyclopropanecarboxylate. 
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Spectrum 1-3. 1H NMR of VF-EX1. 
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Spectrum 1-4. 13C NMR of VF-EX1. 
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Spectrum 1-5. LC-MS of VF-EX1. 
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Spectrum 1-6. 1H NMR of VF-EX2. 
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Spectrum 1-7. 13C NMR of VF-EX2. 
  
28	
Spectrum 1-8. LC-MS of VF-EX2. 
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Synthesis of  
2-(2,7-dichloro-6-((4-methoxybenzyl)oxy)-3-oxo-3H-xanthen-9-yl)-5-((E)-4-((E)-4-
(dimethylamino)styryl)styryl)benzenesulfonic acid (VF2.1.Cl-PMB) 
In a 20 mL scintillation vial dissolved VF2.1.Cl (107 mg, 156 µmol) and cesium 
carbonate (112 mg, 343 µmol) in 1 mL anhydrous dimethylformamide, followed by 
addition of 109 µL of 4-methoxybenzyl bromide (780 µmol). After stirring for 4 hours 
the reaction was diluted with 10 mL of H2O which resulted in the precipitation of an 
orange solid. The precipitate was recovered by vacuum filtration and washed with 
approximately 5 mL of diethyl ether.  
The orange solid was collected and dissolved in 4.5 mL of dimethylformamide 
and 1.5 mL of 1.0 M aqueous lithium hydroxide. The solution was stirred under N2 for 
five hours at 50 °C. The reaction was then diluted with 20 mL of H2O and acidified with 
1.75 mL of 1.0 M aqueous HCl. The aqueous solution was extracted with 40 mL of 10% 
isopropanol in dichloromethane. The organic phase was collected and washed twice with 
10 mL of H2O. The organic phase was dried over magnesium sulfate and solvents 
removed under reduced pressure. The resulting gum was then dissolved in 5 mL of 
dichloromethane. Addition of an equal volume of hexanes led to precipitation of an 
orange solid and solvents were again removed under reduced pressure. Obtained 
VF2.1.Cl-PMB (96.1 mg, 77%) as an orange solid.  
 
1H NMR (900 MHz, (CD3)2SO) δ 8.17 (s, 1H), 7.79 (d, J = 7.6 Hz, 1H), 7.66 (d, J = 7.8 
Hz, 2H), 7.58 – 7.54 (m, 3H), 7.48 – 7.41 (m, 5H), 7.41 – 7.38 (m, 2H), 7.25 (d, J = 7.9 
Hz, 1H), 7.19 (d, J = 16.5 Hz, 1H), 7.06 (s, 1H), 7.04 (d, J = 8.5 Hz, 1H), 7.01 (d, J = 8.5 
Hz, 1H), 7.00 – 6.95 (m, 3H), 6.42 (s, 1H), 5.33 (s, 2H), 3.75 (s, 3H), 2.94 (s, 6H).  
 
13C NMR (226 MHz, (CD3)2SO) δ 176.08, 160.56, 159.32, 157.79, 157.63, 151.95, 
151.62, 147.35, 138.49, 137.71, 135.10, 134.47, 132.45, 132.15, 130.04, 129.66, 129.36, 
128.94, 127.60, 127.36, 127.18, 126.57, 126.46, 126.19, 125.34, 119.72, 118.46, 117.46, 
115.62, 114.26, 114.21, 114.02, 113.61, 103.90, 101.64, 55.26, 55.09.  
 
Analytical HPLC retention time: 6.68 minutes.  
HR-ESI-MS [M-H]- calculated 802.1439, found 802.1411 
 
Synthesis of  
(((2-(2,7-dichloro-6-hydroxy-3-oxo-3H-xanthen-9-yl)-5-((E)-4-((E)-4-
(dimethylamino)styryl)styryl)phenyl)sulfonyl)oxy)methyl 1-methylcyclopropane-1-
carboxylate (VF-EX0) 
In a 20 mL scintillation vial dissolved VF2.1.Cl-PMB (83.9 mg, 104 µmol) and 
iodomethyl 1-methylcyclopropanecarboxylate (108 mg, 417 µmol) in 1 mL of anhydrous 
dimethylformamide, followed by addition of 72.6 µL of diisopropylethylamine (417 
µmol). After stirring for 16 hours at room temperature the reaction was diluted with water 
and concentrated under reduced pressure at a bath temperature of 60 °C. The resulting 
gum was dissolved in approximately 1 mL of dichlorometane and precipitation induced 
by addition of approximately 3 mL of hexanes. The flocculent precipitate was collected 
by vacuum filtration to obtain VF-EX0 (45.3 mg, 47% crude yield) as an orange solid. 
Workup was accompanied by concomitant hydrolysis of the phenolic p-methoxybenzyl 
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protecting group. A small aliquot for characterization was purified by semi-preparative 
HPLC.  
 
1H NMR (900 MHz, (CD3)2SO) δ 8.19 (s, 1H), 7.93 (d, J = 8.4 Hz, 2H), 7.86 (d, J = 8.3 
Hz, 2H), 7.80 (d, J = 7.9 Hz, 1H), 7.75 (d, J = 7.8 Hz, 2H), 7.69 (d, J = 7.9 Hz, 2H), 7.51 
(d, J = 16.6 Hz, 1H), 7.49 (d, J = 16.6 Hz, 1H), 7.43 (d, J = 16.4 Hz, 1H), 7.40 (d, J = 
16.5 Hz, 1H), 7.26 (d, J = 7.8 Hz, 1H), 7.13 (s, 1H), 7.08 (s, 1H), 7.02 (s, 1H), 5.72 (s, 
2H), 3.64 (s, 6H), 1.12 (s, 3H), 0.95 (s, 2H), 0.77 (s, 2H).  
 
13C NMR (226 MHz, (CD3)2SO) δ 172.83, 158.12, 157.99, 152.35, 147.80, 141.87, 
139.65, 138.66, 137.34, 137.29, 136.61, 131.46, 130.57, 130.26, 130.24, 130.20, 130.18, 
128.27, 128.13, 127.92, 127.74, 127.69, 127.02, 126.65, 125.97, 122.50, 84.47, 51.45, 
18.71, 18.44, 17.47. 
 
Analytical HPLC retention time: 5.19 minutes.  
HR-ESI-MS [M+H]+ calculated 796.1533, found 796.1526 
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Spectrum 1-9. 1H NMR of VF-EX0. 
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Spectrum 1-10. 13C NMR of VF-EX0. 
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Spectrum 1-11. LC MS of VF-EX0. 
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Spectroscopic studies  
Stock solutions of dyes were prepared in DMSO (2 mM) and diluted with HBSS 
(zero Ca2+, zero Mg2+, no phenol red, pH 7.4). UV-Vis absorbance and fluorescence 
spectra were recorded using a Shimadzu 2501 Spectrophotometer (Shimadzu) and a 
Quantamaster Master 4 L-format scanning spectrofluorometer (Photon Technologies 
International). The fluorometer is equipped with an LPS-220B 75-W xenon lamp and 
power supply, A-1010B lamp housing with integrated igniter, switchable 814 photon-
counting/analog photomultiplier detection unit, and MD5020 motor driver. Samples were 
measured in 1-cm path length quartz cuvettes (Starna Cells). All measurements were 
done at room temperature.  
 
In vitro PLE reactions and characterization 
Commercially purified pig liver esterase (PLE, MW = 168 kDa) was obtained 
from Sigma-Aldrich (E2884) as a suspension in 3.2 M (NH4)2SO4, and was diluted from 
a stock solution of 28.1 mg/mL to appropriate concentrations in HBSS, pH 7.4. For the 
enzymatic reaction, 1 µL dyes (final concentration of 50 µM) were incubated with 1 µL 
PLE (final concentration of 0.7025 mg/mL) and 1 µL Pluronic F-127 (20% solution in 
DMSO) in 40 µL HBSS at 37 °C for ~ 3 h. The enzymatic products were characterized 
by spectroscopy and HPLC and compared with the starting materials. For 
characterization by spectroscopy, the reaction mixture was diluted to 1 mL HBSS (total 
volume) for measurement. For HPLC characterization, 40 µL of acetonitrile (1:1) was 
added, followed by centrifugation to precipitate the enzyme. Supernatant was extracted 
and filtered for HPLC injection. Absorbance was collected from 300 nm to 700 nm. For 
emission scans, the samples were excited at 520 nm and emission was collected from 525 
nm to 700 nm. Excitation scans were collected by monitoring emission at 550 nm when 
exciting from 300 to 540 nm. To obtain fluorescence turn-on over time, dyes were diluted 
to 1 µM in 1 mL HBSS in a cuvette and incubated with PLE (100 ng/mL) at 37 °C.  
Enzyme kinetics experiments were performed in black, clear-bottom, 96-well 
polystyrene microplates from Corning. Plates were read from the bottom on a Molecular 
Devices SpectraMax Paradigm Multi-Mode detection platform plate reader (λex 520 nm, 
λem 560 nm). All the measurements were done at 37 °C. Enzyme (200 ng/mL) was added 
to the substrates at t=5 min and more data were collected for another 5 min. To obtain the 
kinetic constants, the data were fit to the Michaelis-Menten equation v = !!"#[!]!!![!]  
(GraphPad Prism). 
 
Cell culture, transfection, and dye loading 
All animal procedures were approved by the UC Berkeley Animal Care and Use 
Committees and conformed to the NIH Guide for the Care and Use of Laboratory 
Animals and the Public Health Service (PHS) Policy. 
Human embryonic kidney 293T (HEK) cells were maintained in Dulbecco’s 
modified eagle medium (DMEM) supplemented with 4.5 g/L D-glucose, 10% fetal 
bovine serum (FBS; Thermo Scientific) and 1% GlutaMax (Invitrogen) at 37 °C in a 
humidified incubator with 5 % CO2. Cells were passaged and plated in DMEM (as 
above) at a density of 750,000 cells per well in a 6-well plate. Transfection of plasmids 
was carried out using Lipofectamine 3000 (Invitrogen) ~18-24 h after plating. The cells 
were split again 48 h after transfection and plated onto 12 mm glass coverslips pre-coated 
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with Poly-D-Lysine (PDL; 1 mg/ml; Sigma-Aldrich) at a density of 75,000 cells per 
coverslip in DMEM supplemented with 1 g/L D-glucose, 10% FBS and 1% GlutaMax. 
Imaging was performed 12-18 h after plating. 
Hippocampi were dissected from embryonic day 19 Sprague Dawley rats (Charles 
River Laboratory) in cold, sterile HBSS (zero Ca2+, zero Mg2+, phenol red). All dissection 
products were supplied by Invitrogen, unless otherwise stated. Hippocampal tissue was 
treated with trypsin (2.5%) for 15 min at 37 °C. The tissue was triturated using fire 
polished Pasteur pipettes, in minimum essential media (MEM) supplemented with 5% 
FBS, 2% B-27, 2% 1M dextrose (Fisher Scientific) and 1% GlutaMax. The dissociated 
cells were plated onto 12 mm diameter coverslips (Fisher Scientific) pre-treated with 
PDL (as above) at a density of 25-30,000 cells per coverslip in MEM supplemented 
media (as above). Neurons were maintained at 37 °C in a humidified incubator with 5 % 
CO2. At 1 day in vitro (DIV) half of the MEM supplemented media was removed and 
replaced with Neurobasal media containing 2% B-27 supplement and 1% GlutaMax. 
Transfection of plasmids was carried out using Lipofectamine 3000 (without P3000 
reagent) at 6-7 DIV. Imaging was performed on mature neurons 12-14 DIV.  
Unless stated otherwise, for loading of HEK cells and hippocampal neurons, 
DMSO stock solutions of dyes (2 mM) were diluted with 1:1 Pluronic F-127 (20% 
solution in DMSO) and then further diluted in HBSS to working concentrations. For 
HEK cells, the typical working concentration was 500 nM. For neurons, the working 
concentration was 1 µM. HEK cells were incubated with dye for 30 minutes at 37 °C 
before exchanging dye/HBSS for HBSS without any dye. Neurons were treated 
identically, but for 60 minutes before exchanging dye/HBSS for HBSS without dye. All 
imaging was performed in HBSS at room temperature.  
 
Epifluorescence microscopy 
Imaging was performed on an AxioExaminer Z-1 (Zeiss) equipped with a 
Spectra-X Light engine LED light (Lumencor), controlled with Slidebook (v6, Intelligent 
Imaging Innovations). Images were acquired with a W-Plan-Apo 20x/1.0 water objective 
(20x; Zeiss). Images were focused onto either an OrcaFlash4.0 sCMOS camera (sCMOS; 
Hamamatsu) or an eVolve 128 EMCCD camera (EMCCD; Photometrix). For dye 
imaging, excitation light was delivered at 475 nM (LED, 475 nm, 34 nm bandpass) and 
emission was collected with a 540/50 nm bandpass filter after passing through a 510 nm 
longpass dichroic. 
Image analysis  
For image intensity measurements, regions of interest were drawn around cells or 
neuronal cell bodies and the mean fluorescence was calculated in ImageJ (FIJI, NIH). 
Background fluorescence was subtracted by measuring the fluorescence where no cells 
grew. The fold turn-on was calculated by taking the ratio of transfected cells fluorescence 
and untransfected cells fluorescence, both background subtracted. At least 15-20 cells 
were quantified for each coverslip and 3 coverslips were examined to get the average fold 
turn-on. See Figure 2-8 for an example of regions of interest.  
Analysis of voltage sensitivity in HEK cells was performed using ImageJ (FIJI). 
Briefly, a region of interest (ROI) was selected automatically based on fluorescence 
intensity and applied as a mask to all image frames. Fluorescence intensity values were 
calculated at known baseline and voltage step epochs. For analysis of voltage responses 
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in neurons, regions of interest encompassing cell bodies (all of approximately the same 
size) were drawn in ImageJ and the mean fluorescence intensity for each frame extracted. 
ΔF/F values were calculated by first subtracting a mean background value from all raw 
fluorescence frames, to give a background subtracted trace (bkgsub). A baseline 
fluorescence value (Fbase) is calculated from the median of all the frames, and was 
subtracted from each timepoint of the bkgsub trace to yield a ΔF trace. The ΔF was then 
divided by Fbase to give ΔF/F traces. No averaging has been applied to any voltage traces. 
To get spike rates for serotonin experiments, the fluorescence trace of one movie was 
first converted to a ΔF/F trace as explained above. The number of spikes were counted 
manually and divided by 5 s to obtain the frequency. For each ROI, two movies were 
taken and an average frequency was obtained.  
 
Electrophysiology/Imaging parameters 
For electrophysiological experiments, pipettes were pulled from borosilicate glass 
(Sutter Instruments, BF150-86-10), with a resistance of 5–6 MΩ, and were filled with an 
internal solution; 115 mM potassium gluconate, 10 mM BAPTA tetrapotassium salt, 10 
mM HEPES, 5 mM NaCl, 10 mM KCl, 2 mM ATP disodium salt, 0.3 mM GTP 
trisodium salt (pH 7.25, 275 mOsm). Recordings were obtained with an Axopatch 200B 
amplifier (Molecular Devices) at room temperature. The signals were digitized with a 
Digidata 1440A, sampled at 50 kHz and recorded with pCLAMP 10 software (Molecular 
Devices) on a PC. Fast capacitance was compensated in the on-cell configuration. For all 
electrophysiology experiments, recordings were only pursued if series resistance in 
voltage clamp was less than 30 MΩ. For whole-cell, voltage clamp recordings in HEK 
293T cells, cells were held at -60 mV and hyper- and de- polarizing steps applied from -
100 to +100 mV in 20 mV increments.  
Extracellular field stimulation was delivered by a SD9 Grass Stimulator 
connected to a recording chamber containing two platinum electrodes (Warner), with 
triggering provided through the same Digidata 1332A digitizer and pCLAMP 9 software 
(Molecular Devices) that ran the electrophysiology. Action potentials were triggered by 1 
ms 60 V field potentials delivered at 5 Hz. To prevent recurrent activity, the HBBS bath 
solution was supplemented with synaptic blockers; 10 µM 2,3-Dioxo-6-nitro-1,2,3,4-
tetrahydrobenzo[f]quinoxaline-7-sulfonamide (NBQX; Santa Cruz Biotechnology) and 
25 µM DL-2-Amino-5-phosphonopentanoic acid (APV; Sigma-Aldrich). For both 
evoked action potentials and spontaneous activity, images were binned 4x4 to allow 
sampling rates of 0.5 kHz and 2500 frames (5 s) were acquired for each recording. For 
serotonin experiments, two 5 s movies of spontaneous activity were taken for each ROI. 
 
Plasmid construction  
For expression in HEK cells, PLE with an IgK leader sequence on the N-terminal 
and an HA tag on the C-terminal was subcloned into a pcDNA3 vector with a 
cytomegalovirus (CMV) promoter. For expression in neurons, PLE was subcloned into a 
pcDNA3 vector with a human synapsin promoter (Syn), or calmodulin-dependent protein 
kinase II promoter (CaMKIIa) and a regulatory element from the woodchuck hepatitis 
virus (WPRE). Nuclear-targeted mCherry (NLS-mCherry) was inserted downstream of 
PLE, separated by an internal ribosome entry site (IRES) sequence. All constructs were 
verified by sequencing. The following sequences were used (5' to 3').  
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IgK 
ATGGAGACAGACACACTCCTGCTATGGGTACTGCTGCTCTGGGTTCCAGGTTC
CACTGGTGAC 
 
PLE (minus ER retention signal) 
ATGGTGTGGCTGCTGCCTCTGGTGCTGACCAGCCTGGCCAGCAGCGCCACCT
GGGCCGGCCAGCCCGCCAGCCCTCCCGTGGTGGACACCGCCCAGGGCAGGGT
GCTGGGCAAGTACGTGAGCCTGGAGGGCCTGGCCCAGCCCGTGGCCGTGTTC
CTGGGCGTGCCCTTCGCCAAGCCTCCCTTGGGCAGCCTGAGGTTCGCTCCTCC
TCAGCCTGCTGAGCCCTGGAGCTTCGTGAAGAACACCACCAGCTACCCTCCC
ATGTGCTGCCAGGATCCCGTGGTGGAGCAGATGACCAGCGACCTGTTCACCA
ACGGCAAGGAGAGGCTGACCCTGGAGTTCAGCGAGGACTGCCTGTACCTGAA
CATCTACACACCCGCCGACCTGACCAAGAGAGGCAGGCTGCCCGTGATGGTG
TGGATCCACGGCGGCGGCCTGGTGCTGGGCGGCGCTCCCATGTACGACGGCG
TGGTGCTGGCCGCCCACGAGAACGTGGTGGTGGTGGCCATCCAGTACAGGCT
GGGCATCTGGGGCTTCTTCAGCACCGGCGACGAGCACAGCAGgGGCAACTGG
GGCCACCTGGACCAGGTGGCCGCCCTGCACTGGGTGCAGGAGAACATCGCCA
ACTTCGGCGGCGATCCCGGCAGCGTGACCATCTTCGGCGAGAGCGCCGGCGG
CGAGAGCGTGAGCGTGCTGGTGCTGAGCCCTCTGGCCAAGAACCTGTTCCAC
AGGGCCATCAGCGAGAGCGGCGTGGCCCTGACCGTGGCCCTGGTGAGGAAG
GACATGAAGGCCGCCGCCAAGCAGATCGCCGTGCTGGCCGGCTGCAAGACC
ACCACCAGCGCCGTGTTCGTGCACTGCCTGAGGCAGAAGAGCGAGGACGAG
CTGCTGGACCTGACCCTGAAGATGAAGTTCCTGACCCTGGACTTCCACGGCG
ACCAGAGGGAGAGCCATCCCTTCCTGCCCACCGTGGTGGACGGCGTGCTGCT
GCCCAAGATGCCCGAGGAGATCCTGGCCGAGAAGGACTTCAACACCGTGCCC
TACATCGTGGGCATCAACAAGCAGGAGTTCGGCTGGCTGCTGCCCACTATGA
TGGGCTTCCCTCTGAGCGAGGGCAAGTTGGACCAGAAGACCGCCACCAGCCT
GCTGTGGAAGAGCTATCCCATCGCCAACATTCCCGAGGAGCTGACACCCGTG
GCCACCGACAAGTACCTGGGCGGCACCGACGATCCCGTGAAGAAGAAGGAC
CTGTTCCTGGACCTGATGGGCGACGTGGTGTTCGGCGTGCCCAGCGTGACCGT
GGCCAGGCAGCACAGGGACaCCGGCGCTCCCACCTACATGTACGAGTTCCAG
TACAGGCCCAGCTTCAGCAGCGACAAGAAGCCCAAGTCCGTGATCGGCGACC
ACGGCGACGAGATCTTCAGCGTGTTCGGCTTCCCTCTGCTGAAGGGCGACGC
TCCCGAGGAGGAGGTGAGCCTGAGCAAGACCGTGATGAAGTTCTGGGCCAAC
TTCGCCAGGAGCGGCAATCCCAACGGCGAGGGCCTGCCTCACTGGCCCATGT
ACGACCAGGAGGAGGGCTACCTGCAGATCGGCGTGAACACCCAGGCCGCCA
AGAGGCTGAAGGGCGAGGAGGTGGCCTTCTGGAACGACCTGCTGAGCAAGG
AGGCCGCCAAGAAGCCTCCTAAGATCAAG 
 
HA 
TATCCATATGATGTTCCAGATTATGCT 
 
DAF 
CCAAATAAAGGAAGTGGAACCACTTCAGGTACTACCCGTCTTCTATCTGGGC
ACACGTGTTTCACGTTGACAGGTTTGCTTGGGACGCTAGTAACCATGGGCTTG
CTGACTTAG 
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pDisplay 
GCTGTGGGCCAGGACACGCAGGAGGTCATCGTGGTGCCACACTCCTTGCCCT
TTAAGGTGGTGGTGATCTCAGCCATCCTGGCCCTGGTGGTGCTCACCATCATC
TCCCTTATCATCCTCATCATGCTTTGGCAGAAGAAGCCACGT 
 
IRES 
GCCCCTCTCCCTCCCCCCCCCCTAACGTTACTGGCCGAAGCCGCTTGGAATAA
GGCCGGTGTGCGTTTGTCTATATGTTATTTTCCACCATATTGCCGTCTTTTGGC
AATGTGAGGGCCCGGAAACCTGGCCCTGTCTTCTTGACGAGCATTCCTAGGG
GTCTTTCCCCTCTCGCCAAAGGAATGCAAGGTCTGTTGAATGTCGTGAAGGA
AGCAGTTCCTCTGGAAGCTTCTTGAAGACAAACAACGTCTGTAGCGACCCTTT
GCAGGCAGCGGAACCCCCCACCTGGCGACAGGTGCCTCTGCGGCCAAAAGCC
ACGTGTATAAGATACACCTGCAAAGGCGGCACAACCCCAGTGCCACGTTGTG
AGTTGGATAGTTGTGGAAAGAGTCAAATGGCTCTCCTCAAGCGTATTCAACA
AGGGGCTGAAGGATGCCCAGAAGGCACCCCATTGTATGGGATCTGATCTGGG
GCCTCGGTGCACATGCTTTACATGTGTTTAGTCGAGGTTAAAAAAACGTCTAG
GCCCCCCGAACCACGGGGACGTGGTTTTCCTTTGAAAAACACGATGATAATA
TGGCCACA 
 
NLS-mCherry 
ATGGTGCCCAAGAAGAAGAGGAAAGTCGTGAGCAAGGGCGAGGAGGACAAC
ATGGCCATCATCAAGGAGTTCATGCGCTTCAAGGTGCACATGGAGGGCTCCG
TGAACGGCCACGAGTTCGAGATCGAGGGCGAGGGCGAGGGCCGCCCCTACG
AGGGCACCCAGACCGCCAAGCTGAAGGTGACCAAGGGCGGCCCCCTGCCCTT
CGCCTGGGACATCCTGTCCCCTCAGTTCATGTACGGCTCCAAGGCCTACGTGA
AGCACCCCGCCGACATCCCCGACTACTTGAAGCTGTCCTTCCCCGAGGGCTTC
AAGTGGGAGCGCGTGATGAACTTCGAGGACGGCGGCGTGGTGACCGTGACCC
AGGACTCCTCCCTGCAGGACGGCGAGTTCATCTACAAGGTGAAGCTGCGCGG
CACCAACTTCCCCTCCGACGGCCCCGTAATGCAGAAGAAGACCATGGGCTGG
GAGGCCTCCTCCGAGCGGATGTACCCCGAGGACGGCGCCCTGAAGGGCGAG
ATCAAGCAGAGGCTGAAGCTGAAGGACGGCGGCCACTACGACGCCGAGGTC
AAGACCACCTACAAGGCCAAGAAGCCCGTGCAGCTGCCCGGCGCCTACAAC
GTCAACATCAAGCTGGACATCACCTCCCACAACGAGGACTACACCATCGTGG
AACAGTACGAGCGCGCCGAGGGCCGCCACTCCACCGGCGGCATGGACGAGC
TGTACAAG 
 
WPRE 
GCTTATCGATAATCAACCTCTGGATTACAAAATTTGTGAAAGATTGACTGGTA
TTCTTAACTATGTTGCTCCTTTTACGCTATGTGGATACGCTGCTTTAATGCCTT
TGTATCATGCTATTGCTTCCCGTATGGCTTTCATTTTCTCCTCCTTGTATAAAT
CCTGGTTGCTGTCTCTTTATGAGGAGTTGTGGCCCGTTGTCAGGCAACGTGGC
GTGGTGTGCACTGTGTTTGCTGACGCAACCCCCACTGGTTGGGGCATTGCCAC
CACCTGTCAGCTCCTTTCCGGGACTTTCGCTTTCCCCCTCCCTATTGCCACGGC
GGAACTCATCGCCGCCTGCCTTGCCCGCTGCTGGACAGGGGCTCGGCTGTTG
GGCACTGACAATTCCGTGGTGTTGTCGGGGAAATCATCGTCCTTTCCTTGGCT
GCTCGCCTGTGTTGCCACCTGGATTCTGCGCGGGACGTCCTTCTGCTACGTCC
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CTTCGGCCCTCAATCCAGCGGACCTTCCTTCCCGCGGCCTGCTGCCGGCTCTG
CGGCCTCTTCCGCGTCTTCGCCTTCGCCCTCAGACGAGTCGGATCTCCCTTTG
GGCCGCCTCCCCGCATCGATACCG 
 
Synapsin Promoter 
GTGTCTAGACTGCAGAGGGCCCTGCGTATGAGTGCAAGTGGGTTTTAGGACC
AGGATGAGGCGGGGTGGGGGTGCCTACCTGACGACCGACCCCGACCCACTG
GACAAGCACCCAACCCCCATTCCCCAAATTGCGCATCCCCTATCAGAGAGGG
GGAGGGGAAACAGGATGCGGCGAGGCGCGTGCGCACTGCCAGCTTCAGCAC
CGCGGACAGTGCCTTCGCCCCCGCCTGGCGGCGCGCGCCACCGCCGCCTCAG
CACTGAAGGCGCGCTGACGTCACTCGCCGGTCCCCCGCAAACTCCCCTTCCC
GGCCACCTTGGTCGCGTCCGCGCCGCCGCCGGCCCAGCCGGACCGCACCACG
CGAGGCGCGAGATAGGGGGGCACGGGCGCGACCATCTGCGCTGCGGCGCCG
GCGACTCAGCGCTGCCTCAGTCTGCGGTGGGCAGCGGAGGAGTCGTGTCGTG
CCTGAGAGCGCAGTCGAGA 
 
CaMKIIα Promoter 
CATTATGGCCTTAGGTCACTTCATCTCCATGGGGTTCTTCTTCTGATTTTCTAG
AAAATGAGATGGGGGTGCAGAGAGCTTCCTCAGTGACCTGCCCAGGGTCACA
TCAGAAATGTCAGAGCTAGAACTTGAACTCAGATTACTAATCTTAAATTCCAT
GCCTTGGGGGCATGCAAGTACGATATACAGAAGGAGTGAACTCATTAGGGCA
GATGACCAATGAGTTTAGGAAAGAAGAGTCCAGGGCAGGGTACATCTACACC
ACCCGCCCAGCCCTGGGTGAGTCCAGCCACGTTCACCTCATTATAGTTGCCTC
TCTCCAGTCCTACCTTGACGGGAAGCACAAGCAGAAACTGGGACAGGAGCCC
CAGGAGACCAAATCTTCATGGTCCCTCTGGGAGGATGGGTGGGGAGAGCTGT
GGCAGAGGCCTCAGGAGGGGCCCTGCTGCTCAGTGGTGACAGATAGGGGTG
AGAAAGCAGACAGAGTCATTCCGTCAGCATTCTGGGTCTGTTTGGTACTTCTT
CTCACGCTAAGGTGGCGGTGTGATATGCACAATGGCTAAAAAGCAGGGAGA
GCTGGAAAGAAACAAGGACAGAGACAGAGGCCAAGTCAACCAGACCAATTC
CCAGAGGAAGCAAAGAAACCATTACAGAGACTACAAGGGGGAAGGGAAGG
AGAGATGAATTAGCTTCCCCTGTAAACCTTAGAACCCAGCTGTTGCCAGGGC
AACGGGGCAATACCTGTCTCTTCAGAGGAGATGAAGTTGCCAGGGTAACTAC
ATCCTGTCTTTCTCAAGGACCATCCCAGAATGTGGCACCCACTAGCCGTTACC
ATAGCAACTGCCTCTTTGCCCCACTTAATCCCATCCCGTCTGTTAAAAGGGCC
CTATAGTTGGAGGTGGGGGAGGTAGGAAGAGCGATGATCACTTGTGGACTAA
GTTTGTTCGCATCCCCTTCTCCAACCCCCTCAGTACATCACCCTGGGGGAACA
GGGTCCACTTGCTCCTGGGCCCACACAGTCCTGCAGTATTGTGTATATAAGGC
CAGGGCAAAGAGGAGCAGGTTTTAAAGTGAAAGGCAGGCAGGTGTTGGGGA
GGCAGTTACCGGGGCAACGGGAACAGGGCGTTTCGGAGGTGGTTGCCATGGG
GACCTGGATGCTGACGAAGGCTCGCGAGGCTGTGAGCAGCCACAGTGCCCTG
CTCAGAAGCCCCAAGCTCGTCAGTCAAGCCGGTTCTCCGTTTGCACTCAGGA
GCACGGGCAGGCGAGTGGCCCCTAGTTCTGGGGGCAGCGG 
 
CMV promoter 
GACATTGATTATTGACTAGTTATTAATAGTAATCAATTACGGGGTCATTAGTT
CATAGCCCATATATGGAGTTCCGCGTTACATAACTTACGGTAAATGGCCCGCC
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TGGCTGACCGCCCAACGACCCCCGCCCATTGACGTCAATAATGACGTATGTT
CCCATAGTAACGCCAATAGGGACTTTCCATTGACGTCAATGGGTGGACTATTT
ACGGTAAACTGCCCACTTGGCAGTACATCAAGTGTATCATATGCCAAGTACG
CCCCCTATTGACGTCAATGACGGTAAATGGCCCGCCTGGCATTATGCCCAGT
ACATGACCTTATGGGACTTTCCTACTTGGCAGTACATCTACGTATTAGTCATC
GCTATTACCATGGTGATGCGGTTTTGGCAGTACATCAATGGGCGTGGATAGC
GGTTTGACTCACGGGGATTTCCAAGTCTCCACCCCATTGACGTCAATGGGAGT
TTGTTTTGGCACCAAAATCAACGGGACTTTCCAAAATGTCGTAACAACTCCGC
CCCATTGACGCAAATGGGCGGTAGGCGTGTACGGTGGGAGGTCTATATAAGC
AGAGCT 
 
Benchling links for constructs 
 
CMV-IgK-PLE-HA-DAF-IRES-mCherry 
https://benchling.com/s/H8lrjABb 
 
CMV-IgK-PLE-HA-pDisplay-IRES-mCherry 
https://benchling.com/s/KczxHl33 
 
Synapsin-IgK-PLE-HA-DAF-IRES-mCherry-WPRE 
https://benchling.com/s/ZQVd5dJP 
 
CaMKIIα-IgK-PLE-HA-DAF-IRES-mCherry-WPRE 
https://benchling.com/s/ziwgvSJ9 
 
Immunocytochemistry 
To detect expression and localization of PLE and other protein markers, HEK 
cells or neurons were fixed with 4% paraformaldehyde in PBS for 10 min and 
permeabilized (if required) with 0.3% v/v Triton-X100 (Sigma Aldrich) in PBS for 2 
min. Blocking was done in 5% w/v bovine serum albumin (BSA; Sigma Aldrich) in PBS 
for 1 h. Primary antibody was incubated at 4 °C overnight, followed by AlexaFluor 
secondary antibody (Life Technologies) at room temperature for 2 h. All antibodies were 
used at 1:1000 dilution.  
 
Name Primary/ 
Secondary 
Manufacturer Catalog # Isotype 
Anti-HA Primary CST 3724S Rabbit IgG 
Anti-HA Primary CST 2367S Mouse IgG1 
Anti-CamKIIa Primary EMD Millipore 05-532 Mouse IgG1 
Anti-Synapsin Primary Synaptic Systems 106001 Mouse IgG1 
Anti-GFAP Primary EMD Millipore MAB360 Mouse IgG1 
Anti-GABA Primary Sigma-Aldrich A2052 Rabbit IgG 
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Anti-rabbit 647 Secondary Life Technologies A21244 Goat IgG 
Anti-rabbit 488 Secondary Life Technologies A11008 Goat IgG 
Anti-mouse 488 Secondary Life Technologies A11001 Goat IgG 
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Figures and Schemes 
Scheme 2-1. Design of VoltageFluor targeted by esterase expression (VF-EX).  
 
 
Scheme 2-1. Scheme of neuron-specific targeting with ester/esterase pairs  (components 
are not to scale). 
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Scheme 2-2. Synthesis of VF-EX dyes. 
 
 
 
Scheme 2-2. Synthesis of VoltageFluor-EX 1 and 2. 
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Scheme 2-3. Synthesis of VE-EX0. 
 
Scheme 2-3.  Synthesis of VF-EX0.
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Table 2. Summary of Voltage Indicator Properties. 
    contrastc ΔF/F (%) SNR 
 Φa KM
b 
(µM) 
kcat/KMb  
(M-1s-1) 
in 
vitrod HEK
e neurons (Syn)e 
neurons 
(CaMKII)e HEK
f neuronsg neurons 
VF-EX1 0.004 1.2  2.1x105  53 7 4.1 3.0 19 --- --- 
VF-EX2 0.013 0.12  1.3x106  11 17 4.8 3.7 21 7.2 20 
VF-EX0 0.24 --- --- --- --- --- --- --- --- --- 
VF2.1.Cl 0.08 --- --- --- --- --- --- --- --- --- 
ASAP 1 --- --- --- --- --- >50 --- --- -6.5 4.9 
Ace2N --- --- --- --- --- >50 --- --- -2.9 11 
--- = not determined or not applicable. a Quantum yield of fluorescence. Measured in 
HBSS (pH 7.4). b Determined by reaction of dye with purified PLE in HBSS (pH 7.4). c 
Ratio of VF-EX1 or VF-EX2 fluorescence in PLE-expressing cells (or PLE-containing 
buffer, for in vitro) to cells not expressing PLE. d After 3 hours in buffer, with or without 
PLE. e After 30 min (HEK cells) or 60 min (neurons) at 37 °C. f Per 100 mV 
depolarization, in HEK cells. g Per action potential evoked by field stimulation. All 
constructs are under the control of the Syn promoter. 
. 
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Figure 2-1. Spectroscopic characterization of VoltageFluor-EX 1 and 2.  
 
Figure 2-1. (a,d) UV/vis absorption and (b,e) fluorescence emission spectra of VF-EX1 
(a,b) or VF-EX2 (d,e) in the absence (black line) or presence (green line) of purified 
porcine liver esterase (PLE, 0.7 mg/mL, 3 h). Excitation provided at 520 nm. (c,f) Plot of 
relative initial rate vs. substrate concentration for the reaction of PLE (200 ng/mL) with 
(c) VF-EX1 or (f) VF-EX2. Data points are mean ± S.E.M. for n = 4 independent 
measurements. Solid line is the line of best-fit to the Michaelis-Menten equation 
(Graphpad).
47	
Figure 2-2. Excitation spectra of VF-EX1 and 2. 
 
 
Figure 2-2. Excitation scans of (a) VF-EX1 and (b) VF-EX2 (both at 2 µM, in HBSS. 
Excitation wavelength was from 300 to 540 nm and emission was monitored at 550 nm. 
Green line represents presence of PLE for 3 hours and black line represents absence of 
PLE for the same amount of time. c) and d) Relative increase in fluorescence intensity for 
(c) VF-EX1 and (d) VF-EX2. For each plot, the (+) PLE values (green) were divided by 
the (-) PLE values (black). The result was smoothed using a median filter (moving 
average of ±6 points) and normalized to the maximum value. The largest fold turn-on is 
near the excitation maximum of 525 nm. Lower fold turn-on values are found centered at 
475 nm.  
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Figure 2-3. HPLC analysis of PLE reaction with VF-EX1 and VF-EX2.   
 
 
 
Figure 2-3. HPLC traces of the parent dye VF2.1.Cl and VF-EX dyes with and without 
PLE reaction.  
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Figure 2-4. PLE constructs used in this study.  
 
 
 
Figure 2-4. PLE constructs used in this study.  
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Figure 2-5. Characterization of PLE expression in HEK cells by immunohistochemistry.  
  
 
Figure 2-5. Fixed-cell, wide-field immunofluorescence in HEK cells. a-d) Control HEK 
cells (a) show clear nuclei with Hoechst 33342 (b) and no membrane-associated 
fluorescence as assayed by anti-HA (α-HA) immunofluorescence (c,d). In contrast, HEK 
cells expressing PLE-DAF (e-h) and PLE-pDisplay (i-l) show clear membrane-associated 
fluorescence when probed against the presence of the HA epitope (α-HA, g and k). Scale 
bar is 20 µm.  
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Figure 2-6. Cellular and functional characterization of VoltageFluor-EX 1 and 2.
 
Figure 2-6. Widefield fluorescence microscopy of HEK cells stained with (a-d) VF-EX1 
(500 nM, 30 min) or (g-j) VF-EX2 (500 nM 30 min) show membrane-associated 
fluorescence only in cells expressing cell-surface PLE (indicated by mCherry 
fluorescence). (a,g) Epifluorescence images showing VoltageFluor-associated 
fluorescence. (b,h) Transmitted light image of HEK cells. (c,i) Fluorescence image of 
nuclear-localized mCherry indicating PLE expression. (d,j) Merged imaging showing 
overlay of both VoltageFluor and mCherry fluorescence. Scale bars are 20 µm. (e,k) Plot 
of fractional change in fluorescence (ΔF/F) vs. final membrane potential for (e) VF-EX1 
and (k) VF-EX2  in HEK cells under whole-cell voltage-clamp conditions. Data are mean 
±S.E.M. for 6 cells (VF-EX1) and 8 cells (VF-EX2). (f,l) Representative plots of 
fractional change in fluorescence (ΔF/F) vs. time for a series of hyper- and de-polarizing 
steps from a holding potential of -60 mV to ±100 mV in voltage-clamped HEK cells 
loaded with (f) VF-EX1 or (l) VF-EX2. 
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Figure 2-7. Characterization of VF-EX1 and VF-EX2 with DAF- and pDisplay-PLE in 
HEK cells. 
 
 
Figure 2-7. Live-cell fluorescence imaging of VoltageFluor-EX dyes in HEK cells. 500 
nM of either VF-EX2 or VF-EX1 was incubated with HEK cells transfected with either 
PLE-DAF or PLE-pDisplay. (a-c) Live-cell, wide-field fluorescence images of VF-EX2 
(a) in PLE-DAF expressing HEK cells (marked by mCherry, b). (c) DIC images show 
cells without mCherry/PLE expression. (d-g) Live-cell, wide-field fluorescence images of 
(d) VF-EX2 in PLE-pDisplay expressing HEK cells (marked by mCherry, f). (g) DIC 
images  show cells without mCherry/PLE expression. Panel (e) shows the cells in (d), but 
brightened 2x. (h-k) Live-cell, wide-field fluorescence images of VF-EX1 (h) in PLE-
DAF expressing HEK cells (marked by mCherry, j). (k) DIC images show cells without 
mCherry/PLE expression. Panel (i) shows the cells in (h), but brightened 2x. (l-o) Live-
cell, wide-field fluorescence images of VF-EX1 (l) in PLE-DAF expressing HEK cells 
(marked by mCherry, n). (o) DIC images show cells without mCherry/PLE expression. 
Panel (m) shows the cells in (l), but brightened 3x. Scale bar is 20 µm. Acquisition and 
display setting are identical for panels a,d,h, and l. (p-q) Quantification of cell membrane-
associated fluorescence for (p) VF-EX2 with DAF/pDisplay constructs and (q) VF-
EX1with DAF/pDisplay constructs. Data are mean ± S.E.M. for n = 8-19 regions of 
interest comprising at least 2-3 cells each (individual values for the ROIs are indicated by 
markers).  
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Figure 2-8. Quantification of contrast between PLE-expressing (DAF-targeted) and 
untransfected HEK cells stained with VF-EX1 or VF-EX2.  
 
 
Figure 2-8. 500 nM of either VF-EX2 or VF-EX1 was incubated for 30 minutes at 37 °C 
with HEK cells transfected with PLE-DAF, replaced with dye-free HBSS and imaged. 
Panels (a) and (b) show the measured 16-bit grey values. Panels (c) and (d) show the 
relative contrast (fold turn-on) between control and transfected cells. Panels (e-g) show 
representative regions of interest used to calculate the mean fluorescence in cells. Data 
are mean grey values ±S.E.M. for 4 to 5 independent coverslips of cells. Each coverslip 
comprises 3 fields of view with regions of interest made up of PLE(+) and PLE(-) cells 
(30-40 cells per coverslip). 
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Figure 2-9. Examination of PLE-[linker]-DAF length dependence on VF-EX2 staining. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2-9. (a) Fluorescence intensity of PLE-expressing HEK cells stained with 500 nM 
VF-EX2. The average fluorescence intensity of PLE-expressing cells (i.e. mCherry-
positive) for n = 40-70 ROIs. Values are mean ± standard deviation. (b) Epifluorescence 
images of HEK cells expressing PLE and stained with VF-EX2. (c) Epifluorescence 
images of fixed cells stained against HA for the presence of PLE. Scale bar is 20 µm. 
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Figure 2-10. Timecourse of VF-EX2 accumulation in HEK cells expressing PLE-DAF. 
 
 
Figure 2-10. (a) The relative fluorescence intensity of HEK cells with (green) or without 
(black) PLE-DAF and loaded with VF-EX2 (500 nM) incubated at 37 °C for the 
indicated amount of time prior to exchanging into dye-free HBSS. Values are normalized 
to the first timepoint (15 min) for the untransfected cells. (b) Contrast, or fold turn-on, for 
cells in panel a. Contrast is calculated by dividing the relative fluorescence intensity for 
the PLE(+) by the PLE(-) cells. (c) The relative fluorescence intensity of HEK cells with 
(green) or without (black) PLE-DAF and loaded with VF-EX2 (500 nM) incubated at 37 
°C for 30 minutes, washed into dye-free HBSS and maintained at 37 °C for 0, 15, 30, 60, 
or 90 minutes (x-axis indicates incubation time of 30 min + wash time). Values are 
normalized to the first timepoint (30 min) for the untransfected cells. (d) Contrast, or fold 
turn-on, for cells quantified in panel c. Contrast is calculated by dividing the relative 
fluorescence intensity for the PLE(+) by the PLE(-) cells. Data are mean values for n = 3 
separate coverslips of HEK cells. Each coverslip contained intensity values for 50-60 
cells. Error bars are S.E.M. (n = 3). 
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Figure 2-11. Possible mechanism of cellular uncaging of VF-EX2 in HEK cells.  
 
Figure 2-11. Fluorescence imaging in HEK cells with VF-EX2 to probe the mechanism 
of cellular uncaging. 
Upper panel. HEK cells, not expressing cell-surface PLE, loaded with 1 µM VF-EX2 at 
37 °C for 15 min show negligible cellular fluorescence (a). A transmitted light/differential 
interference contrast (DIC) image shows the presence of cells (b). When a large excess of 
purified PLE (final [PLE] = 28.1 µg/mL, 4.2 units/mL) is added to cells loaded with VF-
EX2, membrane-associated fluorescence is observed after 30 min (panels c-d).  
Lower panel. HEK cells, not expressing cell-surface PLE, loaded with 1 µM VF-EX2 at 
37 °C for 15 min show negligible cellular fluorescence (e-f). Separately, HEK cells 
expressing cell-surface PLE (and nuclear mCherry) were prepared, harvested, suspended, 
and plated on the confluent layers of untransfected HEK cells shown in panels e,f. After 
30 minutes at 37 °C, the cells were then assayed for increase in membrane-associated 
fluorescence in the VF-EX2-loaded/untransfected cells (g-i). The green fluorescence 
intensity proximal to mCherry-positive cells (i, white stars) was compared to green 
57	
fluorescence away from mCherry positive cells. (j) There was no statistically significant 
difference between the regions (p = 0.44, two-tailed, paired t-test), consistent with our 
hypothesis that PLE cannot activate VoltageFluor-EX across cells. Error bars are ±S.E.M. 
for n = 7 images (each with 6-10 cells) 
(k) A positive control confirms that use of trypsin to harvest cells does not destroy PLE 
activity. Cells expressing surface PLE (green dots, (+) PLE) or not expressing surface 
PLE (black triangles, (-) PLE) were harvested with trypsin, as in g-i, washed, loaded with 
2 µM VF-EX1 and the fluorescence increase over time was analyzed via fluorometer (ex. 
520 nm, em. 530nm). PLE(+) cells (green dots) show an increase in fluorescence over 
time, while PLE (-) cells show negligible fluorescence gains over the course of 2 hours.. 
Scale bar = 20 µm. White stars indicate the location of mCherry-positive cells. 
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Figure 2-12. Cell-surface PLE is required for fluorogenic activation of VF-EX2 dyes. 
 
 
Figure 2-12. Wide-field fluorescence microscopy of HEK cells expressing the original 
pCAGS-PLE-IRES-NLS-mCherry construct (Lavis and co-workers, PNAS, 2012), 
stained with 500 nM VF-EX2 for 30 min at 37 °C. (a) mCherry expression indicates the 
expression of ER-localized PLE. (b) Low-levels of background fluorescence are visible 
from VF-EX2, and (c) fluorescence is not correlated with expression of mCherry/PLE. 
(d) Visible light image of cells from a-c. Scale bar is 20 µm. 
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Figure 2-13. Immunocytochemistry of hippocampal neurons expressing PLE-DAF under 
control of the Synapsin promoter. 
 
Figure 2-13. Wide-field fluorescence images of fixed neurons. 
 
Upper panels. (a-d) Fixed neurons expressing PLE-DAF under control of the Synapsin 
(Syn) promoter show good colocalization between neurons positive for cell-surface PLE 
(anti-HA, green) and nuclear mCherry (red). (e-h) PLE (anti-HA, green) colocalize with 
synapsin (anti-synapsin, magenta).  
 
Lower panels. Expression of PLE driven by the Syn promoter in both GABA-negative 
neurons (excitatory) and GABA-positive neurons (inhibitory). (i-m) PLE (anti-HA, 
green) and mCherry (mCherry, red) expression does not co-localize with GABA (anti-
GABA, magenta). White star indicates PLE-(+), but GABA-(-) neuron. (n-r) PLE (anti-
HA, green) and mCherry (mCherry, red) expression does co-localize with of GABA 
(anti-GABA, magenta). White arrowhead indicates PLE-(+) and GABA-(+) neuron. 
Scale bar = 20 µm and apply to the entire row. Images a-d are under non-permeabilizing 
conditions and images e-r are under permeabilizing conditions. 
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Figure 2-14. Immunocytochemistry of hippocampal neurons expressing PLE-DAF under 
control of different promoters. 
 
 
Figure 2-14. Widefield fluorescence images of fixed neurons transfected with Syn-PLE-
DAF or CaMKIIα-PLE-DAF.  
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Upper panels. (a-d) Fixed neurons expressing PLE-DAF under control of the CaMKIIα 
promoter show good colocalization between neurons positive for cell-surface PLE (anti-
HA, green) and nuclear mCherry (red).  
 
Middle panels. (e-h) Expression of PLE driven by the Syn promoter is pan-neuronal. Of 
the two neurons expressing PLE (anti-HA, green), only one (indicated by the star) is 
positive for CaMKIIα (anti-CaMKIIα, magenta). (i-l) Expression of PLE (anti-HA, 
green) driven by the CaMKIIα promoter (targeting excitatory neurons) is restricted to 
neurons which also express CaMKIIα (anti-CaMKIIα, magenta). The PLE-(+) neuron 
(white star) also expresses CaMKIIα. 
 
Lower panels. (m-p) Expression of PLE (anti-HA, green) driven by the pan-neuronal Syn 
promoter results in PLE expression in inhibitory neurons, which are identified by the 
presence of γ-aminobutyric acid (anti-GABA, magenta). The GABA-(+) neuron (white 
arrowhead) is also PLE-(+). Images in m-p are reproduced, in part, from Figure1-
13n,p,q,r to facilitate comparison. (q-t) Expression of PLE (anti-HA, green) driven by the 
CaMKIIα promoter (targeting excitatory neurons) does not colocalize with inhibitory 
neurons, which are identified by the presence of γ-aminobutyric acid (anti-GABA, 
magenta). The white star indicates a PLE-(+), GABA-(-) neuron and the white arrowhead 
indicates a PLE-(-), GABA-(+) neuron. Scale bar = 20 µm. Images a-d are under non-
permeabilizing conditions and images e-t are under permeabilizing conditions. 
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Figure 2-15. Immunocytochemistry of hippocampal neurons expressing PLE-DAF under 
control of different promoters. 
 
Figure 2-15. Widefield fluorescence images of fixed neurons transfected with pCAGS-
PLE-DAF.  
 
Upper panels. (a-d) Fixed neurons expressing PLE-DAF under control of the CAGS 
promoter show good colocalization between neurons positive for cell-surface PLE (anti-
HA, green) and nuclear mCherry (red).  
 
Lower panels. (e-g) Expression of PLE driven by the CAGS promoter results in PLE 
expression (anti-HA, green) in non-neuronal cell types, as identified by the expression of 
glial fibrillary acid protein, GFAP (anti-GFAP, magenta). White star indicates a PLE-(+) 
and GFAP-(+) cell. (h-j) In contrast, expression of PLE driven by the neuron specific Syn 
promoter results in PLE expression (anti-HA, green) that never colocalizes with GFAP 
(anti-GFAP, magenta). White arrowhead indicates PLE-(+) and GFAP-(-) cell. Scale bar 
= 20 µm. Images a-d are under non-permeabilizing conditions and images e-j are under 
permeabilizing conditions. 
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Figure 2-16. Functional imaging in hippocampal neurons with VoltageFluor-EX 1. 
 
 
 
Figure 2-16. Pan- and excitatory-neuron targeting with VF-EX1. (a-h) Live-cell, 
widefield fluorescence images of rat hippocampal neurons stained with 1 µM VF-EX1 
and expressing PLE-DAF under control of the (a-d) synapsin or (e-h) CaMKIIα promoter 
show clear membrane-associated fluorescence. (a,e) Widefield fluorescence image of 
membrane-associated VF fluorescence in PLE-expressing neurons. (b,f) Nuclear-
localized mCherry confirms PLE expression in defined neurons. (c,g) DIC images of 
neurons. (d,h) Merged images of VF and mCherry fluorescence confirms good 
association between bright, membrane-associated fluorescence and mCherry/PLE 
expression. Scale bars are 20 µm. Asterisks indicate mCherry/PLE-positive neurons 
while arrowheads indicate untransfected neurons. (i) Representative ΔF/F traces for rat 
hippocampal neurons stained with VF-EX1 and transfected with Syn-PLE. Traces are 
ΔF/F from regions of interest at the cell bodies of neurons after background offset and are 
uncorrected for bleaching. Images are acquired at 500 Hz and represent single trial 
acquisitions. 
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Figure 2-17. Functional imaging in hippocampal neurons with VoltageFluor-EX 2. 
 
 
 
Figure 2-17. Pan- and excitatory-neuron targeting with VF-EX 2. (a-h) Live cell, 
widefield fluorescence images of rat hippocampal neurons stained with 1 µM VF-EX2 
(60 min.) and expressing PLE-DAF under control of the (a-d) synapsin or (e-h) CaMKIIα  
promoter show clear membrane-associated fluorescence. (a,e) Widefield fluorescence 
image of membrane-associated VF fluorescence in PLE-expressing neurons. (b,f) 
Nuclear-localized mCherry confirms PLE expression in defined neurons. (c,g) 
Differential interference contrast (DIC) images of neurons. (d,h) Merged images of VF 
and mCherry fluorescence confirms good association between bright, membrane-
associated fluorescence and mCherry/PLE expression. Scale bars are 20 µm. Asterisks 
indicate mCherry/PLE-positive neurons while arrowheads indicate untransfected neurons. 
(i) Representative ΔF/F traces for rat hippocampal neurons stained with VF-EX2 and 
transfected with Syn-PLE. Traces are ΔF/F from regions of interest at the cell bodies of 
neurons after background offset and are uncorrected for bleaching. Images are acquired at 
500 Hz and represent single trial acquisition. 
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Figure 2-18. Quantification of VF-EX1 and VF-EX2 / PLE in live neurons. 
 
 
Figure 2-18. Quantification of VF-EX1 and VF-EX2 / PLE in live neurons.  
 
Upper Panel (a) Quantification of the relative fluorescence turn-on in neurons stained 
with either VF-EX1 or VF-EX2 and expressing PLE-DAF under control of the synapsin 
or CaMKII promoter relative to control cells. Individual points are the average contrast 
ratio between for 6-10 neurons expressing PLE and 6-10 neurons not expressing PLE, on 
a single coverslip. Error bars are ±S.E.M. (b) Comparison of the fluorescence intensity 
(pixel grey values, 16-bit scale) of VF-EX1 and VF-EX2 in neurons expressing PLE-
DAF under control of the synapsin promoter. Each point represents an individual neuron. 
(c) Comparison of the relative fluorescence intensity of VF-EX1 and VF-EX2 in neurons 
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expressing PLE-DAF under control of the synapsin promoter. Each point represents an 
individual neuron. Error bars are ±S.E.M. 
 
Lower Panel. Timecourse of VF-EX2 accumulation in neurons expressing PLE-DAF 
(synapsin). (d) The relative fluorescence intensity of neurons with (green) or without 
(black) PLE-DAF and loaded with VF-EX2 (1 µM) incubated at 37 °C for the indicated 
amount of time prior to exchanging into dye-free HBSS. Values are normalized to the 
first timepoint (30 min) for the untransfected cells. (e) Contrast, or fold turn-on, for cells 
in panel d. Contrast is calculated by dividing the relative fluorescence intensity for the 
PLE(+) by the PLE(-) cells. (f) The relative fluorescence intensity of neurons with 
(green) or without (black) PLE-DAF and loaded with VF-EX2 (1 µM) incubated at 37 °C 
for 30 minutes, washed into dye-free HBSS and maintained at 37 °C for 0, 30, or 60 
minutes (x-axis indicates incubation time of 30 min + wash time). Values are normalized 
to the first timepoint (30 min) for the untransfected cells. (g) Contrast, or fold turn-on, for 
cells quantified in panel f. Contrast is calculated by dividing the relative fluorescence 
intensity for the PLE(+) by the PLE(-) cells. Data are mean values for n = 3 separate 
coverslips of neurons. Each coverslip contained intensity values for 15-20 cells. Error 
bars are S.E.M. (n = 3). 
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Figure 2-19. Spiking events recorded optically by VF-EX2/PLE, ASAP 1, and Ace2N. 
 
 
 
Figure 2-19. Comparison of VoltageFluor-EX2 to genetically encoded voltage 
indicators. (a-c) Live-cell, widefield fluorescence imaging of neurons expressing (a) PLE 
and stained with 1 µM VF-EX2 (60 min.), (b) ASAP 1, or (c) Ace2N-mNeon (Ace2N) 
under control of the Syn promoter. Scale bar is 20 µm. (d-f) ΔF/F vs. time plots for action 
potentials evoked and optically recorded with either (d) VF-EX2/PLE, (e) ASAP 1, or (f) 
Ace2N. (d)g-h) Quantification of (g) ΔF/F and (h) signal-to-noise (SNR). Data are mean 
±S.E.M. for n = 16, 7, and 13 neurons (each neuron is the average of 9 evoked action 
potentials). 
68	
Figure 2-20. Spiking events recorded optically by VF-EX2/PLE, ASAP 1, and Ace2N. 
 
 
 
Figure 2-20. Compare evoked action potentials recorded optically by VF-EX2/PLE, 
ASAP 1, and Ace2N. (a) Representative data used to construct plots in Figure 4d-f in the 
main text. Plots show ΔF/F vs time for rat hippocampal neurons expressing the indicated 
constructs under control of the synapsin promoter. (b-d) Representative images showing 
neurons expressing PLE (syn) and stained with VF-EX2. (b) PLE-negative ROIs are 
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indicated in white, and the background ROI is in yellow on the DIC image. The green 
ROI is the PLE-positive cell. (c) mCherry image reveals a single PLE-positive cell. (d) 
The PLE(+) neuron is brighter than the surrounding neurons. Scale bar is 20 µm. (e) 
Evoked activity across the entire field of view can only be observed in the PLE positive 
neuron (green trace); the other cells do not have enough fluorescence signal. 
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Figure 2-21. Spontaneous activity in rat hippocampal neurons and quantification of 
cellular vs. membrane-associated fluorescence. 
 
 
Figure 2-21. Compare spontaneous activity and fluorescence localization of VF-EX2, 
ASAP 1 and Ace2N in cultured neurons.  
 
Left panel. Representative ΔF/F traces for rat hippocampal neurons (a) transfected with 
Syn-PLE  and stained with VF-EX2 or just transfected with (b) ASAP 1, or (c) Ace2N. 
Images were acquired at 500 Hz and ΔF/F was computed by plotting the intensity at an 
ROI encompassing the cell body divided by the initial fluorescence intensity.  
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Middle panel. To quantify the relative amount of membrane-associated fluorescence, 
intensity profiles were acquired for at least 8 neurons from (d) VF-EX2/PLE, (e) ASAP 
1, and (f) Ace2N.  
 
Right and lower panel. For each intensity profile, the distance was normalized (0 to 1.0) 
and rounded to the nearest 0.01 increment. The normalized fluorescence for each profile 
was plotted (grey traces, g-i) and then averaged (green traces, g-i). The ratio of inner 
fluorescent to outer fluorescence was quantified in the following manner. Inner 
fluorescence was defined as the average fluorescence intensity from 0.2 to 0.8 along the 
cell profile. Outer fluorescence was defined as the average fluorescence from 0 to 0.2 and 
from 0.8 to 1.0 along the cell profile. The ratio for each cell was calculated and plotted in 
panel j. Error bars are ±S.E.M. for n = 8 (VF-EX2/PLE or ASAP 1) or 10 cells (Ace2N).  
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Figure 2-22. Interrogation of the neuromodulatory effects of serotonin on neurons from 
the rat hippocampus. 
 
 
Figure 2-22. Optical recording of neuronal activity using VF-EX2 in cultured 
hippocampal neurons upon various drug treatment. (a-c) Hippocampal neurons 
expressing PLE (CaMKIIα-PLE) and stained with 1 µM VF-EX2 (60 min.) were treated 
with (a) 5-HT (10 µM) alone, (b) in the presence of WAY 100635 (10 nM), or (c) in the 
presence of ketanserin (100 nM). The firing rate of neurons was measured before (left 
bars), during (middle bars), and after (right bars) washout of 5-HT. Data are mean ± 
S.E.M. for the average firing rate of 8-10 different coverslips of neurons. Each 
coverslip’s average firing frequency was measured from between 5-8 individual neurons, 
for a total of between 46-93 neurons for each condition. Two-tailed Mann-Whitney tests 
were used to determine statistical significance.  
*** indicates p < 0.005; **** indicates p < 0.001.
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Figure 2-23. Interrogation of the neuromodulatory effects of serotonin on neurons from 
the rat hippocampus. 
 
 
Figure 2-23. Optical recording of neuronal activity using VF-EX2 in cultured 
hippocampal neurons upon various drug treatment. (a) Prior to 5-HT treatment, all 
neurons show similar firing rates, even in the presence of WAY 100635 or ketanserin. (b) 
During 5-HT treatment, cells treated only with 5-HT or cells treated with 5-HT in the 
presence of ketanserin showed a decrease in the spike frequency. There was no statistical 
difference between neurons with and without ketanserin. The presence of the 5-HT1A 
inhibitor, WAY 100635, blocked the effect of 5-HT. (c) After washout of drugs (both 5-
HT and inhibitors), cells return to normal firing frequencies which are statistically 
indistinguishable from one another. Plots show mean ±S.E.M. for n = 12, 8, and 9 
coverslips (control, WAY 100635, and ketanserin treatment). Each coverslip represents 
the average firing frequency of 5-8 neurons. A two-tailed Mann-Whitney test for 
statistical significance was employed; p-values are indicated in comparisons across 
conditions.
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Abstract 
 Given the success of the VF-EX approach described in chapter 2, we aim to 
further optimize the system from both the protein and chemical side, to enhance the 
contrast of targeted staining as well as to expand the scope of targeting to other cell types 
or specific cellular locations. The enzyme-mediated activation strategy can be extended 
to any dyes with a phenolic oxygen, thus we have chosen two dyes with better photo-
physical properties, carboVoltageFluor and isoVF2.2.Cl(OMe), as candidates for 
masking. While both dyes’ fluorescence were effectively quenched by cyclopropyl ester, 
only the former was a substrate, displaying fluorescence turn-on and voltage sensitivity in 
cultured HEK cells and neurons. On the other hand, we also attempted to vary the PLE 
construct for expression with cell type-specificity and subcellular precisions. To enable 
expression in inhibitory neurons, GAD65 and GAD67 promoters were used but the 
immunostaining data to determine their specificity were inconclusive and there was also 
insufficient enzyme expression to allow for contrast in staining. We then changed the 
targeting sequences for pre- and post-synaptic localization but immunostaining showed 
uniform signal across the cellular membrane instead of the expected punctate staining 
pattern.  
 
Introduction 
 We previously showed that fluorescein-based VoltageFluor dyes could be adapted 
to cell-specific targeting through a fluorogenic approach. Alkylation of the phenolic 
oxygen of VF2.1.Cl with either a photo-labile nitrobenzyl protecting group1 or a 
hydrolytically-stable cyclopropylmethyl acetoxy methyl ether2 results in decreased 
fluorescence, which can be restored by photo-uncaging1 or the action of an exogenously 
expressed esterase2. Localization of porcine liver esterase (PLE) on the cell surface 
results in VF fluorescence restricted to cells that express PLE. This hybrid approach 
consisted of small molecule protection and cell-surface enzymatic activation combines 
the speed and sensitivity of PeT-based voltage indicators with the cellular specificity of 
genetic encoding. The VF-EX system described in chapter 2 is a proof-of-concept that 
demonstrates the ability of fluorogenic activation strategy to record neuronal activity in 
cells of interest with high spatial and temporal resolution by our voltage sensitive dye.  
 This chapter describes the efforts and progress towards improving the system and 
generalizing the strategy to dyes of different colors, increased voltage sensitivity or 
enhanced photo-physical properties, which would eventually boost the contrast between 
cells of interest and background, non-specific cells and potentially achieve targeting in 
complex tissues such as ex vivo slices. We have chosen two dyes, carboVoltageFluor 
(carboVF) and isoVF2.2.Cl(OMe), which both exhibit superior performance in both HEK 
cells and neurons, compared to the first generation dye VF2.1.Cl used in the original VF-
EX system.  
 Carbofluoresceins are an attractive target for responsive probes because they 
maintain oxygen substitution patterns at the 3' and 6' positions, similar to fluorescein, 
while simultaneously possessing excitation and emission profiles red-shifted nearly 50 
nm compared to fluorescein. Co-workers in the lab have shown that inclusion of a 
sulfonic acid functional group prevents the spirocyclization typical of carbofluoresceins. 
Dichloro-substituted sulfone carbofluoresceins incorporated into a PeT-based voltage-
sensing scaffold, carboVF2.1(OMe).Cl, possesses >30% ΔF/F response to 100 mV 
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depolarizations in HEK cells, has excitation and emission spectra >560 nm, and readily 
reports on action potentials in mammalian neurons.3 The use of sulfone carbofluoresceins 
in the context of voltage sensing enables complementation with a growing toolkit of 
strategies for fluorogenic targeting. Meanwhile, isoVF2.2.Cl(OMe) has similar spectral 
properties as VF2.1.Cl, as both are fluorescein-based. Nonetheless, modifications on the 
aniline electron-rich donor and position of phenylenevinylene molecular wire relative to 
the fluorophore head significantly improve the voltage sensitivity and signal to noise in 
isoVF2.1.Cl(OMe) with 48% ΔF/F per 100 mV and D’ of 150, relative to 27% ΔF/F per 
100 mV and D’ of 22 for VF2.1.Cl (unpublished data). Hence, we believe that both dyes 
are ideal candidates for cyclopropyl ester-based quenching on phenolic oxygen and PLE-
mediated activation in cells of interest to achieve targeting.  
 In addition to the modifications on the chemical side, we are also working on 
enzyme expression by switching the membrane targeting domain and the promoter 
sequences, to achieve high-contrast voltage imaging at specific cell types and subcellular 
structures. This chapter also presents some preliminary data on inhibitory cell targeting as 
well as pre- and post-synaptic targeting of PLE in cultured hippocampal neurons.  
 
Results & Discussions 
 
3-1: Application of PLE-based fluorogenic activation to carboVoltageFluor 
 Carbo-VoltageFluors targeted by esterase expression (carboVF-EX) are 
synthesized in a single step from carboVF2.1(OMe).Cl (Scheme 3-1-1). Addition of 
stoichiometric (EX 1) or excess (EX 2) iodo-1-methylcyclopropane-carboxylate in DMF 
using N,N-diisopropylethylamine as a base provides the singly and doubly protected 
carboVF-EX derivatives. Alkylation results in a hypsochromatic shift in the absorption 
spectrum, from a maximum at 550 nm for carboVF2.1(OMe).Cl to 420 nm for carboVF-
EX 1 (Figure 3-1-1a). Alkylation of the phenolic oxygen of carboVF2.1(OMe).Cl results 
in a 12-fold decrease in fluorescence quantum yield (Table 3-1-1). 
 The carboVF-EX dyes are substrates for purified PLE (Sigma, E2884). CarboVF-
EX1 and EX2 are hydrolyzed by PLE, resulting in a 45- or 21- fold increase in 
fluorescence, respectively, after 2h. Release of the caged species results in 
carboVF2.1(OMe).Cl-like absorbance and emission profiles (Figure 3-1-1a,b, Figure 3-1-
2a,b). HPLC analysis reveals carboVF2.1(OMe).Cl as the product of PLE-mediated 
hydrolysis reactions (Figure 3-1-3). Both carboVF-EX 1 and 2 show saturation-type 
enzymatic kinetics with PLE (Table 3-1-1, Figure 3-1-1c, Figure 3-1-2c). The Michaelis 
constant, KM, for carboVF-EX 1 is 6.4 ± 1 µM and 0.16 ± 0.06 µM for carboVF-EX 2. 
These values correspond reasonably well with the values we obtained for the fluorescein-
based VF-EX 1 (1.2 ± 0.5 µM) and VF-EX 2 (0.12 ± 0.03 µM).2 All of these values are 
within the range for the reaction of bis(cyclopropylacetoxymethy)-fluorescein, 0.5 µM.4 
The double-protected carboVF-EX 2 is a better substrate for PLE than the singly-
protected carboVF-EX 1: the kcat/KM for carboVF-EX 2 is 4.9 × 105 M-1s-1, nearly 5-fold 
larger than the value for carboVF-EX 1 (1.3 × 105 M-1s-1). Again, the measured kcat/KM 
values for carboVF-EX dyes closely match the values obtained for fluorescein VF-EX 
dyes (Table 3-1-1).2 
 We next sought to determine if we could elicit a similar turn-on phenomenon in 
living cells. CarboVF-EX 1 (500 nM, 30 min or 1 h) was bath applied to HEK cells 
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transfected with cell-surface PLE anchored via a glycophosphatidyl inositol, GPI, anchor 
(GPI sequence derived from decay-accelerating factor, DAF; Figure 3-1-4, Figure 3-1-5). 
CarboVF-EX 1 was uncaged by PLE on the cell surface, displaying membrane-associated 
fluorescence in transfected cells (as indicated by nuclear-localized GFP fluorescence, Fig. 
5a-c). CarboVF-EX 2 did not elicit a turn-on response when bath-applied to PLE-
expressing HEK cells (data not shown). We hypothesize that due to the extra carbon 
dimethyl group (C(CH3)2), carboVF-EX 2 is more lipophilic than VF-EX 2 and does not 
properly load into cell membranes. Due to these results, we carried carboVF-EX 1 
forward in our studies. 
 HEK cells expressing PLE-DAF and stained with carboVF-EX 1 show a 8.9 
(±0.7) fold turn-on after 30 mins, respectively, when compared to non-transfected cells 
from the same culture (Figure 3-1-6a-c). These results match the observed 7-fold increase 
in fluorescence after uncaging of VF-EX 1 in HEK cells. As with fluorescein-based VF-
EX 1, longer incubation times with carboVF-EX 1 increases the overall fluorescence 
associated with carboVF-EX 1 in PLE-expressing cells, but decreases the contrast due to 
accumulation of uncaged carboVF-EX 1 in untransfected cells. Following enzymatic 
uncaging, carboVF-EX 1 was voltage sensitive in PLE-DAF expressing HEK cells, 
displaying an 18% ΔF/F per 100 mV, lower than the 31% ΔF/F displayed by 
carboVF2.1(OMe).Cl (Figure 3-1-6d,e). The lower fractional voltage sensitivity may be a 
result of increased background staining with carboVF-EX 1 compared to 
carboVF2.1(OMe).Cl.  
We observe selective staining of neurons expressing PLE-DAF under the neuron-
specific synapsin promoter (Syn) using carboVF-EX 1 (Figure 3-1-7a-c, Figure 3-1-4). 
Bath-application of carboVF-EX 1 using 500 nM, 1 µM, or 2 µM results in 2.4-, 2.3, and 
1.9-fold turn-on after 30 minutes. We also loaded 500 nM carboVF-EX1 for 1 hr, but saw 
a decrease in contrast with a 1.8-fold turn-on. Our results are comparable to those 
obtained with VF-EX1 (1 µM), which exhibits a 4.1-fold turn-on in neurons after 1 hr.2 
The membrane fluorescence associated with carboVF-EX 1 in neurons is voltage-
sensitive. CarboVF-EX1 responds to field stimulation electrode-evoked action potentials 
with a voltage sensitivity of 8.4% ΔF/F (SNR = 12 ± 0.8, n = 9 cells, Figure 3-1-8) and 
was able to record spontaneous spiking events in cultured neurons transfected with PLE-
DAF (Figure 3-1-7d) – comparable to the values of VF-EX2 / PLE in cultured neurons 
that we previously reported (7.3 ± 0.8%, SNR = 20 ± 2.7).2 
  
3-2: Application of PLE-based fluorogenic activation to isoVF2.2.Cl(OMe) 
 We appended a cyclopropylmethyl acetoxy methyl ether to the phenolic oxygen 
of isoVF2.2.Cl(OMe) to obtain cp-isoVF2.2.Cl(OMe) (isoVF2.2.Cl(OMe) synthesis was 
conducted by Dr. Rishi Kulkarni and cp-isoVF2.2.Cl(OMe) synthesis was conducted by 
Dr. Vincent Grenier). We used the same CMV-PLE-DAF construct in the VF-EX system 
in which a nuclear mCherry acts as a marker for PLE expression (Scheme 3-2-1). The 
ester successfully quenched the fluorescence of the parent dye, as demonstrated in the 
absorption and emission spectra of cp-isoVF2.2.Cl(OMe) (Figure 3-2-1). Unfortunately, 
the masked dye is not a good substrate for PLE. When the dye was reacted with purified 
pig liver esterase (excess, 37 °C for 2 h), negligible absorbance turn-on was observed at λ 
= 520 nm, the absorption maximum for the parent dye isoVF2.2.Cl(OMe) (Figure 3-2-
2a). There was a 5-fold increase in fluorescence (Figure 3-2-2b), which is minimal 
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compared to the more than 20-fold turn-on in both VF-EX and carboVF-EX systems.2-3 
We also confirmed the ineffective conversion by checking the HPLC traces, revealing 
that most of starting material, cp-isoVF2.2.Cl(OMe), remained in the reaction mixture 
after reaction with excess PLE (Figure 3-2-3). Nonetheless, we still moved on to HEK 
cells to evluate the efficiency of PLE unmasking the dye. Again, the cyclopropyl ester 
indeed masked and quenched the fluorescence of the parent dye with minimal signal from 
the cells not expressing PLE (Figure 3-2-4a), compared to the bright, membrane-
associated fluorescence in the parent dye (Figure 3-2-4c). However, in cells expressing 
cell-surface PLE, we did not observe any fluorescence turn-on, suggesting that cp-
isoVF2.2.Cl(OMe) is a poor substrate for the enzyme (Figure 3-2-4b). We hypothesize 
that the kinked shape of cp-isoVF2.2.Cl(OMe) due to the wire orientation prevents the 
enzyme from incorporating the dye into its active site to remove the ester. To verify this, 
we would need to synthesize a few other masked dyes of different wire orientations or 
conduct modeling studies to probe the substrate-active site structure in the PLE enzyme.  
 
3-3: Targeting PLE to inhibitory neurons 
 Since we have successfully expressed PLE in excitatory neurons under the control 
of a CaMKIIα promoter and saw desirable fluorescence turn-on in targeted cells2, we 
next explored the possibility of achieving a similar contrast in inhibitory neurons. We 
have chosen the glutamate decarboxylase  (GAD) promoter since the GAD enzyme is 
known to decarboxylate glutamate to GABA, the important inhibitory neurotransmitter.5-6 
There are two isoforms of the enzyme, GAD65 and GAD67, which differ in their 
molecular weight as their names suggest. Both function at different locations and 
developmental stages and differ at their functions slightly. While GAD65 synthesizes 
GABA to be used as neurotransmitters, GAD65 is found almost exclusively at nerve 
terminals and expressed later during synapse development. On the other hand, GAD67 is 
present uniformly in the cells and throughout development to produce GABA for cellular 
functions other than neurotransmission.7-11 The promoter sequences for both were 
extracted using PCR from rat genomic DNA to prepare two different PLE constructs 
(Figure 3-3-1). 
 We first performed immunohistochemistry on the constructs by staining against 
the HA tag, which is indicative of PLE expression (Figure 3-3-2). Using permeablizing 
conditions, we observed that PLE expression under the GAD67 promoter was mostly 
cytosolic and concentrated in the cell body while that under the GAD65 promoter 
exhibited membrane-bound signal in both the cell body and processes. We also stained 
for all the inhibitory neurons in the culture with an anti-GABA antibody. While most 
anti-HA staining (i.e. PLE expression) matched anti-GABA fluorescence (Figure 3-3-
3a,b for GAD65, Figure 3-3-3d for GAD67), a small portion of PLE-expressing cells did 
not have GABA expression (Figure 3-3-3c for GAD65, Figure 3-3-3e for GAD67), 
suggesting non-inhibitory cell types. These data to verify the expression pattern are 
inconclusive so far; thus, additional staining against anti-CaMKIIα, marker for excitatory 
neurons, or an alternative inhibitory marker such as anti-GAD, would be necessary to 
confirm the cell-type specificity, if any, for both GAD65 and GAD67 promoters.  
 Despite the ambiguous results in immunohistochemistry, we tested the constructs 
with VF-EX2 for live cell staining (Figure 3-3-4). Unfortunately, all the neurons in the 
field view, for both constructs, seemed to have similar fluorescence staining, which is 
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probably cellular auto-fluorescence or minimal background fluorescence from the 
incompletely quenched dye. These results are consistent with the immunostaining data 
that PLE expression on the cell surface under these inhibitory promoters is basically 
inefficient, leading to negligible enzymatic activity for fluorogenic activation. Future 
work involves investigating other inhibitory promoters or alternative PLE analogs.  
 
3-4: Targeting PLE to pre- and post-synaptic terminals 
 We also tried targeting PLE to specific subcellular locations, including pre- and 
post-synaptic terminals. Electrical activities at these structures are challenging to study 
due to their micrometer sizes, that is significantly smaller than a tip of patch pipette in 
electrophysiology. Fluorescent signal in these areas can be easily concealed in the 
background or non-specific staining in all cells; as a result, targeting our dye to those 
subcellular structures with contrast above the background would be necessary to record 
activities with enough signal-to-noise ratio.  
We used the signal peptides and localization sequences from a split GFP-based 
construct mGRASP, which enables synapse imaging.12 When a synapse is formed, the 
GFP fragments reconstitute and fluoresce. By simply replacing the GFP fragments in the 
pre- and post-synaptic constructs with our PLE sequence, we generated four constructs 
under synapsin and CAG promoter (Figure 3-4-1). Cytosolic mCherry was used to better 
visualize the expected punctate staining along the neuronal processes. In cultured 
neurons, expression of PLE under the synapsin promoter was so weak that no 
fluorescence turn-on was seen in cells expressing mCherry (Figure 3-4-2a,b and Figure 3-
4-3a,b). CAG promoter enhanced the enzyme expression as evidenced by selective 
staining and contrast in PLE-expressing neurons (Figure 3-4-2c,d and Figure 3-4-3c,d). 
However, the staining was uniform throughout the membrane, while punctate staining 
should be expected, suggesting that either PLE was not targeted to the desired locations 
or the uncaged dye diffused quickly across the cellular membrane. We then did 
immunostaining on the CAG constructs, confirming that PLE was not expressed at pre- 
or post-synaptic terminals; instead it was trafficked to the cell surface without any 
specificity from the targeting moieties (Figure 3-4-4). Future work on targeting to 
subcellular structures involves exploring other signal peptides, targeting domains or 
promoters.  
 
Conclusion 
 In this chapter, we have demonstrated that PLE/cyclopropyl ester-based activation 
strategy can be applied to selected dyes of improved photo-physical properties. In 
particular, carboVF-EX 1 is the first long-wavelength voltage sensitive dye targeted to 
specific cells via enzyme-mediated fluorogenic activation, providing voltage imaging 
performance rivaling that of previous enzyme-activated voltage indicators (VF-EX), but 
at long wavelengths compatible with GFP. Nonetheless, the low contrast ratio between 
PLE-expressing cells and wild-type cells needs to be addressed, by both decreasing the 
brightness of caged cVF-EX1-type dyes and improving singly-protected cVF-EX1-type 
dyes as substrates for PLE. On the other hand, the isoVF dye with a kinked molecular 
wire, did not seem to fit into the enzyme activate site for ester removal, though more 
studies are required to provide clearer explanations. Attempts at targeting PLE to 
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inhibitory cells, pre- and post-synaptic terminals yielded little positive results, but a 
variety of signal peptides and targeting sequences are yet to be examined.  
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Experimental Section 
 
Spectroscopic studies  
UV-Vis absorbance and fluorescence spectra were recorded using a 2501 
Spectrophotometer (Shimadzu) and a Quantamaster Master 4 L-format scanning 
spectrofluorometer (Photon Technologies International). The fluorometer is equipped 
with an LPS-220B 75-W xenon lamp and power supply, A-1010B lamp housing with 
integrated igniter, switchable 814 photon-counting/analog photomultiplier detection unit, 
and MD5020 motor driver. Samples were measured in 1-cm path length quartz cuvettes 
(Starna Cells). The maximum absorption wavelength (λmax) and maximum emission 
wavelength (λem) were taken in HBSS (zero Ca2+, zero Mg2+, no phenol red, pH 7.4) 
using stock solutions of dyes in DMSO (0.5-2 mM). Absorbance was collected from 300 
nm to 700 nm for both carboVF and isoVF dyes. For emission scans, carboVF dyes were 
excited at 565 nm and emission was collected from 570 nm to 800 nm while isoVF dyes 
were excited at 520 nm and emission was collected from 525 nm to 700 nm. 
 
In vitro PLE reactions and characterization  
Commercially purified pig liver esterase (PLE, MW = 168 kDa) was obtained 
from Sigma-Aldrich (E2884) as a suspension in 3.2 M (NH4)2SO4, and was diluted from 
a stock solution of 28.1 mg/mL to appropriate concentrations in HBSS (pH 7.4). For the 
enzymatic reaction with carboVF-EX and isoVF-ED dyes, the dyes (final concentration 
of 50 µM) were incubated with 1 µL PLE (final concentration of 0.70 mg/mL) and 1 µL 
Pluronic F-127 (20% w/v in DMSO) in 40 µL HBSS at 37 °C for ~ 2 h. For 
characterization by spectroscopy, the reaction mixture was diluted to 1 mL HBSS (total 
volume) for measurement. For HPLC characterization, 40 µL of acetonitrile (1:1) was 
added, followed by centrifugation to precipitate the enzyme. Supernatant was extracted 
and filtered for HPLC injection.  
Enzyme kinetics experiments for carboVF-EX dyes were performed in black, 
clear-bottom, 96-well polystyrene microplates from Corning. Plates were read from the 
bottom on a Molecular Devices SpectraMax Paradigm Multi-Mode detection platform 
plate reader (λex 560 nm, λem 610 nm). All the measurements were done at 37 °C. Enzyme 
(168 ng/mL) was added to the substrates at t = 5 min and more data were collected for 
another 5 min. To obtain the kinetic constants, the data were fit to the Michaelis-Menten 
equation v = !!"#[!]!!![!]  (GraphPad Prism). 
 
Cell culture  
All animal procedures were approved by the UC Berkeley Animal Care and Use 
Committees and conformed to the NIH Guide for the Care and Use and Laboratory 
Animals and the Public Health Policy.  
Human embryonic kidney 293T (HEK) cells were maintained in Dulbecco’s 
modified eagle medium (DMEM) supplemented with 4.5 g/L D-glucose, 10% fetal 
bovine serum (FBS; Thermo Scientific) and 1% GlutaMax (Invitrogen) at 37 °C in a 
humidified incubator with 5% CO2. Cells were passaged and plated in DMEM (as above) 
at a density of 750,000 cells per well in a 6-well plate. Transfection of plasmids was 
carried out using Lipofectamine 3000 (Invitrogen) ~18-24 h after plating. The cells were 
split again 48 h after transfection and plated onto 12 mm glass coverslips pre-coated with 
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Poly-D-Lysine (PDL; 1 mg/ml; Sigma-Aldrich) at a density of 75,000 cells per coverslip 
in DMEM supplemented with 1 g/L D-glucose, 10% FBS and 1% GlutaMax. Imaging 
was performed 12-18 h after plating. 
Hippocampi were dissected from embryonic day 19 Sprague Dawley rats (Charles 
River Laboratory) in cold, sterile HBSS (zero Ca2+, zero Mg2+, phenol red). All dissection 
products were supplied by Invitrogen, unless otherwise stated. Hippocampal tissue was 
treated with trypsin (2.5%) for 15 min at 37 °C. The tissue was triturated using fire 
polished Pasteur pipettes, in minimum essential media (MEM) supplemented with 5% 
FBS, 2% B-27, 2% 1M dextrose (Fisher Scientific) and 1% GlutaMax. The dissociated 
cells were plated onto 12 mm diameter coverslips (Fisher Scientific) pre-treated with 
PDL (as above) at a density of 25-30,000 cells per coverslip in MEM supplemented 
media (as above). Neurons were maintained at 37 °C in a humidified incubator with 5% 
CO2. At 1 day in vitro (DIV) half of the MEM supplemented media was removed and 
replaced with Neurobasal media containing 2% B-27 supplement and 1% GlutaMax. 
Transfection of plasmids was carried out using Lipofectamine 3000 (without P3000 
reagent) at 6-7 DIV. Imaging was performed on mature neurons 13-16 DIV. 
For loading the dyes in HEK cells and hippocampal neurons, DMSO stock 
solutions were diluted first with 1:1 Pluronic F-127 (20% w/v in DMSO) and then further 
diluted in HBSS to working concentrations. Cells were incubated with dyes in HBSS at 
37 °C in the incubator before exchanging dye/HBSS for HBSS without any dye. All 
imaging was performed in HBSS at room temperature. 
 
Epifluorescence microscopy  
Imaging was performed on an AxioExaminer Z-1 (Zeiss) equipped with a 
Spectra-X Light engine LED light (Lumencor), controlled with Slidebook (v6, Intelligent 
Imaging Innovations). Images were acquired with a W-Plan-Apo 20x/1.0 water objective 
(20x; Zeiss). Images were focused onto either an OrcaFlash4.0 sCMOS camera (sCMOS; 
Hamamatsu) or an eVolve 128 EMCCD camera (EMCCD; Photometrix). For carboVF 
images, the excitation light was delivered from a LED at 575/35 nm and emission was 
collected with a triple emission filter (473/22, 543/19, 648/98 nm) after passing through a 
triple dichroic mirror (475/30, 540/25, 642/96 nm). For isoVF dyes, excitation light was 
delivered at 475 nM (LED, 475 nm, 34 nm bandpass) and emission was collected with a 
540/50 nm bandpass filter after passing through a 510 nm longpass dichroic. 
 
Image analysis  
For image intensity measurements, regions of interest were drawn around cells or 
neuronal cell bodies and the mean fluorescence was calculated in ImageJ (FIJI, NIH). 
Background fluorescence was subtracted by measuring the fluorescence where no cells 
grew. The fold turn-on was calculated by taking the ratio of transfected cells fluorescence 
and untransfected cells fluorescence, both background subtracted. At least 15-20 cells 
were quantified for each coverslip and 4 coverslips were examined to get the average fold 
turn-on.   
Analysis of voltage sensitivity in HEK cells was performed using ImageJ (FIJI). 
Briefly, a region of interest (ROI) was selected automatically based on fluorescence 
intensity and applied as a mask to all image frames. Fluorescence intensity values were 
calculated at known baseline and voltage step epochs. For analysis of voltage responses 
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in neurons, regions of interest encompassing cell bodies (all of approximately the same 
size) were drawn in ImageJ and the mean fluorescence intensity for each frame extracted. 
ΔF/F values were calculated by first subtracting a mean background value from all raw 
fluorescence frames, to give a background subtracted trace (bkgsub). A baseline 
fluorescence value (Fbase) is calculated from the median of all the frames, and subtracted 
from each timepoint of the bkgsub trace to yield a ΔF trace. The ΔF was then divided by 
Fbase to give ΔF/F traces. No averaging has been applied to any voltage traces. 
 
Electrophysiology/Imaging parameters  
For electrophysiological experiments, pipettes were pulled from borosilicate glass 
(Sutter Instruments, BF150-86-10), with a resistance of 4–6 MΩ, and were filled with an 
internal solution; 115 mM potassium gluconate, 10 mM BAPTA tetrapotassium salt, 10 
mM HEPES, 5 mM NaCl, 10 mM KCl, 2 mM ATP disodium salt, 0.3 mM GTP 
trisodium salt (pH 7.25, 275 mOsm). Recordings were obtained with an Axopatch 200B 
amplifier (Molecular Devices) at room temperature. The signals were digitized with a 
Digidata 1440A, sampled at 50 kHz and recorded with pCLAMP 10 software (Molecular 
Devices) on a PC. Fast capacitance was compensated in the on-cell configuration. For all 
electrophysiology experiments, recordings were only pursued if series resistance in 
voltage clamp was less than 30 MΩ. For whole-cell, voltage clamp recordings in HEK 
cells, cells were held at -60 mV and hyper- and de- polarizing steps applied from -100 to 
+100 mV in 20 mV increments.   
Extracellular field stimulation was delivered by a SD9 Grass Stimulator 
connected to a recording chamber containing two platinum electrodes (Warner), with 
triggering provided through the same Digidata 1332A digitizer and pCLAMP 9 software 
(Molecular Devices) that ran the electrophysiology. Action potentials were triggered by 1 
ms 60 V field potentials delivered at 5 Hz. To prevent recurrent activity, the HBBS bath 
solution was supplemented with synaptic blockers; 10 µM 2,3-Dioxo-6-nitro-1,2,3,4- 
tetrahydrobenzo[f]quinoxaline-7-sulfonamide (NBQX; Santa Cruz Biotechnology) and 
25 µM DL-2-Amino-5-phosphonopentanoic acid (APV; Sigma-Aldrich). For both 
evoked action potentials and spontaneous activity, images were binned 4x4 to allow 
sampling rates of 0.5 kHz and 2500 frames (5 s) were acquired for each recording.   
 
Rat genomic DNA extraction 
 Extraction of rat genomic DNA was done following a phenol/chloroform-based 
DNA isolation protocol from the Jackson laboratory (https://www.jax.org/jax-mice-and-
services/customer-support/technical-support/genotyping-resources/dna-isolation-
protocols). Briefly, place about 0.5 cm of rat tail (from pregnant female used in the 
neuron prep) in a 2 mL Eppendorf tube and add 0.5 mL of DNA digestion buffer (50 mM 
Tris-HCl pH 8, 100 mM EDTA pH 8.0, 100 mM NaCl and 1% SDS) with proteinase K 
(0.5 mg/ml final concentration). Incubate at 55 °C with shaking for overnight. Add 0.7 ml 
phenol/chloroform/isoamyl alcohol (25:24:1) and mix well (no vortex). Centrifuge the 
mixture at max speed for 5 minutes and transfer 0.5 mL of the top phase to a new tube. 
Add 1 mL 100% ethanol and mix well until DNA precipitate forms. Centrifuge the tube 
at max speed for 5 minutes and remove the supernatant. Wash the precipitate with 0.5 mL 
cold 70% ethanol, centrifuge for 5 minutes, remove the supernatant and air dry at room 
temperature. Re-dissolve the DNA in EB and it can be used directly in PCR. 
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Immunocytochemistry 
To detect expression and localization of PLE and other protein markers, HEK 
cells or neurons were fixed with 4% paraformaldehyde in PBS for 10 min and 
permeabilized (if required) with 0.3% v/v Triton-X 100 (Sigma Aldrich) in PBS for 2 
min. Blocking was done in 5% w/v bovine serum albumin (BSA; Sigma Aldrich) in PBS 
for 1 h. Primary antibody was incubated at 4 °C overnight, followed by AlexaFluor 
secondary antibody (Life Technologies) at room temperature for 2 h. All antibodies were 
used at 1:1000 dilution.  
 
 
Plasmid construction  
All plasmids were constructed using Gibson Assembly and were confirmed by 
sequencing. The following sequences were used (5' to 3'). 
 
IgK 
ATGGAGACAGACACACTCCTGCTATGGGTACTGCTGCTCTGGGTTCCAGGTTC
CACTGGTGAC 
 
PAT3 
CCACCTTCTACTAGTCTTTTGTTGCTTGCTGCACTTCTCCCCTTCGCTCTTCCC
GCTTCAGATTGGAAGACAGGAGAAGTCACCGCTTCC 
 
PLE (minus ER retention signal) 
ATGGTGTGGCTGCTGCCTCTGGTGCTGACCAGCCTGGCCAGCAGCGCCACCT
GGGCCGGCCAGCCCGCCAGCCCTCCCGTGGTGGACACCGCCCAGGGCAGGGT
GCTGGGCAAGTACGTGAGCCTGGAGGGCCTGGCCCAGCCCGTGGCCGTGTTC
CTGGGCGTGCCCTTCGCCAAGCCTCCCTTGGGCAGCCTGAGGTTCGCTCCTCC
TCAGCCTGCTGAGCCCTGGAGCTTCGTGAAGAACACCACCAGCTACCCTCCC
ATGTGCTGCCAGGATCCCGTGGTGGAGCAGATGACCAGCGACCTGTTCACCA
ACGGCAAGGAGAGGCTGACCCTGGAGTTCAGCGAGGACTGCCTGTACCTGAA
CATCTACACACCCGCCGACCTGACCAAGAGAGGCAGGCTGCCCGTGATGGTG
TGGATCCACGGCGGCGGCCTGGTGCTGGGCGGCGCTCCCATGTACGACGGCG
TGGTGCTGGCCGCCCACGAGAACGTGGTGGTGGTGGCCATCCAGTACAGGCT
GGGCATCTGGGGCTTCTTCAGCACCGGCGACGAGCACAGCAGgGGCAACTGG
Name Primary/ 
Secondary 
Manufacturer Catalog # Isotype 
Anti-HA Primary CST 3724S Rabbit IgG 
Anti-HA Primary CST 2367S Mouse IgG1 
Anti-GABA Primary Sigma-Aldrich A2052 Rabbit IgG 
Anti-rabbit 647 Secondary Life Technologies A21244 Goat IgG 
Anti-rabbit 488 Secondary Life Technologies A11008 Goat IgG 
Anti-mouse 488 Secondary Life Technologies A11001 Goat IgG 
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GGCCACCTGGACCAGGTGGCCGCCCTGCACTGGGTGCAGGAGAACATCGCCA
ACTTCGGCGGCGATCCCGGCAGCGTGACCATCTTCGGCGAGAGCGCCGGCGG
CGAGAGCGTGAGCGTGCTGGTGCTGAGCCCTCTGGCCAAGAACCTGTTCCAC
AGGGCCATCAGCGAGAGCGGCGTGGCCCTGACCGTGGCCCTGGTGAGGAAG
GACATGAAGGCCGCCGCCAAGCAGATCGCCGTGCTGGCCGGCTGCAAGACC
ACCACCAGCGCCGTGTTCGTGCACTGCCTGAGGCAGAAGAGCGAGGACGAG
CTGCTGGACCTGACCCTGAAGATGAAGTTCCTGACCCTGGACTTCCACGGCG
ACCAGAGGGAGAGCCATCCCTTCCTGCCCACCGTGGTGGACGGCGTGCTGCT
GCCCAAGATGCCCGAGGAGATCCTGGCCGAGAAGGACTTCAACACCGTGCCC
TACATCGTGGGCATCAACAAGCAGGAGTTCGGCTGGCTGCTGCCCACTATGA
TGGGCTTCCCTCTGAGCGAGGGCAAGTTGGACCAGAAGACCGCCACCAGCCT
GCTGTGGAAGAGCTATCCCATCGCCAACATTCCCGAGGAGCTGACACCCGTG
GCCACCGACAAGTACCTGGGCGGCACCGACGATCCCGTGAAGAAGAAGGAC
CTGTTCCTGGACCTGATGGGCGACGTGGTGTTCGGCGTGCCCAGCGTGACCGT
GGCCAGGCAGCACAGGGACaCCGGCGCTCCCACCTACATGTACGAGTTCCAG
TACAGGCCCAGCTTCAGCAGCGACAAGAAGCCCAAGTCCGTGATCGGCGACC
ACGGCGACGAGATCTTCAGCGTGTTCGGCTTCCCTCTGCTGAAGGGCGACGC
TCCCGAGGAGGAGGTGAGCCTGAGCAAGACCGTGATGAAGTTCTGGGCCAAC
TTCGCCAGGAGCGGCAATCCCAACGGCGAGGGCCTGCCTCACTGGCCCATGT
ACGACCAGGAGGAGGGCTACCTGCAGATCGGCGTGAACACCCAGGCCGCCA
AGAGGCTGAAGGGCGAGGAGGTGGCCTTCTGGAACGACCTGCTGAGCAAGG
AGGCCGCCAAGAAGCCTCCTAAGATCAAG 
 
HA 
TATCCATATGATGTTCCAGATTATGCT 
 
DAF 
CCAAATAAAGGAAGTGGAACCACTTCAGGTACTACCCGTCTTCTATCTGGGC
ACACGTGTTTCACGTTGACAGGTTTGCTTGGGACGCTAGTAACCATGGGCTTG
CTGACTTAG 
 
neurexin-1 
GTACGCTACAAGTATCGCAACAGGGATGAGGGATCTTACCACGTTGACGAAT
CTAGGAACTATATCAGTAACAGCGCTCAGAGTAATGGCGCCGTGGTTAAAGA
GAAACAGCCCTCCAGCGCCAAATCAGCAAACAAAAACAAGAAAAACAAGGA
TAAAGAGTACTACGTAAGATCT 
 
CD4-2 
GTCGACTTTCAGAAAGCTAGCTCTATTGTTTATAAGAAGGAGGGGGAACAGG
TGGAGTTCAGTTTCCCATTGGCCTTCACAGTCGAGAAGCTCACAGGATCAGG
AGAGTTGTGGTGGCAGGCCGAAAGAGCCTCCTCCAGCAAGAGTTGGATCACT
TTTGATCTGAAAAACAAAGAAGTGAGCGTGAAGAGAGTCACACAGGACCCT
AAGCTGCAGATGGGCAAGAAGTTGCCTTTGCACTTGACACTCCCCCAAGCCC
TGCCCCAGTATGCTGGCTCCGGGAACCTCACCCTCGCCTTGGAGGCTAAGAC
CGGAAAGTTGCATCAGGAGGTCAACCTCGTGGTGATGAGGGCAACACAGCTG
CAGAAGAACCTGACCTGCGAAGTGTGGGGTCCCACCTCACCTAAACTGATGC
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TGTCTCTGAAGCTGGAGAATAAGGAGGCTAAAGTCAGTAAAAGAGAGAAGG
CTGTGTGGGTCCTTAACCCGGAGGCAGGGATGTGGCAGTGTCTTCTTAGCGA
CTCTGGACAGGTGCTGCTGGAGAGCAACATCAAGGTGCTTCCTACTTGGTCA
ACACCAGTACAGCCGATGGCCCTGATCGTACTCGGGGGAGTCGCCGGCCTGC
TTCTGTTTATCGGCCTGGGCATCTTCTTCTGC 
 
Neuroligin-1 (N-terminal) 
ATGGCACTTCCTAGATGTATGTGGCCTAATTATGTATGGCGAGCTATGATGGC
CTGCGTGGTGCACCGAGGGAGTGGCGCCCCACTTACACTCTGCCTGTTGGGTT
GCCTCCTCCAGACTTTCCACGTTCTTTCACAGAAGCTGGATGAC 
 
Neuroligin-1 (C-terminal) 
GGGACGCTCGAGCTGGTGCCCCACTTGCATAACCTCAATGACATCAGCCAAT
ACACAAGTACAACCACCAAGGTCCCAAGCACTGACATCACCCTTCGACCAAC
TCGGAAAAACTCAACCCCTGTGACCAGCGCATTTCCAACCGCTAAGCAAGAC
GACCCCAAACAACAGCCTAGTCCATTTAGCGTAGACCAAAGGGACTACAGCA
CAGAGCTGTCCGTGACCATAGCTGTAGGAGCTTCCCTGCTTTTCCTGAACATT
CTGGCTTTCGCGGCCCTCTATTACAAGAAGGACAAAAGGCGCCACGACGTAC
ATAGGAGATGTAGTCCGCAACGAACTACAACCAATGATCTTACGCACGCACC
TGAGGAGGAGATCATGAGTCTTCAGATGAAACACACAGACCTGGACCACGA
GTGTGAATCCATCCATCCCCATGAGGTGGTGCTGAGGACAGCATGCCCTCCG
GACTATACCCTGGCAATGCGCCGAAGCCCAGACGACATTCCCCTGATGACAC
CCAATACCATAACCATGATTCCCAACACTATTCCAGGAATCCAGCCTCTCCAC
ACTTTCAACACATTCACTGGTGGACAGAATAATACTCTCCCTCATCCGCATCC
ACACCCCCACTCCCACAGCACAACACGGGTGGGTGGCAGCGGTGGCAGATCT 
 
IRES 
GCCCCTCTCCCTCCCCCCCCCCTAACGTTACTGGCCGAAGCCGCTTGGAATAA
GGCCGGTGTGCGTTTGTCTATATGTTATTTTCCACCATATTGCCGTCTTTTGGC
AATGTGAGGGCCCGGAAACCTGGCCCTGTCTTCTTGACGAGCATTCCTAGGG
GTCTTTCCCCTCTCGCCAAAGGAATGCAAGGTCTGTTGAATGTCGTGAAGGA
AGCAGTTCCTCTGGAAGCTTCTTGAAGACAAACAACGTCTGTAGCGACCCTTT
GCAGGCAGCGGAACCCCCCACCTGGCGACAGGTGCCTCTGCGGCCAAAAGCC
ACGTGTATAAGATACACCTGCAAAGGCGGCACAACCCCAGTGCCACGTTGTG
AGTTGGATAGTTGTGGAAAGAGTCAAATGGCTCTCCTCAAGCGTATTCAACA
AGGGGCTGAAGGATGCCCAGAAGGCACCCCATTGTATGGGATCTGATCTGGG
GCCTCGGTGCACATGCTTTACATGTGTTTAGTCGAGGTTAAAAAAACGTCTAG
GCCCCCCGAACCACGGGGACGTGGTTTTCCTTTGAAAAACACGATGATAATA
TGGCCACA 
 
T2A 
GAGGGTCGGGGCTCTCTGCTCACATGTGGCGACGTCGAGGAGAATCCCGGAC
CGGCCCCGGGGTCGACA 
 
Nuclear Localization Sequencing 
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ATGGTGCCCAAGAAGAAGAGGAAAGTCGTGAGCAAGGGCGAGGAGGACAAC
ATGGCCATCATCAAGGAGTTCATGCGCTTCAAGGTGCAC 
 
mCherry 
ATGGAGGGCTCCGTGAACGGCCACGAGTTCGAGATCGAGGGCGAGGGCGAG
GGCCGCCCCTACGAGGGCACCCAGACCGCCAAGCTGAAGGTGACCAAGGGC
GGCCCCCTGCCCTTCGCCTGGGACATCCTGTCCCCTCAGTTCATGTACGGCTC
CAAGGCCTACGTGAAGCACCCCGCCGACATCCCCGACTACTTGAAGCTGTCC
TTCCCCGAGGGCTTCAAGTGGGAGCGCGTGATGAACTTCGAGGACGGCGGCG
TGGTGACCGTGACCCAGGACTCCTCCCTGCAGGACGGCGAGTTCATCTACAA
GGTGAAGCTGCGCGGCACCAACTTCCCCTCCGACGGCCCCGTAATGCAGAAG
AAGACCATGGGCTGGGAGGCCTCCTCCGAGCGGATGTACCCCGAGGACGGC
GCCCTGAAGGGCGAGATCAAGCAGAGGCTGAAGCTGAAGGACGGCGGCCAC
TACGACGCCGAGGTCAAGACCACCTACAAGGCCAAGAAGCCCGTGCAGCTG
CCCGGCGCCTACAACGTCAACATCAAGCTGGACATCACCTCCCACAACGAGG
ACTACACCATCGTGGAACAGTACGAGCGCGCCGAGGGCCGCCACTCCACCGG
CGGCATGGACGAGCTGTACAAG 
 
WPRE 
GCTTATCGATAATCAACCTCTGGATTACAAAATTTGTGAAAGATTGACTGGTA
TTCTTAACTATGTTGCTCCTTTTACGCTATGTGGATACGCTGCTTTAATGCCTT
TGTATCATGCTATTGCTTCCCGTATGGCTTTCATTTTCTCCTCCTTGTATAAAT
CCTGGTTGCTGTCTCTTTATGAGGAGTTGTGGCCCGTTGTCAGGCAACGTGGC
GTGGTGTGCACTGTGTTTGCTGACGCAACCCCCACTGGTTGGGGCATTGCCAC
CACCTGTCAGCTCCTTTCCGGGACTTTCGCTTTCCCCCTCCCTATTGCCACGGC
GGAACTCATCGCCGCCTGCCTTGCCCGCTGCTGGACAGGGGCTCGGCTGTTG
GGCACTGACAATTCCGTGGTGTTGTCGGGGAAATCATCGTCCTTTCCTTGGCT
GCTCGCCTGTGTTGCCACCTGGATTCTGCGCGGGACGTCCTTCTGCTACGTCC
CTTCGGCCCTCAATCCAGCGGACCTTCCTTCCCGCGGCCTGCTGCCGGCTCTG
CGGCCTCTTCCGCGTCTTCGCCTTCGCCCTCAGACGAGTCGGATCTCCCTTTG
GGCCGCCTCCCCGCATCGATACCG 
 
Synapsin Promoter 
GTGTCTAGACTGCAGAGGGCCCTGCGTATGAGTGCAAGTGGGTTTTAGGACC
AGGATGAGGCGGGGTGGGGGTGCCTACCTGACGACCGACCCCGACCCACTG
GACAAGCACCCAACCCCCATTCCCCAAATTGCGCATCCCCTATCAGAGAGGG
GGAGGGGAAACAGGATGCGGCGAGGCGCGTGCGCACTGCCAGCTTCAGCAC
CGCGGACAGTGCCTTCGCCCCCGCCTGGCGGCGCGCGCCACCGCCGCCTCAG
CACTGAAGGCGCGCTGACGTCACTCGCCGGTCCCCCGCAAACTCCCCTTCCC
GGCCACCTTGGTCGCGTCCGCGCCGCCGCCGGCCCAGCCGGACCGCACCACG
CGAGGCGCGAGATAGGGGGGCACGGGCGCGACCATCTGCGCTGCGGCGCCG
GCGACTCAGCGCTGCCTCAGTCTGCGGTGGGCAGCGGAGGAGTCGTGTCGTG
CCTGAGAGCGCAGTCGAGA 
 
CAG Promoter 
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TCGAGGTGAGCCCCACGTTCTGCTTCACTCTCCCCATCTCCCCCCCCTCCCCA
CCCCCAATTTTGTATTTATTTATTTTTTAATTATTTTGTGCAGCGATGGGGGCG
GGGGGGGGGGGGGGGCGCGCGCCAGGCGGGGCGGGGCGGGGCGAGGGGCG
GGGCGGGGCGAGGCGGAGAGGTGCGGCGGCAGCCAATCAGAGCGGCGCGCT
CCGAAAGTTTCCTTTTATGGCGAGGCGGCGGCGGCGGCGGCCCTATAAAAAG
CGAAGCGCGCGGCGGGCG 
 
GAD65 Promoter 
GAGATTTCTGGGTGGCGTGAACAAGGAATAGGTAATCCCACAAAACCTTGCA
GTGGGCTATTCTGGAGATTTTGGCGTGGGTCTCCTACTTTAGAGGGGAAGCTA
TAGTCTTGGTTCCCAGTCTGCTGCCTCCTTTGTGAACTAATGACTGTAATTATT
ACCTCCCAGAGCTCTTTTGTTATCAACAACCAGGAGCCTGGGGGGGATGGGC
CCTTTGGGGAAAGGGGAAAAAATTTACAAAGCAAATTGCTGTCTAGGAAGGG
TTGGAATTTTTTTAAAAAGACAAACCCAATTTCAGCCTGTATCCGAAGTGGGG
AGTGGCAATGTTTTTTAATGTAAATATCATTAGATTTTTAAAAAAATTCTCAG
AGCTGTGGATTCAATTGCATTTCAACAGTACTGCTTTAAGTCACTATTTTTGA
CGAAGTTAAATTCAGATGTTGAGAGTCTGTCCTCTTGTTTTCATCCATTTCTTC
CTTGTGAGGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTTTATGAACCAT
TTTATTTCTGACCACTCATCCGTGGTAAAAAGCTTCAACCCCAGCCAGCTGGC
TTGAAGAGAGAATTATTTGCAGGATTTGGTATGGATTTAAACAAAGACCCAG
GCTCTCCAAGTCCTGTTGGCAAGGCTGGGTGGAGAGAGTGCCCAGCATTCCA
GGAGATGTTGCCTCTGCCAACCGAAGTCACCAGGCCTGGAGTACCCTAAAGA
TTGACCAAGTTAAGGCGTAGGGTCAAGATGACTACCTTCCCTCAACATGCTCC
TGCTTTTGGCTTAGAGACGTGCCTGGGTAGCACCTCAACAGGGTCAATCACA
CTCCCCACGCCTCCCTAGTCCCGCGACTTCTGTGGGCATCCACTATCTAGATC
CTCCCTGGCCGTCAGGATTCTGGCAACTGGGAAGAAGTAAAGCTTTGGGGAG
AGAATGCACTTGGAGGCCCAAGACTTGGGCTTCTGTACAGTTACCCGAGGTC
TCAGGATCCCTAACAAAATAAGTGATCCTGGTCGCCAAAACCAAGTAGGGTC
CCTGCTCAGGCAAGAGCTTTGGTGCCTTTTTTGAAAACTCAAAAGAAGGAAC
GAAGAAATGCTGTGGAGACCAGGGAGACTGCAGCCCCTTGCTCAGGGAGCG
CAGGAAAGGAGATCCGGATGGCTGAAAGCAGCACCTTCCCGCTAGTCTTTCT
TGAGCTATGTGTAAATCGGAAACCAAGGGTCTAGTATAAGCGAGCCAAAACA
AAGCGGAGTCCGAGGGCCCCACATCTTCCTTAAGGCGCTGTCCCGCAGTTTA
TGGGCCTTTAGGGAAGAGAAAACAGAAAGGATTGTTTCATTCCTTTATTAGA
AAACACAAACGAAACTACTTCTCTCTGGGCCGGGAAATTGCCAATCTTGCGT
TCCTAGGCACCTCCTGACCTTAAGGACTCTTCTGGGGGAGGGGAGAGGTCAG
TGGTTTCAGTACTCCTGAAACTACCCGAGTGCCTTTTCTCCTGGAATTTGAAA
GTCTGGTTTGCTTACTTCGAAAACCCCTGAATCCCGCCTAAGCACAGGTGCAT
AAGCAGCAAGCCAAGGTCACCAAGTAACCGGATCCCCTCCCCCATCAACCAT
AAATCCTGTGGTCTGTGTCAGCTCTCCGCTGCTCCCTTTCAAGAAGTTTCTGTT
CGTTTTATTTATTTAATTTTTCCCAGCCTGAGGTCCTCAGTGATAGACTCCAGC
GTGGATTTTAATTGCTTCAATCAGCAGTCTTTCTCCTCAGCCGTCAGTCAAAA
CCTGGACGGTGGGTCTGGGGACTCAGCGCTTGACTGCACAGGAAGTGGACGA
CCCCCCCAGGCTGGCTCAGCTCAGTAGGCAGACGTTTTTAGGCTCGGCTAAG
GAAGGAGATGAAATGAGTCCGTCGGCGTGGAAGCGATACACCTTCCTCCCTC
TTTGGTTCCTTCCCCGTGCTCTGGAGCTCTGCCTGATTGCGGCCAGGTGGCCT
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GGGCTCTTGAGGTCACAGCGACCTCCGCACGGGTTTGGAGGAAGGAGGGTGC
GAAAACCGCTTTTGCTCGGCCGGCCTCAGCCAGAGACAGCTCTCAAACAATG
AGCCAATCGCTGCACATGTGAAGTCGCTTTCAGTCACCCCCCAAGATTGTCA
AGGTCTCCCTGGTGCCCAGGGTCACCGAGGCCAGCGTGCAGCGGGCTGCGGT
AGCACCCTGGACAGCGCGTCCCGGCCGAAGAGGACCTGGAGCGCCTGTGGCT
GGGTCAGCGCTGCGCAGGCACGCCTCCCACCCCCGCATCTGACTCGCGCTCA
AACGCACAGCCTCGCACCTCACGACCCAGCTCCTCCATTTCCCTTTCGTCACT
CTCTGGTCTCCCCACCAAACTCCTCTCCCTAAAAATTCTCTTGGGTCCTTTCCA
CTTTCCAATCTCCAGACTGCGAGGATCAGGCTACTCCCCCATTTAACCACCGC
GCAGAGCACAACGGCTCGTCCCTACGCCCTGACTCGAACACTCACACGCACG
AGCACTGGCATACGCAGACAGCACGTTTCCTGTCCCTGTGTGACACCCACCCT
CGTCGCGCGGCTGCTCCAGCCCTCGCGCGGTGCCCTCCTCCCGCCACACACAC
TCGCACACGCACGCAGGCGCGTGCAGGGTCGAGCCGAAGGCAGCTTGCCCGC
AGCCACTCGGAGGCGACCAGCGCCAGACTAGCAGAACCC 
 
GAD67 Promoter 
GTCTCTGTGTGTTTGGCGCCCTCTGGTGGAAAATTTTCCCAAAACCGCCTTTTT
ATGGTGGGGGACTTCACCCCGCTCAGTAAGGTGCTTAAATACTGCCAAAAGA
GAATCATTAAACACCGTGAAACTGAAAAGAAGCGCGGAGAGTGGGCCAAGA
CAAGGAGTGCGGTCCTGGCTTCCCGGAGCCACCCTCCACGCTCCGGTTCCCC
AGGCGTGTGGAGCGGCACTCGTGCATGTTATTAACCTTCAGACATGATCAAT
CACAGAGATTTCTTTTCCCCCTCTCAAGGGAGAGGGCTCAGAGAAAGGGAAA
TAGACCCCTTTCCTCTTTTGGTACCAGGTAGCTGTGTTCGAACGAGGTAGTTT
GGAGATGAACTGGATGAAGATACTGGAGTGCAGAAACTCCACGGTCTGGGTG
GGTGGTCCCCTCAGCTCTGCTTTGCCTGTACAGCCACATTGGCTCACTAGAGC
GCTCCCCATGACACCACCCAGAGAAAACCTTCTGGATTCGCCAATCCAGGAC
AACCACCGGAAATTGATTAAGGCAAAGCAAATATTTTAATCTCCTCCAAGAT
ACGGGAAGGAGGGCAAAAAGGAAGAGAAAGAAGAATCACCCGGTGAGACA
AAATTCTTCGTAAGAATGATTTTTTCCCTTGCTGTCACCCAACATTGCTTATCT
CAAAAATAATTGGGAAAAAAACAAAAAACAGAGCGTGCTGAGTGCATTCTG
GATTACTCATAGGACTTTGTCACACACACCCTCCTTTCTGGTCGCAAACCCAT
GAGCTGGCTTTATCATCGAAATATAAAGCGCCAGAGGCAGTCAGACACCTGC
AAAGGAGCCCCAGGCTGCGCGGACGAGCTGCCCCCGCGAGCAGCGGCTTCGT
GATTCCCCCGCCGAGCGGGTCCCCGCCTCCCCACTCCGCCCCCGCCTCCCCCA
AGCCCAGCGGCGGCCTCTCCGGATCTCTCTCTTCTTCGGGCTCTCCGTGCCGG
ACCAGGGATCCTGCAAGCAAGGAAGCAGCCCCGGGGTGACACCCAGCACGT
ACGTCTGTGGCAGAGCAAAGCCAAGCCCAAGCGGGGGACGCTTCGCGGAGG
AGTCGCGGGAGGGTCCAGCTCGC 
 
 
CMV Promoter 
GACATTGATTATTGACTAGTTATTAATAGTAATCAATTACGGGGTCATTAGTT
CATAGCCCATATATGGAGTTCCGCGTTACATAACTTACGGTAAATGGCCCGCC
TGGCTGACCGCCCAACGACCCCCGCCCATTGACGTCAATAATGACGTATGTT
CCCATAGTAACGCCAATAGGGACTTTCCATTGACGTCAATGGGTGGACTATTT
ACGGTAAACTGCCCACTTGGCAGTACATCAAGTGTATCATATGCCAAGTACG
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CCCCCTATTGACGTCAATGACGGTAAATGGCCCGCCTGGCATTATGCCCAGT
ACATGACCTTATGGGACTTTCCTACTTGGCAGTACATCTACGTATTAGTCATC
GCTATTACCATGGTGATGCGGTTTTGGCAGTACATCAATGGGCGTGGATAGC
GGTTTGACTCACGGGGATTTCCAAGTCTCCACCCCATTGACGTCAATGGGAGT
TTGTTTTGGCACCAAAATCAACGGGACTTTCCAAAATGTCGTAACAACTCCGC
CCCATTGACGCAAATGGGCGGTAGGCGTGTACGGTGGGAGGTCTATATAAGC
AGAGCT 
 
Benchling links for constructs 
 
CMV-IgK-PLE-HA-DAF-IRES-EGFP 
https://benchling.com/s/seq-MsN0VuNN8tG1ucr6pwUx 
 
Synapsin-IgK-PLE-HA-DAF-IRES-EGFP-WPRE 
https://benchling.com/s/seq-0DOcbWomXeGrsHX1SY79 
 
GAD65-IgK-PLE-HA-DAF-IRES-mCherry-WPRE 
https://benchling.com/s/1JsffIPZ 
 
GAD67-IgK-PLE-HA-DAF-IRES-mCherry-WPRE 
https://benchling.com/s/Ex3xRXLJ 
 
Synapsin-PAT3-PLE-HA -CD42-neurexin1-T2A-mCherry 
https://benchling.com/s/1JU7x5Ja 
 
CAG-PAT3-PLE-HA -CD42-neurexin1-T2A-mCherry 
https://benchling.com/s/gVycBBch 
 
Synapsin-PLE-HA-neuroligin1-mCherry 
https://benchling.com/s/Orv5yCs9 
 
CAG-PLE-HA-neuroligin1-mCherry 
https://benchling.com/s/44OO0SWR 
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Figures and Schemes 
Scheme 3-1-1. Design of fluorogenic activation using a red-shifted VF dye, carboVF, in 
specific cells of interest. 
 
 
 
 
Scheme 3-1-1. Scheme of neuron-specific targeting with cell-surface PLE and 
carboVoltageFluor (components are not to scale).  
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Scheme 3-2-1. Design of fluorogenic activation using a second generation VF dye, 
isoVF2.2Cl(OMe), in specific cells of interest. 
 
Scheme 3-2-1. Scheme of neuron-specific targeting with cell-surface PLE and cp-
isoVF2.2.Cl(OMe) (components are not to scale). 
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Figure 3-1-1. In vitro characterization of carboVF-EX 1.  
 
Figure 3-1-1. PLE-mediated uncaging of carboVF-EX 1 in vitro. Normalized (a) 
absorbance and (b) emission spectra of carboVF-EX 1 (0.5 µM) in HBSS with 0.01% 
SDS. Spectra are acquired 2h after adding PLE (0.7 mg/mL, orange) or blank (blue). (c) 
Plot of relative initial rate vs. [carboVF-EX 1]. Error bars are ± S.E.M. for n = 7 
independent determinations. [PLE] is 168 ng/mL (1 nM) for saturation kinetics 
measurements. 
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Figure 3-1-2. In vitro characterization of carboVF-EX 2.  
 
Figure 3-1-2. Spectroscopic characterization of carboVF-EX 2 in vitro. (a) UV-vis 
absorption and (b) fluorescence emission spectra of carboVF-EX 2 in the absence (blue 
lines) or presence (orange lines) of PLE (0.7 mg/mL, 2 h). (c) Plot of relative initial rate 
vs substrate concentration for the reaction of PLE (168 ng/mL) with carboVF-EX 2. Data 
points are the mean ± S.E.M. for n = 8 independent measurements. The solid line is the 
best fit to the Michaelis-Menten equation (Graphpad). 
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Figure 3-1-3. HPLC analysis of PLE reaction with carboVF-EX 1 and 2. 
 
 
 
Figure 3-1-3. HPLC analysis of PLE reaction with carboVF-EX 1 and 2. Note: the 
reaction of carboVF-EX2 + PLE leads to carboVF2.1(OMe).Cl (4.99 min) and the 
intermediate in which only the sulfonate is esterified (4.80 min).
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Figure 3-1-4. PLE constructs used in this study.   
 
 
 
Figure 3-1-4. PLE constructs used in this study. 
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Figure 3-1-5. Characterization of cell-surface PLE expression in HEK cells using 
immunohistochemistry.   
 
 
 
Figure 3-1-5. Immunohistochemistry of cell-surface PLE in HEK cells.  (a) Membrane-
associated anti-HA staining shows cell-surface PLE expression. (b) PLE expression is 
indicated by nuclear EGFP. (c) Merged images of anti-HA staining and EGFP. (d) DIC 
images of fixed cells. (e) Nuclei staining of Hoechst 33342. Scale bar is 20 µm. 
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Figure 3-1-6. Characterization of carboVF-EX 1 in HEK cells.  
 
 
 
Figure 3-1-6. Cellular characterization of carboVF-EX 1. (a-c) Wide-field fluorescence 
microscopy of HEK cells stained with carboVF-EX 1 (500 nM, 30 min) shows membrane 
labeling of the cell expressing cell surface PLE, as indicated by (a) GFP fluorescence. (b) 
DIC image of HEK cells and (c) epifluorescence image showing carboVF-associated 
fluorescence in PLE-expressing cell. Scale bar is 10 µm. (d) Voltage sensitivity of 
carboVF-EX 1 in patch-clamped PLE-expressing HEK cells. (e) Plot of ΔF/F vs 
membrane potential (in mV) for carboVF-EX 1. Data are mean ± S.D. for five cells.  
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Figure 3-1-7. Characterization of carboVF-EX 1 in cultured hippocampal neurons. 
 
 
 
Figure 3-1-7. Cellular characterization of carboVF-EX 1. (a-c) Live cell wide-field 
images of rat hippocampal neurons expressing PLE-DAF under the control of the 
synapsin promoter (Syn) and stained with carboVF-EX 1 (500 nM, 30 min). (c) GFP 
fluorescence indicated PLE expression in neurons shown in the b) DIC image. (a) 
Membrane-associated fluorescence of carboVF in PLE expressing neuron. Scale bar is 20 
µm. (d) Representative ΔF/F traces for spontaneous activity of neurons transfected with 
Syn-PLE and stained with carboVF-EX 1. Images were acquired at 500 Hz and represent 
single-trial acquisitions. Inset shows expanded time scale of indicated area of the upper 
trace. 
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Figure 3-1-8. Activity profiling with carboVF-EX1 in neurons. 
 
 
 
Figure 3-1-8. Field stimulation of neurons expressing PLE and stained with carboVF-
EX1. (a) DIC Image of neurons sparsely transfected with PLE and stained with 500 nM 
carboVF-EX1. (b) EGFP fluorescence image of neurons from panel a. (c) Fluorescence 
image indicating the selective uncaging of carboVF-EX1 in the presence of PLE. Scale 
bar is 20 µm. (d-e) Field stimulation of neurons expressing PLE and stained with (d) 500 
nM carboVF-EX 1 and (e) 1 µM carboVF-EX 1. 
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Figure 3-2-1. In vitro characterization of isoVF2.2.Cl(OMe). 
a)  
 
 
 
 
 
 
 
b)  
 
 
 
 
 
 
Figure 3-2-1. Characterizing the effect of cyclopropyl ester on quenching the 
fluorescence of the parent dye. Normalized (a) absorbance and (b) emission spectra of 
isoVF2.2.Cl(OMe) (green trace) and cp-isoVF2.2.Cl(OMe (black trace).  
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Figure 3-2-2. In vitro characterization of PLE reaction with cp-isoVF2.2.Cl(OMe). 
a)  
 
 
 
 
 
 
 
 
 
b)  
 
 
 
 
 
 
 
 
 
 
Figure 3-2-2. Spectroscopic characterization of cp-isoVF2.2.Cl(OMe) with PLE reaction 
in vitro. (a) UV-vis absorption and (b) fluorescence emission spectra of cp-
isoVF2.2.Cl(OMe) in the absence (black lines) or presence (blue lines) of PLE (0.7 
mg/mL, 2 h). Spectra for the parent dye isoVF2.2.Cl(OMe) are shown in green lines.  
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Figure 3-2-3. HPLC analysis of PLE reaction with cp-isoVF2.2.Cl(OMe). 
 
 
 
 
Figure 3-2-3. HPLC analysis of PLE reaction with cp-isoVF2.2.Cl(OMe).
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Figure 3-2-4. Characterization of cp-isoVF2.2.Cl(OMe) in HEK cells.  
 
 
 
Figure 3-2-4. Live-cell wide-field imaging of HEKs. All images are acquired using the 
VF channel. (a) Negative control cells without PLE transfection and loaded with 1 µM 
cp-isoVF2.2.Cl(OMe) at 37 °C for 30 min. (b) HEK cells sparsely transfected with PLE-
DAF and loaded with cp-isoVF2.2.Cl(OMe). (c) HEK cells sparsely transfected with 
PLE-DAF and loaded with 1 µM isoVF2.2.Cl(OMe) at 37 °C for 30 min. Dye 
concentrations are matched at wire absorbance. Scale bar is 20 µm.  
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Figure 3-3-1. PLE constructs used for expression in inhibitory neurons.  
 
Figure 3-3-1. GAD65 and GAD67 promoters are used for expression in inhibitory 
neurons.  
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Figure 3-3-2. Characterization of inhibitory PLE constructs in cultured neurons using 
immunohistochemistry. 
 
 
 
Figure 3-3-2. Fixed cell wide-field images of rat hippocampal neurons expressing (a,b) 
GAD67-PLE-DAF or (c,d) GAD65-PLE-DAF under permeable conditions. Two 
representative regions of interest are shown for each construct. Anti-HA staining 
indicates PLE expression. Scale bar is 20 µm. 
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Figure 3-3-3. Characterization of specificity of inhibitory PLE constructus in cultured 
neurons using immunohistochemistry. 
 
 
 
Figure 3-3-3. Representative images of neurons expressing PLE constructs with 
inhibitory promoters. Fixed cell wide-field images of rat hippocampal neurons expressing 
(a-c) GAD65-PLE-DAF or (d,e) GAD67-PLE-DAF under permeablizing condition. Blue: 
Hoechst 33342 stains nucleus. Some PLE-expressing cells also express GABA (a,b,d) 
while a few do not (c,e). Green: anti-HA staining indicates PLE expression. Red: anti-
GABA staining indicates inhibitory cells. Scale bar is 20 µm. 
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Figure 3-3-4. Characterization of inhibitory PLE constructs in cultured neurons.  
 
 
 
Figure 3-3-4. Cellular characterization of PLE constructs with inhibitory promoters. Live 
cell wide-field images of rat hippocampal neurons expressing (a-c) GAD67-PLE-DAF or 
(d-f) GAD65-PLE-DAF and stained with VF-EX 2 (1 µM, 60 min). (a,d) Uniform VF 
fluorescence was seen in all neurons in the field of view.  (b,e) Nuclear mCherry 
expression indicates PLE expression. (c,f) Merged image of VF and mCherry 
fluorescence. Scale bar is 20 µm. 
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Figure 3-4-1. PLE constructs used for expression in subcellular structures.  
 
 
 
Figure 3-4-1. Constructs used to target PLE to pre- and post-synaptic terminals.  
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Figure 3-4-2. Characterization of presynaptic PLE constructs in cultured neurons 
 
  
 
Figure 3-4-2. Cellular characterization of PLE constructs expressing presynaptic terminal 
targeting sequences. Live cell wide-field images of rat hippocampal neurons expressing 
(a,b) Syn-presynaptic-PLE or (c,d) CAG-presynaptic-PLE and stained with VF-EX 2 (1 
µM, 60 min). (a,c) DIC images of neurons. (b, d) Merge image of mCherry fluorescence 
(PLE expression) and VF staining. (b) Uniform and dim VF fluorescence was seen in all 
neurons.  (d) Selective VF staining in the cell expressing PLE but fluorescence is seen 
throughout the cellular membrane. Scale bar is 20 µm. 
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Figure 3-4-3. Characterization of postsynaptic PLE constructs in cultured neurons 
 
  
 
Figure 3-4-3. Cellular characterization of PLE constructs expressing postsynaptic 
terminal targeting sequences. Live cell wide-field images of rat hippocampal neurons 
expressing (a,b) Syn-postsynaptic-PLE or (c,d) CAG-postsynaptic-PLE and stained with 
VF-EX 2 (1 µM, 60 min). (a,c) DIC images of neurons. (b,d) Merge image of mCherry 
fluorescence (PLE expression) and VF staining. (b) Uniform and dim VF fluorescence 
was seen in all neurons.  (d) Selective VF staining in the cell expressing PLE but 
fluorescence is seen throughout the cellular membrane. Scale bar is 20 µm. 
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Figure 3-4-4. Characterization of CAG-pre- and postsynaptic PLE constructs in cultured 
neurons using immunohistochemistry. 
 
  
 
Figure 3-4-4. Fixed cell wide-field images of rat hippocampal neurons expressing (a) 
CAG-presynaptic-PLE or (b) CAG-postsynaptic-PLE. Anti-HA staining was observed to 
stain the cellular membrane uniformly. Scale bar is 20 µm. 
. 
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Table 3-1-1. Properties of carboVF2.1(OMe).Cl and carboVF-EX dyes. 
 
    contrastc % ΔF/F  
SNR 
 
dye Φ
 a 
 
KMb 
 
Kcat/KMb 
 
in 
vitrod 
 
HEKe 
 
neuronse 
 
HEKf 
 
neuronsg 
 neurons 
cVF 0.0012 --- --- --- --- --- 31±2 13.9±1.4 28±1.9 
cVF-EX1 0.001 6.4±1.4 µM 
1.3 x 105 
M-1s-1 45 8.9±0.7 2.4±0.08 18±3 8.4±0.4 12±0.8 
cVF-EX2 0.011 0.16±0.08 µM 
4.9 x 105 
M-1s-1 21 --- --- --- --- --- 
 
--- = not determined or not applicable. a Quantum yield of fluorescence. Measured in 
HBSS (pH 7.4). b Determined by reaction of dye with purified PLE in HBSS (pH 7.4). c 
Ratio of VF-EX 1 or VF-EX 2 fluorescence in PLE-expressing cells (or PLE-containing 
buffer, for in vitro) to cells not expressing PLE. d After 2 hours in buffer, with or without 
PLE. e After 30 min using 500 nM cVF-EX 1 at 37 °C. f Per 100 mV depolarization, in 
HEK cells. g Per action potential evoked by field stimulation. 
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Chapter 4: 
Covalent Labeling of Voltage Sensitive Dyes to Neurons 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Portions of this work were performed in collaboration with the following persons:  
Synthesis and cellular characterization was assisted by Parker Deal  
Cloning was assisted by Vikram Muller 
In utero electroporation was assisted by Kiarash Sharmadani 
Slice patching and live animal imaging was assisted by Hillel Adesnik 
118	
Abstracts 
Voltage-sensitive fluorescent dyes (VSDs) are powerful tools that enable the 
recording of millisecond-scale neuronal dynamics. VSDs are attractive for such 
measurements due to their extremely fast kinetics, high sensitivities to membrane 
potential changes, and easily tunable absorbance and emission profiles. Despite these 
advantages, previously developed VSDs have found limited use in complex tissue 
preparations, such as brain slice and live animal, because of their indiscriminate staining 
of all cellular membranes. We addressed this limitation by developing genetically 
targeted voltage dyes using a HaloTag-based system. It is a hybrid approach, consisting 
of previously reported tetramethylrhodamine-based voltage reporter RhoVRs coupled to 
a chloroalkane ligand (RhoVR-HaloTag) and a cell-surface HaloTag protein expressed 
selectively in cells of interest. We demonstrated that RhoVR-HaloTags can selectively 
label and record activity from dissociated rat hippocampal neurons and in ex vivo mouse 
brain slice with single cell resolution. In addition, we showed that the good two-photon 
cross sections typical of tetramethylrhodamines enabled clear visualization of subcellular 
structures in slices. These results present the potential of hybrid chemogenetic voltage 
indicators to combine the optical performance of small-molecule chromophores with the 
inherent selectivity of genetically-encodable systems, permitting imaging modalities 
inaccessible to either technique individually. 
 
Introduction 
 For decades, researchers have been interested in measuring and studying the 
membrane potential (Vm) changes in cells, in particular neurons, where rapid 
depolarization of Vm about 100 mV, or action potential, is a key component in neuronal 
signaling pathways. The traditional method or gold standard to monitor Vm is electrode-
based electrophysiology, which offers remarkable speed and sensitivity of measurement. 
However, it is extremely invasive, low throughput and has limitations in spatial 
resolution given the relatively large size of patch pipette tip compared to subcellular 
structures. To resolve some of the problems, optical tools, including small molecule-
based1 and protein-based2-4, have been explored and developed for voltage sensing in 
hundreds of cells simultaneously. One class of small molecule fluorescent dye designed 
by our lab, VoltageFluors (VF)5, possesses exceptional and readily tunable photo-
physical properties (i.e. absorption and emission profiles, photo-stability, brightness, 
voltage sensitivity, etc.)6-9, which allows us to evaluate neuronal activity and connectivity 
with outstanding sensitivity in cultured neurons in a high throughput manner.  
On the other hand, a common issue with all small molecule dye imaging, the 
inability to target to specific cells of interest, remains a challenge to use the dyes in 
complex biological settings. For instance, our VF dyes indiscriminately labels all 
membranes and increases unproductive or background fluorescence dominating the 
desired voltage readout. This high background poses difficulties for voltage imaging in 
ex vivo brain slice and in vivo live animal. While our lab has developed both 
photoactivatable10 and enzymatically uncaged11-12 VF that reduce off-target fluorescence 
through fluorogenic activation of the dye in cells of interest, these systems still lacked the 
specificity necessary to enable in vivo voltage imaging. One explanation is the inefficient 
quenching at the phenolic oxygen of fluorescein-based VF dyes, contributing to the 
compromised contrast ratio between transfected and non-transfected cells. In addition, 
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these strategies are not untranslatable to red-shifted rhodamine-based VF dyes RhoVR 16 
and BeRST 17, which have improved photo-physical properties compared to the first 
generation fluorescein-based dyes. Alternatively, we have also developed VF dyes that 
could be ligated directly to cells of interest using self-labeling enzymes like the 
SpyTag/SpyCatcher system.13 While contrast has been significantly enhanced, the slow 
reaction kinetics of SpyCatcher and low fluorescence signal of fluorescein hinder its 
application in mouse brain slices.  
Inspired by the covalent labeling system, we combined the selectivity of 
genetically-encodable systems with the favorable photo-physics and tunability of VF 
dyes, using a rhodamine-based voltage reporter (RhoVR) and the protein tagging system 
HaloTag. We choose to target RhoVR1 due to its red-shifted absorption/emission, large 
voltage sensitivities (47% ΔF/F per 100 mV), ease of synthesis and functionalization as 
well as high two-photon cross-section, which is desirable for deep tissue in imaging for in 
vivo applications. The HaloTag system is selected due to its small enzyme size for 
engineering and fast kinetics with exceptional affinity and selectivity.14 By expressing 
HaloTag on the cell surface and adding RhoVR 1 linked to the HaloTag ligand via a 
flexible polyethene glycol linker (PEG), we hoped to gain selectivity through the protein 
component while maintaining the photo-physical properties of RhoVR 1, which would 
provide sufficient contrast for complicated biological systems (Scheme 4-1). 
  
Results & Discussions 
To design the protein component of the hybrid system, we selected the HaloTag 
system due to its remarkable affinity and selectivity, ease of ligand synthesis and 
extremely fast kinetics.14 In order to express the HaloTag enzyme on the cell surface, we 
fused a transmembrane domain (pDisplay) derived from platelet-derived growth factor 
receptor (PDGFR)15 to the C-terminal of the HaloTag sequence (Figure 4-1a). We also 
appended a secretion signal peptide from immunoglobulin K (IgK) to the N-terminal to 
enhance extracellular trafficking. To track the protein expression in live cells, we 
included a nuclear-localized EGFP downstream of HaloTag, separated by an internal 
ribosome entry site (IRES)16. These modifications successfully resulted in cell surface 
expression of HaloTag in HEK cells, as shown by live cell staining using a cell-
impermeant tetramethylrodamine TMR-HaloTag ligand (Figure 4-1b-d). Bath application 
of TMR-HaloTag at 50 nM for 30 minutes displayed clear membrane-bound 
fluorescence, which matched EGFP signal in transfected cells.  
 To improve water solubility and flexibility of the dye-ligand complex, we 
introduced a polyethylene glycol linker of variable lengths (Scheme 4-2, synthesis 
conducted by Dr. Parker Deal).17 We hypothesize that a longer linker for the voltage 
reporter might be necessary to confer flexibility and the ability to adopt a proper 
orientation in the membrane for voltage sensing when the dye is covalently tethered to 
the enzyme. All the dyes localized to the cell surface of HEK cells sparsely transfected 
with HaloTag-pDipslay (Figure 4-2a). Compared to the control dye RhoVR 1 which 
stained all membrane indiscriminately, RhoVR-HaloTag dyes exhibited selective staining 
only in cells expressing HaloTag enzyme. We next conducted whole-cell patch-clamp 
electrophysiology to evaluate the voltage sensitivity by monitoring the fluorescence 
change in response to a series of voltage steps from -100 mV to + 100mV with 20 mV 
increments. We observed an increase in sensitivity (up to 34% ΔF/F per 100 mV for 
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longest linker n = 25) with an increasing length of linker or flexibility (Figure 4-3). 
Interestingly, the PEG0 dye displayed no sensitivity but greater brightness compared to 
others (Figure 4-2b); we propose that the PEG0 dye was too closely bound to the HaloTag 
enzyme and thus probably not in the membrane, explaining the lack of voltage sensitivity 
and higher brightness due to the absence of membrane-associated PeT quenching effect.  
 Given the best voltage sensitivity, we decided to carry forward RhoVR1-PEG25-
HaloTag for subsequent characterization and experiments. Using confocal microscopy, 
we imaged RhoVR1-PEG25-HaloTag in HEK cells expressing cell-surface HaloTag 
(Figure 4-4). Membrane-associated fluorescence was observed in cells expression nuclear 
EGFP (HaloTag) while non-transfected cells showed minimal background fluorescence 
when 50 nM of dye was used, indicating that the fast HaloTag reaction outcompetes non-
specific insertion of the dye into the membranes. For experiments in cultured 
hippocampal neurons, we used a human synapsin promoter to enable neuron-specific 
expression (Figure 4-1a). Again, neurons stained with 50 nM RhoVR1-PEG25-HaloTag 
displayed exceptional contrast (Figure 4-5) and importantly, spontaneous spiking events 
can be captured with desirable signal-to-noise (Figure 4-6). We also co-stained the same 
culture with a far-red dye BeRST 1, which non-selectively labeled all the neurons (Figure 
4-7a), RhoVR1-PEG25-HaloTag highlighted specific cells of interest and clearly 
presented neuronal projections from those cells in a complex network of neuronal 
processes (Figure 4-7b). 
 Having demonstrated the effectiveness of RhoVR1-PEG25-HaloTag to record 
neuronal activity with remarkable contrast, we then compared it to the commonly used 
GEVIs ASAP118 and Ace2N-mNeon (Ace2N)19. Our dye outperformed both ASAP1 and 
Ace2N, exhibiting brighter and red-shifted membrane fluorescence at matched light 
powers (Figure 4-8a), turn-on responses to action potentials (ASAP1 and Ace2N-mNeon 
both possess turn-off responses) (Figure 4-8a) and an average ΔF/F per spike of 10.4% ± 
0.2% (SNR= 16.5:1) for evoked action potentials, compared to -4.4% ± 0.1% (SNR= 
10:1) per spike for ASAP1 and -1.7% ± 0.1% per spike for Ace2N (SNR= 8:1) (Figure 4-
8b,c). The low SNR in the GEVIs can be explained by the appreciable amount of 
cytosolic fluorescence due to protein trafficking, which contributes to an elevated 
background or noise level. On the other hand, our genetic component, HaloTag, is non-
fluorescent while the dye does not cross the membrane, thus confining all fluorescence 
signals to the membrane for voltage sensing.  
Since the red-shifted absorbance/emission profile of the dye enables application 
alongside green fluorescent tools, we conducted a dual-color imaging to probe calcium 
and voltage responses in genetically defined cells by replacing the nuclear EGFP marker 
with a genetically encode calcium sensor GCaMP6s20 (Figure 4-1). Cells of interest 
revealed cytosolic green fluorescence for GCaMP6s and membrane-associated red 
fluorescence for RhoVR1-PEG25-HaloTag (Figure 4-9b-d). The cells were 
simultaneously excited with both blue and green light, and the resulting emission was 
split into GCaMP6s and RhoVR fluorescence channels6, which allowed us to detect both 
the rapid changes in membrane potential and the corresponding slower increase in [Ca2+] 
during spontaneous spiking events (Figure 4-9a). In all cases, the fast voltage spike 
precedes the subsequent Ca2+ transient. Because of the fast kinetics of action potentials 
compared to Ca2+ fluctuations, the voltage trace resolves individual spiking events, which 
provides more information in neuronal firing, while Ca2+ trace lacks such resolution. 
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Inspired by the performance of RhoVR1-PEG25-HaloTag in cultured cells, we 
applied the strategy in a more complex biological system. We acquired acute mouse brain 
slices expressing cell-surface HaloTag using in utero electroporation (IUE). The 
constructs used in cultured neurons with IRSE-EGFP was not suitable for IUE since the 
expression of EGFP was too weak to screen in neonates (data not shown); in addition, 
shortening the construct by removing the unnecessary IRES-EGFP is expected to 
improve plasmid take-up and expression in neurons (Figure 4-1a). Instead, the new 
construct is co-injected with either a pCAG-mTagBFP2 or pCAG-EGFP for screening 
purpose in neonates and in slice preparation.  
The slice was loaded with 250 nM RhoVR1-PEG25-HaloTag at room temperature 
for 15 min and z-stack images from surface of the slice to about 100 µm in depth were 
taken under a confocal microscopy (Figure 4-10a-c). Sparsely labeled EGFP cells were 
found in layer 2/3 of the cortex (Figure 4-10a). The dye concentration and brightness of 
staining decreased as we imaged deeper inside the tissue and was barely visible at 100 
µm, suggesting that the small molecule was able to penetrate and diffuse fairly deep in 
the 15 min loading time (Figure 4-10b). Selective staining in EGFP-positive cells was 
observed but contrast was not obvious near surface of the slice where effective dye 
concentration was relatively high that non-specific labeling in background cells was 
prominent. Deeper in the slice, contrast was greatly enhanced with clear visualization of 
both the cell bodies and neuronal processes. Interestingly, not all EGFP-positive cells had 
cell-surface labeling and we hypothesize that it could be a problem with co-injection in 
which the separate fluorescent protein plasmid tended to express better under a stronger 
CAG promoter. We also confirmed the voltage sensitivity of the selectively labeled dye 
by performing current-clamp electrophysiology to evoke activity in the targeted cell. The 
recorded fluorescence trace revealed approximately 5% ΔF/F per action potential and 
individual spikes were resolved in single-trials (Figure 4-10d, e).  
Two-photon microscopy has become popular and desirable for in vivo imaging 
due its long excitation wavelength that increases tissue penetration while minimizing 
light scattering and phototoxicity.21-22 Since rhodamine exhibits excellent two-photon 
absorption23, we conducted two-photon imaging in the slice labeled with our targeted 
RhoVR1-PEG25-HaloTag. Although RhoVR1-PEG25-HaloTag absorbs best at around 820 
nm (Figure 4-11a), we still managed to visualize the stained cell at 1040 nm (Figure 4-
11b), the longest wavelength available on the microscope and a preferred wavelength for 
in vivo imaging. Upon closer inspection, subcellular structures such as dendritic spines 
could be distinguished from the background (Figure 4-11c), signifying the potential of 
monitoring voltage activities at these defined positions. We also compared the selective 
staining with the non-targeted parent dye RhoVR 1, which stained all cellular membranes 
indiscriminately and one can only identify the cell bodies as the black holes since the dye 
did not enter the cytosol (Figure 4-11d). With the resolution conferred by two-photon 
illumination, we achieved exceptional contrast of staining in selected neurons compared 
to background cells, which would be useful for analyzing electrical activities in specific 
subset of cells. We have also conducted preliminary imaging experiments in live 
anesthetized mouse expressing HaloTag. The RhoVR1-PEG25-HaloTag was delivered by 
stereotactic injection to the area of BFP marker fluorescence, followed by Z-stack 
imaging at 860 nm excitation. Only a few numbers of cells including neuronal projections 
were stained and easily distinguished from the surrounding background (Figure 4-12). 
122	
Immediate experiments involve optimizing imaging parameters to detect voltage activity 
in selectively stained cells in vivo.   
 
Conclusions 
 We have presented the design and application of genetically targetable 
tetramethylrhodamine voltage indicator (RhoVR1-PEG25-HaloTag) that marries the 
specificity of self-labeling protein HaloTag with the favorable photo-physics of small-
molecule VSDs. The specificity afforded through this hybrid chemical/genetic approach 
enabled voltage imaging of single neurons in brain slice, a feat previously impossible 
with VSDs. We also demonstrated the potential of RhoVR1-PEG25-HaloTag for use with 
two-photon microscopy that is attractive for in vivo applications due to its higher tissue 
penetrance and reduced photo-toxicity relative to one-photon microscopy. 
 Current work focuses on characterizing the voltage sensitivity of targeted 
RhoVR1-PEG25-HaloTag in two-photon illumination as well as optimizing the labeling 
protocol in live animal. Meanwhile, we are preparing a HaloTag virus to enable cell-type 
specific expression by the Cre-loxP system and to boost the enzyme expression. Labeling 
of cells of interest depends on expression of enzyme on the cell surface. The 1:1 
stoichiometry of indicator and enzyme will limit the total number of indicators, and 
therefore fluorescence intensity, on the cell surface. As a result, using a viral vector with 
superior transduction and expression efficiency would increase the amount of dye labeled 
and the signal-to-noise for voltage imaging.  
 
Experimental Sections 
 
Cell Culture  
All animal procedures were approved by the UC Berkeley Animal Care and Use 
Committees and conformed to the NIH Guide for the Care and Use and Laboratory 
Animals and the Public Health Policy.  
Human embryonic kidney 293T (HEK) cells were passaged and plated onto 12 
mm glass coverslips pre-coated with Poly-D-Lysine (PDL; 1 mg/ml; Sigma-Aldrich) to 
provide a confluency of ~15% and 50% for electrophysiology and imaging, respectively. 
HEK cells were plated and maintained in Dulbecco’s modified eagle medium (DMEM) 
supplemented with 4.5 g/L D-glucose, 10% FBS and 1% Glutamax. Transfection of 
genetic tools was carried out using Lipofectamine 3000 24 h after plating. Imaging was 
performed 18-24 h following transfection. For whole-cell patch clamp electrophysiology, 
cells were plated in DMEM (as above) at a density of 750,000 cells per well in a 6-well 
plate. Transfection of plasmids was carried out ~18-24 h after plating. The cells were 
split again 48 h after transfection and plated onto 12 mm glass coverslips pre-coated with 
Poly-D-Lysine at a density of 75,000 cells per coverslip in DMEM supplemented with 1 
g/L D-glucose, 10% FBS and 1% GlutaMax. Imaging was performed 12-18 h after 
plating. 
Hippocampi were dissected from embryonic day 19 Sprague Dawley rats (Charles 
River Laboratory) in cold sterile HBSS (zero Ca2+, zero Mg2+). All dissection products 
were supplied by Invitrogen, unless otherwise stated. Hippocampal tissue was treated 
with trypsin (2.5%) for 15 min at 37 °C. The tissue was triturated using fire polished 
Pasteur pipettes, in minimum essential media (MEM) supplemented with 5% fetal bovine 
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serum (FBS; Thermo Scientific), 2% B-27, 2% 1M D-glucose (Fisher Scientific) and 1% 
Glutamax. The dissociated cells were plated onto 12 mm diameter coverslips (Fisher 
Scientific) pre-treated with PDL at a density of 30-35,000 cells per coverslip in MEM 
supplemented media (as above). Neurons were maintained at 37 °C in a humidified 
incubator with 5 % CO2. At 1 day in vitro (DIV) half of the MEM supplemented media 
was removed and replaced with Neurobasal media containing 2% B-27 supplement and 
1% Glutamax. Transfection of genetic tools was carried out using Lipofectamine 3000 at 
7 DIV. Functional imaging was performed on mature neurons 13-20 DIV. 
 
In utero electroporation  
Pregnant mice at E15-16 were anaesthetized with 2.0% isoflurane, the abdomen 
was cleaned with 70% ethanol and swabbed with iodine, and a small vertical incision was 
made in the skin and abdominal wall and 8–12 embryos gently exposed. Each embryo 
was injected with 0.5–1 µl of DNA solution and 0.05% Fast Green dye. We used a 
pressure-controlled beveled glass pipette (Drummond, Custom Microbeveller) for 
injection. After each injection, the embryos were moistened with saline and voltage steps 
via tweezertrodes (BTX, 5 mm round, platinum, BTX electroporator) were applied with 
the positive electrode placed over the visual cortex and the negative electrode placed 
under the head of the embryo. Voltage was 40 V for 5 pulses at 1 Hz, each pulse lasting 
50 ms. The embryos were returned to the abdomen, which was sutured, followed by 
suturing of the skin. The procedure typically lasted under 30 min.  
 
Acute brain slice preparation  
Mice were deeply anesthetized with isoflurane and quickly decapitated. After 
removing the scalp and skull, ice-cold artificial cerebrospinal fluid with sucrose (ACSF-
sucrose) cutting solution (in mM: NaCl, 83; KCl, 2.5; MgSO4, 3.3; Na2HPO4, 1; 
NaHCO3, 26.2; D-glucose, 22; sucrose, 72; and CaCl2, 0.5) was applied to the brain. BFP 
fluorescence was checked with a hand held laser before the brain was taken out. The 
brain was cut into 300 µm thick slices with a DTK-1000 slicer in ice-cold sucrose cutting 
solution. The cut slices were incubated in sucrose cutting solution, bubbled with 95% O2 
and 5% CO2, first at 31 °C for about 30 min and then at room temperature until further 
use. For bath application of the dye and cell staining, a slice was transferred to a 35 mm 
dish with 3mL sucrose cutting solution (total volume) bubbled with 95% O2 and 5% CO2 
to which dye stock solution was added (250 nM final concentration). The slice was 
incubated with the dye at room temperature for 15 min with carbogen. For functional 
imaging, the slice was transferred to a fresh dish with ACSF recording solution (in mM: 
NaCl, 119; KCl, 2.5; MgSO4, 1.3; NaH2PO4, 1.3; NaHCO3, 26; D-glucose, 20 and CaCl2, 
2.5) using a plastic Pasteur pipette and washing is not necessary. A small harp or staple is 
used to press down the slice to minimize disturbance on the slice during perfusion and to 
make sure slice is flat for even illumination.  
 
Imaging Parameters  
Epifluorescence imaging was performed on an AxioExaminer Z-1 (Zeiss) 
equipped with a Spectra-X Light engine LED light (Lumencor), controlled with 
Slidebook (v6, Intelligent Imaging Innovations). Co-incident excitation with multiple 
LEDs was controlled by Lumencor software triggered through a Digidata 1332A digitizer 
and pCLAMP 10 software (Molecular Devices). Images were acquired with a W-Plan-
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Apo 20x/1.0 water objective (20x; Zeiss). Images were focused onto either an 
OrcaFlash4.0 sCMOS camera (sCMOS; Hamamatsu) or an eVolve 128 EMCCD camera 
(EMCCD; Photometrix). More detailed imaging information for each experimental 
application is expanded below. For RhoVR images, the excitation light was delivered 
from a LED (1.73-9.72 W/cm2) at 542/33 (bandpass) nm and emission was collected with 
a quadruple emission filter (430/32, 508/14, 586/30, 708/98 nm) after passing through a 
quadruple dichroic mirror (432/38, 509/22, 586/40, 654 nm LP). For EGFP images, 
excitation light was delivered from a LED (0.82-5.77 W/cm2) at 475/34 nm and emission 
was collected with a quadruple emission filter (430/32, 508/14, 586/30, 708/98 nm) after 
passing through a quadruple dichroic mirror (432/38, 509/22, 586/40, 654 nm LP).  
Confocal imaging was performed with a Zeiss LSM 880 NLO AxioExaminer 
equipped with a Diode 405 nm laser line, Argon 458, 488, and 514 laser lines, a DPSS 
561 nm laser line, a HeNe 633 laser line and and a BiG-2 detector with a 690+ dichroic. 
Images were acquired using a W-Plan-Apo 20x/1.0 water objective and a Zeiss Airyscan 
detector. For 2P imaging, samples were excited using 820-1040 nm light with 2-5% laser 
for 820-860 nm and 100% at 1040 nm.  
Unless stated otherwise, for loading of HEK cells and hippocampal neurons, 50 
µM DMSO stock solutions of were diluted 1:1000 in HBSS for loading, without 
solubilizing reagents. All imaging experiments were performed in HBSS.  
 
Imaging activity in cultured neurons  
For evoked activity, coverslips of neurons were placed in a recording chamber 
containing two platinum electrodes (Warner), which were connected to a SD9 Grass 
Stimulator, which delivered the extracellular field stimulation. The triggering was 
provided through the same Digidata 1332A digitizer and pCLAMP 9 software that ran 
the electrophysiology. Action potentials were triggered by 1 ms 60 V field potentials 
delivered at 5 Hz. Synaptic blockers including 10 µM 2,3-Dioxo-6-nitro-1,2,3,4-
tetrahydrobenzo[f]quinoxaline-7-sulfonamide (NBQX; Santa Cruz Biotechnology) and 
25 µM DL-2-Amino-5-phosphonopentanoic acid (APV; Sigma-Aldrich) were added to 
the HBSS solution to prevent recurrent activity. For both evoked action potentials and 
spontaneous activity, images were obtained using the sCMOS camera with a 20x water 
objective. Images were binned 4x4 to allow sampling rates of 0.5 kHz and 2500 frames 
(5 s) were acquired for each recording.  
 
In vitro two-photon cross section measurement 
 Measurement and calculation of two-photon cross section for the dyes were done 
according to the previously published protocol.9 Briefly, all measurement were done on a 
confocal microscope equipped with two-photon laser. Two-photon cross section of 
RhoVR1-PEG25-HaloTag was measured and calculated by comparison to a Rhodamine B 
standard. The dyes were diluted in PBS with 0.1% SDS (pH 7.4) in a 35 mm imaging 
dish. Images were acquired using a 20x water objective. The excitation was from 700 nm 
to 1040 nm with 10 nm increments and power at each wavelength was calculated by 
multiplying the percentage of laser power used and the total power of laser. Total 
fluorescence intensity of each acquired image was measured in ImageJ. Brightness per 
unit power was calculated at each wavelength for both RhoVR1-PEG25-HaloTag and 
Rhodamine B. Two-photon cross section (σTPE) of a dye at a specific wavelength is 
125	
inversely proportional to its quantum yield (ϕ) and directly proportional to photon 
emitted at that wavelength (F, or brightness per unit power as abovementioned). Thus, 
σTPE of RhoVR1-PEG25-HaloTag can be calculated according to the following equation 
with known values of ϕRhodamine B, ϕRhoVR1-PEG25-HaloTag, σTPE(RhodamineB) and measured 
brightness per unit power for both dyes: σ!"#!"#$! = ϕ!"#$%&'() !ϕ!"#$!  ×  F!"#$!F!"#$%&'() !  × σ!"#!"#$%&'() !   
where ϕ!"#$%&'() ! = 0.31 and ϕ!"#$! = 0.05. 
 
Dual-View imaging  
Dual-view imaging was preformed using a 20x objective paired with the sCMOS 
camera. RhoVR1-PEG25-HaloTag was excited using the 542 nm LED with a light 
intensity of 2.40-9.73 W/cm2 while GCaMP6s was excited simultaneously using a 475 
nm LED with a light intensity of 0.82-1.20 W/cm2. Emission was collected with a QUAD 
filter and dichroic (see above) used in conjunction with a Dual-View emission splitter 
(Optical Insights). The Dual-View was equipped with a 585dcxr dichroic (Chroma) and 
520/28 nm (Semrock) and 610/75 nm (Chroma) emission filters, which separated the 
GCaMP6s and RhoVR signals. 
 
Image Analysis  
Analysis of voltage sensitivity in HEK cells and neurons was performed using 
ImageJ (FIJI). Briefly, a region of interest (ROI) was selected automatically based on 
fluorescence intensity and applied as a mask to all image frames. Fluorescence intensity 
values were calculated at known baseline and voltage step epochs. ΔF/F values were 
calculated by first subtracting a mean background value from all raw fluorescence 
frames, bypassing the noise amplification which arises from subtracting background for 
each frame, to give a background subtracted trace (bkgsub). A baseline fluorescence 
value (Fbase) is calculated either from the first several (10-20) frames of the experiment 
for evoked activity, or from the median for spontaneous activity, and was subtracted from 
each timepoint of the bkgsub trace to yield a ΔF trace. The ΔF was then divided by Fbase 
to give ΔF/F traces. No averaging has been applied to any voltage traces. 
 
Electrophysiology  
For electrophysiological experiments, pipettes were pulled from borosilicate glass 
(Sutter Instruments, BF150-86-10), with a resistance of 4–8 MΩ, and were filled with an 
internal solution; 115 mM potassium gluconate, 10 mM BAPTA tetrapotassium salt, 10 
mM HEPES, 5 mM NaCl, 10 mM KCl, 2 mM ATP disodium salt, 0.3 mM GTP 
trisodium salt (pH 7.25, 275 mOsm). Recordings were obtained with an Axopatch 200B 
amplifier (Molecular Devices) at room temperature. The signals were digitized with 
Digidata 1440A, sampled at 50 kHz and recorded with pCLAMP 10 software (Molecular 
Devices) on a PC. Fast capacitance was compensated in the on-cell configuration. For all 
electrophysiology experiments, recordings were only pursued if series resistance in 
voltage clamp was less than 30 MΩ. For whole-cell, voltage clamp recordings in HEK 
293T cells, cells were held at -60 mV and 100 ms hyper- and de- polarizing steps applied 
from -100 to +100 mV in 20 mV increments. Imaging was performed using a 20x 
objective and the EMCCD camera at a sampling rate of 0.5 kHz. Dyes were excited using 
126	
the 542 nm LED with an intensity of 9.73 W/cm2. For initial voltage characterization 
emission was collection with the QUAD filter and dichroic (see above). For whole-cell, 
current clamp in slices, experiments were conducted on the microscope set up for slice 
patching in the Adesnik lab. Briefly, slices were transferred to the microscope perfusion 
chamber with ACSF recording solution. Illumination of the samples was done by a 
spectra-X Light engine LED light (Lumencor), controlled with Matlab script written by 
the Adesnik lab. Images were acquired with a W-Plan-Apo 20x/1.0 water objective (20x; 
Zeiss) at a sampling rate of 1 kHz.  
 
DNA constructs  
To express the HaloTag protein on the cell surface, an IgK leader sequence was 
fused to the N-terminal and a transmembrane domain (pDisplay) was added to the C-
terminal of the HaloTag sequence. For the purpose of inmmunostaining, an HA tag was 
inserted. Mammalian expression vector pcDNA3 with either a cytomegalovirus (CMV) 
promoter or human synapsin promoter (Syn) was used for protein expression in HEK 
cells and cultured neurons, respectively. To increase expression in neurons, a regulatory 
element from the woodchuck hepatitis virus (WPRE) was used. In some constructs, 
nuclear-targeted EGFP (NLS-EGFP) was inserted down stream of HaloTag, separated by 
an internal ribosome entry site (IRES) sequence, in order to track the expression of 
HaloTag in live cells. For dual voltage and calcium imaging, a GCaMP6s with an IRES 
sequence was inserted down stream of HaloTag. The cloned constructs were verified by 
sequencing. All the constructs were prepared using Qiagen Maxiprep kit, except those 
with CMV promoter. The following sequences were used (5' to 3'): 
 
IgK  
ATGGAGACAGACACACTCCTGCTATGGGTACTGCTGCTCTGGGTTCCAGGTTC
CACTGGTGAC  
 
HaloTag  
GCAGAAATCGGTACTGGCTTTCCATTCGACCCCCATTATGTGGAAGTCCTGGG
CGAGCGCATGCACTACGTCGATGTTGGTCCGCGCGATGGCACCCCTGTGCTG
TTCCTGCACGGTAACCCGACCTCCTCCTACGTGTGGCGCAACATCATCCCGCA
TGTTGCACCGACCCATCGCTGCATTGCTCCAGACCTGATCGGTATGGGCAAAT
CCGACAAACCAGACCTGGGTTATTTCTTCGACGACCACGTCCGCTTCATGGAT
GCCTTCATCGAAGCCCTGGGTCTGGAAGAGGTCGTCCTGGTCATTCACGACTG
GGGCTCCGCTCTGGGTTTCCACTGGGCCAAGCGCAATCCAGAGCGCGTCAAA
GGTATTGCATTTATGGAGTTCATCCGCCCTATCCCGACCTGGGACGAATGGCC
AGAATTTGCCCGCGAGACCTTCCAGGCCTTCCGCACCACCGACGTCGGCCGC
AAGCTGATCATCGATCAGAACGTTTTTATCGAGGGTACGCTGCCGATGGGTG
TCGTCCGCCCGCTGACTGAAGTCGAGATGGACCATTACCGCGAGCCGTTCCT
GAATCCTGTTGACCGCGAGCCACTGTGGCGCTTCCCAAACGAGCTGCCAATC
GCCGGTGAGCCAGCGAACATCGTCGCGCTGGTCGAAGAATACATGGACTGGC
TGCACCAGTCCCCTGTCCCGAAGCTGCTGTTCTGGGGCACCCCAGGCGTTCTG
ATCCCACCGGCCGAAGCCGCTCGCCTGGCCAAAAGCCTGCCTAACTGCAAGG
CTGTGGACATCGGCCCGGGTCTGAATCTGCTGCAAGAAGACAACCCGGACCT
GATCGGCAGCGAGATCGCGCGCTGGCTGTCGACGCTCGAGATTTCCGGC  
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HA  
TATCCATATGATGTTCCAGATTATGCT 
 
DAF  
CCAAATAAAGGAAGTGGAACCACTTCAGGTACTACCCGTCTTCTATCTGGGC
ACACGTGTTTCACGTTGACAGGTTTGCTTGGGACGCTAGTAACCATGGGCTTG
CTGACTTAG  
 
pDisplay 
GCTGTGGGCCAGGACACGCAGGAGGTCATCGTGGTGCCACACTCCTTGCCCT
TTAAGGTGGTGGTGATCTCAGCCATCCTGGCCCTGGTGGTGCTCACCATCATC
TCCCTTATCATCCTCATCATGCTTTGGCAGAAGAAGCCACGT 
 
IRES  
GCCCCTCTCCCTCCCCCCCCCCTAACGTTACTGGCCGAAGCCGCTTGGAATAA
GGCCGGTGTGCGTTTGTCTATATGTTATTTTCCACCATATTGCCGTCTTTTGGC
AATGTGAGGGCCCGGAAACCTGGCCCTGTCTTCTTGACGAGCATTCCTAGGG
GTCTTTCCCCTCTCGCCAAAGGAATGCAAGGTCTGTTGAATGTCGTGAAGGA
AGCAGTTCCTCTGGAAGCTTCTTGAAGACAAACAACGTCTGTAGCGACCCTTT
GCAGGCAGCGGAACCCCCCACCTGGCGACAGGTGCCTCTGCGGCCAAAAGCC
ACGTGTATAAGATACACCTGCAAAGGCGGCACAACCCCAGTGCCACGTTGTG
AGTTGGATAGTTGTGGAAAGAGTCAAATGGCTCTCCTCAAGCGTATTCAACA
AGGGGCTGAAGGATGCCCAGAAGGCACCCCATTGTATGGGATCTGATCTGGG
GCCTCGGTGCACATGCTTTACATGTGTTTAGTCGAGGTTAAAAAAACGTCTAG
GCCCCCCGAACCACGGGGACGTGGTTTTCCTTTGAAAAACACGATGATAATA
TGGCCACA  
 
NLS-EGFP  
ATGGTGCCCAAGAAGAAGAGGAAAGTCAGCAAGGGCGAGGAGCTGTTCACG
GGGTGGTGCCCATCCTGGTCGAGCTGGACGGCGACGTAAACGGCCACAAGTT
CAGCGTGTCCGGCGAGGGCGAGGGCGATGCCACCTACGGCAAGCTGACCCTG
AAGTTCATCTGCACCACCGGCAAGCTGCCCGTGCCCTGGCCCACCCTCGTGA
CCACCCTGACCTACGGCGTGCAGTGCTTCAGCCGCTACCCCGACCACATGAA
GCAGCACGACTTCTTCAAGTCCGCCATGCCCGAAGGCTACGTCCAGGAGCGC
ACCATCTTCTTCAAGGACGACGGCAACTACAAGACCCGCGCCGAGGTGAAGT
TCGAGGGCGACACCCTGGTGAACCGCATCGAGCTGAAGGGCATCGACTTCAA
GGAGGACGGCAACATCCTGGGGCACAAGCTGGAGTACAACTACAACAGCCA
CAACGTCTATATCATGGCCGACAAGCAGAAGAACGGCATCAAGGTGAACTTC
AAGATCCGCCACAACATCGAGGACGGCAGCGTGCAGCTCGCCGACCACTACC
AGCAGAACACCCCCATCGGCGACGGCCCCGTGCTGCTGCCCGACAACCACTA
CCTGAGCACCCAGTCCGCCCTGAGCAAAGACCCCAACGAGAAGCGCGATCAC
ATGGTCCTGCTGGAGTTCGTGACCGCCGCCGGGATCACTCTCGGCATGGACG
AGCTGTACAAG 
 
GCaMP6s  
ATGGGTTCTCATCATCATCATCATCATGGTATGGCTAGCATGACTGGTGGACA
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GCAAATGGGTCGGGATCTGTACGACGATGACGATAAGGATCTCGCCACCATG
GTCGACTCATCACGTCGTAAGTGGAATAAGACAGGTCACGCAGTCAGAGCTA
TAGGTCGGCTGAGCTCACTCGAGAACGTCTATATCAAGGCCGACAAGCAGAA
GAACGGCATCAAGGCGAACTTCCACATCCGCCACAACATCGAGGACGGCGG
CGTGCAGCTCGCCTACCACTACCAGCAGAACACCCCCATCGGCGACGGCCCC
GTGCTGCTGCCCGACAACCACTACCTGAGCGTGCAGTCCAAACTTTCGAAAG
ACCCCAACGAGAAGCGCGATCACATGGTCCTGCTGGAGTTCGTGACCGCCGC
CGGGATCACTCTCGGCATGGACGAGCTGTACAAGGGCGGTACCGGAGGGAG
CATGGTGAGCAAGGGCGAGGAGCTGTTCACCGGGGTGGTGCCCATCCTGGTC
GAGCTGGACGGCGACGTAAACGGCCACAAGTTCAGCGTGTCCGGCGAGGGT
GAGGGCGATGCCACCTACGGCAAGCTGACCCTGAAGTTCATCTGCACCACCG
GCAAGCTGCCCGTGCCCTGGCCCACCCTCGTGACCACCCTGACCTACGGCGT
GCAGTGCTTCAGCCGCTACCCCGACCACATGAAGCAGCACGACTTCTTCAAG
TCCGCCATGCCCGAAGGCTACATCCAGGAGCGCACCATCTTCTTCAAGGACG
ACGGCAACTACAAGACCCGCGCCGAGGTGAAGTTCGAGGGCGACACCCTGG
TGAACCGCATCGAGCTGAAGGGCATCGACTTCAAGGAGGACGGCAACATCCT
GGGGCACAAGCTGGAGTACAACCTGCCGGACCAACTGACTGAAGAGCAGAT
CGCAGAATTTAAAGAGGCTTTCTCCCTATTTGACAAGGACGGGGATGGGACA
ATAACAACCAAGGAGCTGGGGACGGTGATGCGGTCTCTGGGGCAGAACCCC
ACAGAAGCAGAGCTGCAGGACATGATCAATGAAGTAGATGCCGACGGTGAC
GGCACAATCGACTTCCCTGAGTTCCTGACAATGATGGCAAGAAAAATGAAAT
ACAGGGACACGGAAGAAGAAATTAGAGAAGCGTTCGGTGTGTTTGATAAGG
ATGGCAATGGCTACATCAGTGCAGCAGAGCTTCGCCACGTGATGACAAACCT
TGGAGAGAAGTTAACAGATGAAGAGGTTGATGAAATGATCAGGGAAGCAGA
CATCGATGGGGATGGTCAGGTAAACTACGAAGAGTTTGTACAAATGATGACA
GCGAAGTGA  
 
WPRE  
GCTTATCGATAATCAACCTCTGGATTACAAAATTTGTGAAAGATTGACTGGTA
TTCTTAACTATGTTGCTCCTTTTACGCTATGTGGATACGCTGCTTTAATGCCTT
TGTATCATGCTATTGCTTCCCGTATGGCTTTCATTTTCTCCTCCTTGTATAAAT
CCTGGTTGCTGTCTCTTTATGAGGAGTTGTGGCCCGTTGTCAGGCAACGTGGC
GTGGTGTGCACTGTGTTTGCTGACGCAACCCCCACTGGTTGGGGCATTGCCAC
CACCTGTCAGCTCCTTTCCGGGACTTTCGCTTTCCCCCTCCCTATTGCCACGGC
GGAACTCATCGCCGCCTGCCTTGCCCGCTGCTGGACAGGGGCTCGGCTGTTG
GGCACTGACAATTCCGTGGTGTTGTCGGGGAAATCATCGTCCTTTCCTTGGCT
GCTCGCCTGTGTTGCCACCTGGATTCTGCGCGGGACGTCCTTCTGCTACGTCC
CTTCGGCCCTCAATCCAGCGGACCTTCCTTCCCGCGGCCTGCTGCCGGCTCTG
CGGCCTCTTCCGCGTCTTCGCCTTCGCCCTCAGACGAGTCGGATCTCCCTTTG
GGCCGCCTCCCCGCATCGATACCG 
 
CMV promoter  
GACATTGATTATTGACTAGTTATTAATAGTAATCAATTACGGGGTCATTAGTT
CATAGCCCATATATGGAGTTCCGCGTTACATAACTTACGGTAAATGGCCCGCC
TGGCTGACCGCCCAACGACCCCCGCCCATTGACGTCAATAATGACGTATGTT
CCCATAGTAACGCCAATAGGGACTTTCCATTGACGTCAATGGGTGGACTATTT
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ACGGTAAACTGCCCACTTGGCAGTACATCAAGTGTATCATATGCCAAGTACG
CCCCCTATTGACGTCAATGACGGTAAATGGCCCGCCTGGCATTATGCCCAGT
ACATGACCTTATGGGACTTTCCTACTTGGCAGTACATCTACGTATTAGTCATC
GCTATTACCATGGTGATGCGGTTTTGGCAGTACATCAATGGGCGTGGATAGC
GGTTTGACTCACGGGGATTTCCAAGTCTCCACCCCATTGACGTCAATGGGAGT
TTGTTTTGGCACCAAAATCAACGGGACTTTCCAAAATGTCGTAACAACTCCGC
CCCATTGACGCAAATGGGCGGTAGGCGTGTACGGTGGGAGGTCTATATAAGC
AGAGCT 
 
Synapsin Promoter  
GTGTCTAGACTGCAGAGGGCCCTGCGTATGAGTGCAAGTGGGTTTTAGGACC
AGGATGAGGCGGGGTGGGGGTGCCTACCTGACGACCGACCCCGACCCACTG
GACAAGCACCCAACCCCCATTCCCCAAATTGCGCATCCCCTATCAGAGAGGG
GGAGGGGAAACAGGATGCGGCGAGGCGCGTGCGCACTGCCAGCTTCAGCAC
CGCGGACAGTGCCTTCGCCCCCGCCTGGCGGCGCGCGCCACCGCCGCCTCAG
CACTGAAGGCGCGCTGACGTCACTCGCCGGTCCCCCGCAAACTCCCCTTCCC
GGCCACCTTGGTCGCGTCCGCGCCGCCGCCGGCCCAGCCGGACCGCACCACG
CGAGGCGCGAGATAGGGGGGCACGGGCGCGACCATCTGCGCTGCGGCGCCG
GCGACTCAGCGCTGCCTCAGTCTGCGGTGGGCAGCGGAGGAGTCGTGTCGTG
CCTGAGAGCGCAGTCGAGA 
 
Benchling links for constructs 
 
CMV-IgK-HaloTag-HA-pDisplay-IRES-EGFP 
https://benchling.com/s/seq-hnmTQqUI6MJ8uOIEuXa8 
 
Synapsin-IgK-HaloTag-HA-pDisplay-IRES-EGFP-WPRE 
https://benchling.com/s/seq-kCT5loPFZtiFqYywoksg 
 
Synapsin-IgK-HaloTag-HA-pDisplay-IRES-GCaMP6s-WPRE 
https://benchling.com/s/seq-ibK9qbzeFVNIJeaz6LmV 
 
Synapsin-IgK-HaloTag-HA-pDisplay-WPRE 
https://benchling.com/s/seq-zWvHNSFd26mff9OStRXg 
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Figures and Schemes 
Scheme 4-1. Design of covalent labeling of RhoVR dyes in specific cells of interest. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 4-1. Scheme of neuron-specific targeting with cell-surface HaloTag and RhoVR-
HaloTag (components are not to scale). 
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Scheme 4-2. Structures of RhoVR-HaloTag dyes used in this study. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 4-2. Structures of RhoVR1-PEGx-HaloTag with variable linker size synthesized 
and tested in the covalent labeling strategy. 
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Figure 4-1. HaloTag constructs used in this study and characterization in HEK cells.  
  a) 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4-1. Engineering a cell-surface HaloTag for covalent labeling of RhoVR-HaloTag 
dyes. (a) HaloTag constructs used in this study. (b-e) Selective staining of TMR-PEG13-
HaloTag in HEK cells sparsely transfected with HaloTag-pDisplay construct. (b) 
Differential interference contrast (DIC) images of HEK cells. (c) Nuclear EGFP 
fluorescence indicates HaloTag expression. (d) Membrane-associated fluorescence is 
observed in specific cells after bath application of 200 nM dye for 30 min at 37 °C. (e) 
Merge of EGFP and TMR fluorescence confirms good association between cell-surface 
staining and HaloTag expression. Scale bar is 20 µm. 
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Figure 4-2. Characterization of RhoVR-PEGx- HaloTag brightness in HEK cells.  
 
Figure 4-2. Comparing brightness of RhoVR1-PEGx-HaloTag dyes in HEK cells. (a) 
RhoVR1-PEGx-HaloTag dyes exhibit membrane-associated fluorescence that matches 
nuclear EGFP, which indicates HaloTag expression. RhoVR1, as a control, stained all 
cells non-selectively. All dyes were loaded at 50 nM at 37 °C for 30 min. Scale bar is 20 
µm. (b) Quantification of fluorescence staining for all the dyes (n = 20 cells for each 
dye). Error bars are ±S.E.M.  
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Figure 4-3. Characterization of RhoVR-PEGx-HaloTag voltage sensitivity in HEK cells.  	
	
Figure 4-3. Voltage-sensitivity plot (% ΔF/F vs mV) of RhoVR-HaloTag dyes of 
variable linker lengths. Whole-cell voltage clamp electrophysiology was performed to 
step the membrane potential from -100 mV to +100 mV with 20 mV increments while 
fluorescence change was monitored (n = 3-9 cells per dye, error bars not shown). 
Increasing linker length improved voltage sensitivity with a maximum of 34% % ΔF/F 
per 100mV for PEG25 dye.  
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Figure 4-4. Characterization of RhoVR1-PEG25-HaloTag localization in HEK cells.  
 
 
Figure 4-4. Confocal microscope imaging of RhoVR1-PEG25-HaloTag in HEK cells. (a) 
DIC images of HEK cells transfected with HaloTag-pDisplay construct. (b) Nuclear 
EGFP fluorescence indicates HaloTag expression in a few selected cells among densely 
packed cells. d) Membrane-associated and high-contrast fluorescence is observed in 
specific cells after bath application of 50 nM RhoVR1-PEG25-HaloTag for 30 min at 37 
°C. (e) Merge of EGFP and RhoVR-HaloTag fluorescence confirms good association 
between bright, cell-surface staining and HaloTag expression. Scale bar is 10 µm. 
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Figure 4-5. Characterization of RhoVR1-PEG25-HaloTag staining in cultured neurons.   	
		
Figure 4-5. Confocal microscopy imaging of RhoVR1-PEG25-HaloTag staining in 
cultured hippocampal neurons. Both dyes were loaded at 50 nM at 37 °C for 30 min. 
Selective staining of RhoVR1-PEG25-HaloTag (a-d) in neuronal culture sparsely 
transfected with HaloTag. (a) Nuclear EGFP fluorescence indicates HaloTag expression. 
(b) Membrane-associated and high-contrast fluorescence is observed in a specific cell. (c) 
DIC images of cultured neurons. (d) Merge of EGFP and RhoVR-HaloTag fluorescence 
confirms good association between bright, cell-surface staining and HaloTag expression. 
Scale bar is 20 µm. 
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Figure 4-6. Functional imaging with RhoVR1-PEG25-HaloTag in cultured neurons. 
 
Figure 4-6. Recording neuronal activity by RhoVR1-PEG25-HaloTag in cultured 
hippocampal neurons. Representative traces of spontaneous spiking events in neurons as 
shown by RhoVR1-PEG25-HaloTag. 
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Figure 4-7. Characterization of BeRST 1 and RhoVR1-PEG25-HaloTag in cultured 
neurons. 	
	
 
Figure 4-7. Confocal microscopy imaging of (a) non-targeted far-red dye BeRST1 and 
(b) targeted dye RhoVR1-PEG25-HaloTag co-stained in the same neuronal culture. While 
BeRST1 shows uniform, non-selective staining in the field of view, RhoVR1-PEG25-
HaloTag highlights only two cells of interest with clear visualization of their respective 
neuronal projections. Scale bar is 20 µm. 
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Figure 4-8. Characterization of RhoVR1-PEG25-HaloTag with genetically encoded 
voltage indicators (GEVIs).  
 
		
Figure 4-8: Comparing of RhoVR1-PEG25-HaloTag with GEVIs ASAP1 and Ace2N-
mNeon. (a) Representative voltage recordings of evoked activity measured with the 
voltage reporters. Voltage traces were acquired with identical parameters and matched 
light power. RhoVR1-PEG25-HaloTag outperforms the GEVIs with improved voltage 
sensitivities (b) and signal-to-noise ratio (c) measured from averages of individual 
evoked spike (n=77-205). Error bars are ± S.E.M. 
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Figure 4-9. Simultaneous calcium and voltage imaging using GCaMP6s and RhoVR1-
PEG25-HaloTag.  
 
		
Figure 4-9. Recording spontaneous activity using a dual-view set-up for both calcium 
and voltage responses. (a) The green trace represents Ca2+ fluctuations recorded by a 
genetically encoded calcium indicator GCaMP6s. The red trace represents voltage 
changes recorded by RhoVR1-PEG25-HaloTag. The inset shows an expanded time scale 
of the boxed region. (b) DIC image of cultured neurons. (c) Cytosolic fluorescence from 
GCaMP6s. (d) Membrane-associated fluorescence from RhoVR1-PEG25-HaloTag. Scale 
bar is 50 µm. 
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Figure 4-10. Imaging RhoVR1-PEG25-HaloTag in mouse brain slice.  
142	
 
 
Figure 4-10. One-photon confocal microscopy imaging of RhoVR1-PEG25-HaloTag in 
mouse brain slice expressing HaloTag-pDisplay and pCAG-EGFP following in utero 
electroporation. Z-stack imaging was conducted from surface of the slice to deeper into 
the tissue and the depth relevant to the surface was indicated in each image. (a) EGFP 
was used for screening positive pups and expressing slices. (b) RhoVR staining shows 
membrane-associated fluorescence in selected cells that express EGFP and exhibits high 
contrast with respect to background and non-transfected cells. White asterisks indicate 
cell bodies of neurons with selective staining.  (c) Merge images of EGFP and RhoVR 
channels. Yellow asterisks indicate neurons expressing only EGFP without RhoVR 
staining. (d) Wide-field fluorescence image of RhoVR stained slice acquired during 
patch-clamp electrophysiology. (e) Representative ΔF/F trace of evoked voltage activity 
recorded by RhoVR1-PEG25-HaloTag in a neuron patch-clamped for current injection. 
Images are acquired at 1 kHz and represent single-trial acquisitions.  
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Figure 4-11. Two-photon imaging of RhoVR1-PEG25-HaloTag mouse brain slice. 
 
 
 
Figure 4-11. Two-photon imaging of RhoVR1-PEG25-HaloTag (a) in vitro and (b-c) in 
mouse brain slice stained (250 nM, 15 min at RT). (a) Two-photon cross-section (GM) 
was measured at 500 nM in PBS with 0.1% SDS. (b) Two-photon laser at 1040 nm was 
used to excite and visualize the sample. In this region of interest, only one neuron 
expresses HaloTag and gets labele. A closer inspection (c) reveals its projections and 
subcellular structures such as dendritic spines (white arrows). (d) Representative image of 
non-targeted parent dye RhoVR1 in brain slice White asterisks indicate cell bodies. Scale 
bar is 20 µm. 
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Figure 4-12. Imaging RhoVR1-PEG25-HaloTag in live anesthetized mouse. 	
		
Figure 4-12. Two-photon imaging of RhoVR1-PEG25-HaloTag in live anesthetized 
mouse expressing Syn-HaloTag-pDisplay and pCAG-mTagBFP2. (a) BFP fluorescence 
indicates HaloTag expression. (b) RhoVR staining shows membrane-associated signal in 
selected cells with high contrast with respect to background and non-transfected cells. (c) 
Merge image of cytosolic BFP and membrane-associated RhoVR fluorescence.	Scale bar 
is 20 µm 
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Chapter 5: 
Application of HaloTag-based Covalent Labeling 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Portions of this work were performed in collaboration with the following persons:  
Synthesis of VF-PEG13-HaloTag was assisted by Vincent Grenier  
Synthesis  and cellular characterization of mBeRST-PEG25-HaloTag was assisted by 
Gloria Ortiz  
Cloning was assisted by Vikram Muller 
In utero electroporation was assisted by Kiarash Shamardani 
Slice patch-clamping was assisted by Hillel Adesnik 
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Abstract 
  An alternative targeting strategy to fluorogenic activation is covalent labeling, a 
hybrid approach consisting of a cell surface enzyme expressed on specific cells and a 
chemically modified dye containing an enzyme-specific ligand. Using HaloTag and 
RhoVR1-PEG25-HaloTag, we have established high-contrast staining in cultured neurons, 
mouse brain slice and live animal. To build upon that, we converted two more dyes, 
VF2.1.Cl and BeRST 1, to VF-HaloTag and mBeRST-HaloTag and proved that both can 
be targeted to cells expressing HaloTag. While VF-HaloTag is not an ideal target due to 
its rapid bleaching, mBeRST-HaloTag reports spontaneous spiking events with high 
signal-to-noise in cultured neurons and exhibits selective staining in mouse brain slice. In 
addition, targeting voltage dye exclusively to cell bodies was accomplished by utilizing a 
soma targeting sequence on the HaloTag construct, thus maximizing effective signal for 
data analysis. These efforts intend to design a HaloTag system that can be eventually 
used as a practical tool to replace traditional electrophysiology and Ca2+-based imaging to 
monitor neuronal activity in complex biological system.  
 
Introduction 
  Covalent labeling of a rhodamine-based voltage sensitive dye (RhoVR 1) by a 
cell-surface HaloTag permits specific staining to cells of interest. Compared to the 
esterase-based fluorogenic activation described in Chapter 2 and Chapter 3, contrast has 
been substantially increased as a result of the fast and high-affinity reaction between the 
HaloTag enzyme and its ligand, which outcompetes the non-selective labeling process of 
the hydrophobic molecular wire entering the plasma membrane. Selective staining with 
remarkable contrast has been achieved in not only cultured cells, but also mouse brain 
slice and live animal. Encouraged by these results, we have decided to expand the 
strategy to other dyes, creating the possibility of conducting multi-color targeted staining 
when combined with other targeting strategies and to optimize the system from the 
chemical side.  
 This chapter reports the design and initial data of combining HaloTag with two 
other dyes, VF2.1.Cl and BeRST 1. Both dyes have different spectral properties and 
voltage sensitivity from RhoVR 1. VF2.1.Cl is the first generation, fluorescein-based 
VoltageFluor dye with desirable quantum yield and sensitivity.1 Its ability to report 
spontaneous activity was demonstrated in heterogeneous preparations such as leech 
ganglia but targeting the dye remains a challenge. In the past years, photo-labile2 or ester3 
groups have been used to diminish its fluorescence and activity but the fluorescence turn-
on was not robust enough for tissue applications. As a result, we turned to HaloTag-based 
covalent labeling strategy to discover a solution.  
 The key to the performance of HaloTag-based targeting appears to rely on the 
properties of the chemical dye rather than the enzyme expression. Thus, we selected the 
one of the best voltage sensitive dyes developed in the lab, Berkeley Red Sensor of 
Transmembrane potential, or BeRST 1. With its far-red spectral profile and high photo-
stability, BeRST 1 enables high-speed and sensitive voltage recording in conjunction 
with other optogenetic tools such as GCaMP and channelrhodopsin.4 It would be 
advantageous to combine BeRST 1 with a protein component to introduce specificity to 
the dye, in an effort to expand the scope of its application to more complex samples. 
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Besides switching the dyes, we also worked on targeting HaloTag to precise 
cellular locations. While HaloTag allows for specific staining in a defined set of neurons, 
including the extensive neuronal projections, staining of the projections increases the 
overall signal of the image, thus raising the background noise. For data analysis, soma 
fluorescence is usually measured as the signal to quantify membrane potential changes; 
as a result, staining all the membranes reduces signal-to-noise. Therefore, we aimed to 
restrict all the essential fluorescence signals to the cell body or soma and to eliminate the 
background fluorescence from neuronal processes. To do so, re-designing the HaloTag 
construct would be necessary.  
  
Results & Discussions 
 
5-1: Application of HaloTag-based covalent labeling to VF2.1.Cl 
 VF-HaloTag was synthesized by attaching the HaloTag ligand to VF2.1.Cl 
connected by a polyethylene glycol (PEG) linker (Scheme 5-1-1b, synthesis was 
conducted by Dr. Vince Grenier). We modified the plasmid construct used for RhoVR1-
HaloTag (Chapter 4, Figure 4-1) by switching to a red fluorescent protein mCherry for 
spectral separation from the fluorescein-based dye (Figure 5-1-1). Bath application of 50 
nM VF-HaloTag to HEK cells sparsely transfected with CMV-HaloTag-pDisplay 
resulted in clear membrane-associated fluorescence (Figure 5-1-2c) that matched the 
nuclear mCherry or HaloTag expression (Figure 5-1-2b,d). In a patch of densely packed 
cells, fluorescence was only observed in specific cells (Figure 5-1-2a,c). The selectivity 
of staining is remarkable with a 15-fold contrast, which is defined as the ratio of 
background-subtracted fluorescence from transfected cells to non-transfected cells. 
To drive neuron-specific expression in rat hippocampal cultures, a human 
synapsin promoter was used (Figure 5-1-1). The contrast of VF-HaloTag labeling was 
maintained in the neuronal culture (Figure 5-1-3a) and cell-surface staining was only 
visualized in a specific cell expressing nuclear mCherry (Figure 5-1-3b,c). We acquired 
these VF-HaloTag images 8 days after transfection when the enzyme production 
increased markedly to capture sufficient dye molecules to provide the contrast. Unlike the 
RhoVR1-HaloTag system, expression or stained dye signal earlier than that time point 
was not as robust (data not shown), which might point to a fact that the mCherry 
construct may not express as well as the EGFP construct. We also varied the dye 
concentration and noticed only a slight difference in fluorescence intensity between 50 
nM and 10 nM (Figure 5-1-3e) since the HaloTag binding site is probably getting 
saturated at low nano-molar concentrations. The contrast between transfected and non-
transfected neurons improved at 10 nM compared to 50 nM, due to a decreased non-
specific staining in non-transfected cells. The voltage sensitivity of the targeted dye was 
confirmed by recording spontaneous activity (Figure 5-1-4), though the signal-to-noise 
was not ideal. Another observation was that the dye bleached fast when we acquired the 
activity traces (data not shown), which can be explained by the inherent photo-instability 
of VF2.1.Cl. Despite the limited application of VF-HaloTag for future studies due to its 
green spectral profile and inferior photo-physical properties, it is promising that the 
HaloTag-based strategy is easily transferrable to other dyes.  
 
5-2: Application of HaloTag-based covalent labeling to mBeRST 
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 The original BeRST 1 was modified by shifting the molecular wire from para- to 
meta- position on the pendant ring to enhance its voltage sensitivity.5-7 Following that, 
mBeRST was converted to the HaloTag version by appending a PEG linker and 
haloalkane ligand to generate mBeRST-PEG25-HaloTag (Figure 5-2-1, synthesis was 
conducted by Gloria Ortiz).  
 For characterization in cultured cells, we used the same EGFP constructs as 
RhoVR1-PEG25-HaloTag (Chapter 4, Figure 4-1). Selective and membrane-associated 
fluorescence of mBeRST-PEG25-HaloTag was only detected in EGFP-expressing cells in 
both sparsely transfected HEK cells (Figure 5-2-2a-c) and cultured rat hippocampal 
neurons (Figure 5-2-3a-c). By whole-cell patch clamp electrophysiology in HEK cells, 
we calculated a voltage sensitivity of 20.6% ± 1.5% ΔF/F per 100 mV (n = 7 cells, Figure 
5-2-2d). Spontaneous spiking events in cultured neurons were successfully recorded in 
cells of interest with this targeted dye (Figure 5-2-3d).  
 Acute brain slices were acquired and stained in a manner similar to that in the 
RhoVR1-PEG25-HaloTag study (Chapter 4, Experimental Section). Only a few cells were 
labeled with the dye, displaying bright and membrane-associated fluorescent signal in 
both cell bodies and neuronal processes (Figure 5-2-4a). We then performed current-
clamp electrophysiology to evoke activity while simultaneously monitoring fluorescence 
change and found out that the stained dye was voltage sensitive to report action potentials 
(Figure 5-2-4b,c). This again illustrates the generalizability of HaloTag-based selective 
labeling strategy to another voltage dye of different color, sensitivity and photostability.  
 
5-3: Target mBeRST and RhoVR staining to neuronal cell body 
The dendritic K+ channel Kv2.1 is densely expressed on the soma and proximal 
dendrites. Mutation studies have revealed a 26-amino acid sequence from the cytoplasmic 
tail of the protein that is responsible for the localization.8 Thus, we inserted the soma 
targeting (ST) sequence downstream of pDisplay, the transmembrane domain (Figure 5-
3-1). The construct expressed poorly in cultured hippocampal neurons, evidenced by dim 
and low-contrast RhoVR1-PEG25-HaloTag staining using the same transfection and 
labeling protocol as Syn-HaloTag-pDisplay (Figure 5-3-2). There seemed to be stronger 
signal on the cell body compared to the processes, but a co-staining experiment with a 
dye that labels the cellular membrane uniformly would be necessary to compare the 
difference in signal.  
We next evaluated the expression and localization of this construct in mouse brain 
slice, as it has been previously reported by the Adesnik lab that the ST sequence does not 
work as efficiently in cultured cells as in slices (data not shown). Using RhoVR1-PEG25-
HaloTag, we only saw staining on the cell body (Figure 5-3-3a-c) and did not observe 
labeled projections. We also collected a series of z-stack images over a depth of 22 µm to 
cover not only the cell body but also the surrounding processes, and did a max-intensity 
projection of the images. The resulting image only showed soma staining, suggesting the 
specificity of the ST sequencing in slices (Figure 5-3-3d). Repeating the staining with 
mBeRST-PEG25-HaloTag yielded similar results that only cell body was stained, 
indicating specific expression of HaloTag on the soma (Figure 5-3-4). Despite the 
inconclusive results in cultured neurons, the soma targeting sequence indeed localized the 
HaloTag and therefore the dye staining exclusively on the cell body. Future experiments 
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include confirming the voltage sensitivity of the stained dye and improving the 
expression the enzyme to enhance dye labeling and fluorescent signal.  
Conclusion 
 The transformation of a VoltageFluor dye to its HaloTag version is relatively 
straightforward by simply attaching the haloalkane ligand to the dye via a water-soluble 
and flexible PEG linker. These modifications do not seem to affect the photo-physical 
properties of the sensor itself while allowing for specific labeling to cells of interest 
expressing an engineered cell-surface HaloTag enzyme. We have demonstrated selective 
staining using both VF2.1.Cl and BeRST1, two dyes of different spectral characteristics 
and voltage sensitivity, emphasizing the generalizability of this particular strategy. 
Despite its bright and targeted staining of VF-HaloTag in cultured neurons, its low 
sensitivity and photo-stability may encounter setbacks in potential applications. On the 
other hand, BeRST1 is by far one of the best VoltageFluor dyes developed with high 
speed, sensitivity, photo-stability and long-wavelength fluorescence profiles. We were 
able to add in the targeting feature that enables staining and voltage imaging in defined 
cells in cultured neurons and live mouse brain slice. Additional characterization will be 
useful to optimize the BeRST-HaloTag hybrid approach to probe neuronal activity and 
connectivity in complex biological settings. We have also added an additional targeting 
sequence to the transmembrane domain in the HaloTag construct to restrict its expression 
and RhoVR staining on the cell body, with successful soma staining demonstrated in 
mouse brain slice. This approach further enhances signal-to-noise ratio for both imaging 
and data analysis in a complex biological sample by confining all fluorescence to 
neuronal somas where membrane potential is usually measured. All these preliminary 
data point to the possibility of wedding the superior photo-physical properties of 
VoltageFluor dyes and the cellular and subcellular specificity conferred by the HaloTag 
enzyme to enable high throughput and precise dissection of neural circuits and pathways.  
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Experimental Section 
 
Cell culture  
All animal procedures were approved by the UC Berkeley Animal Care and Use 
Committees and conformed to the NIH Guide for the Care and Use and Laboratory 
Animals and the Public Health Policy.  
Human embryonic kidney 293T (HEK) cells were maintained in Dulbecco’s 
modified eagle medium (DMEM) supplemented with 4.5 g/L D-glucose, 10% fetal 
bovine serum (FBS; Thermo Scientific) and 1% GlutaMax (Invitrogen) at 37 °C in a 
humidified incubator with 5% CO2. Cells were passaged and plated in DMEM (as above) 
at a density of 750,000 cells per well in a 6-well plate. Transfection of plasmids was 
carried out using Lipofectamine 3000 (Invitrogen) ~18-24 h after plating. The cells were 
split again 48 h after transfection and plated onto 12 mm glass coverslips pre-coated with 
Poly-D-Lysine (PDL; 1 mg/ml; Sigma-Aldrich) at a density of 75,000 cells per coverslip 
in DMEM supplemented with 1 g/L D-glucose, 10% FBS and 1% GlutaMax. Imaging 
was performed 12-18 h after plating. 
Hippocampi were dissected from embryonic day 19 Sprague Dawley rats (Charles 
River Laboratory) in cold, sterile HBSS (zero Ca2+, zero Mg2+, phenol red). All dissection 
products were supplied by Invitrogen, unless otherwise stated. Hippocampal tissue was 
treated with trypsin (2.5%) for 15 min at 37 °C. The tissue was triturated using fire 
polished Pasteur pipettes, in minimum essential media (MEM) supplemented with 5% 
FBS, 2% B-27, 2% 1M dextrose (Fisher Scientific) and 1% GlutaMax. The dissociated 
cells were plated onto 12 mm diameter coverslips (Fisher Scientific) pre-treated with 
PDL (as above) at a density of 25-30,000 cells per coverslip in MEM supplemented 
media (as above). Neurons were maintained at 37 °C in a humidified incubator with 5% 
CO2. At 1 day in vitro (DIV) half of the MEM supplemented media was removed and 
replaced with Neurobasal media containing 2% B-27 supplement and 1% GlutaMax. 
Transfection of plasmids was carried out using Lipofectamine 3000 (without P3000 
reagent) at 6-7 DIV. Imaging was performed on mature neurons 13-16 DIV. 
No solubilizing reagent was used for loading the dyes in HEK cells and 
hippocampal neurons. DMSO stock solutions were diluted directly in HBSS to working 
concentrations. Cells were incubated with dyes in HBSS at 37 °C in the incubator before 
exchanging dye/HBSS for HBSS without any dye. All imaging was performed in HBSS 
at room temperature. 
 
Epifluorescence microscopy  
Imaging was performed on an AxioExaminer Z-1 (Zeiss) equipped with a 
Spectra-X Light engine LED light (Lumencor), controlled with Slidebook (v6, Intelligent 
Imaging Innovations). Images were acquired with a W-Plan-Apo 20x/1.0 water objective 
(20x; Zeiss). Images were focused onto an OrcaFlash4.0 sCMOS camera (sCMOS; 
Hamamatsu). Confocal imaging was performed with a Zeiss LSM 880 NLO 
AxioExaminer equipped with a Diode 405 nm laser line, Argon 458, 488, and 514 laser 
lines, and a DPSS 561 nm laser line and a Helium-neon 633nm laser line. Images were 
acquired using a W-Plan-Apo 20x/1.0 DIC objective and a Zeiss Airyscan detector.  
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Image analysis  
Analysis of voltage sensitivity in HEK cells was performed using ImageJ (FIJI). 
Briefly, a region of interest (ROI) was selected automatically based on fluorescence 
intensity and applied as a mask to all image frames. Fluorescence intensity values were 
calculated at known baseline and voltage step epochs. ΔF/F values were calculated by 
first subtracting a mean background value from all raw fluorescence frames, to give a 
background subtracted trace (bkgsub). A baseline fluorescence value (Fbase) is 
calculated from the median of all the frames, and subtracted from each timepoint of the 
bkgsub trace to yield a ΔF trace. The ΔF was then divided by Fbase to give ΔF/F traces. 
No averaging has been applied to any voltage traces. 
 
Electrophysiology/Imaging parameters  
For electrophysiological experiments, pipettes were pulled from borosilicate glass 
(Sutter Instruments, BF150-86-10), with a resistance of 4–6 MΩ, and were filled with an 
internal solution; 115 mM potassium gluconate, 10 mM BAPTA tetrapotassium salt, 10 
mM HEPES, 5 mM NaCl, 10 mM KCl, 2 mM ATP disodium salt, 0.3 mM GTP 
trisodium salt (pH 7.25, 275 mOsm). Recordings were obtained with an Axopatch 200B 
amplifier (Molecular Devices) at room temperature. The signals were digitized with a 
Digidata 1440A, sampled at 50 kHz and recorded with pCLAMP 10 software (Molecular 
Devices) on a PC. Fast capacitance was compensated in the on-cell configuration. For all 
electrophysiology experiments, recordings were only pursued if series resistance in 
voltage clamp was less than 30 MΩ. For whole-cell, voltage clamp recordings in HEK 
293T cells, cells were held at -60 mV and hyper- and de- polarizing steps applied from -
100 to +100 mV in 20 mV increments.  For whole-cell, current clamp in slices, 
experiments were conducted on the microscope set up for slice patching in the Adesnik 
lab. Briefly, slices were transferred to the microscope perfusion chamber with ACSF 
recording solution (in mM: NaCl, 119; KCl, 2.5; MgSO4, 1.3; NaH2PO4, 1.3; NaHCO3, 
26; D-glucose, 20 and CaCl2, 2.5. To illumination the samples, spectra-X Light engine 
LED light (Lumencor), controlled with MATLAB script written by the Adesnik lab. 
Images were acquired with a W-Plan-Apo 20x/1.0 water objective (20x; Zeiss) at a 
sampling rate of 1 kHz. 
 
In utero electroporation  
Pregnant mice at E15-16 were anaesthetized with 2.0% isoflurane, the abdomen 
was cleaned with 70% ethanol and swabbed with iodine, and a small vertical incision was 
made in the skin and abdominal wall and 8–12 embryos gently exposed. Each embryo 
was injected with 0.5–1 µl of DNA solution and 0.05% Fast Green dye. We used a 
pressure-controlled beveled glass pipette (Drummond, Custom Microbeveller) for 
injection. After each injection, the embryos were moistened with saline and voltage steps 
via tweezertrodes (BTX, 5 mm round, platinum, BTX electroporator) were applied with 
the positive electrode placed over the visual cortex and the negative electrode placed 
under the head of the embryo. Voltage was 40 V for 5 pulses at 1 Hz, each pulse lasting 
50 ms. The embryos were returned to the abdomen, which was sutured, followed by 
suturing of the skin. The procedure typically lasted under 30 min.  
 
Acute brain slice preparation  
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Mice were deeply anesthetized with isoflurane and quickly decapitated. After 
removing the scalp and skull, ice cold sucrose cutting solution (in mM: NaCl, 83; KCl, 
2.5; MgSO4, 3.3; Na2HPO4, 1; NaHCO3, 26.2; D-glucose, 22; sucrose, 72; and CaCl2, 
0.5) was applied to the brain. BFP fluorescence was checked with a hand held 405 nm 
laser before the brain was taken out. The brain was cut into 300 µm thick slices with a 
DTK-1000 slicer in ice-cold sucrose cutting solution. The cut slices were incubated in 
sucrose cutting solution, bubbled with 95% O2 and 5% CO2, first at 31 °C for about 30 
min and then at room temperature until further use. For bath application of the dye and 
cell staining, a slice was transferred to a 35 mm dish with sucrose cutting solution 
bubbled with 95% O2 and 5% CO2 to which dye stock solution was added (250 nM final 
concentration). The slice was incubated with the dye at room temperature for 15 min 
before imaging. 
 
DNA constructs  
To express the HaloTag protein on the cell surface, an IgK leader sequence was 
fused to the N-terminal and a transmembrane domain (pDisplay) was added to the C-
terminal of the HaloTag sequence. For the purpose of inmmunostaining, an HA tag was 
inserted. Mammalian expression vector pcDNA3 with either a cytomegalovirus (CMV) 
promoter or human synapsin promoter (Syn) was used for protein expression in HEK 
cells and cultured neurons, respectively. To increase expression in neurons, a regulatory 
element from the woodchuck hepatitis virus (WPRE) was used. In some constructs, 
nuclear-targeted EGFP or mCherry was inserted down stream of HaloTag, separated by 
an internal ribosome entry site (IRES) sequence, in order to track the expression of 
HaloTag in live cells. For soma targeting, the sequence of C-terminal tail of Kv2.1 K+ 
channel was fused with pDisplay. The cloned constructs were verified by sequencing. All 
the constructs were prepared using Qiagen Maxiprep kit, except those with CMV 
promoter. The following sequences were used (5' to 3'): 
 
IgK  
ATGGAGACAGACACACTCCTGCTATGGGTACTGCTGCTCTGGGTTCCAGGTTC
CACTGGTGAC  
 
HaloTag  
GCAGAAATCGGTACTGGCTTTCCATTCGACCCCCATTATGTGGAAGTCCTGGG
CGAGCGCATGCACTACGTCGATGTTGGTCCGCGCGATGGCACCCCTGTGCTG
TTCCTGCACGGTAACCCGACCTCCTCCTACGTGTGGCGCAACATCATCCCGCA
TGTTGCACCGACCCATCGCTGCATTGCTCCAGACCTGATCGGTATGGGCAAAT
CCGACAAACCAGACCTGGGTTATTTCTTCGACGACCACGTCCGCTTCATGGAT
GCCTTCATCGAAGCCCTGGGTCTGGAAGAGGTCGTCCTGGTCATTCACGACTG
GGGCTCCGCTCTGGGTTTCCACTGGGCCAAGCGCAATCCAGAGCGCGTCAAA
GGTATTGCATTTATGGAGTTCATCCGCCCTATCCCGACCTGGGACGAATGGCC
AGAATTTGCCCGCGAGACCTTCCAGGCCTTCCGCACCACCGACGTCGGCCGC
AAGCTGATCATCGATCAGAACGTTTTTATCGAGGGTACGCTGCCGATGGGTG
TCGTCCGCCCGCTGACTGAAGTCGAGATGGACCATTACCGCGAGCCGTTCCT
GAATCCTGTTGACCGCGAGCCACTGTGGCGCTTCCCAAACGAGCTGCCAATC
GCCGGTGAGCCAGCGAACATCGTCGCGCTGGTCGAAGAATACATGGACTGGC
TGCACCAGTCCCCTGTCCCGAAGCTGCTGTTCTGGGGCACCCCAGGCGTTCTG
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ATCCCACCGGCCGAAGCCGCTCGCCTGGCCAAAAGCCTGCCTAACTGCAAGG
CTGTGGACATCGGCCCGGGTCTGAATCTGCTGCAAGAAGACAACCCGGACCT
GATCGGCAGCGAGATCGCGCGCTGGCTGTCGACGCTCGAGATTTCCGGC  
 
HA  
TATCCATATGATGTTCCAGATTATGCT  
 
pDisplay 
GCTGTGGGCCAGGACACGCAGGAGGTCATCGTGGTGCCACACTCCTTGCCCT
TTAAGGTGGTGGTGATCTCAGCCATCCTGGCCCTGGTGGTGCTCACCATCATC
TCCCTTATCATCCTCATCATGCTTTGGCAGAAGAAGCCACGT 
 
Soma Targeting (ST) 
CAGTCCCAGCCCATCCTCAACACCAAGGAGATGGCCCCGCAGAGCAAGCCTC
CAGAGGAGCTGGAGATGAGCAGCATGCCCAGCCCCGTGGCCCCTCTGCCCGC
ACGCACGGAGGGCGTCATCGACATGCGGAGCATGTCCAGCATTGACAGCTTC
ATCAGCTGTGCCACGGACTTCCCTGAAGCCACCAGATTC 
 
IRES  
GCCCCTCTCCCTCCCCCCCCCCTAACGTTACTGGCCGAAGCCGCTTGGAATAA
GGCCGGTGTGCGTTTGTCTATATGTTATTTTCCACCATATTGCCGTCTTTTGGC
AATGTGAGGGCCCGGAAACCTGGCCCTGTCTTCTTGACGAGCATTCCTAGGG
GTCTTTCCCCTCTCGCCAAAGGAATGCAAGGTCTGTTGAATGTCGTGAAGGA
AGCAGTTCCTCTGGAAGCTTCTTGAAGACAAACAACGTCTGTAGCGACCCTTT
GCAGGCAGCGGAACCCCCCACCTGGCGACAGGTGCCTCTGCGGCCAAAAGCC
ACGTGTATAAGATACACCTGCAAAGGCGGCACAACCCCAGTGCCACGTTGTG
AGTTGGATAGTTGTGGAAAGAGTCAAATGGCTCTCCTCAAGCGTATTCAACA
AGGGGCTGAAGGATGCCCAGAAGGCACCCCATTGTATGGGATCTGATCTGGG
GCCTCGGTGCACATGCTTTACATGTGTTTAGTCGAGGTTAAAAAAACGTCTAG
GCCCCCCGAACCACGGGGACGTGGTTTTCCTTTGAAAAACACGATGATAATA
TGGCCACA  
 
Nuclear Localization Sequencing 
ATGGTGCCCAAGAAGAAGAGGAAAGTCGTGAGCAAGGGCGAGGAGGACAAC
ATGGCCATCATCAAGGAGTTCATGCGCTTCAAGGTGCAC 
 
mCherry 
ATGGAGGGCTCCGTGAACGGCCACGAGTTCGAGATCGAGGGCGAGGGCGAG
GGCCGCCCCTACGAGGGCACCCAGACCGCCAAGCTGAAGGTGACCAAGGGC
GGCCCCCTGCCCTTCGCCTGGGACATCCTGTCCCCTCAGTTCATGTACGGCTC
CAAGGCCTACGTGAAGCACCCCGCCGACATCCCCGACTACTTGAAGCTGTCC
TTCCCCGAGGGCTTCAAGTGGGAGCGCGTGATGAACTTCGAGGACGGCGGCG
TGGTGACCGTGACCCAGGACTCCTCCCTGCAGGACGGCGAGTTCATCTACAA
GGTGAAGCTGCGCGGCACCAACTTCCCCTCCGACGGCCCCGTAATGCAGAAG
AAGACCATGGGCTGGGAGGCCTCCTCCGAGCGGATGTACCCCGAGGACGGC
GCCCTGAAGGGCGAGATCAAGCAGAGGCTGAAGCTGAAGGACGGCGGCCAC
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TACGACGCCGAGGTCAAGACCACCTACAAGGCCAAGAAGCCCGTGCAGCTG
CCCGGCGCCTACAACGTCAACATCAAGCTGGACATCACCTCCCACAACGAGG
ACTACACCATCGTGGAACAGTACGAGCGCGCCGAGGGCCGCCACTCCACCGG
CGGCATGGACGAGCTGTACAAG 
 
EGFP  
AGCAAGGGCGAGGAGCTGTTCACCGGGGTGGTGCCCATCCTGGTCGAGCTGG
ACGGCGACGTAAACGGCCACAAGTTCAGCGTGTCCGGCGAGGGCGAGGGCG
ATGCCACCTACGGCAAGCTGACCCTGAAGTTCATCTGCACCACCGGCAAGCT
GCCCGTGCCCTGGCCCACCCTCGTGACCACCCTGACCTACGGCGTGCAGTGCT
TCAGCCGCTACCCCGACCACATGAAGCAGCACGACTTCTTCAAGTCCGCCAT
GCCCGAAGGCTACGTCCAGGAGCGCACCATCTTCTTCAAGGACGACGGCAAC
TACAAGACCCGCGCCGAGGTGAAGTTCGAGGGCGACACCCTGGTGAACCGC
ATCGAGCTGAAGGGCATCGACTTCAAGGAGGACGGCAACATCCTGGGGCAC
AAGCTGGAGTACAACTACAACAGCCACAACGTCTATATCATGGCCGACAAGC
AGAAGAACGGCATCAAGGTGAACTTCAAGATCCGCCACAACATCGAGGACG
GCAGCGTGCAGCTCGCCGACCACTACCAGCAGAACACCCCCATCGGCGACGG
CCCCGTGCTGCTGCCCGACAACCACTACCTGAGCACCCAGTCCGCCCTGAGC
AAAGACCCCAACGAGAAGCGCGATCACATGGTCCTGCTGGAGTTCGTGACCG
CCGCCGGGATCACTCTCGGCATGGACGAGCTGTACAAGTAA 
 
WPRE  
GCTTATCGATAATCAACCTCTGGATTACAAAATTTGTGAAAGATTGACTGGTA
TTCTTAACTATGTTGCTCCTTTTACGCTATGTGGATACGCTGCTTTAATGCCTT
TGTATCATGCTATTGCTTCCCGTATGGCTTTCATTTTCTCCTCCTTGTATAAAT
CCTGGTTGCTGTCTCTTTATGAGGAGTTGTGGCCCGTTGTCAGGCAACGTGGC
GTGGTGTGCACTGTGTTTGCTGACGCAACCCCCACTGGTTGGGGCATTGCCAC
CACCTGTCAGCTCCTTTCCGGGACTTTCGCTTTCCCCCTCCCTATTGCCACGGC
GGAACTCATCGCCGCCTGCCTTGCCCGCTGCTGGACAGGGGCTCGGCTGTTG
GGCACTGACAATTCCGTGGTGTTGTCGGGGAAATCATCGTCCTTTCCTTGGCT
GCTCGCCTGTGTTGCCACCTGGATTCTGCGCGGGACGTCCTTCTGCTACGTCC
CTTCGGCCCTCAATCCAGCGGACCTTCCTTCCCGCGGCCTGCTGCCGGCTCTG
CGGCCTCTTCCGCGTCTTCGCCTTCGCCCTCAGACGAGTCGGATCTCCCTTTG
GGCCGCCTCCCCGCATCGATACCG 
 
CMV promoter  
GACATTGATTATTGACTAGTTATTAATAGTAATCAATTACGGGGTCATTAGTT
CATAGCCCATATATGGAGTTCCGCGTTACATAACTTACGGTAAATGGCCCGCC
TGGCTGACCGCCCAACGACCCCCGCCCATTGACGTCAATAATGACGTATGTT
CCCATAGTAACGCCAATAGGGACTTTCCATTGACGTCAATGGGTGGACTATTT
ACGGTAAACTGCCCACTTGGCAGTACATCAAGTGTATCATATGCCAAGTACG
CCCCCTATTGACGTCAATGACGGTAAATGGCCCGCCTGGCATTATGCCCAGT
ACATGACCTTATGGGACTTTCCTACTTGGCAGTACATCTACGTATTAGTCATC
GCTATTACCATGGTGATGCGGTTTTGGCAGTACATCAATGGGCGTGGATAGC
GGTTTGACTCACGGGGATTTCCAAGTCTCCACCCCATTGACGTCAATGGGAGT
TTGTTTTGGCACCAAAATCAACGGGACTTTCCAAAATGTCGTAACAACTCCGC
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CCCATTGACGCAAATGGGCGGTAGGCGTGTACGGTGGGAGGTCTATATAAGC
AGAGCT 
 
Synapsin Promoter  
GTGTCTAGACTGCAGAGGGCCCTGCGTATGAGTGCAAGTGGGTTTTAGGACC
AGGATGAGGCGGGGTGGGGGTGCCTACCTGACGACCGACCCCGACCCACTG
GACAAGCACCCAACCCCCATTCCCCAAATTGCGCATCCCCTATCAGAGAGGG
GGAGGGGAAACAGGATGCGGCGAGGCGCGTGCGCACTGCCAGCTTCAGCAC
CGCGGACAGTGCCTTCGCCCCCGCCTGGCGGCGCGCGCCACCGCCGCCTCAG
CACTGAAGGCGCGCTGACGTCACTCGCCGGTCCCCCGCAAACTCCCCTTCCC
GGCCACCTTGGTCGCGTCCGCGCCGCCGCCGGCCCAGCCGGACCGCACCACG
CGAGGCGCGAGATAGGGGGGCACGGGCGCGACCATCTGCGCTGCGGCGCCG
GCGACTCAGCGCTGCCTCAGTCTGCGGTGGGCAGCGGAGGAGTCGTGTCGTG
CCTGAGAGCGCAGTCGAGA 
 
 
Benchling links for constructs 
 
CMV-IgK-HaloTag-HA-pDisplay-IRES-mCherry 
https://benchling.com/s/seq-3iB3t8JmLupY99jEd7ui 
 
Synapsin-IgK-HaloTag-HA-pDisplay-IRES-mCherry-WPRE 
https://benchling.com/s/seq-DkNtujCDk5FLpTwp0B3V 
 
Synapsin-IgK-HaloTag-HA-pDisplay-ST-WPRE 
https://benchling.com/s/seq-g55yVpVAS4MIThH0gpcM 
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Figures and Schemes 
Scheme 5-1-1. Design of covalent labeling of VF2.1.Cl in specific cells of interest. 
 
 
 
Scheme 5-1-1. (a) Scheme of neuron-specific targeting with cell-surface HaloTag and 
VF-HaloTag (components are not to scale). (b) Structure of VF-PEG13-HaloTag used in 
this study. 
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Figure 5-1-1. HaloTag constructs used in this study.   
 
 
Figure 5-1-1. HaloTag constructs used in this study. 
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Figure 5-1-2. Characterization of VF-HaloTag in HEK cells.  
 
 
Figure 5-1-2. Wide-field fluorescence microscopy of HEK cells stained with VF-
HaloTag (50 nM, 30 min). (a) Differential interference contrast (DIC) image of HEK 
cells. (b) Nulcear mCherry fluorescence indicates HaloTag expression. (c) Membrane-
associated VF fluorescence. (d) Merge image of VF and mCherry fluorescence. Scale bar 
is 20 µm.  
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Figure 5-1-3. Characterization of VF-HaloTag in cultured hippocampal neurons. 
 
 
Figure 5-1-3. Cellular characterization of VF-HaloTag in cultured hippocampal neurons. 
(a-d) Wide-field fluorescence microscopy of HEK cells stained with VF-HaloTag (10 
nM, 30 min). (a) DIC image of cultured neurons. (b) Nulcear mCherry fluorescence 
indicates HaloTag expression. (c) Membrane-associated VF fluorescence showing clear 
staining in both cell body and neuronal processes. (d) Merge image of VF and mCherry 
fluorescence. Scale bar is 20 µm. (e) Quantification of VF-HaloTag staining at different 
dye concentrations. 
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Figure 5-1-4. Characterization of VF-HaloTag in cultured hippocampal neurons. 
 
 
Figure 5-1-4. Cellular characterization of VF-HaloTag in cultured neurons. 
Representative ΔF/F traces for spontaneous activity of neurons transfected with Syn-
HaloTag-mCherry and stained with VF-HaloTag (50 nM, 30 min). Images were acquired 
at 500 Hz and represent single-trial acquisitions.  
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Figure 5-2-1. Structure of mBeRST-PEG25-HaloTag used in this study. 
 
 
 
Figure 5-2-1. Structure of mBeRST-PEG25-HaloTag used in this study. 
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Figure 5-2-2. Characterization of mBeRST-PEG25-HaloTag in HEK cells. 
 
 
 
Figure 5-2-2. Wide-field fluorescence microscopy of HEK cells transfected with CMV-
HaloTag-pDisplay and stained with mBeRST-PEG25-HaloTag (50 nM, 30 min). (a) DIC 
image of HEK cells. (b) Nulcear EGFP fluorescence indicates HaloTag expression. (c) 
Membrane-associated BeRST fluorescence. Scale bar is 10 µm. (d) Plot of ΔF/F vs 
membrane potential (in mV) for mBeRST-PEG25-HaloTag. Data are mean ± S.D. for 7 
cells. 
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Figure 5-2-3. Characterization of mBeRST-PEG25-HaloTag in cultured neurons. 
 
 
 
Figure 5-2-3. Cellular characterization of mBeRST-PEG25-HaloTag in cultured 
hippocampal neurons transfected with Syn-HaloTag-pDisplay. (a-c) Wide-field 
fluorescence microscopy of neurons stained with mBeRST-PEG25-HaloTag (50 nM, 30 
min). (a) Nulcear EGFP fluorescence indicates HaloTag expression. (b) DIC image of 
cultured neurons. (c) Membrane-associated BeRST fluorescence showing clear staining 
in both cell body and neuronal processes. Scale bar is 30 µm. (d) Representative ΔF/F 
traces for spontaneous activity recorded by mBeRST-PEG25-HaloTag. Images are 
acquired at 500 Hz and represent single-trial acquisitions. 
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Figure 5-2-4. Characterization of mBeRST-PEG25-HaloTag in mouse brain slice. 
 
 
 
Figure 5-2-4. Imaging mBeRST-PEG25-HaloTag in mouse brain slice expressing 
HaloTag-pDisplay and pCAG-EGFP following in utero electroporation. (a) 
Representative image of a slice stained with mBeRST-PEG25-HaloTag (250nM, 15 min 
at RT). Sample was excited and visualized with a 633 nm laser on confocal microscope. 
(b) Wide-field image of the stained slice acquired during patch-clamp electrophysiology. 
(c) Example ΔF/F trace of evoked voltage activity recorded by mBeRST-PEG25-HaloTag 
in a neuron patch-clamped for current injection. Images are acquired at 1 kHz and 
represent single-trial acquisitions. Scale bar is 20 µm. 
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Figure 5-3-1. Soma-targeting HaloTag construct used in this study. 
 
 
 
Figure 5-3-1. Soma-targeting HaloTag construct used in this study. 
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Figure 5-3-2. Characterization of soma-targeting HaloTag construct in cultured 
neurons. 
 
 
 
Figure 5-3-2. Representative wide-field images of cultured hippocampal neurons 
transfected with Syn-HaloTag-pDisplay-ST and stained with RhoVR1-PEG25-HaloTag 
(50 nM, 30min). Brighter fluorescence signal was observed from the cell body compared 
to the processes. Scale bar is 20 µm. 
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Figure 5-3-3. Characterization of soma-targeting HaloTag construct in mouse brain 
slice with RhoVR1-PEG25-HaoTag.  
 
 
 
Figure 5-3-3. Imaging RhoVR1-PEG25-HaloTag in mouse brain slice expressing 
HaloTag-pDisplay-ST and pCAG-mTagBFP2 following in utero electroporation. (a-d) 
Representative image of a slice stained with RhoVR1-PEG25-HaloTag (250nM, 15 min at 
RT). Sample was excited and visualized with a 561 nm laser on a confocal microscope. 
(a) Bright-field image of the slice. (b) Membrane-associated fluorescence stains only cell 
body. (c) Cytosolic BFP fluorescence indicates HaloTag expression. (d) Max intensity 
projection of Z-stack images over 22 µm depth in another region of interest. Scale bar is 
20 µm. 
169	
Figure 5-3-4. Characterization of soma-targeting HaloTag construct in mouse brain 
slice with mBeRST-PEG25-HaoTag. 
 
 
 
Figure 5-3-4. Imaging mBeRST-PEG25-HaloTag in mouse brain slice expressing 
HaloTag-pDisplay and pCAG-mTagBFP2 following in utero electroporation. (a-d) 
Representative image of a slice stained with mBeRST-PEG25-HaloTag (250nM, 15 min 
at RT). Sample was excited and visualized with a 633 nm laser on a confocal microscope. 
(a) Bright-field image of the slice. (b) Membrane-associated fluorescence stains only cell 
body. (c) Cytosolic BFP fluorescence indicates HaloTag expression.  (d) Max intensity 
projection of Z-stack images over 17 µm depth in the same region of interest. Scale bar is 
20 µm. 
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Abstract 
  The use of light to control the bioactivity of small molecule has attracted 
increasing attention in the past years due to its high spatial and temporal resolution. A 
photo-labile group can be used to quench the function of the bioactive molecule until 
photolysis reaction occurs. Here, we show that by installing a meso-methylhydroxy 
moiety, the boron dipyrromethene (BODIPY) scaffold can be converted into an efficient 
caging group, removable by green light. Water solubility of the scaffold can be further 
enhanced by installing sulfonic acid groups on the 3, 5 positions while retaining the 
photolysis kinetics. We describe caging and uncaging of important chemical 
functionalities and demonstrate green light mediated control over biological processes in 
cultured cell lines and neurons. 
 
Introduction 
 The molecular mechanisms that govern biological functions are highly 
sophisticated and complex. Elucidation and manipulation of such processes on a 
molecular level requires precise external spatiotemporal control over their function. Light 
is an attractive way to achieve this goal, as it is non-invasive and readily delivered with 
high spatial and temporal precision. Thus, light has been harnessed to control biological 
processes through a method termed “caging”1, in which the biological activity of a target 
small- or macro-molecule is abrogated by covalent ligation to a photolabile protecting 
group (PPG or caging groups). Exposure to light at a specific wavelength releases the 
molecule in its active form (Scheme 6-1a). This useful method has been applied to 
investigate and manipulate the activity of a wide range of biological processes by 
controlling the activity of small-molecules, proteins, RNA and gene expression.2  
Over the years, dozens of caging groups have been developed, yet most operate in 
the UV range3 (250-400 nm), which is problematic due to low tissue penetration and high 
tissue damage caused by the high energy UV irradiation. In addition, the narrow window 
limits the ability to control multiple cues through differentially caged compounds. While 
some of these concerns have been ameliorated through the use of two-photon excitation4, 
the technique’s applicability to several important fields (synthetic chemistry, material 
sciences, therapeutics delivery) is inherently limited by its small focal-point and low 
conversion throughput. Thus, there still exists a strong need for PPGs that operate by one-
photon outside of the 250-400 nm window, to enable multiplex imaging and optical 
control of biological systems. Recently, several efforts have been made to identify novel 
scaffolds that would address this need.   
Specific modifications in the structure of the known caging group 4-
methylhydroxycoumarin enabled pushing their absorbance to the blue-cyan range.5-6 
Very recently, 4-arylalkoxy-boron dipyrromethene were demonstrated to release phenols 
when photolized with green light.7 The light-induced cleavage of the boron-arylalkoxy 
bond was elegantly utilized to uncage a biogenic amine through a self-immolating linker, 
yet caging with these molecules requires a multi-step synthesis (up to 5 synthetic steps) 
and the stability of the boron-arylalkoxy bond under physiological conditions is a 
concern. Cyanine dyes were also converted into near-IR caging groups though uncaging 
in biological settings required prolonged irradiation times8 (30 minutes). Metal 
complexes have likewise been explored as potential scaffolds for photocaging. Photolysis 
of amines from ruthenium complexes by blue-green light has been demonstrated and was 
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applied in cellular environment.9-11 Nevertheless, their broad absorption spectrum 
impedes multiplex fluorescence imaging and their photosensitizer-based design leads to 
sensitizer-dependent phototoxicity. Another interesting approach is the contact-quenching 
induced scission of a Co–C bond that enables tuning of the light absorbance wavelength, 
up to the near-IR range, by selecting an appropriate fluorophore serving as an antenna.12- 
13  
 
Here, we demonstrate that a specific derivatization of the boron dipyrromethene 
(BODIPY) core (Scheme 6-1b) enables its translation into an efficient green light 
excitable caging group. The excellent spectroscopic properties of BODIPYs render them 
potentially attractive caging groups. This family of chromophores is characterized by 
sharp and tunable light absorption (490-650 nm), high molar absorption coefficient 
(30,000-80,000 L·mol-1·cm-1) and chemical flexibility and stability, making them ideally 
suited for biological applications.14 Taking a cue from the structures of coumarin-based 
PPGs, the recent efforts to convert xanthenes into PPGs15-16, and the ease with which 
multiple functional groups are incorporated into the meso position of BODIPY14,17-23, we 
hypothesized that equipping the BODIPY scaffold with a methylhydroxy moiety on at 
this position (Scheme 6-1c) will similarly enable caging and uncaging of molecules of 
interest.   
  
Results & Discussion 
 
6-1: Synthesis and application of first generation m&m-BODIPY compounds 
 To test our hypothesis, we synthesized 2,6-diethyl-1,3,5,7-tetramethyl-BODIPY 
bearing a methylhydroxy group on the meso position (m&m-BODIPY, Scheme 6-1-1). 
The molecule features strong absorbance centered at 537 nm, high molar absorption 
coefficient (ε537 = 53,300 L·mol-1·cm-1) and is highly fluorescent (Φfl = 0.90). The 
hydroxyl group of m&m-BODIPY can be straightforwardly conjugated to various 
chemical functionalities. Thus, conjugation of several model leaving groups to m&m-
BODIPY through distinct chemical bonds was efficiently accomplished in one or two 
synthetic steps (Scheme 6-1-1).  Upon green light illumination, the photolysis product 
was verified by spectroscopy and HPLC, proving that the novel scaffold can be applied to 
cage diverse chemical functionalities 
To establish the utility of m&m-BODIPY as a platform for photocaging and 
activation of biomolecules in living cells, we synthesized the histamine-conjugated form 
of m&m-BODIPY (Scheme 6-1-1). Histamine is an important physiological effector 
molecule, with diverse consequences for human health and disease. Binding of histamine 
to the histamine H1 receptor initiates a cascade of intracellular events, including Ca2+ 
release.24 We hypothesized that capping of the primary amine of histamine with a 
carbamate-linked m&m-BODIPY would mask the functionality of histamine and enable 
light-induced photoactivation and delivery of histamine.   
To test this, we loaded HeLa cells with the Ca2+-selective fluorescent indicator, 
fura-2. Treatment with histamine (5 µM, Figure 6-1-1a,b,f) resulted in 89% of the cells 
(in the field of view) responding by prompt oscillations in intracellular [Ca2+]i, as 
measured by changes in fura-2 fluorescence. Upon incubation with m&m-BODIPY-
caged histamine (5 µM), no oscillations were observed prior to uncaging with 540 nm 
light. Uncaging light, in the presence of m&m-BODIPY-histamine, recapitulated the 
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oscillations seen with treatment by free histamine in 27% of the cells (Figure 6-1-5c,f). 
Pre-incubation of cells with the H1 receptor antagonist pyrilamine completely blocked 
this response (Figure 6-1-1c), demonstrating that the Ca2+ response is evoked by 
histamine photochemically liberated from the m&m-BODIPY cage. Importantly, no 
oscillations were observed in the presence of m&m-BODIPY-histamine but in the 
absence of light (Figure 6-1-1e). Additional control experiments further establish that 
Ca2+ flux depends on caged m&m-BODIPY-histamine and light, as light alone (no 
m&m-BODIPY-histamine, Figure 6-1-1g) and m&m-BODIPY-OH combined with 
irradiation (as a non-histamine releasing control, Figure 6-1-1h) do not promote 
correspondingly similar [Ca2+]i changes. Taken together, these data establish m&m-
BODIPY cages as an effective platform for photocaging biologically active molecules. 
To further explore the versatility of m&m-BODIPY-type PPGs, we sought to 
apply this strategy to caging the catecholamine neurotransmitter dopamine (Scheme 6-1-
1). This important neurotransmitter is vital for movement, motivation and cognition, and 
its misregulation is implicated in a number of human pathologies.25 Methods to 
photocage dopamine exist, but rely on photocages with UV uncaging profiles26 or use of 
transition metals.27 A visible-light uncaging strategy with dopamine would be of utility 
for interrogating the role of dopamine in neuronal signalling. In a manner similar to the 
caging of histamine, the amino group of dopamine was modified with a carbamate-linked 
m&m-BODIPY. 
In vitro characterization establish that the photocage shows good stability in the 
absence of light, but prompt release of dopamine following irradiation. (Figure 6-1-6). To 
examine the efficiency of m&m-BODIPY-dopamine, we again used fura-2 to monitor 
changes in [Ca2+]i upon photo-induced release of dopamine. Mixed hippocampal/cortical 
rat neurons loaded with fura-2, sensitized with KCl, and treated with dopamine (10 µM) 
substantial fluxes in [Ca2+]i in 88% of the cells, similar to those observed with histamine 
(Figure 6-1-2a,b,f). Incubation with m&m-BODIPY-dopamine (10 µM) followed by 
uncaging with 540 nm light resulted in similar oscillations of Ca2+ (51% of cells respond, 
Figure 6-1-2c,f), consistent with dopamine receptor agonism.28 Importantly, control 
experiments established that hippocampal/cortical neuron activation by m&m-BODIPY-
dopamine and light is abolished by the dopamine receptor antagonist (+)-butaclamol (100 
µM Figure 6-1-2d), and that m&m-BODIPY-dopamine with no light (Figure 6-1-2e), 
light only (Figure 6-1-2g) or non-photolyzable m&m-BODIPY with light (Figure 6-1-
2h), all result in baseline neuronal activity. 
 
6-2: Synthesis and application of second generation m&m-BODIPY compounds 
 Following the success of m&m-BODIPY as a photo-labile group to mask the 
bioactivity of small molecules until the action of light, a second generation scaffold that 
aims to address the issue of hydrophobicity of the m&m-BODIPY scaffold is synthesized 
and tested. The inherently high hydrophobicity complicates the calculation of the 
effective compound concentration in aqueous buffer and the cage-compound complex is 
more likely to enter the cellular membrane, which is advantageous if intracellular events 
are targeted but poses potential challenges for studying processes occurring 
extracellularly such as ligand-receptor interaction on the cell surface. Efforts have been 
made to improve the water-solubility of the m&m-BODIPY scaffold by incorporating 
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anionic moieties on the structure while maintaining its favorable spectroscopic and 
photoreaction properties.  
Previous studies focused on increasing solubility of BODIPY involve introducing 
long polyethylene glycol (PEG) chains or charged moieties such as carboxylates, 
sulfonates, phosphonates and quaternary ammonium.29 Using sulfonates as the target 
moiety, we first incorporated the sulfonates on the 2, 6 positions and p-nitroaniline 
(PNA) as a model leaving group. However, mono- and di-sulfonated BODIPYs did not 
respond to green light (545/30 nm, 40 mW/cm2) to release PNA (data not shown). It is 
possible that the electron withdrawing effect of sulfonate diminishes the rate if photolysis 
significantly. Alternatively, we modified the 3, 5 positions with sulfonic acid groups 
using 2-mercaptoethanesulfonic acid sodium salt (mesna) as a preferred nucleophile to 
prepare mono- and di-mesnaBODIPY. Both underwent efficient photolysis to yield 
free PNA in vitro (data not shown).  
 We next tested this scaffold in a biological context by conjugating to a bioactive 
molecule, histamine. Intracellular calcium increase induced by histamine is well-studied 
in various cell types including neurons. Thus, we used cultured rat hippocampal neurons 
to study the effect of light-controlled release of histamine on neuronal calcium 
fluctuations. Neurons were loaded with a Ca2+ fluorescent sensor, fura-2 and fluorescence 
intensity change was measured to reflect Ca2+ concentration changes. When treated with 
5 µM (Figure 6-2-1a), calcium fluctuations were detected in cells. A similar and strong 
response was observed in di-mesnaBODIPY-histamine with 540 nm uncaging light 
(Figure 6-2-1b) while a reduced response was seen with compound alone (Figure 6-2-1c), 
suggesting that light is required for the release of the caged compound. In the presence of 
histamine receptor H1 antagonist pyrilamine (1 µM, Figure 6-2-1e), calcium response 
was completely quenched despite the release of histamine after photolysis, indicating that 
the calcium fluctuation was mediated through the H1 receptor pathway. We also recorded 
the cellular response with green light only (Figure 6-2-1d) and did not observe any effect, 
which again establishes the fact that the effect is histamine-related.  
Sulfonated BODIPY compounds also exhibited increased water-solubility in 
cultured cells, compared to previously synthesized scaffold, m&m-BODIPY. Using 
caged dopamine as an example, we examined the localization of these compounds in 
cultured neurons under 540 nm light excitation. While m&m-BODIPY-dopamine shows 
significant cytosolic accumulation, sulfonated BODIPYs mostly remain in the 
extracellular buffer (Figure 6-2-2). To probe the effect of caged-dopamine on cultured 
neurons, we monitored [Ca2+]i change using fura-2 and green light activation, similar to 
the histamine studies. Dopamine is also an essential neurotransmitter that regulates many 
neuronal signaling pathways and involved in several neurological disorders such as 
Parkinson’s disease.25 Thus, strategies for controlled delivery of dopamine would be 
beneficial to investigate its specific impact at different stages of biological pathways or 
even diseases. These data have also highlighted the generalizability of this novel di-
mesnaBODIPY scaffold to cage a variety of biomolecules and their application in 
biological studies.  
Neuronal response to dopamine was primed by KCl before treatment of the caged 
compound. Neurons incubated with di-mesnaBODIDY-dopamine (5 µM) following 540 
nm light activation (Figure 6-2-3b) showed a robust calcium response, similar to the 
control dopamine treatment (5 µM, Figure 6-2-3a). When a dopamine receptor 
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antagonist, (+)-butaclamol (100 µM) was added (Figure 6-2-3c) or light alone (Figure 6-
2-3e), we noted a considerable decrease in calcium fluctuations, suggesting a dopamine-
dependent effect. Additional control experiment with di-mesnaBOIDPY-dopamine alone 
further confirms the light-dependent release of the bioactive molecule as no cellular 
activity was observed in the absence of light (Figure 6-2-3d). 
 
6-3: Voltage imaging in cultured neurons treated with mono-mesnaBODIPY-serotonin. 
 Besides Ca2+ imaging, we also attempted voltage imaging with a far-red voltage 
sensitive dye (BeRST 1)30 to study the effect of caged serotonin and effect of photolysis. 
Spontaneous activity of mature neurons (13 to 15 DIV) was recorded and firing 
frequency was calculated from a 10 s activity trace of spiking events. The 
neurotransmitter serotonin (5-HT) is known to exert an inhibitory effect on neuronal 
activity with a decrease in the firing frequency through the 5-HT1A receptor.31 We first 
established a baseline firing frequency in imaging buffer HBSS and noticed no change in 
firing frequency when 2 µM of mono-mesnaBODIPY-serotonin was added, suggesting 
that the caging is effective to quench the bioactivity of serotonin. When green light was 
shone, a strong inhibitory effect was seen, with all the neurons remaining quiescent and 
displaying an average frequency close to zero. The effect is reversible since washing out 
the compound and replenishing with fresh HBSS restored the neuronal activity (Figure 6-
3-1a). Nonetheless, when we repeated the experiment with a 5-HT1A-selective 
antagonist, WAY 100635 (10 nM; 1.4 nM IC50)32, a similar and still robust inhibitory 
effect was observed, indicating that the reduction in firing frequency was not through 5-
HT mediated pathway or the released 5-HT from mono-mesnaBODIPY was not 
responsible for the effect (Figure 6-3-1b). Green light or acetic acid, another by-product 
in the BODIPY photolysis reaction, did not seem to affect neuronal activity (data not 
shown), suggesting that other factors such as some sort of interactions involving the dye, 
green light, BODIPY or released serotonin might play a role.  
 
Conclusions  
The incorporation of a methylhydroxy moiety at the meso position of BODIPY 
core transforms this commonly used fluorophore into an effective, green-light excitable 
photo-labile protecting group. The introduced hydroxyl group can be straightforwardly 
conjugated to diverse chemical functionalities, enabling simple caging of molecules of 
interest through a variety of chemical bonds. Caging of 6 separate substrates, including 
phenol, aniline, a primary amine and acetic acid was readily accomplished within one or 
two synthetic steps and similar chemistry should be applicable for caging additional 
functional groups, including alcohols and thiols. These cageable functional groups are 
frequently represented in many biogenic and bioactive molecules. Uncaging from m&m-
BODIPY was effectively facilitated by green light for all caged functionalities, with 
small variations in release rate and yield, which seems to depend on the nature of the 
leaving group, as well as on the chemical bond connecting it to the BODIPY cage. 
Additional modifications of introducing sulfonic acid groups enhance water solubility of 
the scaffold, which effectively inhibits cellular entrance of the compound and ensures 
that the caged molecule remains in the aqueous buffer for reaction with cell surface 
receptors after photolysis.  
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Using both types of scaffold, the bioactivity of two biogenic amines, histamine 
and dopamine, was successfully controlled in cell cultures and in neurons by biologically 
benign green light, demonstrating the biological relevance and practical application of 
this novel caging group. Finally, m&m-BODIPY’s structure readily enables tuning of 
color to encompass the whole cyan-red range, as well as to determine cellular 
permeability or impermeability. Thus, we expect that the general strategy presented 
herein will enable expansion of the BODIPY cage to include these properties. 
 
Experimental section 
 
General Cell Culture Methods  
All animal procedures were approved by the UC Berkeley Animal Care and Use 
Committees and conformed to the NIH Guide for the Care and Use and Laboratory 
Animals and the Public Health Policy. 
HeLa cells were cultured in DMEM with 10% FBS and plated on 12 mm round 
poly-D-lysine coated coverslips in 24 well trays at a density of 1.6 × 105 cells/well 12-18 
hours prior to imaging experiments. Prior to imaging, cells were incubated with 2 µM 
fura2-AM (LifeTech) in HBSS at room temperature (25 °C) for 1 hour, washed once, and 
transferred to a 35 mm imaging dish containing 2 mL HBSS. Compounds (m&m-
BODIPY photocages) were diluted from stocks in DMSO (1000x) to 3x concentration in 
1 mL HBSS. This was added to the imaging dish and then the experiment began. 
Pyrilamine maleate (1 µM, Sigma) was added prior to addition of the BODIPY 
compounds.   
Neurons were harvested from rat embryonic hippocampus and cortex. After 
culturing for 14 days in vitro (DIV) in neurobasal media supplemented with B27, cells 
were loaded in a fashion identical to the HeLa cells described above. (+)-butaclamol (100 
µM, Sigma) was added prior to treatment with dopamine (10 µM) or BODIPY 
compounds (10 µM). Neurons were treated with a 3x stock of KCl (150 mM stock, 50 
mM final) to prime the response to dopamine. After initial Ca2+ transients, as measured 
by fura-2 reached baseline levels, dopamine or BODIPY was added and the photolysis 
began.  
 
Imaging Instrumentation and Experimental  
All imaging was performed on an AxioExaminer Z-1 (Zeiss) equipped with a 
Spectra-X Light engine LED light (Lumencor). Light was delivered through a W-Plan-
Apo 20x/1.0 objective and focused onto an OracFlash4.0 sCMOS camera (Hamamatsu). 
Excitation for fura-2 imaging was provided at 390/22, passed through a quadruple 
dichroic mirror (432/38, 509/22, 586/40, 654LP), and a quadruple emission filter (430/32, 
508/14, 586/30, 708/98). In this configuration, increases in [Ca2+]i result in decreases in 
fura-2 fluorescence. Samples were uncaged with 542 nm light for 15 seconds at 
maximum power, followed by fura-2 imaging, 25 ms exposures every second for ~5 
minutes after uncaging. For BeRST 1 voltage imaging, the excitation light was delivered 
from a LED at 631/28 (bandpass) nm and emission was collected with a quadruple 
emission filter (430/32, 508/14, 586/30, 708/98 nm) after passing through a quadruple 
dichroic mirror (432/38, 509/22, 586/40, 654 nm LP). Images were binned 4x4 to allow 
sampling rates of 0.5 kHz and 5000 frames (10 s) were acquired for each recording. 
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Data Analysis  
Plots of ΔF/F were constructed by creating regions of interest (ROI) around cells, 
subtracting background (ROI of non-cell region), and dividing by the mean fluorescence 
for the first 10 frames of the acquisition. These values were plotted as ΔF/F vs. time.  
HeLa cells: Images opened in FIJI (v1.49b, FIJI is just ImageJ, NIH). Corrected 
drift, with Plugins>Registration>StackReg>Rigid Body Transformation. Bleaching was 
corrected, if necessary, with Image>Adjust>Bleach Correction>Exponential Fit. Then an 
average intensity Z-project was calculated for the first 10 frames (to set F0). The 
Registered, Bleach-corrected stack was then divided by F0 to give the F/F0 movie, which 
was scaled from 0.75 to 1.25 in all cases, except for m&m-BODIPY540 control. 
Neurons: Images opened in FIJI (v1.49b, FIJI is just ImageJ, NIH). Corrected 
drift, with Plugins>Registration>StackReg>Rigid Body Transformation. Bleaching was 
corrected, if necessary, with Image>Adjust>Bleach Correction>Exponential Fit. Then an 
average intensity Z-project was calculated for the 10 frames near the beginning of the 
acquisition (to set F0). The Registered, Bleach-corrected stack was then divided by F0 to 
give the F/F0 movie, which was scaled from 0.75 to 1.25 in all cases.   
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Figures and Schemes 
 
Scheme 6-1. Design and structure of meso-methylhydryoxy BODIPY as a photo-labile 
group to cage biomolecules.  
 
 
Scheme 6-1. (a) Schematic representation of light-mediated control over a small- or 
macro-molecule of interest (MOI) activity. (b,c) General structure of BODIPY core (b) 
and meso-methylhydroxy BODIPY (m&m-BODIPY) applied for photocaging (c). 
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Scheme 6-1-1. Synthesis of m&m-BODIPY and its conjugates. 
 
Scheme 6-1-1. Synthesis and chemical structures of m&m-BODIPY and its conjugates. 
In parentheses: chemical yields. 
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Figure 6-1-1. Characterization of m&m-BODIPY-histamine in HeLa cells. 
 
 
 
Figure 6-1-1. Live cell epifluorscence imaging of Ca2+ release triggered by m&m-
BODIPY-histamine in HeLa cells. All cells were loaded with fura-2 AM and then treated 
with either 5 µM histamine (a, b), 5 µM BODIPY-histamine and green light (c), 5 µM 
BODIPY-histamine, light, and the H1 receptor antagonist, pyrilamine (d), or 5 µM 
BODIPY-histamine without light (e), or green light alone (g) or 5 µM BODIPY-OH. 
Shown are changes in Fura-2 fluorescence as quantified from representative cells. Scale 
bar is 20 µm. (f) Percentage of responding cells in each treatment, as quantified for the 
whole field of view (n > 65 cells in each treatment). 
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Figure 6-1-2. Characterization of m&m-BODIPY-dopamine in cultured neurons. 
 
 
Figure 6-1-2. Live cell epifluorscence imaging of Ca2+ release triggered by BODIPY-
dopamine in KCl-primed rat cortical/hippocampal neurons. All cells were loaded with 
fura-2 AM and then treated with either dopamine (10 µM) (a,b), BODIPY-dopamine (10 
µM) and green light (c), BODIPY dopamine, light, and the dopamine receptor antagonist, 
(+)-butaclamol (100 µM) (d), or BODIPY-dopamine without light (e), or green light only 
(g), or BODIPY-OH (h). Shown are changes in Fura-2 fluorescence as quantified from 
representative cells. Scale bar is 20 µm. (f) Percentage of responding cells in each 
treatment, as quantified for the whole field of view (n > 17 cells in each treatment). 
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Figure 6-2-1. Characterization of di-mesnaBODIPY-histamine in cultured neurons. 
 
 
 
Figure 6-2-1. Uncaging of dopamine with di-mesna BODIPY histamine causes robust 
Ca2+ oscillations in cultured rat hippocampal neurons. Ca2+ imaging in neurons treated 
with (a) histamine (5 µM), or (b) di-mesna BODIPY histamine (5 µM) and uncaging 
light, or (c) di-mesna BODIPY dopamine (5 µM) without uncaging light, or (d) only with 
uncaging light, or (e) di-mesna BODIPY histamine (5 µM) and uncaging light in the 
presence of the dopamine receptor antagonist pyrilamine (1 µM). Plots represent F/Fmax 
for representative cells vs. time and are inverted. An increase in cellular Ca2+ 
concentration results in a decrease in fura-2 fluorescence, under the illumination 
conditions used in this study. 
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Figure 6-2-2. Compare localization of various BODIPY scaffold.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6-2-2. Sulfonated BODIPY caged compounds show differential accumulation in 
neurons. Wide-field epifluorescence microscopy of cultured rat hippocampal neurons 
stained with (a) EthylBODIPY-dopamine, (b) mono-mesnaBODIPY-dopamine, or (c) di-
mesnaBODIPY-dopamine. DIC images of neurons stained with (d) EthylBODIPY-
dopamine, (e) mono-mesnaBODIPY-dopamine, or (f) di-mesnaBODIPY-dopamine. 
Because of the low membrane-associated fluorescence of mono- and di-mesna BODIPY 
compounds, the images were brightened by 10x for (g) mono-mesnaBODIPY and (h) di-
mesnaBODIPY-dopamine. Scale bar is 20 µm. 
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Figure 6-2-3. Characterization of di-mesnaBODIPY-dopamine in cultured neurons. 
 
 
Figure 6-2-3. Uncaging of dopamine with di-mesna BODIPY dopamine causes robust 
Ca2+ oscillations in cultured rat hippocampal neurons. Ca2+ imaging in neurons treated 
with (a) dopamine (5 µM), or (b) di-mesna BODIPY dopamine (5 µM) and uncaging 
light, or (c) di-mesna BODIPY dopamine (5 µM) and uncaging light in the presence of 
the dopamine receptor antagonist butaclamol (100 µM), or (d) di-mesna BODIPY 
dopamine (5 µM) without uncaging light, and (e) only with uncaging light. Plots 
represent F/Fmax for representative cells vs. time and are inverted. An increase in cellular 
Ca2+ concentration results in a decrease in fura-2 fluorescence, under the illumination 
conditions used in this study.  
 
186	
Figure 6-3-1. Voltage imaging of spontaneous activity in cultured neurons treated with 
mono-mesnaBODIPY-serotonin.  
 
 
 
Figure 6-3-1. Optical recording of neuronal activity using BeRST1 in cultured 
hippocampal neurons upon various compound treatment. (a) Hippocampal neurons were 
treated with mono-mesnaBODIPY-serotonin (2 µM) alone and (b) in the presence of 
WAY 100635 (10 nM). The firing rate of neurons was measured before (first bars), 
during without light (second bars), during with light (third bards) and after (fourth bars) 
washout of mono-mesnaBODIPY-serotonin. Data are mean ± S.E.M. for the average 
firing rate of 2 different coverslips of neurons. Each coverslip’s average firing frequency 
was measured from between 50-60 individual neurons, for a total of about 120 neurons 
for each condition. Two-tailed Mann-Whitney tests were used to determine statistical 
significance.  
**** indicates p < 0.001. 
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Appendix 1: 
Fluorogenic Activation by a Cell-Surface β-galactosidase 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Portions of this work were performed in collaboration with the following persons:  
AO-β-gal cloning and immunostaining were assisted by Hannah Thorner 
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Introduction 
 Fluorescein-based VoltageFluor dyes such as VF2.1.Cl contain phenolic oxygens, 
which are ideal targets for masking by a small molecule moiety. The presence of these 
protection groups efficiently reduce the fluorescence and voltage sensitivity while a turn-
on response can be accomplished in cells of interest expressing a specific enzyme that 
removes the protection group. One example is the cyclopropyl ester and PLE pair that has 
been demonstrated in Chapter 2 (VF-EX)1 and Chapter 3-1 (carboVF-EX)2 in which 
targeted staining and voltage imaging are observed in defined cells, including cultured 
neurons. Nonetheless, preliminary efforts that translate this strategy to mouse brain slice 
failed to produce sufficient contrast between PLE-expressing and non-expressing cells. In 
addition, due to the bulky and relative hydrophobic ester group, a solubilizing reagent is 
required for dye loading, which may become a potential problem as detergent-based 
delivery reagents are usually not favored in biology. As a result, we decided to explore 
other enzyme-substrate pairs that can circumvent these problems and become applicable 
to a more complex biological sample.  
 We have chosen β-galactosidase, which cleaves a glycosidic bond in β-
galactoside.3 One common chromogenic assay that involves β-galactosidase is the blue-
white colony screening in molecular cloning. Bacterial lacZ gene encodes a β-
galactosidase that reacts with a synthetic substrate X-Gal to form a blue precipitate, 
allowing for screening when bacteria were plated on X-Gal-containing agar plates.4-6 One 
of the appealing features of the β-galactosidase approach to our fluorogenic activation is 
its galactose sugar substrate that can be adapted as a protecting group. The hydroxyl 
groups would substantially enhance the water solubility of our relatively hydrophobic VF 
dye containing the greasy molecular wire. Also, galactose has already been used as 
caging moiety for fluorescein including FDG (Fluorescein di-β-D-galactopyranoside), a 
fluorogenic substrate to assess β-galactosidase activity.7-10 These prior examples have 
motivated us to use galactose to quench the fluorescence of VF2.1.Cl and to engineer a 
cell-surface β-galactosidase for fluorogenic activation.  
  
Results & Discussions 
 We designed and prepared four constructs for expressing bacterial β-galactosidase 
(lacZ) in HEK cells (Scheme A1-1). We used either the GPI-anchor (DAF) or 
transmembrane domain (pDisplay) and the IgK secretion signal peptide for cell-surface 
targeting. Besides CMV promoter, a CAG promoter was also utilized to enhance the 
protein expression.11-12 When immunostaining was performed under non-permeabilizing 
condition in which the antibody was only allowed to bind extracellular epitopes, we 
observed negligible anti-HA staining (Figure A1-2a-f), suggesting that none of the 
constructs expressed lacZ on the cell surface. Some lacZ expression was observed in the 
cytosol when cells were permeabilized (Figure A1-2g-l). In particular, protein expression 
was greatly boosted when driven by a CAG protmoer (Figure A1-2e,k) while the DAF 
construct seems to express better than the pDisplay version (Figure A1-2k,l). Since lacZ 
is a tetramer of four identical subunits of 116 kD each, we hypothesize that the large size 
hinders its trafficking to the cell surface.  
 To verity if lacZ is actually produced by the mammalian cell machinery and 
remains functional, we performed a X-Gal assay, where a blue precipitate forms after the 
indole released in the β-galactosidase reaction undergoes dimerization and oxidation 
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spontaneously (Figure A1-3a).5-6 We plated and transfected HEK cells according to 
standard protocols, added the X-Gal to the cells about 24 h after transfection and 
monitored the formation of blue precipitate by checking the solution color (Figure A1-
3b). Only a faint blue was noticed in the cells expressing CAG-lacZ-DAF after 4 hours. 
After 24 hours, we started to see color changes in cells transfected with all four 
constructs. Cells expressing CAG-lacZ-DAF exhibited the most intense blue and those 
expressing CMV-lacZ-pDislay showed the faintest while the solution for non-transfected 
control remained colorless. These observations indicate that DAF construct expresses 
better that the pDisplay construct while CAG increases protein production in general. As 
X-Gal is cell permeable and anti-HA staining detects no cell-surface expression, we 
believe that a portion of lacZ is generated inside the cell and is reactive to cleave β-
galactose under physiological conditions although the kinetics seem rather slow with a 
conversion rate on the scale of hours. Therefore, other targeting moieties should be 
explored to improve extracellular export and localization.  
 On the other hand, we diverted our attention to other types of β-galactosidase, in 
search for a smaller monomeric enzyme that hopefully encounters fewer challenges for 
expression and trafficking. We chose the β-galactosidase from a fungus Aspergillus 
oryzae, which is known to hydrolyze lactose in an extracellular environment.13 It 
functions at an optimal pH of 5.0 and temperature at 50 °C; at physiological conditions 
(pH 7.0 and 37 °C), it retains approximately 50% of its maximal activity.13-14 In addition, 
AO-β-gal has been extensively used in industrial processing of dairy products and is 
commercially available for our in vitro characterization purposes.15 Inspired by these 
findings, we cloned the AO-β-gal gene15 into our pcDNA3 vector with a GPI-anchor for 
extracellular targeting. To our delight, immunostaining reveals very robust cell surface 
expression using the CMV-DAF construct (Figure A1-4). When we carried out the 
cellular assay using X-Gal, no color change was observed (data no shown). A variety of 
acidic pHs (pH = 2, 5 or 7) were experimented but cells didn’t survive well. Nonetheless, 
X-Gal may not be the perfect substrate since it is cell permeable and the AO-β-gal is 
present on the cell surface. β-gal-VF2.1.Cl dye synthesis is undergoing and can be tested 
with our construct to further validate the enzyme activity.  
 
Conclusion 
We have attempted to express both a bacterial and fungal β-galactosidase to cell-
surface in order to achieve fluorogenic activation of our voltage sensitive dye. LacZ from 
E. coli is indeed expressed in HEK cells, with the ability to convert X-Gal to products 
with a relatively slow kinetics, but fails to express extracellularly due to its large 
tetrameric size. On the contrary, the monomeric β-galactosidase from A. oryzae displays 
efficient localization on the cell-surface but favors a highly acidic environment for 
optimal enzymatic activity. Extensive literature research is required to pinpoint a most 
suitable β-galactosidase, with a relatively small size and good compatibility with 
physiological conditions to suit our purpose.  
 
 
 
 
 
192	
Experimental Sections 
 
Cell Culture  
Human embryonic kidney 293T (HEK) cells were maintained and plated in 
Dulbecco’s modified eagle medium (DMEM) supplemented with 4.5 g/L D-glucose, 10% 
fetal bovine serum (FBS; Thermo Scientific) and 1% GlutaMax (Invitrogen) at 37 °C in a 
humidified incubator with 5 % CO2. Cells were passaged and plated in DMEM (as above) 
at a density of 75,000 cells onto 12 mm glass coverslips pre-coated with Poly-D-Lysine 
(PDL; 1 mg/ml; Sigma-Aldrich) per well in a 24-well plate. Transfection of plasmids was 
carried out using Lipofectamine 3000 (Invitrogen) ~18-24 h after plating. Imaging was 
performed 12-18 h after transfection.  
 
β-galactosidase activity assay using X-Gal 
  X-Gal (5-bromo-4-chloro-3-indolyl β-D-galactopyranoside) was purchased from 
Thermo Fischer  (Cat. B1690) and stored at -20 °C as a solid and stock solution was 
prepared in DMSO. For activity assay of β-gal in HEK cells, cells were transfected with 
the constructs as stated above and the assay was conducted about 24 h after transfection. 
Media was aspirated and replaced with 0.5 mL of X-Gal in HBSS (final concentration 1 
mg/mL). Reaction was done at 37 °C for 4 h or 24 h before taking images. For AO-β-gal, 
HBSS solutions of various acidic pHs were used. 
 
Imaging Parameters  
Epifluorescence imaging was performed on an AxioExaminer Z-1 (Zeiss) 
equipped with a Spectra-X Light engine LED light (Lumencor), controlled with 
Slidebook (v6, Intelligent Imaging Innovations). Images were acquired with a W-Plan-
Apo 20x/1.0 water objective (20x; Zeiss). Images were focused onto an OrcaFlash4.0 
sCMOS camera (sCMOS; Hamamatsu).  
 
Immunocytochemistry 
To detect expression and localization of β-galactosidase, HEK cells were fixed 
with 4% paraformaldehyde in PBS for 10 min. Permeabilization was performed with 
0.3% Triton-X in PBS for 2 min at room temperature (RT). Blocking was done in 5% w/v 
bovine serum albumin (BSA; Sigma Aldrich) in PBS for 1 h. Primary anti-HA antibody 
(rabbit IgG, Cell Signaling Technologies Cat. 3724S) was incubated at 4 °C overnight, 
followed by anti-rabbit AlexaFluor 647 secondary antibody (goat IgG, Life Technologies 
A21244) at RT for 2 h. Hoechst 33342 was added for 15 min at RT to visualize the 
nucleus. All antibodies and counterstain were used at 1:1000 dilution.  
 
DNA constructs  
To express the β-galactosidase protein on the cell surface, an IgK leader sequence 
was fused to the N-terminal and either a signal peptide for GPI addition (DAF) or a 
transmembrane domain (pDisplay) was added to the C-terminal. For the purpose of 
immunostaining, an HA tag was inserted. Mammalian expression vector pcDNA3 with 
either a cytomegalovirus (CMV) promoter or chick beta-actin (CAG) promoter was used 
for protein expression in HEK cells. In all constructs, nuclear-targeted mCherry (NLS-
mCherry) was inserted down stream of β-galactosidase, separated by an internal ribosome 
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entry site (IRES) sequence, in order to track the expression of β-galactosidase in live 
cells. All constructs were confirmed by sequencing. The following sequences were used 
(5' to 3'): 
 
IgK  
ATGGAGACAGACACACTCCTGCTATGGGTACTGCTGCTCTGGGTTCCAGGTTC
CACTGGTGAC  
 
Bacterial β-galactosidase (lacZ) from E. coli 
GTCGTTTTACAACGTCGTGACTGGGAAAACCCTGGCGTTACCCAACTTAATCG
CCTTGCAGCACATCCCCCTTTCGCCAGCTGGCGTAATAGCGAAGAGGCCCGC
ACCGATCGCCCTTCCCAACAGTTGCGCAGCCTGAATGGCGAATGGCGCTTTG
CCTGGTTTCCGGCACCAGAAGCGGTGCCGGAAAGCTGGCTGGAGTGCGATCT
TCCTGAGGCCGATACTGTCGTCGTCCCCTCAAACTGGCAGATGCACGGTTACG
ATGCGCCCATCTACACCAACGTAACCTATCCCATTACGGTCAATCCGCCGTTT
GTTCCCACGGAGAATCCGACGGGTTGTTACTCGCTCACATTTAATGTTGATGA
AAGCTGGCTACAGGAAGGCCAGACGCGAATTATTTTTGATGGCGTTAACTCG
GCGTTTCATCTGTGGTGCAACGGGCGCTGGGTCGGTTACGGCCAGGACAGTC
GTTTGCCGTCTGAATTTGACCTGAGCGCATTTTTACGCGCCGGAGAAAACCGC
CTCGCGGTGATGGTGCTGCGTTGGAGTGACGGCAGTTATCTGGAAGATCAGG
ATATGTGGCGGATGAGCGGCATTTTCCGTGACGTCTCGTTGCTGCATAAACCG
ACTACACAAATCAGCGATTTCCATGTTGCCACTCGCTTTAATGATGATTTCAG
CCGCGCTGTACTGGAGGCTGAAGTTCAGATGTGCGGCGAGTTGCGTGACTAC
CTACGGGTAACAGTTTCTTTATGGCAGGGTGAAACGCAGGTCGCCAGCGGCA
CCGCGCCTTTCGGCGGTGAAATTATCGATGAGCGTGGTGGTTATGCCGATCGC
GTCACACTACGTCTGAACGTCGAAAACCCGAAACTGTGGAGCGCCGAAATCC
CGAATCTCTATCGTGCGGTGGTTGAACTGCACACCGCCGACGGCACGCTGAT
TGAAGCAGAAGCCTGCGATGTCGGTTTCCGCGAGGTGCGGATTGAAAATGGT
CTGCTGCTGCTGAACGGCAAGCCGTTGCTGATTCGAGGCGTTAACCGTCACG
AGCATCATCCTCTGCATGGTCAGGTCATGGATGAGCAGACGATGGTGCAGGA
TATCCTGCTGATGAAGCAGAACAACTTTAACGCCGTGCGCTGTTCGCATTATC
CGAACCATCCGCTGTGGTACACGCTGTGCGACCGCTACGGCCTGTATGTGGT
GGATGAAGCCAATATTGAAACCCACGGCATGGTGCCAATGAATCGTCTGACC
GATGATCCGCGCTGGCTACCGGCGATGAGCGAACGCGTAACGCGAATGGTGC
AGCGCGATCGTAATCACCCGAGTGTGATCATCTGGTCGCTGGGGAATGAATC
AGGCCACGGCGCTAATCACGACGCGCTGTATCGCTGGATCAAATCTGTCGAT
CCTTCCCGCCCGGTGCAGTATGAAGGCGGCGGAGCCGACACCACGGCCACCG
ATATTATTTGCCCGATGTACGCGCGCGTGGATGAAGACCAGCCCTTCCCGGCT
GTGCCGAAATGGTCCATCAAAAAATGGCTTTCGCTACCTGGAGAGACGCGCC
CGCTGATCCTTTGCGAATACGCCCACGCGATGGGTAACAGTCTTGGCGGTTTC
GCTAAATACTGGCAGGCGTTTCGTCAGTATCCCCGTTTACAGGGCGGCTTCGT
CTGGGACTGGGTGGATCAGTCGCTGATTAAATATGATGAAAACGGCAACCCG
TGGTCGGCTTACGGCGGTGATTTTGGCGATACGCCGAACGATCGCCAGTTCTG
TATGAACGGTCTGGTCTTTGCCGACCGCACGCCGCATCCAGCGCTGACGGAA
GCAAAACACCAGCAGCAGTTTTTCCAGTTCCGTTTATCCGGGCAAACCATCG
AAGTGACCAGCGAATACCTGTTCCGTCATAGCGATAACGAGCTCCTGCACTG
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GATGGTGGCGCTGGATGGTAAGCCGCTGGCAAGCGGTGAAGTGCCTCTGGAT
GTCGCTCCACAAGGTAAACAGTTGATTGAACTGCCTGAACTACCGCAGCCGG
AGAGCGCCGGGCAACTCTGGCTCACAGTACGCGTAGTGCAACCGAACGCGAC
CGCATGGTCAGAAGCCGGGCACATCAGCGCCTGGCAGCAGTGGCGTCTGGCG
GAAAACCTCAGTGTGACGCTCCCCGCCGCGTCCCACGCCATCCCGCATCTGA
CCACCAGCGAAATGGATTTTTGCATCGAGCTGGGTAATAAGCGTTGGCAATT
TAACCGCCAGTCAGGCTTTCTTTCACAGATGTGGATTGGCGATAAAAAACAA
CTGCTGACGCCGCTGCGCGATCAGTTCACCCGTGCACCGCTGGATAACGACA
TTGGCGTAAGTGAAGCGACCCGCATTGACCCTAACGCCTGGGTCGAACGCTG
GAAGGCGGCGGGCCATTACCAGGCCGAAGCAGCGTTGTTGCAGTGCACGGCA
GATACACTTGCTGATGCGGTGCTGATTACGACCGCTCACGCGTGGCAGCATC
AGGGGAAAACCTTATTTATCAGCCGGAAAACCTACCGGATTGATGGTAGTGG
TCAAATGGCGATTACCGTTGATGTTGAAGTGGCGAGCGATACACCGCATCCG
GCGCGGATTGGCCTGAACTGCCAGCTGGCGCAGGTAGCAGAGCGGGTAAACT
GGCTCGGATTAGGGCCGCAAGAAAACTATCCCGACCGCCTTACTGCCGCCTG
TTTTGACCGCTGGGATCTGCCATTGTCAGACATGTATACCCCGTACGTCTTCC
CGAGCGAAAACGGTCTGCGCTGCGGGACGCGCGAATTGAATTATGGCCCACA
CCAGTGGCGCGGCGACTTCCAGTTCAACATCAGCCGCTACAGTCAACAGCAA
CTGATGGAAACCAGCCATCGCCATCTGCTGCACGCGGAAGAAGGCACATGGC
TGAATATCGACGGTTTCCATATGGGGATTGGTGGCGACGACTCCTGGAGCCC
GTCAGTATCGGCGGAATTCCAGCTGAGCGCCGGTCGCTACCATTACCAGTTG
GTCTGGTGTCAAAAA 
 
Fungal β-galactosidase from A. oryzae 
ATGAAGCTCCTTTCAGTTGCAGCCGTCGCTTTGCTTGCAGCACAAGCAGCAGG
CGCCTCAATCAAACATCGCTTGAACGGTTTCACAATTTTGGAGCATCCAGATC
CAGCCAAACGCGACTTGCTCCAAGATATCGTGACCTGGGACGACAAGAGTCT
TTTCATAAATGGTGAGAGGATAATGCTTTTTAGCGGTGAGGTCCATCCTTTTC
GCCTGCCCGTGCCTAGTCTTTGGTTGGATATATTCCATAAGATCCGAGCTCTG
GGCTTTAACTGTGTCAGTTTCTATATAGATTGGGCATTGCTGGAAGGGAAACC
AGGCGATTACAGAGCAGAGGGTATATTCGCTCTTGAGCCATTTTTTGACGCA
GCCAAGGAGGCAGGGATATATCTTATAGCACGACCAGGGAGTTACATTAACG
CAGAAGTATCAGGCGGCGGTTTTCCCGGTTGGTTGCAGCGAGTAAACGGCAC
ACTGCGGAGCTCTGATGAACCTTTTCTGAAAGCAACAGATAATTATATTGCCA
ACGCTGCAGCCGCTGTCGCCAAGGCACAAATCACTAATGGCGGACCCGTCAT
CCTGTACCAGCCAGAGAATGAGTATTCAGGTGGCTGCTGCGGTGTTAAATAC
CCTGACGCTGATTACATGCAGTATGTTATGGACCAGGCACGGAAGGCCGATA
TAGTGGTGCCCTTCATCTCAAACGACGCTTCACCCTCAGGACACAACGCACCT
GGCAGCGGAACTTCTGCAGTAGATATATATGGACACGACAGCTACCCCCTGG
GGTTTGATTGCGCCAATCCCTCAGTCTGGCCCGAAGGTAAGCTCCCTGACAAT
TTCAGGACTTTGCACTTGGAGCAGTCACCATCCACCCCATACTCCCTGCTCGA
ATTTCAGGCAGGGGCCTTTGACCCTTGGGGTGGTCCAGGCTTCGAGAAGTGC
TACGCCCTGGTGAACCATGAATTTTCCCGGGTCTTTTACCGGAATGATCTTTC
CTTTGGTGTTAGCACTTTTAACCTGTATATGACCTTTGGCGGTACAAACTGGG
GTAACCTCGGACATCCTGGCGGGTACACTTCCTACGACTACGGTTCTCCAATC
ACAGAAACCAGGAATGTAACCAGAGAGAAGTATTCCGACATTAAATTGCTTG
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CTAACTTTGTCAAAGCTTCTCCCTCATACCTTACAGCCACACCTCGGAATCTG
ACTACTGGAGTATACACCGATACCAGTGATCTGGCCGTTACACCCCTCATTGG
CGATAGTCCAGGCTCTTTTTTTGTTGTGCGGCATACTGACTATTCTTCTCAAGA
ATCTACAAGCTATAAATTGAAATTGCCCACATCCGCCGGTAATCTGACCATTC
CTCAGTTGGAGGGGACCTTGAGCCTTAACGGGCGCGACAGTAAGATTCACGT
TGTTGATTACAATGTCAGCGGTACCAACATTATATATTCAACTGCCGAGGTCT
TCACCTGGAAAAAGTTCGATGGTAACAAGGTACTCGTACTGTATGGGGGACC
TAAGGAACACCATGAACTCGCTATCGCCAGCAAGAGCAATGTTACTATTATC
GAGGGTTCAGACAGTGGGATAGTAAGCACTCGCAAGGGATCCAGCGTTATTA
TAGGGTGGGACGTTAGTAGCACCCGACGGATAGTGCAGGTCGGGGACCTTAG
GGTATTCCTTTTGGACCGGAACTCTGCTTATAATTACTGGGTGCCCGAGTTGC
CTACTGAAGGGACCAGTCCTGGGTTTAGCACTAGTAAAACCACCGCTAGCAG
CATTATAGTGAAAGCTGGCTACCTCCTGCGGGGTGCACATTTGGACGGTGCC
GATCTGCATCTTACAGCAGATTTCAACGCTACTACTCCAATAGAAGTAATAG
GCGCTCCCACAGGAGCAAAAAATTTGTTTGTTAACGGGGAGAAGGCATCACA
CACCGTCGACAAAAATGGAATTTGGAGTTCCGAGGTTAAATACGCAGCACCC
GAAATTAAACTGCCTGGTCTTAAGGACCTGGATTGGAAGTACCTGGATACCC
TCCCTGAGATTAAAAGCTCATACGACGACTCTGCCTGGGTCTCCGCAGATTTG
CCCAAGACCAAGAACACACATCGGCCTCTTGACACACCAACCAGTCTCTATA
GTTCCGACTACGGCTTTCATACCGGGTACCTGATTTATCGGGGCCATTTTGTA
GCTAACGGCAAAGAGTCTGAGTTCTTCATCCGCACACAGGGAGGGTCTGCTT
TCGGATCTAGCGTCTGGCTGAATGAAACTTACCTCGGCAGCTGGACTGGAGC
CGACTATGCAATGGATGGTAACTCTACTTACAAGCTGAGTCAACTGGAAAGT
GGAAAGAATTACGTAATCACTGTGGTAATCGATAATCTTGGCTTGGACGAGA
ACTGGACTGTAGGTGAGGAAACTATGAAAAATCCAAGAGGCATCCTCTCCTA
CAAATTGTCAGGGCAGGATGCCAGTGCAATTACATGGAAGCTCACTGGGAAC
CTCGGCGGTGAAGATTATCAGGACAAAGTGAGAGGTCCATTGAATGAAGGCG
GCCTCTACGCAGAGCGACAAGGTTTTCACCAGCCCCAGCCCCCATCTGAAAG
TTGGGAATCTGGGAGCCCCCTGGAAGGTCTGTCAAAACCAGGTATTGGCTTC
TATACCGCACAATTCGACTTGGACCTGCCTAAAGGCTGGGACGTCCCTCTTTA
TTTTAATTTTGGAAATAATACACAGGCTGCCCGCGCTCAGCTTTACGTCAACG
GCTACCAATATGGGAAATTCACTGGGAACGTTGGCCCTCAAACTTCCTTCCCC
GTTCCAGAGGGGATCCTCAACTATCGCGGAACTAATTATGTGGCTTTGAGCCT
GTGGGCTCTCGAAAGCGACGGTGCTAAACTTGGATCCTTTGAGCTTTCTTATA
CAACCCCCGTGCTCACTGGTTATGGTAACGTAGAGAGTCCAGAGCAACCAAA
GTATGAGCAACGCAAAGGTGCTTAT 
 
HA  
TATCCATATGATGTTCCAGATTATGCT 
 
DAF  
CCAAATAAAGGAAGTGGAACCACTTCAGGTACTACCCGTCTTCTATCTGGGC
ACACGTGTTTCACGTTGACAGGTTTGCTTGGGACGCTAGTAACCATGGGCTTG
CTGACTTAG  
 
pDisplay 
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GCTGTGGGCCAGGACACGCAGGAGGTCATCGTGGTGCCACACTCCTTGCCCT
TTAAGGTGGTGGTGATCTCAGCCATCCTGGCCCTGGTGGTGCTCACCATCATC
TCCCTTATCATCCTCATCATGCTTTGGCAGAAGAAGCCACGT 
 
IRES  
GCCCCTCTCCCTCCCCCCCCCCTAACGTTACTGGCCGAAGCCGCTTGGAATAA
GGCCGGTGTGCGTTTGTCTATATGTTATTTTCCACCATATTGCCGTCTTTTGGC
AATGTGAGGGCCCGGAAACCTGGCCCTGTCTTCTTGACGAGCATTCCTAGGG
GTCTTTCCCCTCTCGCCAAAGGAATGCAAGGTCTGTTGAATGTCGTGAAGGA
AGCAGTTCCTCTGGAAGCTTCTTGAAGACAAACAACGTCTGTAGCGACCCTTT
GCAGGCAGCGGAACCCCCCACCTGGCGACAGGTGCCTCTGCGGCCAAAAGCC
ACGTGTATAAGATACACCTGCAAAGGCGGCACAACCCCAGTGCCACGTTGTG
AGTTGGATAGTTGTGGAAAGAGTCAAATGGCTCTCCTCAAGCGTATTCAACA
AGGGGCTGAAGGATGCCCAGAAGGCACCCCATTGTATGGGATCTGATCTGGG
GCCTCGGTGCACATGCTTTACATGTGTTTAGTCGAGGTTAAAAAAACGTCTAG
GCCCCCCGAACCACGGGGACGTGGTTTTCCTTTGAAAAACACGATGATAATA
TGGCCACA  
 
Nuclear localization sequence (NLS) 
ATGGTGCCCAAGAAGAAGAGGAAAGTC 
 
mCherry   
GTGAGCAAGGGCGAGGAGGACAACATGGCCATCATCAAGGAGTTCATGCGC
TTCAAGGTGCACATGGAGGGCTCCGTGAACGGCCACGAGTTCGAGATCGAGG
GCGAGGGCGAGGGCCGCCCCTACGAGGGCACCCAGACCGCCAAGCTGAAGG
TGACCAAGGGCGGCCCCCTGCCCTTCGCCTGGGACATCCTGTCCCCTCAGTTC
ATGTACGGCTCCAAGGCCTACGTGAAGCACCCCGCCGACATCCCCGACTACT
TGAAGCTGTCCTTCCCCGAGGGCTTCAAGTGGGAGCGCGTGATGAACTTCGA
GGACGGCGGCGTGGTGACCGTGACCCAGGACTCCTCCCTGCAGGACGGCGAG
TTCATCTACAAGGTGAAGCTGCGCGGCACCAACTTCCCCTCCGACGGCCCCGT
AATGCAGAAGAAGACCATGGGCTGGGAGGCCTCCTCCGAGCGGATGTACCCC
GAGGACGGCGCCCTGAAGGGCGAGATCAAGCAGAGGCTGAAGCTGAAGGAC
GGCGGCCACTACGACGCCGAGGTCAAGACCACCTACAAGGCCAAGAAGCCC
GTGCAGCTGCCCGGCGCCTACAACGTCAACATCAAGCTGGACATCACCTCCC
ACAACGAGGACTACACCATCGTGGAACAGTACGAGCGCGCCGAGGGCCGCC
ACTCCACCGGCGGCATGGACGAGCTGTACAAG 
 
CMV promoter  
GACATTGATTATTGACTAGTTATTAATAGTAATCAATTACGGGGTCATTAGTT
CATAGCCCATATATGGAGTTCCGCGTTACATAACTTACGGTAAATGGCCCGCC
TGGCTGACCGCCCAACGACCCCCGCCCATTGACGTCAATAATGACGTATGTTC
CCATAGTAACGCCAATAGGGACTTTCCATTGACGTCAATGGGTGGACTATTTA
CGGTAAACTGCCCACTTGGCAGTACATCAAGTGTATCATATGCCAAGTACGC
CCCCTATTGACGTCAATGACGGTAAATGGCCCGCCTGGCATTATGCCCAGTAC
ATGACCTTATGGGACTTTCCTACTTGGCAGTACATCTACGTATTAGTCATCGC
TATTACCATGGTGATGCGGTTTTGGCAGTACATCAATGGGCGTGGATAGCGG
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TTTGACTCACGGGGATTTCCAAGTCTCCACCCCATTGACGTCAATGGGAGTTT
GTTTTGGCACCAAAATCAACGGGACTTTCCAAAATGTCGTAACAACTCCGCC
CCATTGACGCAAATGGGCGGTAGGCGTGTACGGTGGGAGGTCTATATAAGCA
GAGCT 
 
CAG Promoter  
TCGAGGTGAGCCCCACGTTCTGCTTCACTCTCCCCATCTCCCCCCCCTCCCCA
CCCCCAATTTTGTATTTATTTATTTTTTAATTATTTTGTGCAGCGATGGGGGCG
GGGGGGGGGGGGGGGCGCGCGCCAGGCGGGGCGGGGCGGGGCGAGGGGCG
GGGCGGGGCGAGGCGGAGAGGTGCGGCGGCAGCCAATCAGAGCGGCGCGCT
CCGAAAGTTTCCTTTTATGGCGAGGCGGCGGCGGCGGCGGCCCTATAAAAAG
CGAAGCGCGCGGCGGGCG 
 
Benchling links for constructs 
 
CMV-IgK-lacZ-HA-DAF-IRES-mCherry 
https://benchling.com/s/a64YYj70 
 
CAG-IgK-lacZ-HA-DAF-IRES-mCherry 
https://benchling.com/s/22YaFaAm 
 
CMV-IgK-lacZ-HA-pDisplay-IRES-mCherry 
https://benchling.com/s/seq-nR4dGXprwx9GFqtbyb0W 
 
CAG-IgK-lacZ-HA-pDisplay-IRES-mCherry 
https://benchling.com/s/08GCP2uT 
 
CMV-IgK-AO-β-gal-DAF-IRES-mCherry 
https://benchling.com/s/seq-ZAPDqNkXC2fm1EZBnwgR 
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Figures and Schemes 
Scheme A1-1. Design of β-galactosidase-based fluorogenic activation. 
 
 
Scheme A1-1. Structure of galactose-masked dye β-gal-VF2.1.Cl and its fluorescence 
turn-on following β-galactosidase reaction. 
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Figure A1-1. β-galactosidase constructs used in this study. 
 
 
 
Figure A1-1. Constructs designed and tested for expressing β-galactosidase on the cell 
surface.  
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Figure A1-2. Characterization of bacterial β-galactosidase (lacZ) expression in HEK 
cells using immunohistochemistry. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure A1-2. Wide-field images of anti-HA staining for fixed HEK cells (a,g) without 
any plasmid transfection or expressing (b,h) CMV-PLE-DAF positive control or (c,i) 
CMV-lacZ-DAF or (d,j) CMV-lacZ-pDisplay or (e,k) CAG-lacZ-DAF or (f,l) CAG-lacZ-
pDisplay. Images a-f are acquired in non-permeable conditions and images g-l in 
permeable condition. Scale bar is 20 µm. 
 
201	
Figure A1-3. Functional assay of cell-surface lacZ in HEK cells. 
 
 
Figure A1-3. Activity assay of cell-surface lacZ in HEK cells using a cell permeable 
substrate X-Gal. (a) Indole released after galactosidase reaction dimerizes and is oxidized 
to form a blue precipitate. (b) Images of HEK cells in 24-well plate transfected with 
CMV-lacZ-DAF, CAG-lacZ-DAF, CMV-lacZ-pDisplay, CAG-lacZ-pDisplay or non-
transfected (from left to right) after treatment with 1 mg/mL X-Gal for 4 h (top panel) or 
24 h (bottom panel) in HBSS at 37 °C. 
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Figure A1-4. Characterization of fungal (Aspergillus oryzae) β-galactosidase (AO-β-gal) 
expression in HEK cells using immunohistochemistry. 
 
 
 
Figure A1-4. Wide-field images of fixed HEK cells expressing CMV-AO-β-gal-DAF 
under permeablizing condition. (a) Membrane-associated fluorescence of anti-HA 
staining indicates cell-surface expression for AO-β-gal. (b) Differential interference 
contrast (DIC) images of HEK cells. (c) Nulcear mCherry indicates AO-β-gal expression. 
(d) Merge image of anti-HA staining (AO-β-gal) and nuclear mCherry confirms co-
expression. Scale bar is 20 µm. 
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Fluorogenic Activation by a Cell-Surface β-lactamase 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Portions of this work were performed in collaboration with the following persons:  
Synthesis was assisted by Vincent Grenier 
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Introduction 
 Masking the phenolic oxygen in the VoltageFluor dyes successfully quenches 
their fluorescence and voltage sensitivity. The use of a specific protecting group followed 
by its cognate enzyme-mediated activation enables targeted fluorogenic turn-on in 
defined cells of interest. We have previously demonstrated the efficiency of a selectively 
expressed pig liver esterase to cleave a cyclopropyl ester protecting group to achieve 
specific staining with desirable contrast using both VF2.1.Cl (Chapter 2)1 and carboVF 
(Chapter 3-1)2. Limitations of this strategy includes a relatively slow kinetics, in 
particular at room temperature, and inadequate cell-surface expression, probably due to a 
membrane-trafficking problem caused by its large size of 168 kD monomer and 
formation of trimer. As a result, it is worthwhile to explore other enzyme-substrate pairs 
for alternative fluorogenic activation to carry forward the strategy to more complex 
biological settings such as ex vivo brain slices or in vivo live animals.  
 β-lactamase is a small bacterial enzyme, existing and functional as a 29 kD 
monomer.3-5 It is produced by certain bacteria species for antibiotic resistance such as 
penicillin4, whose core structure involves a four-membered nitrogen-containing ring, also 
known as β-lactam. The mechanism of action relies on the ring opening with a very rapid 
kinetics due to the strained and unstable nature of the lactam ring.6 In addition, a series of 
novel fluorogenic substrates to assay β-lactamase activity have been designed.7-9 The 
synthesis to append the lactam-based protecting group to the phenolic oxygen is well-
characterized. Combining these favorable features, we have decided to engineer a cell-
surface β-lactamase (BLA) and synthesize a lactam-masked VF dye. 
 
Results & Discussions 
 To express BLA on the surface, we again started with DAF and pDisplay 
targeting sequences and used CMV promoter for HEK cell expression and Synapsin 
promoter for neuron-specific expression (Figure A2-1). We verified the cell-surface 
expression using a non-permeablizing immunostaining protocol (Figure A2-2) where the 
anti-HA antibody is unlikely to cross the membrane to target any intracellular protein. 
Membrane-associate anti-HA fluorescence was observed (Figure A2-2a), which matched 
the nuclear mCherry expression (Figure A2-2d), suggesting that BLA is indeed expressed 
on the extracellular surface of the HEK cells expressing our fluorescent protein marker. 
We compared the efficiency of the DAF and pDisplay construct using immunostaining 
and found out that DAF construct had a higher anti-HA signal, indicating better 
expression or trafficking to the membrane, which is consistent with studies done with 
CMV-PLE constructs. In neurons, BLA is expressed on the cell surface too as shown 
from the immunostaining results (Figure A2-4). However, compared to Syn-PLE-DAF, 
the Syn-BLA constructs exhibited much weaker signal and pDisplay construct expression 
was barely seen, in agreement with the data from CMV constructs (Figure A2-5).  
 We next moved on to evaluate the functional aspect of BLA in both HEK cells 
and neurons. A cell impermeant substrate, nitrocefin was used to examine the activity of 
the cell-surface enzyme.10 Nitrocefin displays a shift in absorbance during the BLA-
mediated lactam ring opening (Figure 2-6a). Both control nitrocefin solution or nitrocefin 
exposed to non-transfected cells showed a major absorbance peak at 390 nm and minimal 
absorbance at 490 nm, while nitrocefin treated with BLA-expressing cells had a decrease 
in the starting material absorption with a concomitant appearance of the 490 nm product 
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absorption peak (Figure A2-6b, Figure A2-7). The shift is more prominent in treatment 
with HEK cells than neurons as it’s dependent on the amount of BLA expression which is 
more robust in HEK cells. This also matched our results from PLE experiments in which 
a much larger fluorescence turn-on was measured in HEK cells than in neurons (Table 2). 
Encouraged by the data from immunostaining and functional assay of cell-surface 
BLA in both HEK cells and neurons, my colleague, Vincent Grenier, synthesized the 
masked dye BLA-VF2.1.Cl based on the literature.7 During the synthesis, we 
encountered a couple of challenges with the complexity and instability of the lactam and 
spent copious time and effort to achieve the final compound. When we applied the dye to 
HEK cells expression CMV-BLA-DAF (500 nM at RT for 15 min), all the cells were 
uniformly stained with no selectivity in mCherry-positive cells (Figure A2-8). We 
hypothesize that the dye was not stable enough and hydrolyzed quickly to release the 
fluorescent, non-specific VF2.1.Cl.  
 
Conclusion 
We have successfully expressed a β-lactamase on the cell surface for both HEK 
cells and neurons, with the capability to act on a cell-impermeant substrate nitrocefin. 
Expression is limited in neurons as proven from a less efficient nitrocefin conversion, 
which can be potentially solved by changing into a stronger promoter such as CAG. 
Unfortunately, the lactam-masked VF2.1.Cl is unstable and undergoes hydrolysis rapidly 
when treated to live cells and no selective staining was observed. A second-generation 
dye with improved stability and more accessible synthetic route would be desired to 
achieve BLA-mediated fluorogenic activation.  
 
Experimental Sections 
 
Cell Culture  
All animal procedures were approved by the UC Berkeley Animal Care and Use 
Committees and conformed to the NIH Guide for the Care and Use and Laboratory 
Animals and the Public Health Policy.  
Human embryonic kidney 293T (HEK) cells were maintained and plated in 
Dulbecco’s modified eagle medium (DMEM) supplemented with 4.5 g/L D-glucose, 10% 
fetal bovine serum (FBS; Thermo Scientific) and 1% GlutaMax (Invitrogen) at 37 °C in a 
humidified incubator with 5 % CO2. Cells were passaged and plated in DMEM (as 
above) at a density of 75,000 cells onto 12 mm glass coverslips pre-coated with Poly-D-
Lysine (PDL; 1 mg/ml; Sigma-Aldrich) per well in a 24-well plate. Transfection of 
plasmids was carried out using Lipofectamine 3000 (Invitrogen) ~18-24 h after plating. 
Imaging was performed 12-18 h after transfection.  
Hippocampi were dissected from embryonic day 19 Sprague Dawley rats (Charles 
River Laboratory) in cold, sterile HBSS (zero Ca2+, zero Mg2+, phenol red). All dissection 
products were supplied by Invitrogen, unless otherwise stated. Hippocampal tissue was 
treated with trypsin (2.5%) for 15 min at 37 °C. The tissue was triturated using fire 
polished Pasteur pipettes, in minimum essential media (MEM) supplemented with 5% 
FBS, 2% B-27, 2% 1M dextrose (Fisher Scientific) and 1% GlutaMax. The dissociated 
cells were plated onto 12 mm diameter coverslips (Fisher Scientific) pre-treated with 
PDL (as above) at a density of 25-30,000 cells per coverslip in MEM supplemented 
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media (as above). Neurons were maintained at 37 °C in a humidified incubator with 5% 
CO2. At 1 day in vitro (DIV) half of the MEM supplemented media was removed and 
replaced with Neurobasal media containing 2% B-27 supplement and 1% GlutaMax. 
Transfection of plasmids was carried out using Lipofectamine 3000 (without P3000 
reagent) at 6-7 DIV. Imaging was performed on mature neurons 13-16 DIV. 
 
BLA activity assay using nitrocefin 
 Nitrocefin solid was purchased from VWR (Cat. 80017-706) and concentrated 
stock solution was prepared in DMSO and stored at -20 °C, protected from light. For 
activity assay of BLA in HEK cells, HEK cells were transfected with CMV-BLA-DAF as 
stated above and the assay was conducted about 24 h after transfection. Media was 
aspirated and replaced with 1 mL of nitrocefin in HBSS (final concentration 5 µg/mL). 
Reaction was done at RT for 15 min, protected from light. For activity assay in neurons, 
neurons were transfected with Syn-BLA-DAF as stated above and the assay was 
conducted 7 days after transfection. Media was aspirated and replaced with 1 mL of 
nitrocefin in HBSS (final concentration 100 µg/mL). Reaction was done at 37 °C for 1 h. 
For UV/Vis absorption measurement, the solution (supernatant) was transferred to a 
cuvette after the reaction was finished. Negative controls included non-treated 1mL of 
nitrocefin in HBSS and solution treated to non-transfected cells.  
 
Imaging Parameters  
Epifluorescence imaging was performed on an AxioExaminer Z-1 (Zeiss) 
equipped with a Spectra-X Light engine LED light (Lumencor), controlled with 
Slidebook (v6, Intelligent Imaging Innovations). Images were acquired with a W-Plan-
Apo 20x/1.0 water objective (20x; Zeiss) and focused onto an OrcaFlash4.0 sCMOS 
camera (sCMOS; Hamamatsu). For VF dye, excitation light was delivered at 475 nm 
(LED, 475 nm, 34 nm bandpass) and emission was collected with a 540/50 nm bandpass 
filter after passing through a 510 nm longpass dichroic. 
 
Immunocytochemistry 
To detect expression and localization of BLA, HEK cells or neurons were fixed 
with 4% paraformaldehyde in PBS for 10 min. Blocking was done in 5% w/v bovine 
serum albumin (BSA; Sigma Aldrich) in PBS for 1 h. Primary anti-HA antibody (rabbit 
IgG, Cell Signaling Technologies Cat. 3724S) was incubated at 4 °C overnight, followed 
by anti-rabbit AlexaFluor 647 secondary antibody (goat IgG, Life Technologies A21244) 
at room temperature (RT) for 2 h. Hoechst 33342 was added for 15 min at RT to visualize 
the nucleus. All antibodies and counterstain were used at 1:1000 dilution.  
 
DNA constructs  
To express the BLA protein on the cell surface, an IgK leader sequence was fused 
to the N-terminal and either a signal peptide for GPI addition (DAF) or a transmembrane 
domain (pDisplay) was added to the C-terminal. An HA tag was inserted for 
immunstaining. Mammalian expression vector pcDNA3 with either a CMV promoter or 
Synapsin promoter was used for protein expression in HEK cells and neurons, 
respectively. To increase expression in neurons, a regulatory element from the 
woodchuck hepatitis virus (WPRE) was used. In all constructs, nuclear-targeted mCherry 
208	
(NLS-mCherry) was inserted down stream of BLA, separated by an internal ribosome 
entry site (IRES) sequence, to track the expression of BLA in live cells. All constructs 
were confirmed by sequencing. The following sequences were used (5' to 3'): 
 
IgK  
ATGGAGACAGACACACTCCTGCTATGGGTACTGCTGCTCTGGGTTCCAGGTTC
CACTGGTGAC  
 
β-lactamase  
ATGAGTATTCAACATTTCCGTGTCGCCCTTATTCCCTTTTTTGCGGCATTTTGC
CTTCCTGTTTTTGCTCACCCAGAAACGCTGGTGAAAGTAAAAGATGCTGAAG
ATCAGTTGGGTGCACGAGTGGGTTACATCGAACTGGATCTCAACAGCGGTAA
GATCCTTGAGAGTTTTCGCCCCGAAGAACGTTTTCCAATGATGAGCACTTTTA
AAGTTCTGCTATGTGGCGCGGTATTATCCCGTATTGACGCCGGGCAAGAGCA
ACTCGGTCGCCGCATACACTATTCTCAGAATGACTTGGTTGAGTACTCACCAG
TCACAGAAAAGCATCTTACGGATGGCATGACAGTAAGAGAATTATGCAGTGC
TGCCATAACCATGAGTGATAACACTGCGGCCAACTTACTTCTGACAACGATC
GGAGGACCGAAGGAGCTAACCGCTTTTTTGCACAACATGGGGGATCATGTAA
CTCGCCTTGATCGTTGGGAACCGGAGCTGAATGAAGCCATACCAAACGACGA
GCGTGACACCACGATGCCTGCAGCAATGGCAACAACGTTGCGCAAACTATTA
ACTGGCGAACTACTTACTCTAGCTTCCCGGCAACAATTAATAGACTGGATGG
AGGCGGATAAAGTTGCAGGACCACTTCTGCGCTCGGCCCTTCCGGCTGGCTG
GTTTATTGCTGATAAATCTGGAGCCGGTGAGCGTGGGTCTCGCGGTATCATTG
CAGCACTGGGGCCAGATGGTAAGCCCTCCCGTATCGTAGTTATCTACACGAC
GGGGAGTCAGGCAACTATGGATGAACGAAATAGACAGATCGCTGAGATAGG
TGCCTCACTGATTAAGCATTGG 
 
HA  
TATCCATATGATGTTCCAGATTATGCT 
 
DAF  
CCAAATAAAGGAAGTGGAACCACTTCAGGTACTACCCGTCTTCTATCTGGGC
ACACGTGTTTCACGTTGACAGGTTTGCTTGGGACGCTAGTAACCATGGGCTTG
CTGACTTAG  
 
pDisplay 
GCTGTGGGCCAGGACACGCAGGAGGTCATCGTGGTGCCACACTCCTTGCCCT
TTAAGGTGGTGGTGATCTCAGCCATCCTGGCCCTGGTGGTGCTCACCATCATC
TCCCTTATCATCCTCATCATGCTTTGGCAGAAGAAGCCACGT 
 
IRES  
GCCCCTCTCCCTCCCCCCCCCCTAACGTTACTGGCCGAAGCCGCTTGGAATAA
GGCCGGTGTGCGTTTGTCTATATGTTATTTTCCACCATATTGCCGTCTTTTGGC
AATGTGAGGGCCCGGAAACCTGGCCCTGTCTTCTTGACGAGCATTCCTAGGG
GTCTTTCCCCTCTCGCCAAAGGAATGCAAGGTCTGTTGAATGTCGTGAAGGA
AGCAGTTCCTCTGGAAGCTTCTTGAAGACAAACAACGTCTGTAGCGACCCTTT
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GCAGGCAGCGGAACCCCCCACCTGGCGACAGGTGCCTCTGCGGCCAAAAGCC
ACGTGTATAAGATACACCTGCAAAGGCGGCACAACCCCAGTGCCACGTTGTG
AGTTGGATAGTTGTGGAAAGAGTCAAATGGCTCTCCTCAAGCGTATTCAACA
AGGGGCTGAAGGATGCCCAGAAGGCACCCCATTGTATGGGATCTGATCTGGG
GCCTCGGTGCACATGCTTTACATGTGTTTAGTCGAGGTTAAAAAAACGTCTAG
GCCCCCCGAACCACGGGGACGTGGTTTTCCTTTGAAAAACACGATGATAATA
TGGCCACA  
 
Nuclear localization sequence (NLS) 
ATGGTGCCCAAGAAGAAGAGGAAAGTC 
 
mCherry   
GTGAGCAAGGGCGAGGAGGACAACATGGCCATCATCAAGGAGTTCATGCGC
TTCAAGGTGCACATGGAGGGCTCCGTGAACGGCCACGAGTTCGAGATCGAGG
GCGAGGGCGAGGGCCGCCCCTACGAGGGCACCCAGACCGCCAAGCTGAAGG
TGACCAAGGGCGGCCCCCTGCCCTTCGCCTGGGACATCCTGTCCCCTCAGTTC
ATGTACGGCTCCAAGGCCTACGTGAAGCACCCCGCCGACATCCCCGACTACT
TGAAGCTGTCCTTCCCCGAGGGCTTCAAGTGGGAGCGCGTGATGAACTTCGA
GGACGGCGGCGTGGTGACCGTGACCCAGGACTCCTCCCTGCAGGACGGCGAG
TTCATCTACAAGGTGAAGCTGCGCGGCACCAACTTCCCCTCCGACGGCCCCG
TAATGCAGAAGAAGACCATGGGCTGGGAGGCCTCCTCCGAGCGGATGTACCC
CGAGGACGGCGCCCTGAAGGGCGAGATCAAGCAGAGGCTGAAGCTGAAGGA
CGGCGGCCACTACGACGCCGAGGTCAAGACCACCTACAAGGCCAAGAAGCC
CGTGCAGCTGCCCGGCGCCTACAACGTCAACATCAAGCTGGACATCACCTCC
CACAACGAGGACTACACCATCGTGGAACAGTACGAGCGCGCCGAGGGCCGC
CACTCCACCGGCGGCATGGACGAGCTGTACAAG 
 
WPRE  
GCTTATCGATAATCAACCTCTGGATTACAAAATTTGTGAAAGATTGACTGGTA
TTCTTAACTATGTTGCTCCTTTTACGCTATGTGGATACGCTGCTTTAATGCCTT
TGTATCATGCTATTGCTTCCCGTATGGCTTTCATTTTCTCCTCCTTGTATAAAT
CCTGGTTGCTGTCTCTTTATGAGGAGTTGTGGCCCGTTGTCAGGCAACGTGGC
GTGGTGTGCACTGTGTTTGCTGACGCAACCCCCACTGGTTGGGGCATTGCCAC
CACCTGTCAGCTCCTTTCCGGGACTTTCGCTTTCCCCCTCCCTATTGCCACGGC
GGAACTCATCGCCGCCTGCCTTGCCCGCTGCTGGACAGGGGCTCGGCTGTTG
GGCACTGACAATTCCGTGGTGTTGTCGGGGAAATCATCGTCCTTTCCTTGGCT
GCTCGCCTGTGTTGCCACCTGGATTCTGCGCGGGACGTCCTTCTGCTACGTCC
CTTCGGCCCTCAATCCAGCGGACCTTCCTTCCCGCGGCCTGCTGCCGGCTCTG
CGGCCTCTTCCGCGTCTTCGCCTTCGCCCTCAGACGAGTCGGATCTCCCTTTG
GGCCGCCTCCCCGCATCGATACCG 
 
CMV promoter  
GACATTGATTATTGACTAGTTATTAATAGTAATCAATTACGGGGTCATTAGTT
CATAGCCCATATATGGAGTTCCGCGTTACATAACTTACGGTAAATGGCCCGCC
TGGCTGACCGCCCAACGACCCCCGCCCATTGACGTCAATAATGACGTATGTT
CCCATAGTAACGCCAATAGGGACTTTCCATTGACGTCAATGGGTGGACTATTT
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ACGGTAAACTGCCCACTTGGCAGTACATCAAGTGTATCATATGCCAAGTACG
CCCCCTATTGACGTCAATGACGGTAAATGGCCCGCCTGGCATTATGCCCAGT
ACATGACCTTATGGGACTTTCCTACTTGGCAGTACATCTACGTATTAGTCATC
GCTATTACCATGGTGATGCGGTTTTGGCAGTACATCAATGGGCGTGGATAGC
GGTTTGACTCACGGGGATTTCCAAGTCTCCACCCCATTGACGTCAATGGGAGT
TTGTTTTGGCACCAAAATCAACGGGACTTTCCAAAATGTCGTAACAACTCCGC
CCCATTGACGCAAATGGGCGGTAGGCGTGTACGGTGGGAGGTCTATATAAGC
AGAGCT 
 
Synapsin Promoter  
GTGTCTAGACTGCAGAGGGCCCTGCGTATGAGTGCAAGTGGGTTTTAGGACC
AGGATGAGGCGGGGTGGGGGTGCCTACCTGACGACCGACCCCGACCCACTG
GACAAGCACCCAACCCCCATTCCCCAAATTGCGCATCCCCTATCAGAGAGGG
GGAGGGGAAACAGGATGCGGCGAGGCGCGTGCGCACTGCCAGCTTCAGCAC
CGCGGACAGTGCCTTCGCCCCCGCCTGGCGGCGCGCGCCACCGCCGCCTCAG
CACTGAAGGCGCGCTGACGTCACTCGCCGGTCCCCCGCAAACTCCCCTTCCC
GGCCACCTTGGTCGCGTCCGCGCCGCCGCCGGCCCAGCCGGACCGCACCACG
CGAGGCGCGAGATAGGGGGGCACGGGCGCGACCATCTGCGCTGCGGCGCCG
GCGACTCAGCGCTGCCTCAGTCTGCGGTGGGCAGCGGAGGAGTCGTGTCGTG
CCTGAGAGCGCAGTCGAGA 
 
Benchling links for constructs 
 
CMV-IgK-BLA-HA-DAF-IRES-mCherry 
https://benchling.com/s/0wwx4e8t 
 
CMV-IgK-BLA-HA-pDisplay-IRES-mCherry 
https://benchling.com/s/G49opVl6 
 
Synapsin-IgK-BLA-HA-DAF-IRES-mCherry-WPRE 
https://benchling.com/s/iuGArWYF 
 
Synapsin-IgK-BLA-HA-pDisplay-IRES-mCherry-WPRE 
https://benchling.com/s/seq-Oh8DkivFBsIV6I9e4T73 
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Figures and Schemes 
Scheme A2-1. Design of β-lactamase-based fluorogenic activation. 
 
 
 
Scheme A2-1. Structure of lactam-masked dye BLA-VF2.1.Cl and its fluorescence turn-
on following β-lactamase reaction. 
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Figure A2-1. β-lactamase constructs used in this study. 
 
 
 
Figure A2-1. Constructs designed and tested for expressing β-lactamase on the cell 
surface.  
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Figure A2-2. Characterization of BLA expression in HEK cells using 
immunohistochemistry. 
 
 
 
Figure A2-2. Wide-field images of fixed HEK cells expressing CMV-BLA-DAF under 
non-permeablizing condition. (a) Anti-HA staining shows membrane-associated 
fluorescence. (b) Nuclear mCherry indicates BLA expression. (c) Hoechst 33342 stains 
nucleus. (d) Merge image of anti-HA staining and mCherry. Scale bar is 20 µm. 
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Figure A2-3. Compare DAF and pDisplay construct by immunohistochemistry. 
 
 
 
Figure A2-3. Wide-field images of anti-HA staining in fixed HEK cells expressing 
CMV-BLA-DAF (a) or CMV-BLA-pDisplay (b) under non-permeablizing condition. 
Scale bar is 20 µm. 
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Figure A2-4. Characterization of BLA expression in cultured hippocampal neurons using 
immunohistochemistry. 
 
 
 
Figure A2-4. Fixed cell wide-field images of rat hippocampal neurons expressing 
Synapsin-BLA-DAF. (a) Anti-HA staining shows membrane-associated fluorescence. (b) 
Merge image of anti-HA staining and nuclear mCherry which indicates BLA expression. 
(c) Merge image of anti-HA staining and Hoechst 33342 which stains nucleus. Scale bar 
is 20 µm. 
216	
Figure A2-5. Characterization of BLA expression in cultured hippocampal neurons using 
immunohistochemistry. 
 
 
 
Figure A2-5. Wide-field images of anti-HA staining in fixed hippocampal neurons 
expressing (a) Synapsin-PLE-DAF or (b) Synapsin-BLA-DAF or (c) Synapsin-BLA-
pDisplay. The settings (acquisition and display) for all images are the same. Scale bar is 
20 µm. 
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Figure A2-6. Functional assay of cell-surface BLA in HEK cells. 
 
 
Figure A2-6. Activity assay of cell-surface BLA in HEK cells using a cell impermeable 
lactam substrate nitrocefin. (a) Absorbance change of nitrocefin from 390 nm to 490 nm 
upon reaction with BLA. (b) UV/Vis absorption spectra of control nitrocefin only 
(yellow), nitrocefin reacted with plated non-transfected HEK cells (orange) or nitrocefin 
reacted with plated CMV-BLA-DAF transfected HEK cells (red). Concentration of 
nitrocefin used is 5 µg/mL and reactions with HEK cells are done at room temperature for 
15 min before measurement.  
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Figure A2-7. Functional assay of cell-surface BLA in cultured hippocampal neurons. 
 
 
 
Figure A2-7. Activity assay of cell-surface BLA in neurons using a cell impermeable 
lactam substrate nitrocefin. (a) Absorbance change of nitrocefin from 390 nm to 490 nm 
upon reaction with BLA. (b) UV/Vis absorption spectra of control nitrocefin only 
(yellow), nitrocefin reacted with plated non-transfected neurons (orange) or nitrocefin 
reacted with plated Syn-BLA-DAF transfected neurons (red). Concentration of nitrocefin 
used is 100 µg/mL and reactions with neurons are done at 37 °C for 1 h before 
measurement. 
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Figure A2-8. Characterization of BLA-VF2.1.Cl in BLA-expressing HEK cells. 
 
 
 
Figure A2-8. Wide-field fluorescence microscopy of HEK cells stained with BLA-
VF2.1.Cl (500 nM, 15 min, RT) shows membrane labeling of the cell expressing cell 
surface BLA. (a) Differential interference contrast (DIC) images of HEK cells. (b) 
Nuclear mCherry indicates BLA expression. (c) VF staining stains all cells uniformly. 
Scale bar is 20 µm. 
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Appendix 3: 
Designing a HaloTag Virus for In Vivo Applications 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Portions of this work were performed in collaboration with the following persons:  
Adult mice viral injection and slice imaging were assisted by Daniel Kramer 
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Abstract 
 In chapter 4, we have demonstrated that covalent labeling of VoltageFluor dyes 
using cell-surface HaloTag allows for selective staining in HEK cells, cultured neurons 
and live mouse brain slice. The targeted dye is able to report membrane potential changes 
in the abovementioned samples in a fast and sensitive manner. However, due to the 1:1 
stoichiometric nature of the labeling system, the amount of dye entering the membrane 
depends on the enzyme expression. In this chapter, we describe some of the efforts to 
modify the HaloTag expression using viral vector-based delivery system. We used adeno-
associated viral vectors to generate the HaloTag plasmids which worked well in HEK 
cells. The plasmids were readily packaged into the viral genome with AAV2/9 serotype 
that is known to infect and express rigorously in the central nervous system. However, 
when we tested the virus in cultured cells and later in mouse brain slice through neonatal 
viral injection, the low efficiency of the virus resulted in not only a small percentage of 
cells being transduced but also a weak expression in those infected cells, which 
ultimately led to a dim RhoVR signal with significantly eroded contrast. Ongoing efforts 
aim at solving the viruses’ efficiency issue or exploring alternative methods to increase 
HaloTag expression.  
 
Introduction 
 Covalent labeling of VoltageFluor dyes to cells of interest has proven to generate 
high contrast between transfected and non-transfected cells.1 Cell-surface HaloTag, a 
small bacterial enzyme that reacts with a haloalkane ligand conjugated to VF dyes, 
enables fast and highly specific staining of RhoVR1-PEG25-HaloTag in both cultured 
cells and mouse brain slices with plasmid-based transfection techniques. While the 
contrast is remarkable in a complex tissue environment when nanomolar dye 
concentration was applied, the signal from the stained cells is so low that functional 
imaging to record voltage changes is only applicable to a small portion of HaloTag-
expressing cells. We realized this problem when trying to conduct patch-clamp 
electrophysiology on the transfected cells after in utero electroporation. Only very few 
brightly stained cells would emit enough photons to record distinctly resolved spikes 
above noise level. We believe that the HaloTag binding site is probably saturated as an 
increased dye concentration only raised the background non-specific staining. Thus, to 
boost the dye signal, we have decided to use a virus to enhance HaloTag expression. 
Virus-mediated delivery has been commonly utilized to send genetic materials to host 
cells due to its superb infectivity and expression efficiency.2-3  
 Adeno-associated virus (AAV) has been chosen as an ideal delivery vehicle for 
several reasons. Besides its desirable infectivity and expression, one of the most 
favorable reasons is its safety as AAV generally elicits little immune response.4 Also, the 
AAV system has been extensively used in targeting the central nervous system with well-
studied distribution pattern and expression efficiency of various AAV serotypes.5-6 
Nonetheless, the drawback includes a relatively limited packaging size of 4.7 kb 
exogenous gene of interest.7 This is not a concern in our case since the HaloTag enzyme 
is roughly 900 bp8 while the transmembrane targeting domain, either pDisplay or DAF, is 
only approximately 150 bp9 and the fluorescent protein marker, mTagBFP2 or EGFP is 
around 700 bp10-11. All the key fragments have compact sizes that would fit nicely into 
the cassette when designing the construct for virus packaging.  
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 Besides, we also incorporated the specificity feature by inserting the Lox 
sequences. The Cre-Lox recombination system is one of the most frequently applied 
strategies to control gene expression in cells of interest.12-13 Cre recombinase expressed in 
selected cell types recognizes a specific pair of Lox sequences flanking the target gene of 
reversed sequence and thus inverts the reversed gene to its normal orientation for 
expression.14 There has been a diverse range of commercially available mouse lines 
expressing Cre recombinase in different cell types, such as CaMKIIα-Cre for excitatory 
cells15 and VGAT-Cre for inhibitory cells expression16. As a result, we can simply inject 
a virus containing the HaloTag sequence flanked by Lox sites (floxed-HaloTag) to those 
mice of specific Cre genotype for targeted expression and dye labeling. 
The workflow is as follows: we inserted the HaloTag components to a viral vector 
backbone to yield the plasmids. After characterization in cultured cells, we then sent the 
plasmids to Dr. Mei Li at School of Optometry, UC Berkeley to make viruses of AAV2/9 
serotype. The whole process of cloning and virus prep took about five weeks. The virus 
was first tested in cultured cells before injection into Cre mouse lines and the slices were 
obtained for staining and imaging. In the meanwhile, another collaborator, the 
Heppenstall lab, has sent us a HaloTag AAV virus that allows us to do some initial test in 
cells and slices.  
 
Results & Discussions 
 
A3-1: Characterization of pAAV-hSyn-HaloTag-DAF virus. 
 The pAAV-hSyn-HaloTag-DAF virus with AAV1/2 serotype and titer of 
3.1×1013 vg/mL is a gift from the Heppenstall lab (EMBL). Before using the virus in 
vivo, we tested it in cultured hippocampal neurons and stained the cells with RhoVR1-
PEG25-HaloTag. The virus infected cells with very high efficiency, evidenced by uniform 
and bright staining throughout the culture (Figure A3-1-1a,b) while the non-transduced 
control did not display any labeling (Figure A3-1-1 c,d). For virus injection to adult mice, 
we collaborated with the Bateup lab (UC Berkeley) to delivery the virus to cortex and 
striatum using four different concentrations (Figure A3-1-2a,b). We observed specific 
staining in areas of injection when stained with TMR-PEG13-HaloTag (Figure A3-1-2a) 
and RhoVR1-PEG25-HaloTag (Figure A3-1-2b). We also took a closer look and spotted 
cell body-like structures (Figure A3-1-2c), but due to a lack of marker for the HaloTag 
enzyme, it was challenging to accurately differentiate specific, expression-dependent 
staining from non-specific background or debris staining. On the other hand, a non-
injected region of interest showed minimal dye signal (Figure A3-1-2d). As result, we 
found it necessary to include a fluorescent protein marker in the construct to pinpoint 
HaloTag expression in a complex environment.  
 
A3-2: Design and characterization DIO-based viruses 
We cloned a cell-surface HaloTag construct using the transmembrane domain 
pDisplay and a bright blue fluorescent protein mTagBFP210 as expression marker for 
spectral separation from the rhodamine-based dye (Figure A3-2-1). A self-cleaving 
peptide sequence, P2A17, was selected to replace the long sequence of IRES, considering 
the limitation in viral genome packaging length. A strong promoter CAG was used to 
boost the enzyme expression. The cloning was carried out using the recombinase-free 
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Sure2 strain as the presence of inverted terminal repeats (ITRs) in the vector backbone is 
prone to recombination.18 For virus preparation, endotoxin-free maxiprep DNA was 
obtained and confirmed by sequencing as well as SmaI restriction digestion to rule out 
recombination (Figure A3-2-2).18 Additional characterization in HEK cells was 
conducted by co-transfecting the construct with a Cre recombinase plasmid. Only BFP-
positive cells were stained with RhoVR1-PEG25-HaloTag (Figure A3-2-2c,d,e) and all 
BFP-positive cells expressed Cre recombinase as indicated by the nuclear EGFP marker 
(Figure A3-2-2b,c,f). Selective staining was also observed in cultured neurons when Cre-
EGFP plasmid was co-transfected (Figure A3-2-3). These results suggest that the DIO 
plasmid was Cre-dependent and had efficient expression in cultured cells.  
 The virus was prepared with a high titer of 5.14 × 1014 vg/mL. To determine its 
efficiency in cultured cells, we transduced HEK cells with the virus and transfected with 
a Cre recombinase plasmid containing an EGFP marker. We stained and imaged the cells 
4 days after transduction and observed very little cytosolic BFP or membrane-associated 
RhoVR dye fluorescence, despite robust Cre recombinase expression (Figure A3-2-4a-d). 
Nonetheless, in the controls cells where only the virus was transduced, we saw 
completely no BFP or RhoVR signal (Figure A3-2-4e-h), suggesting that the recombinase 
is necessary for the expression of the floxed virus. We checked the expression again 4 
days later (i.e. 8 days after transduction) where the cells were 100% confluent and fewer 
than 10 cells displayed bright dye labeling which matched the cytosolic BFP expression 
(Figure A3-2-5).  
 For in vivo characterization, the virus was injected to neonatal mice (P2-P5) 
expressing Cre recombinase in specific cell types. Parvalbumin (PV) neurons, a class of 
GABAergic interneurons, were chosen because of their sparse expression and fast-
spiking activity profile.19 We first crossed a PV-Cre (i.e. Cre recombinase is only 
expressed in PV cells) homozygous female with a floxed-GCaMP6f heterozygous male, 
producing offsprings, which all expressed PV-Cre and half of them expressed GCaMP6f 
in PV cells. When we collected and stained P28 (post-natal day 28) acute brain slices, 
there was no BFP or RhoVR fluorescence when imaged under confocal microscope (data 
not shown). In some animals, GCaMP6f signal was detected which was most abundant in 
the cerebellum, indicating that Cre-recombinase was indeed present in specific cells and 
expression pattern matched the expected distribution of PV cells in the brain.20 We then 
repeated the neonatal viral injections twice more in PV-Cre heterozygous animals, but no 
BFP expression or RhoVR staining was seen (data now shown).  
Besides the PV-Cre line, we also tested the virus in EMX-Cre mouse. The EMX1 
gene encodes for a transcription factor that distributes ubiquitously in the cortex.21 
Abundance of EMX-positive neurons exceeds that of PV neurons and given the low 
expression efficiency in HEK cells, infecting a larger pool of Cre-positive cells might 
yield more HaloTag-positive cells. We acquired some P20 slices, stained with RhoVR1-
PEG25-HaloTag and saw that BFP expression was not only dim but also sparser than the 
expected EMX distribution. Nonetheless, the dye was selectively stained on the cell 
surface despite a low contrast against the background (Figure A3-2-6a-c). At P26, we 
imaged again and observed an increase in BFP expression and brighter dye staining with 
better contrast (Figure A3-2-6d-f), suggesting that HaloTag expression was enhanced 
relative to a week earlier. Compared to previous experiments with plasmid-based in utero 
electroporation, a much higher light power (almost twice high) was used to illuminate the 
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sample to visualize the dim staining. We attribute the compromised contrast to a weak 
HaloTag expression that led to fewer dye molecules bound. All the results in both PV-
Cre and EMX-Cre slices corroborated the HEK cell data and emphasized the fact that the 
virus is ineffective that very few cells could successfully express HaloTag or get labeled 
with our dye. It is puzzling that the plasmid itself is very effective but the virus did not 
work as well as imagined. Nonetheless, other researchers have constantly used the same 
viral vector and virus serotype for gene delivery very efficiently.  
 Meanwhile, since the pAAV-hSyn-HaloTag-DAF virus was shown to work in 
slices, we decided to prepare two other constructs using the GPI-anchor targeting moiety 
DAF and using an EGFP marker (Figure A3-2-1) and these variations could hopefully 
offer some explanations to the low efficiency of the pDisplay-mTagBFP2 virus. Both 
constructs were successfully obtained and confirmed by sequencing and SmaI digestion 
(Figure A3-2-7). HEK cells transfected DAF-mTagBFP2 or DAF-EGFP plasmid alone 
did not show any BFP or RhoVR fluorescence (Figure A3-2-8e-h, Figure A3-2-9g-i). Co-
transfection of DAF-mTagBFP2 and pCAG-Cre-H2B-EGFP expressed cytosolic BFP 
and effectively labeled TMR-PEG13-HaloTag on the cell surface (Figure A3-2-8a-d). For 
the DAF-EGFP construct, we first co-transfected HEK cells with pCAG-Cre-H2B-
mCherry and stained with dye. Cytosolic EGFP was clearly visualized, suggesting that 
the floxed HaloTag construct was expressed; on the other hand, the nuclear mCherry was 
so bright that it obscured the signal from the relatively dim membrane-bound TMR dye 
(Figure A3-2-9a-c). Alternatively, we used a pCAG-Cre-H2B-EGFP plasmid for 
transfection, in which dim cytosolic EGFP from DAF-EGFP could not be seen but 
membrane-bound TMR signal was detected (Figure A3-2-9d-f).  
Having demonstrated that the plasmids function well in HEK cells, we sent them 
for virus packaging and got the DAF-mTagBFP2 and DAF-mTagBFP2 viruses with a 
titer of 1.10×1015 vg/ml and 2.61×1015 vg/ml, respectively. We transduced the DAF-
mTagBFP2 to HEK cells followed by pCAG-Cre-H2B-EGFP plasmid transfection. The 
expression of Cre recombinase expression is very robust as indicated by the bright 
nuclear EGFP fluorescence (A3-2-10b). While cytosolic BFP fluorescence was seen in a 
few cells that also had TMR staining, the TMR signal was very low and complicated with 
bleed-through from the EGFP fluorescence (Figure A3-2-10c-f). We did a control 
experiment with the DAF-mTagBFP2 virus alone and saw no expression or staining 
(Figure A3-2-11), suggesting that HaloTag expression was dependent on Cre 
recombinase. We repeated the experiment with the DAF-EGFP virus and pCAG-Cre-
H2B-EGFP plasmid transfection and observed fairly sparse and weak dye staining 
(Figure A3-2-12). Transduction of both viruses in cultured hippocampal neurons resulted 
in selective staining of low contrast above the background in expressing neurons (Figure 
3-2-13). It may seem that DAF-mTagBFP2 and DAF-EGFP viruses performed better 
than the pDisplay-mTagBFP2 since stronger selective staining was detected in both HEK 
cells and neurons; however, a brighter TMR dye was used for characterization, rather 
than the dimmer RhoVR dye in the previous experiments. We are currently waiting for 
EMX-Cre mice for characterization in brain slices.  
 
Conclusion 
We have cloned and verified three new plasmids that worked well in cultured 
cells to express HaloTag and capture RhoVR1-PEG25-HaloTag in a Cre-dependent and 
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cell-type specific manner. However, when the plasmids were packaged into the viral 
genome and used for viral infection, only a limited portion of cells expressed HaloTag 
with little dye labeled. We are still investigating the reasons underlying the ineffective 
viruses. Current work focuses on designing and testing a non-floxed virus to rule out the 
possibility of any problems with Cre recombinase.  
 
Experimental Sections 
 
Cell Culture  
All animal procedures were approved by the UC Berkeley Animal Care and Use 
Committees and conformed to the NIH Guide for the Care and Use and Laboratory 
Animals and the Public Health Policy.  
Human embryonic kidney 293T (HEK) cells were maintained and plated in 
Dulbecco’s modified eagle medium (DMEM) supplemented with 4.5 g/L D-glucose, 10% 
fetal bovine serum (FBS; Thermo Scientific) and 1% GlutaMax (Invitrogen) at 37 °C in a 
humidified incubator with 5 % CO2. Cells were passaged and plated in DMEM (as 
above) at a density of 75,000 cells onto 12 mm glass coverslips pre-coated with Poly-D-
Lysine (PDL; 1 mg/ml; Sigma-Aldrich) per well in a 24-well plate. Transfection of 
plasmids was carried out using Lipofectamine 3000 (Invitrogen) ~18-24 h after plating. 
Viral transduction was conducted immediately after plating with a multiplicity of 
infection (MOI) of approximately 106. No media change was conducted for both plasmid 
transfection and viral transduction; reagents were added directly to cells in regular media. 
Hippocampi were dissected from embryonic day 19 Sprague Dawley rats (Charles 
River Laboratory) in cold, sterile HBSS (zero Ca2+, zero Mg2+, phenol red). All dissection 
products were supplied by Invitrogen, unless otherwise stated. Hippocampal tissue was 
treated with trypsin (2.5%) for 15 min at 37 °C. The tissue was triturated using fire 
polished Pasteur pipettes, in minimum essential media (MEM) supplemented with 5% 
FBS, 2% B-27, 2% 1M dextrose (Fisher Scientific) and 1% GlutaMax. The dissociated 
cells were plated onto 12 mm diameter coverslips (Fisher Scientific) pre-treated with 
PDL (as above) at a density of 25-30,000 cells per coverslip in MEM supplemented 
media (as above). Neurons were maintained at 37 °C in a humidified incubator with 5% 
CO2. At 1 day in vitro (DIV) half of the MEM supplemented media was removed and 
replaced with Neurobasal media containing 2% B-27 supplement and 1% GlutaMax. 
Transfection of plasmids was carried out using Lipofectamine 3000 (without P3000 
reagent) at 6-7 DIV. Viral transduction was conducted 1 – 3 h after cells were plated in 
regular culture media and half media change at 1DIV was conducted as normal. Imaging 
was performed on mature neurons about 7 days after plasmid transfection.  
 
Imaging Parameters  
Epifluorescence imaging was performed on an AxioExaminer Z-1 (Zeiss) 
equipped with a Spectra-X Light engine LED light (Lumencor), controlled with 
Slidebook (v6, Intelligent Imaging Innovations). Images were acquired with a W-Plan-
Apo 20x/1.0 water objective (20x; Zeiss). Images were focused onto an OrcaFlash4.0 
sCMOS camera (sCMOS; Hamamatsu). Confocal imaging was performed with a Zeiss 
LSM 880 NLO AxioExaminer equipped with a Diode 405 nm laser line, Argon 458, 488, 
and 514 laser lines, and a DPSS 561 nm laser line and a BiG-2 detector with a 690+ 
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dichroic. Images were acquired using a W-Plan-Apo 20x/1.0 water objective and a Zeiss 
Airyscan detector. 
 
Acute brain slice preparation  Mice	were	deeply	anesthetized	with	isoflurane	and	quickly	decapitated.	After	removing	the	scalp	and	skull,	ice	cold	sucrose	cutting	solution	(in	mM:	NaCl,	83;	KCl,	2.5;	MgSO4,	 3.3;	 NaH2PO4,	 1;	 NaHCO3,	 26.2;	 D-glucose,	 22;	 sucrose,	 72;	 and	 CaCl2,	0.5)	was	applied	to	the	brain.	BFP	fluorescence	was	checked	with	a	hand	held	405	nm	laser	before	the	brain	was	taken	out.	The	brain	was	cut	into	300	μm	thick	slices	with	 a	 DTK-1000	 slicer	 in	 ice	 cold	 sucrose	 cutting	 solution.	 The	 cut	 slices	 were	incubated	in	sucrose	cutting	solution,	bubbled	with	95%	O2	and	5%	CO2,	first	at	31	°C	for	 about	 30	 min	 and	 then	 at	 room	 temperature	 until	 further	 use.	 For	 bath	application	of	the	dye	and	cell	staining,	a	slice	was	transferred	to	a	35	mm	dish	with	sucrose	 cutting	 solution	 bubbled	 with	 95%	 O2	 and	 5%	 CO2	 to	 which	 dye	 stock	solution	was	added	(250	nM	final	concentration,	3	mL	total	volume).	The	slice	was	incubated	with	the	dye	at	room	temperature	for	15	min	before	imaging.	
	
Virus	injection	
 For adult animal injection, 450 nl of virus was injected to 4 regions at 4 different 
concentrations. After around two weeks, the animals were sacrificed to acquire 150 µm 
thick slices. After recovery at 34 °C	for	15	min,	the	slices	were	incubated	with	125	nM	dye	for	30	min	at	RT.	The	slices	were	then	fixed	overnight	in	4%	PFA,	washed	with	PBS	and	mounted	for	imaging.			 For	 neonatal	 animal	 injection,	 P2-P5	 animals	were	 used.	 The	 viruses	were	not	diluted	and	injected	to	3	spots	with	3	depths	in	each	spot	(roughly	350,	250	and	150 µm beneath surface) and 18.4 nl per injection. The visual cortex of the left 
hemisphere was targeted and the 3 spots are about 1 – 2 mm apart forming an equilateral 
triangle. Slices of 300 µm thickness were acquired around P12 – 25.  
 
Cloning  
It is recommended to contact Dr. Mei Li (mei.li@berkeley.edu), who can offer 
suggestions or specific requirements on viral vector cloning. The HaloTag inserts were 
cloned into a paavCAG vector with flanking loxP sites. The paavCAG vector plasmids 
were provided by Savitha (savi.sridharan@berkeley.edu) from the Adesnik lab. Due to 
the presence of inverted terminal repeats (ITRs) in the backbone, recombinase-free 
strains are used (for example Sure2 or Stbl3). DH5α strains can be used but often led to a 
low chance of getting the correct sequence. Sequencing and SmaI digestion were done on 
the Miniprep DNA before retransformation. Maxiprep DNA was prepared from the 
retransformed colonies and characterized by sequencing, SmaI digestion and transfection 
in cultured cells before sending it out for virus prep by Dr. Mei Li at School of 
Optometry, UC Berkeley. Dr. Li usually requires sequencing and digestion data before 
accepting the plasmids. Contact her early (maybe when the miniprep DNA is obtained) to 
inquire about her schedule and order the reagents she might need. 
SmaI-digested products were analyzed by DNA gel electrophoresis. Briefly, 1 µg 
DNA was digested with 0.5 µL enzyme in cut-smart buffer in a total volume of 20 µL. 
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The reaction was done at 25 °C for 30 min and all the reaction mixture was loaded to an 
agarose gel for analysis. The following sequences were used (5' to 3'): 
 
IgK  
ATGGAGACAGACACACTCCTGCTATGGGTACTGCTGCTCTGGGTTCCAGGTTC
CACTGGTGAC  
 
HaloTag  
GCAGAAATCGGTACTGGCTTTCCATTCGACCCCCATTATGTGGAAGTCCTGGG
CGAGCGCATGCACTACGTCGATGTTGGTCCGCGCGATGGCACCCCTGTGCTG
TTCCTGCACGGTAACCCGACCTCCTCCTACGTGTGGCGCAACATCATCCCGCA
TGTTGCACCGACCCATCGCTGCATTGCTCCAGACCTGATCGGTATGGGCAAAT
CCGACAAACCAGACCTGGGTTATTTCTTCGACGACCACGTCCGCTTCATGGAT
GCCTTCATCGAAGCCCTGGGTCTGGAAGAGGTCGTCCTGGTCATTCACGACTG
GGGCTCCGCTCTGGGTTTCCACTGGGCCAAGCGCAATCCAGAGCGCGTCAAA
GGTATTGCATTTATGGAGTTCATCCGCCCTATCCCGACCTGGGACGAATGGCC
AGAATTTGCCCGCGAGACCTTCCAGGCCTTCCGCACCACCGACGTCGGCCGC
AAGCTGATCATCGATCAGAACGTTTTTATCGAGGGTACGCTGCCGATGGGTG
TCGTCCGCCCGCTGACTGAAGTCGAGATGGACCATTACCGCGAGCCGTTCCT
GAATCCTGTTGACCGCGAGCCACTGTGGCGCTTCCCAAACGAGCTGCCAATC
GCCGGTGAGCCAGCGAACATCGTCGCGCTGGTCGAAGAATACATGGACTGGC
TGCACCAGTCCCCTGTCCCGAAGCTGCTGTTCTGGGGCACCCCAGGCGTTCTG
ATCCCACCGGCCGAAGCCGCTCGCCTGGCCAAAAGCCTGCCTAACTGCAAGG
CTGTGGACATCGGCCCGGGTCTGAATCTGCTGCAAGAAGACAACCCGGACCT
GATCGGCAGCGAGATCGCGCGCTGGCTGTCGACGCTCGAGATTTCCGGC 
 
HA  
TATCCATATGATGTTCCAGATTATGCT 
 
DAF  
CCAAATAAAGGAAGTGGAACCACTTCAGGTACTACCCGTCTTCTATCTGGGC
ACACGTGTTTCACGTTGACAGGTTTGCTTGGGACGCTAGTAACCATGGGCTTG
CTGACTTAG  
 
pDisplay 
GCTGTGGGCCAGGACACGCAGGAGGTCATCGTGGTGCCACACTCCTTGCCCT
TTAAGGTGGTGGTGATCTCAGCCATCCTGGCCCTGGTGGTGCTCACCATCATC
TCCCTTATCATCCTCATCATGCTTTGGCAGAAGAAGCCACGT 
 
P2A 
GCTACTAACTTCAGCCTGCTGAAGCAGGCTGGAGACGTGGAGGAGAACCCTG
GACCT 
 
mTagBFP2 
ATGGTGTCTAAGGGCGAAGAGCTGATTAAGGAGAACATGCACATGAAGCTGT
ACATGGAGGGCACCGTGGACAACCATCACTTCAAGTGCACATCCGAGGGCGA
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AGGCAAGCCCTACGAGGGCACCCAGACCATGAGAATCAAGGTGGTCGAGGG
CGGCCCTCTCCCCTTCGCCTTCGACATCCTGGCTACTAGCTTCCTCTACGGCA
GCAAGACCTTCATCAACCACACCCAGGGCATCCCCGACTTCTTCAAGCAGTC
CTTCCCTGAGGGCTTCACATGGGAGAGAGTCACCACATACGAAGACGGGGGC
GTGCTGACCGCTACCCAGGACACCAGCCTCCAGGACGGCTGCCTCATCTACA
ACGTCAAGATCAGAGGGGTGAACTTCACATCCAACGGCCCTGTGATGCAGAA
GAAAACACTCGGCTGGGAGGCCTTCACCGAGACGCTGTACCCCGCTGACGGC
GGCCTGGAAGGCAGAAACGACATGGCCCTGAAGCTCGTGGGCGGGAGCCAT
CTGATCGCAAACGCCAAGACCACATATAGATCCAAGAAACCCGCTAAGAACC
TCAAGATGCCTGGCGTCTACTATGTGGACTACAGACTGGAAAGAATCAAGGA
GGCCAACAACGAGACCTACGTCGAGCAGCACGAGGTGGCAGTGGCCAGATA
CTGCGACCTCCCTAGCAAACTGGGGCACAAGCTTAATTAA 
 
EGFP  
AGCAAGGGCGAGGAGCTGTTCACCGGGGTGGTGCCCATCCTGGTCGAGCTGG
ACGGCGACGTAAACGGCCACAAGTTCAGCGTGTCCGGCGAGGGCGAGGGCG
ATGCCACCTACGGCAAGCTGACCCTGAAGTTCATCTGCACCACCGGCAAGCT
GCCCGTGCCCTGGCCCACCCTCGTGACCACCCTGACCTACGGCGTGCAGTGCT
TCAGCCGCTACCCCGACCACATGAAGCAGCACGACTTCTTCAAGTCCGCCAT
GCCCGAAGGCTACGTCCAGGAGCGCACCATCTTCTTCAAGGACGACGGCAAC
TACAAGACCCGCGCCGAGGTGAAGTTCGAGGGCGACACCCTGGTGAACCGC
ATCGAGCTGAAGGGCATCGACTTCAAGGAGGACGGCAACATCCTGGGGCAC
AAGCTGGAGTACAACTACAACAGCCACAACGTCTATATCATGGCCGACAAGC
AGAAGAACGGCATCAAGGTGAACTTCAAGATCCGCCACAACATCGAGGACG
GCAGCGTGCAGCTCGCCGACCACTACCAGCAGAACACCCCCATCGGCGACGG
CCCCGTGCTGCTGCCCGACAACCACTACCTGAGCACCCAGTCCGCCCTGAGC
AAAGACCCCAACGAGAAGCGCGATCACATGGTCCTGCTGGAGTTCGTGACCG
CCGCCGGGATCACTCTCGGCATGGACGAGCTGTACAAGTAA 
 
WPRE  
GCTTATCGATAATCAACCTCTGGATTACAAAATTTGTGAAAGATTGACTGGTA
TTCTTAACTATGTTGCTCCTTTTACGCTATGTGGATACGCTGCTTTAATGCCTT
TGTATCATGCTATTGCTTCCCGTATGGCTTTCATTTTCTCCTCCTTGTATAAAT
CCTGGTTGCTGTCTCTTTATGAGGAGTTGTGGCCCGTTGTCAGGCAACGTGGC
GTGGTGTGCACTGTGTTTGCTGACGCAACCCCCACTGGTTGGGGCATTGCCAC
CACCTGTCAGCTCCTTTCCGGGACTTTCGCTTTCCCCCTCCCTATTGCCACGGC
GGAACTCATCGCCGCCTGCCTTGCCCGCTGCTGGACAGGGGCTCGGCTGTTG
GGCACTGACAATTCCGTGGTGTTGTCGGGGAAATCATCGTCCTTTCCTTGGCT
GCTCGCCTGTGTTGCCACCTGGATTCTGCGCGGGACGTCCTTCTGCTACGTCC
CTTCGGCCCTCAATCCAGCGGACCTTCCTTCCCGCGGCCTGCTGCCGGCTCTG
CGGCCTCTTCCGCGTCTTCGCCTTCGCCCTCAGACGAGTCGGATCTCCCTTTG
GGCCGCCTCCCCGCATCGATACCG 
 
CAG promoter  
TCGAGGTGAGCCCCACGTTCTGCTTCACTCTCCCCATCTCCCCCCCCTCCCCA
CCCCCAATTTTGTATTTATTTATTTTTTAATTATTTTGTGCAGCGATGGGGGCG
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GGGGGGGGGGGGGGGCGCGCGCCAGGCGGGGCGGGGCGGGGCGAGGGGCG
GGGCGGGGCGAGGCGGAGAGGTGCGGCGGCAGCCAATCAGAGCGGCGCGCT
CCGAAAGTTTCCTTTTATGGCGAGGCGGCGGCGGCGGCGGCCCTATAAAAAG
CGAAGCGCGCGGCGGGCG 
 
Benchling links for constructs 
 
CAG-DIO-IgK-HaloTag-HA-pDisplay-P2A-mTagBFP2-WPRE 
https://benchling.com/s/seq-DB4ss4O7HHm7xurB8HwB 
 
CAG-DIO-IgK-HaloTag-HA-DAF-P2A-mTagBFP2-WPRE 
https://benchling.com/s/seq-9wY0aaiw2sW4FDrHaj71 
 
CAG-DIO-IgK-HaloTag-HA-DAF-P2A-EGFP-WPRE 
https://benchling.com/s/seq-0Yr7AvAXd4vYcX5m7b7K 
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Figures and Schemes 
 
Figure A3-1-1. Characterization of pAAV-hSyn-HaloTag-DAF in cultured neurons. 
 
 
 
Figure A3-1-1. Wide-field fluorescence microscopy of cultured hippocampal neurons (a) 
transduced with pAAV-hSyn-HaloTag-DAF or (b) non-transduced, stained with 
RhoVR1-PEG25-HaloTag (50 nM, 30 min). (a,c) RhoVR staining. (b,d) DIC image of 
HEK cells. Scale bar is 20 µm. 
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Figure A3-1-2. Characterization of pAAV-hSyn-HaloTag-DAF in mouse brain slice. 
 
 
Figure A3-1-2. Mouse brain slices expressing pAAV-hSyn-HaloTag-DAF and stained 
with (a) TMR-PEG13-HaloTag or (b-d) RhoVR1-PEG25-HaloTag (125 nM, 30 min, RT). 
One-photon confocal microscopy imaging of stained slices in (a) area of injection or (b) 
non-injected area. Scale bar is 10 µm.
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Figure A3-2-1. Double-floxed inverted (DIO) constructs used in this study. 
 
 
Figure A3-2-1. Double-floxed inverted (DIO) constructs used in this study. 
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Figure A3-2-2. Characterization of paavCAG-DIO-IgK-HaloTag-HA-pDisplay-P2A-
mTagBFP2 plasmid by SmaI digestion and gel electrophoresis. 
 
 
 
Figure A3-2-2. DNA gel images of SmaI-digested plasmid run at 100 V for (a) 20 min 
and (b) 50 min. The gels clearly showed the expected band sizes (2883bp, 2289bp, 
1629bp and 396bp). 
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Figure A3-2-2. Characterization of paavCAG-DIO-IgK-HaloTag-HA-pDisplay-P2A-
mTagBFP2 plasmid in HEK cells.  
 
 
Figure A3-2-2. One-photon confocal microscopy of HEK cells transfected with 
paavCAG-DIO-IgK-HaloTag-HA-pDisplay-P2A-mTagBFP2 and pCAG-Cre-H2B-EGFP 
plasmids and stained with RhoVR1-PEG25-HaloTag (50 nM, 30 min). (a) DIC image of 
HEK cells. (b) Nuclear EGFP fluorescence indicates Cre recombinase expression. (c) 
Cytosolic BFP fluorescence indicates HaloTag expression. (d) Membrane-associated 
RhoVR fluorescence. (e) Merge image of RhoVR and BFP. (f) Merge image of EGFP 
and BFP. Asterisks indicate cells that express Cre recombinase but have neither HaloTag 
expression nor RhoVR staining. Scale bar is 20 µm. 
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Figure A3-2-3. Characterization of paavCAG-DIO-IgK-HaloTag-HA-pDisplay-P2A-
mTagBFP2 plasmid in cultured neurons.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure A3-2-3. Wide-field fluorescence microscopy of cultured hippocampal neurons 
transfected with paavCAG-DIO-IgK-HaloTag-HA-pDisplay-P2A-mTagBFP2 and 
pCAG-Cre-H2B-EGFP plasmids and stained with RhoVR1-PEG25-HaloTag (50 nM, 30 
min). (a) DIC image of neurons. (b) Nuclear EGFP fluorescence indicates Cre 
recombinase expression. (c) Cytosolic BFP fluorescence indicates HaloTag expression. 
(d) Membrane-associated RhoVR fluorescence that is specific to BFP fluorescence or 
BFP expression. Scale bar is 20 µm. 
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Figure A3-2-4. Characterization of paavCAG-DIO-IgK-HaloTag-HA-pDisplay-P2A-
mTagBFP2 virus in HEK cells. 
 
 
 
Figure A3-2-4. One-photon confocal microscopy of HEK cells (a-d) transfected with 
pCAG-Cre-H2B-EGFP plasmid and transduced with paavCAG-DIO-IgK-HaloTag-HA-
pDisplay-P2A-mTagBFP2 virus or  (e-h) transduced with virus alone. Cells are stained 
with RhoVR1-PEG25-HaloTag (50 nM, 30 min) 4 days after viral transduction. (a,e) DIC 
image of HEK cells. (b,f) Nuclear EGFP fluorescence indicates Cre recombinase 
expression. (c,g) Cytosolic BFP fluorescence indicates HaloTag expression. (d,h) RhoVR 
fluorescence. Scale bar is 20 µm. 
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Figure A3-2-5. Characterization of paavCAG-DIO-IgK-HaloTag-HA-pDisplay-P2A-
mTagBFP2 virus in HEK cells. 
 
 
 
Figure A3-2-5. One-photon confocal microscopy of HEK cells transfected with pCAG-
Cre-H2B-EGFP plasmid and transduced with paavCAG-DIO-IgK-HaloTag-HA-
pDisplay-P2A-mTagBFP2 virus. Cells are stained with RhoVR1-PEG25-HaloTag (50 
nM, 30 min) 8 days after viral transduction. (a) DIC image of HEK cells. (b) Nuclear 
EGFP fluorescence indicates Cre recombinase expression. (c) Cytosolic BFP 
fluorescence indicates HaloTag expression. (d) Bright and membrane-associated RhoVR 
fluorescence. (e) Merge image of BFP and RhoVR. (f) Merge image of EGFP and BFP. 
Scale bar is 20 µm. 
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Figure A3-2-6. Characterization of paavCAG-DIO-IgK-HaloTag-HA-pDisplay-P2A-
mTagBFP2 virus in mouse brain slice.  
 
 
 
Figure A3-2-6. One-photon confocal microscopy of (a-c) P20 and (d-f) P26 EMX-Cre 
mouse brain slices infected with paavCAG-DIO-IgK-HaloTag-HA-pDisplay-P2A-
mTagBFP2 virus at P2 and stained with 500 nM RhoVR1-PEG25-HaloTag for 20 min at 
RT. (a,d) Bright field images of slices. (b,e) Cytosolic BFP fluorescence indicates 
HaloTag expression. (c,f) RhoVR staining. Scale bar is 20 µm. 
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Figure A3-2-7. Characterization of paavCAG-DIO-IgK-HaloTag-HA-DAF-P2A-
mTagBFP2 and paavCAG-DIO-IgK-HaloTag-HA-DAF-P2A-EGFP plasmids by SmaI 
digestion and gel electrophoresis.  
 
 
Figure A3-2-7. DNA gel images of SmaI-digested (a,b) paavCAG-DIO-IgK-HaloTag-
HA-DAF-P2A-mTagBFP2 and (c,d) paavCAG-DIO-IgK-HaloTag-HA-DAF-P2A-EGFP 
plasmids. Gels were run at 100 V for (a,c) 20 min and (b,d) 50 min and each sample was 
duplicated (i.e. the two sample lanes were exactly the same). The gels clearly showed the 
expected band sizes (2883bp, 2256bp/2253bp, 1629bp and 396bp). 
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Figure A3-2-8. Characterization of paavCAG-DIO-IgK-HaloTag-HA-DAF-P2A-
mTagBFP2 plasmid in HEK cells. 
 
 
 
Figure A3-2-8. One-photon confocal microscopy of HEK cells transfected with (a-d) 
pCAG-Cre-H2B-EGFP and paavCAG-DIO-IgK-HaloTag-HA-DAF-P2A-mTagBFP2 
plasmids, or (e-h) paavCAG-DIO-IgK-HaloTag-HA-DAF-P2A-mTagBFP2 plasmid 
alone. Cells are stained with TMR-PEG13-HaloTag (50 nM, 15min, RT). (a,e) DIC image 
of HEK cells. (b,f) Nuclear EGFP fluorescence indicates Cre recombinase expression. 
(c,g) Cytosolic BFP fluorescence indicates HaloTag expression. (d,h) RhoVR 
fluorescence. Scale bar is 20 µm. 
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Figure A3-2-9. Characterization of paavCAG-DIO-IgK-HaloTag-HA-DAF-P2A-EGFP 
plasmid in HEK cells. 
 
 
 
Figure A3-2-9. One-photon confocal microscopy of HEK cells transfected with (a-c) 
pCAG-Cre-H2B-mCherry and paavCAG-DIO-IgK-HaloTag-HA-DAF-P2A-EGFP 
plasmids, or  (d-f) pCAG-Cre-H2B-EGFP and paavCAG-DIO-IgK-HaloTag-HA-DAF-
P2A-EGFP plasmids, or (g-i) paavCAG-DIO-IgK-HaloTag-HA-DAF-P2A-EGFP 
plasmid alone. Cells are stained with TMR-PEG13-HaloTag (50 nM, 15min, RT). (a,d,g) 
DIC image of HEK cells. (b) Cytosolic EGFP fluorescence indicates paavCAG-DIO-
IgK-HaloTag-HA-DAF-P2A-EGFP expression. (e) Nuclear EGFP fluorescence indicates 
Cre recombinase expression. (h) No EGFP fluorescence was observed without the Cre 
plasmid. (c,f,i) RhoVR fluorescence. Scale bar is 20 µm. 
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Figure A3-2-10. Characterization of paavCAG-DIO-IgK-HaloTag-HA-DAF-P2A-
mTagBFP2 virus in HEK cells. 
 
 
 
Figure A3-2-10. One-photon confocal microscopy of HEK cells transfected with pCAG-
Cre-H2B-EGFP plasmid and transduced with paavCAG-DIO-IgK-HaloTag-HA-DAF-
P2A-mTagBFP2 virus. Cells are stained with TMR-PEG13-HaloTag (250 nM, 15min, 37 
°C) 2 days after viral transduction. (a) DIC image of HEK cells. (b) Nuclear EGFP 
fluorescence indicates Cre recombinase expression. (c) Cytosolic BFP fluorescence 
indicates HaloTag expression but mostly shows bleed-through from the strong nuclear 
EGFP signal. (d) Membrane-associated RhoVR fluorescence indicates dye staining while 
nuclear fluorescence shows bleed-through from the EGFP signal. (e) Merge image of 
BFP and RhoVR. (f) Merge image of EGFP and BFP. Scale bar is 20 µm.  
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Figure A3-2-11. Characterization of paavCAG-DIO-IgK-HaloTag-HA-DAF-P2A-
mTagBFP2 virus without Cre expression in HEK cells. 
 
 
 
Figure A3-2-11. One-photon confocal microscopy of HEK cells transduced paavCAG-
DIO-IgK-HaloTag-HA-DAF-P2A-mTagBFP2 virus. Cells are stained with TMR-PEG13-
HaloTag (250 nM, 15min, 37 °C) 2 days after viral transduction. (a) DIC image of HEK 
cells. (b) No BFP fluorescence or HaloTag expression was observed. (c) No RhoVR 
fluorescence was observed. Scale bar is 50 µm. 
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Figure A3-2-12. Characterization of paavCAG-DIO-IgK-HaloTag-HA-DAF-P2A-EGFP 
virus in HEK cells. 
 
 
 
Figure A3-2-12. One-photon confocal microscopy of HEK cells transfected with pCAG-
Cre-H2B-EGFP plasmid and transduced with paavCAG-DIO-IgK-HaloTag-HA-DAF-
P2A-EGFP virus. Cells are stained with TMR-PEG13-HaloTag (250 nM, 15min, 37 °C) 2 
days after viral transduction. (a) DIC image of HEK cells. (b) Nuclear EGFP 
fluorescence indicates Cre recombinase expression. (c) Membrane-associated RhoVR 
fluorescence indicates dye staining while nuclear fluorescence shows bleed-through from 
the EGFP signal. Scale bar is 20 µm. 
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Figure A3-2-13. Characterization of paavCAG-DIO-IgK-HaloTag-HA-DAF-P2A-
mTagBFP2 and paavCAG-DIO-IgK-HaloTag-HA-DAF-P2A-EGFP viruses in cultured 
neurons.  
 
 
 
Figure A3-2-13. Wide-field fluorescence microscopy of cultured hippocampal neurons 
transfected pCAG-Cre-H2B-EGFP plasmid and transduced with (a-d) paavCAG-DIO-
IgK-HaloTag-HA-DAF-P2A-mTagBFP2 or (e-g) paavCAG-DIO-IgK-HaloTag-HA-
DAF-P2A-mTagBFP2 and stained with TMR-PEG13-HaloTag (250 nM, 15 min, 37 °C) 
14 days after viral transduction. (a,e) DIC image of neurons. (b,f) Nuclear EGFP 
fluorescence indicates Cre recombinase expression. (c) Cytosolic BFP fluorescence 
indicates HaloTag expression but signal is complicated with bleed-through from EGFP 
brightness. (d,g) Dim but membrane-associated RhoVR fluorescence. Scale bar is 20 µm. 	
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Appendix 4: 
In Utero Electroporation and Slice Preparation Protocols 
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Introduction 
 In utero electroporation is a commonly used technique to delivery genetic 
materials to animal. Briefly, plasmid DNA is injected to the ventricular space of 
embryonic rodent brains and enters surrounding cells via electroporation. Expression 
from IUE is transient and less efficient compared to virus-mediated genetic perturbation. 
Unlike viral transduction, IUE relies on plasmid, which is safer and easier to prepare. The 
procedure is relatively straightforward and can be done within an hour for a litter of 
embryos. Virus preparation takes about five weeks and is usually more expensive. As a 
result, we have chosen to use IUE to test and optimize plasmid expression and 
VoltageFluor dye labeling. This project is collaboration with Professor Hillel Adesnik’s 
lab (UC Berkeley), who will perform IUE and maintain the animals in general. 
 IUE is done on E15 mice and a fluorescent marker is injected for screening at P0 
or P1. Positive animals are kept while the others are sacrificed. Acute brain slices can be 
acquired from P12 to P35 animals. Animals younger than P12 have soft and fragile brain 
tissue that cannot withstand microtome cutting. Those older than P35 produce slices that 
are more challenging to survive ex vivo or conduct electrophysiology on. ACSF buffer 
with slightly different compositions may be required for older slices. Unused animals that 
are too old for slice preparation and experiments can be maintained for adult animal 
imaging. 
  
General Experimental Considerations 
 
Preparation of plasmid construct 
 The plasmid has to be prepared using an endotoxin-free maxiprep kit. The DNA 
can be eluted with sterile water or buffer TE. The concentration is preferably at least 1 
µg/µL since 1 µL of DNA is usually used per injection and the amount of DNA affects 
expression level. It is recommended to sequence and characterize the DNA in cultured 
cells before sending it out for IUE.   
 
Choice of co-injection plasmid 
 When the pups are born, it is possible to use a hand held laser or fluorescence 
macroscope to screen for expression at P0 or P1. Pups older than that are difficult to 
screen due to increased thickness of skull and skin auto-fluorescence. The construct 
containing IRES-FP (i.e. IRES-mCherry or IRES-BFP) does not express enough 
fluorescent protein for neonatal screening, which is often too dim to confirm or 
complicated with tissue auto-fluorescence. Injection with SpyCather-T2A-mCherry 
construct cannot be screened either, suggesting all the constructs have relatively low 
expression. As a result, for the HaloTag constructs used for IUE, the IRES-EGFP portion 
is removed completely as a smaller plasmid is expected to enter the cells more readily. 
However, it is necessary to include a FP as an expression marker, which helps to identify 
positive animals and slices. We have tried pCAG-mTagBFP2 and pCAG-EGFP with the 
HaloTag construct for co-injection. The ratio of HaloTag plasmid to FP plasmid is 
usually 5:1. We first attempted pCAG-EGFP and were able to screen for and keep 
positive pups. Unfortunately, there was significant bleed-through from the EGFP to the 
RhoVR channel during two-photon imaging. We then lowered the amount of EGFP 
plasmid used for co-injection (1:20) but the problem still persisted. Then we switched to 
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pCAG-mTagBFP2 but could not screen for positive pups due to its blue-shifted spectral 
profile and relatively low expression when the animals were young. However, during 
slice preparation at P12 or older, we were able to screen for BFP fluorescence after 
removing the skull or during slice cutting. There was no cross-talk between BFP and 
RhoVR in one-photon or two-photon imaging.  
 
Buffer recipe and preparation 
 There are two different solutions used in slice preparation and imaging. The 
artificial cerebrospinal fluid with sucrose or ACSF-sucrose solution is used for cutting 
and storing the slices while ACSF recording solution is used for activity imaging. ACSF-
sucrose solution has a lower sodium concentration to maintain slice health and increase 
chances of survival during cutting. Usually, 2L of 1x working solution is prepared and 
the compositions are as follows: 
 
For 2 liters of 
ACSF-sucrose Grams 
Concentration 
(mM) MW 
NaCl 9.70 83 58.44 
KCl 0.37 2.5 74.55 
MgSO4. 7H2O 1.63 3.3 246.47 
Na2HPO4. 2H2O 0.36 1 177.99 
NaHCO3 4.37 26 84.01 
Glucose 7.93 22 180.16 
Sucrose 49.28 72 342.3 
CaCl2 0.4 mL of 2.5 mM 0.5  
 
  
For 2 liters of 
ACSF-recording Grams 
Concentration 
(mM) MW 
NaCl 13.91 119 58.44 
KCl 0.37 2.5 74.55 
MgSO4. 7H2O 0.64 1.3 246.47 
Na2HPO4. 2H2O 0.37 1.3 177.99 
NaHCO3 4.37 26 84.01 
Glucose 7.21 22 180.16 
CaCl2 2 mL of 2.5 mM 2.5  
 
2.5 mM CaCl2 stock solution is prepared in Milli-Q water. Other chemicals are weighed 
and transferred to a 2 L volumetric flask and Milli-Q is used. When all the solids are 
dissolved, transfer the solution to a 2 L glass bottle before CaCl2 is added. For ACSF-
sucrose solution, add CaCl2 directly, mix well and the solution is ready to use. For ACSF 
recording solution, the solution will become cloudy with white precipitates immediately 
after CaCl2 addition. Thus, the solution needed to be bubbled with carbogen (95% O2 and 
5% CO2) for about 10 – 15 minutes or until the solution clears up. Osmolarity of the 
solutions should be around 300 – 320 mOsm/L. Solutions are stored at 4 °C. 
 
Acute brain slice preparation 
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1. About 1 hour before slicing, take out ACSF-sucrose and ACSF-recording solutions 
from the cold room. The ACSF-sucrose solution for slice storage needs to be warmed to 
31 °C while ACSF-recording solution should go to room temperature.  
 
2. Pour some ACSF-sucrose solution to the incubation chamber with the 6-well insert 
(Figure A4-1), connect the chamber to tubing for carbogen perfusion and place the 
chamber in a water bath set at 31 °C.  
 
3. Fill the glassware (one beaker and one crystallization dish) with about 60 mL ACSF-
sucrose each (Figure A4-2), leave it on ice and start carbogen perfusion.  
 
4. Tools for slicing include a pair ring-tip forceps, big spatula, small spatula, a pair of 
angled scissors, scalpel and a pair of big scissors (from left to right, Figure A4-3). All the 
tools except the big scissors are placed in the beaker (left, Figure A4-2) with perfused 
ice-cold ACSF-sucrose until usage. A 3mL plastic Pasteur pipette cut at the 1 mL mark 
will also be used for slice transfer. 
 
5. The slicing chamber (top, Figure A4-3) should be cooled on ice and a piece of 
kimwipe can be placed inside the chamber to absorb condensation.  
 
6. Install the blade and prepare a piece of absorbent unerpad, two pieces of filter paper , 
glue, a hand-held laser and goggles.  
 
7. Allow the ACSF-sucrose in the incubation chamber to reach 31 °C, which takes 
roughly 45 minutes. Meanwhile, the cutting tools should be chilled as well.  
 
8. Put a piece of paper towel in the anesthesia chamber (Figure A4-4), pour 1 – 2 mL of 
isoflurane and quickly put a mouse inside. Watch until the animal’s breathing is about 
once per second and immediately take it out to decapitate using the big scissors.  
 
9. Gently expose the brain by pushing the skin towards the rostral end and pipette ~1 mL 
ice-cold ACSF-sucrose to the brain. Use the angled scissors to remove the scalp if 
necessary.  
 
10. Check the FP expression using the hand-held laser and note the hemisphere and rough 
region with expression. If the expression is weak, try another animal; it’s not worth the 
effort to go through the whole slicing procedure since there are always extra animals.  
 
11. Use the angled scissors to make a cut (perpendicular to the midline) at the rostral 
(behind the eye balls) and caudal (behind the cerebellum) side of the skull.  From the 
opening on the caudal side, cut along the midline until the opening on the rostral side 
such that the skull is in two separate pieces. Carefully avoid stabbing into the brain tissue 
by pointing the tip upward and slightly toward the non-expressing hemisphere during 
cutting. Cutting in one fluid motion without withdrawing the scissors multiple times will 
help avoid stabbing of the brain. 
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12. Use the ring-tip forceps to peel off the skull gently to expose the brain tissue. Make 
sure that the skull does not scratch or damage the brain tissue. Pipette ~1 mL ice-cold 
ACSF-sucrose to the brain tissue. 
 
13. Use the scalpel to make two cuts: one rostral to the expressing area and the other in 
the cerebellum to create a large base where it will be readily glued to the slicing chamber 
(Figure A4-5). Make sure that the cuts are perpendicular to the midline.  
 
14. Use the small spatula to scoop out the brain from the caudal side and gently place it in 
the ice-cold ACSF-sucrose in the crystallization dish (right, Figure A4-2).  
 
15. Take the slicing chamber off the ice, wipe away any condensation and put in a new 
piece of kimwipe. The chamber needs to be dry for the glue to stick well.  
 
16. Use the big spatula (use the small spatula to assist if necessary) to take out the brain 
from ACSF-sucrose and let it ‘stand’ on the filter paper on the caudal side where a base is 
created from scalpel cut. Leave it there for a few seconds and move the brain to another 
dry area on the filter paper.  It is necessary to absorb as much solution as possible; 
otherwise, the brain would not stick well on the glue.  
 
17. Meanwhile, apply some glue in the center of the slicing chamber and immediately 
(before the glue dries) transfer the brain to glued area using the spatula and allow the base 
to stick to the glue. Briefly, I will use the big spatula to scoop up the brain with base  (the 
caudal side) facing the tip and bring it close to the glued area. Then, use the small spatula 
to gently push down the brain while tilting the big spatula to let the brain slide down such 
that the base will fall to the glued area nicely. Try to make the brain perpendicular to the 
chamber as much as possible. In this manner, we are collecting coronal slices.  
 
18. Gently press down on the caudal side using the small spatula to make sure the brain 
sticks well. Mount the slicing chamber to the microtome and gently pour the ice-cold 
ACSF-sucrose into the slicing chamber to immerse the brain completely.  
 
19. Lower the blade such that it is parallel to the slicing chamber and in the cutting 
solution completely. Adjust the cutting frequency to 7 and cutting speed to in between 3 – 
4 and start slicing. Cutting should be done within 15 minutes, which should be enough 
time to get at least 6 slices. I usually acquire 300 µm thick slices. Each time the blade 
moves forward and cuts through the brain, remember to raise the blade by 100 µm (one 
full turn on the dial knob) before backing the blade. Transfer the slice from slicing 
chamber to one of the wells in the incubation chamber. Then lower the blade by 400 µm 
such that the next slice is 300 µm thick. This is to ensure that the blade doesn’t damage 
the tissue when going back.  
 
20. During slicing, the brain and cutting solution needs to remain ice-cold and 
oxygenated for optimal slice health. Thus, for every 30 second or so, remove 1-2 mL of 
solution from the slicing chamber and replace with fresh solution from the crystallization 
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dish. Another purpose is to remove any debris and reduce the local heat generated from 
cutting.  
 
21. Check the fluorescence constantly and only collect the slices with good expression. 
 
22. About 30 minutes after the first slice is placed in the incubation chamber (i.e. 
recovery period), turn off the water bath heat and allow the slices to recover for another 
30 minutes at room temperature before using. The slices should be healthy in the 
chamber with carbogen perfusion for 4 – 6 hours at room temperature. 
 
23. Check the carbogen flow regularly to make sure it is bubbling.  
 
Slice health evaluation 
 It is not possible to know if a slice is healthy or not by visual inspection. In 
general, be gentle when handling the tissue. For instance, during slice transfer using the 
plastic Pasteur pipette, be careful not to suction in or push out the slice too fast or too 
violently. Quality of the slice could be checked under a microscope with IR illumination. 
Cells closer to the surface are less healthier with lots of debris from the blade cutting. It 
seems that cells at a depth of 20 – 50 µm beneath the surface are healthy and easier to 
access for patching purpose. Morphologically, unhealthy neurons have a shriveled or 
irregular shape and there is no good contrast with the surrounding tissue. Alternatively, 
functional imaging such as patch-clamp electrophysiology is the confirmative assessment 
of slice health.  
 
Slice dye loading 
 Dye loading is done in a 35 mm imaging dish. 2 mL of ACSF-sucrose is 
transferred to the dish first and bubbled with carbogen through a 27-gauge needle (Figure 
A4-6). Carbogen flow should be adjusted to the slowest possible (e.g. 1-2 bubbles per 
second and slice should remain steady in the solution) as too much bubbling causing 
excessive disturbance can compromise slice health. The dye of 3x concentration is then 
added to the dish and swirled to mix well. With the setup ready, check the fluorescence 
again with a hand-held laser and transfer the slice in 1 mL of ACSF-sucrose gently to the 
dish. Note that 3 mL total volume is used, so 3x dye is added to 2 mL of buffer initially. 
After incubation is done, the slice is transferred either to a new dish with fresh buffer for 
confocal imaging or to the perfusion chamber on patching rig in a plastic Pasteur pipette. 
No washing is required since a low concentration of dye is used.  
 
Imaging 
 To visualize staining, Trinity at Molecular Imaging Center is used for confocal 
microscopy imaging. A harp or staple is used to press down the slice for even 
illumination. Perfusion setup and activity imaging on Trinity are not optimized yet, but 
the slice does not have to stay alive for taking snaps and without perfusion the signal of 
stained dye remains robust at least 1 h after dye loading. For activity imaging or patch-
clamp electrophysiology, there is a rig set up for slice electrophysiology with 
fluorescence imaging in the Adesnik lab. The perfusion and electrophysiology are both in 
place, so no additional preparation is required.  
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Troubleshooting 
Hydrocephalus 
 Sometimes, after cutting into the brain of a physically healthy mouse, a big hole 
in the injected hemisphere is seen. This is due to build-up of fluid in the ventricle or 
hydrocephalus, which happens with excess volume of DNA injected during IUE. There 
might still be expression but it is recommended to use a new animal since physiologically 
the brain slice is already compromised.  
 
Animal issue 
 The IUE could fail because of the following problems with the animals: female 
not pregnant, pups aborted or female eats the pups (for nutrients). These do not occur 
very frequent but are definitely not rare. It is therefore important to plan the experiments 
and order back-up animals in advance.  
 
No expression 
The success rate or number of positive animals in a litter of injected animals 
depends highly on the proficiency of the person doing the IUE procedure. Quality of the 
DNA matters too, so try switching to a new maxiprep DNA if IUE keeps failing.   
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Figures & Schemes 
 
Figure A4-1. Incubation chamber.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure A4-1. Incubation chamber with 6-well insert. ACSF-sucrose with carbogen 
perfusion is used to store the slices. It should be warmed up to 31 °C in a water bath 
before slicing starts. Put one slice per well.  
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Figure A4-2. Glassware for storing ACSF-sucrose and tools. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure A4-2. Both should have about 60 mL ACSF-sucrose solution and be kept on ice 
with carbogen perfusion. Tools are left in the beaker on the left while the extracted brain 
is placed in the crystallization dish on the right.  
257	
Figure A4-3. Tools used in slicing. 
 
 
 
Figure A4-3. Tools used in slicing. Top: slicing chamber, glue. Bottom (from left to 
right): ring-tip forceps to peel off the skull, small spatula to transfer the brain, big spatula 
to transfer the brain, angled scissors to cut the scalp and skull, scalpel to cut the brain to 
create the base for glue, big scissors for animal decapitation.  
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Figure A4-4. Anesthesia chamber. 
 
 
 
Figure A4-4. Use the chamber that says ‘iso only’. There are other chambers for survival 
procedures for pups.  
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Figure A4-5. Scheme of mouse brain for scalpel cuts. 
 
 
 
Figure A4-5. Scheme of where I use the scalpel to make cuts after exposing the brain 
(red dotted lines). Green area indicates FP expression 
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Figure A4-6. Dye loading setup. 
 
 
 
Figure A4-6. Needles and dish used for dye loading.  
 	
